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         year (Māori and New Zealand European 2007–2015) using MAT and BDM denominator   
         data 141
Figure 5.3:   Stillbirth rolling three-year rates (per 1000 births) by ethnicity and year (Māori and    
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The Health Quality & Safety Commission (the Commission) welcomes the 11th 
report of the Perinatal and Maternal Mortality Review Committee (the PMMRC). 
This report considers perinatal and maternal mortality and morbidity from 1 January to 31 December 2015; 
perinatal mortality from 2007 to 2015; maternal mortality from 2006 to 2015; and babies with neonatal 
encephalopathy from 2010 to 2015. 
In this report the PMMRC have also introduced data and discussion related to Māori. We need to focus our 
lens on outcomes for Māori mothers and infants, as the inequity between Māori and non-Māori continues. 
The outlying causes of stillbirth and neonatal death among babies of Māori mothers are spontaneous 
preterm birth, antepartum haemorrhage, maternal conditions (mostly diabetes-related), and hypertension. 
There is a significantly higher, almost double, maternal mortality ratio among Māori mothers than New 
Zealand European mothers. Tragically, Māori women are over-represented among maternal suicides. The 
main contributory factors amongst these deaths continue to be barriers to access and/or engagement with 
care, which the PMMRC will be working with the sector to improve. 
Also new to the PMMRC report is the work of the Maternal Morbidity Working Group (MMWG). In May 
2016 we welcomed this working group dedicated to reducing maternal morbidity to the PMMRC. The 
MMWG transitioned to the Commission from the existing Severe Acute Maternal Morbidity (SAMM) 
research group based at the University of Otago. Supported and funded by the Ministry of Health, the 
group will be active through to June 2019. The MMWG is responsible for nationally reviewing incidences 
of women who are pregnant or have recently delivered who are also very ill, and developing quality 
improvement initiatives alongside the maternal health services. This group is supporting the work of the 
PMMRC to improve the quality and experience of maternity care for women, babies and whānau, informed 
by robust, consistent, reportable and women-centred maternal morbidity review. 
The perinatal related mortality rate in 2015 is the lowest reported since the PMMRC began collecting data 
in 2007 and is significantly lower than the rate for the years 2007–2014 combined.
We are pleased to report a statistically significant reduction in fetal deaths (stillbirths and late terminations of 
pregnancy combined) from 2007 to 2015, and an ongoing statistically significant reduction in stillbirths. 
The neonatal death rate has not changed significantly in New Zealand from 2007 to 2015, and note that 
the PMMRC have indicated that this will be a key are of investigation for 2017–2018. There have been 
significant reductions in neonatal mortality in the United Kingdom (UK), Australia and Scandinavia, and we 
will look to learn from those experiences.
This report would not be possible without the substantial contribution of a dedicated team of people: the 
local coordinators across the country who provide these data; Dr Sue Belgrave and the PMMRC; the 
National Coordination Service based at the University of Auckland; the New Zealand Mortality Review 
Data Group based at University of Otago; and the mortality review committee staff at the Commission.
On behalf of the Commission, I sincerely thank Dr Belgrave for leading this committee’s important work.
Foreword
Professor Alan Merry ONZM FRSNZ
Chair, Health Quality & Safety Commission
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We acknowledge the grief of families and whānau who have lost babies and mothers in 2015. Their 
information is presented in this report. The goal of the PMMRC is not only to accurately report mortality 
and morbidity but also to work with the wider maternity community to reduce deaths and enhance 
maternity care in New Zealand. We report on perinatal deaths from 2007 to 2015, maternal deaths from 
2006–2015, and babies with neonatal encephalopathy from 2010 to 2015.
The perinatal related mortality rate in 2015 (9.7/1000 births) is the lowest reported since the PMMRC 
began collecting data in 2007. However, the trend in overall perinatal related mortality is not statistically 
significant. A statistically significant reduction in stillbirths continues to be evident, and a statistically 
significant reduction in fetal death (stillbirths and late terminations of pregnancy combined) is reported for 
the first time.
New initiatives in the 2017 report are the development of a Māori chapter, a change in dataset to enable 
multivariable analysis, and an initial report of the Maternal Morbidity Working Group (MMWG).
This year we include a chapter on Māori perinatal and maternal mortality in collaboration with the 
Mortality Review Committees’ Māori Caucus. The main areas of concern for  
Māori are the maternal suicide rate, especially of young Māori women, and the loss of babies to very 
preterm labour. 
The PMMRC has recommended in previous reports that the New Zealand National Maternity Collection 
(MAT) dataset be available in order to report independent associations of perinatal death. The change of 
denominator from the Births, Deaths and Marriages (BDM) birth registration dataset to the MAT dataset 
has allowed us to use more clinical information but unfortunately not to perform multivariable analysis of 
perinatal related deaths as planned. This analysis was unable to adjust adequately for differences in the 
populations of women living in different DHBs across the country with regard to smoking, BMI, and parity 
due to missing registration data among women under DHB primary maternity services at some DHBs. 
The missing data from some DHBs in the MAT dataset is selectively from the women who are most likely 
to suffer a perinatal loss. Without this information, we are unable to make valid comparisons of care and 
outcomes between DHBs.
In 2015 we report an unusually high number of deaths at 41 weeks. A further review of these deaths 
has highlighted the importance of risk assessment leading up to term and appropriate induction of labour 
for recognised indications. This is a topic for discussion at our annual conference and has led to a 
recommendation for an interdisciplinary consensus guideline on induction of labour. 
The neonatal mortality rate is unchanged over the time we have been reporting. However, there has been 
a reduction in other countries. This will be a focus in our next report.
The establishment of the MMWG is an important initiative with the aim of reducing the incidence 
and severity of acute severe maternal morbidity. The initial areas of focus are maternal sepsis and 
unplanned peripartum hysterectomy. The in-depth reviews with inclusion of women’s stories will guide 
recommendations for improvement in care.
There has been no significant change in the maternal death rate since the PMMRC began reporting in 
2006. Our challenges are our rates of suicide and deaths from amniotic fluid embolism. Work with the 
Chair’s Introduction 
This is the 11th annual report of the Perinatal and Maternal Mortality Review 
Committee (the PMMRC) and my fourth as Chair.  
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Ministry of Health is continuing on the Perinatal and Infant Mental Health Network, and the PMMRC 
supports the wider national review on suicide. Amniotic fluid embolism will be discussed further at our 
conference this year, and we include the practice point from the 10th report to highlight the importance of 
early recognition and management.
Although there appears to be a downward trend in rates of neonatal encephalopathy (NE) from 
2010–2015, it is not statistically significant. NE is associated with maternal ethnicity, socioeconomic 
deprivation, gestation, birthweight and nulliparity. The framework for assessment of potential avoidability 
in reviews of NE has highlighted areas for improvement in care and has informed and assisted the 
establishment of the Neonatal Encephalopathy Taskforce, which has the long-term aim of reducing the 
burden of NE on New Zealand families.
We also recognise the challenges of the clinicians working with women and their families and whānau.
Dr Sue Belgrave
Chair, Perinatal and Maternal Mortality Review Committee
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This foreword is designed for parents, families and whānau of the babies who died during the 2015 year. 
Let me introduce myself. My name is Linda and my eldest daughter died shortly after birth. Her name was 
Georgia, and she fell into the ‘unexplained death’ category at the time (1999). I sit on the PMMRC and my 
job with this group is to represent you and me: bereaved parents. So, chances are, you and I understand 
child loss in a way that not all clinicians do. This is not a position any of us wanted to be in, or have any 
idea how to live with in the beginning. The shock and grief can seem to be a bottomless pit, and the 
unfairness of it all seems overwhelming. 
This report from the PMMRC is the 11th annual edition of the report. What is becoming clear to those of us 
who work with the PMMRC is that positive, measurable changes are occurring in the mortality rate for our 
families here in New Zealand. There will sadly, and unavoidably, be deaths for our babies (and sometimes 
their mothers), but the purpose of this review group, and this report each year, is to see where and when we 
can make changes to the way we do things to try to minimise those deaths.
The PMMRC investigates all processes involved in the delivery of a baby. Everything is considered, from 
the medical details about the baby and the mother, the staff involved, the processes, the equipment and 
resources, the size of hospital where the mother lived, the transportation to a bigger hospital (if required) 
and even the weather, if this played a part. This is done through a review of your baby’s case within your 
own district health board (DHB) shortly after your baby died. The DHB review is to determine the cause of 
your baby’s death and to ensure the correct care was provided to you and your child. Each individual death 
is added to the national information so that trends can be identified.
As well as scrutinising the medical issues in each death, we also look at the processes from when a mother 
registers with antenatal care, the processes during the delivery of your baby, the personnel involved at each 
level, how information about risk is communicated to you the families, and how systems can be improved 
in all of those stages. There is a huge amount of information collected about each mother and baby, from 
before pregnancy, during pregnancy and in the weeks after birth. All of this complex information takes time 
to sort through, and it takes even more time to accumulate enough information over a few years to start to 
see trends. 
In a nutshell, we can begin to see what possibly went wrong in some deaths, and therefore make changes 
to prevent future losses. In 2015 there were fewer deaths of babies up to 28 days of age than any other 
year since reporting began in 2007. 
I realise that if you are reading this, then things have probably not gone well for you. Let me explain why 
your baby’s short life and your whole experience make a difference. 
Without all the details of your pregnancy, we cannot learn how to try to avoid this happening again, either 
to you or to other families with circumstances similar to yours. Sometimes, it is only in hindsight that we can 
try to understand the complications that led to a loss. This is why your story, and the stories of other families, 
are so important to ongoing understanding of perinatal loss. 
Post-mortem examinations are valuable to help find why a baby has died. In my own case, I was hugely 
relieved to find that there was nothing I could have done to stop Georgia’s death, and that I did not 
accidentally do something to make her sick. My partner and I were also desperate to know if any future 
baby of ours was going to die. Whilst there was no guarantee, we got some relief when we learned that 
there were no congenital (inherited) problems and that we could go ahead and have more babies. So, 
along with a post-mortem providing information to add to that obtained from other babies’ deaths to help 
the PMMRC with review, it was for us as parents the only source of courage we had to try and have a 
Parents, Families, Whānau
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healthy baby (incidentally, we went on to have live twins five years later).
On behalf of the PMMRC, I want to say how desperately sorry we are that you are in this position. From my 
own point of view, I get it. Your loss is a massive life-changing event, and it can seem overwhelming. Sands 
is an international organisation here in New Zealand designed to support you and your family. Go to www.
sands.org.nz for information on physical support groups in your area, virtual support groups online, and a 
host of articles and reading materials that you may find helpful. I can tell you that whilst your pain will not 
lessen, it does get easier to carry around over time.
This may have been a little life, but is not a little loss. Many thanks for reading this, and I hope it has 
helped you understand how the PMMRC and the maternity services in New Zealand are working to 




Executive Summary and Recommendations
Terms of Reference and Mortality Definitions PMMRC
Terms of Reference of the Perinatal and Maternal Mortality Review Committee
The Perinatal and Maternal Mortality Review Committee (PMMRC) is responsible for reviewing 
perinatal and maternal mortality and other mortality and morbidity as directed by the Health 
Quality & Safety Commission.
Mortality Definitions used by the PMMRC
Fetal death is the death of a fetus at 20 weeks gestation or beyond (≥20 weeks) or weighing 
at least 400g if gestation is unknown. Fetal death includes stillbirth and termination of 
pregnancy.
Termination of pregnancy includes any interrupted ongoing pregnancy from 20 weeks 
(whether the baby was stillborn or live born).
Neonatal death is the death of any baby showing signs of life at 20 weeks gestation or 
beyond or weighing at least 400g if gestation is unknown that occurs up until midnight of the 
27th day of life. Early neonatal death is a death that occurs up until midnight of the sixth day 
of life. Late neonatal death is a death that occurs between the seventh day and midnight of the 
27th day of life.
Perinatal mortality is fetal and early neonatal death from 20 weeks gestation (or weighing at 
least 400g if gestation is unknown) until midnight of the sixth day of life.
Perinatal related mortality is fetal deaths (including terminations of pregnancy and stillbirths) 
and neonatal deaths (up to midnight of the 27th day of life) per 1000 total babies born at 20 
weeks or beyond, or weighing at least 400g if gestation was unknown.
A maternal death is the death of a woman while pregnant or within 42 days of termination 
of pregnancy (miscarriage, termination or birth), irrespective of the duration and site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its management. It 
does not include accidental or incidental causes of death of a pregnant woman.
Maternities are all live births and all fetal deaths at 20 weeks or beyond or weighing at 
least 400g if gestation is unknown. The maternal mortality ratio is calculated per 100,000 
maternities.
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Findings 2017 Report (Data 2015)
Significant changes to the report 2017
1. The 11th report introduces chapters on Ma- ori perinatal and maternal mortality and the Maternal 
Morbidity Working Group (MMWG).
2. The New Zealand National Maternity Collection (MAT) dataset has been substituted for the Births, 
Deaths and Marriages (BDM) birth registration dataset as the denominator for analyses because it 
is the most complete record of births in a year and it contains more maternity clinical data. 
Demography
3. From 2007 to 2015, there was a reduction in mothers under 20 years old, fewer mothers 
smoking, and fewer births at 40 and 41+ weeks among all births in New Zealand.
4. The change to using the MAT denominator in place of birth registrations has made a difference to 
the associations seen between ethnicity and perinatal related mortality. It is not known whether the 
ethnicity variable derived in the MAT dataset is the best approximation of self-defined ethnicity.
Perinatal related mortality
5. The perinatal related mortality rate in 2015, at 9.7/1000 births, is the lowest reported since the 
PMMRC began collecting data in 2007, but the test for trend is not statistically significant over 
this time. The rate in 2015 is, however, significantly lower than the rate for the years 2007–2014 
combined (p=0.025), and the overall perinatal related mortality rate at 10.0 and 9.7/1000 in 
two of the past three years was lower than in any single year from 2007 to 2012.
Using NZ definition Using UK definition*
n Rate n Rate
Total births  59,808  59,551 
Fetal deaths (terminations of pregnancy and stillbirths)#  412  6.89  -  - 
Terminations of pregnancy  107  1.79  -  - 
Stillbirths  305  5.10  212  3.56 
Early neonatal deaths <7 days  131  2.21  76  1.28 
Late neonatal deaths 7–27 days  35  0.59  34  0.57 
Neonatal deaths <28 days+  166  2.79  110  1.85 
Perinatal mortalities^  543  9.08  288  4.84 
Perinatal related mortalities•  578  9.66  322  5.41 
Perinatal mortalities excluding lethal and terminated fetal abnormalities~  402  6.72  249  4.18 
Perinatal related mortalities excluding lethal and terminated fetal abnormalities~  420  7.02  266  4.47 
Summary of New Zealand perinatal mortality rates 2015 (Table 3.1)
*Rates calculated using UK definition for perinatal mortality: births from 24 weeks excluding terminations of pregnancy (CMACE 2011).
# Fetal death rate per 1000 babies born (includes terminations and stillbirths).
+ Neonatal death rate per 1000 live born babies.
^ Fetal deaths and early neonatal deaths per 1000 babies born.
• Fetal deaths and early and late neonatal deaths per 1000 babies born.
~ Lethal and terminated fetal abnormalities are all perinatal related deaths with Perinatal Society of Australia and New Zealand perinatal death classification 
(PSANZ-PDC) of congenital abnormality and neonatal deaths with Perinatal Society of Australia and New Zealand neonatal death classification (PSANZ-NDC) of 
congenital abnormality.
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Perinatal related mortality rolling three-year rates (per 1000 births) using New Zealand definitions 2007–
2015 (Figure 3.2)
6. There is an ongoing statistically significant reduction in stillbirths from 2007 to 2015 (chi-squared 
test for trend p=0.0099).
7. There is a statistically significant reduction in fetal deaths (stillbirths and late terminations of 
pregnancy combined) reported for the first time, from 2007 to 2015 (chi-squared test for trend 
p=0.035).
8. The late termination of pregnancy rate in 2015 was lower than any previously reported year 
(1.8/1000 births) and significantly lower than the years 2007–2014 combined (p=0.004), 
although the test for trend is not statistically significant.
9. There is a significant reduction in hypoxic peripartum deaths among total perinatal related deaths 
(births from 20 weeks) from 2007 to 2015 (chi-squared test for trend p=0.00031) and a trend to 
reduced deaths from fetal growth restriction (chi-squared test for trend p=0.053).
10. There is a significant reduction in stillbirths (p=0.00023), fetal deaths (p=0.0006) and overall 
perinatal related mortality rate (p=0.0011) using the international definition (≥1000g or 28 





















Perinatal related mortalities Stillbirths Neonatal deaths Terminations of pregnancy
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Perinatal related mortality rolling three-year rates (per 1000 births) using international definitions 2007–
2015 (Figure 3.3)
11. Statistically significant reductions in hypoxic peripartum death (p=0.0003), and death from 
antepartum haemorrhage (p=0.031) and fetal growth restriction (p=0.015) are in part 
responsible for the significant reduction in perinatal related mortality using the international 
definition (from 1000g or 28 weeks if birthweight is unknown).
12. The neonatal death rate has not changed significantly in New Zealand from 2007 to 2015. This 
will be investigated in detail in 2017–2018. Meanwhile there have been significant reductions in 
neonatal mortality in the UK (from 2004 to 2014), Australia, and Scandinavia.
13. Mothers in their first pregnancy have higher stillbirth and neonatal death rates compared to 
women who are having their second birth, and mothers in their fourth or later pregnancies have 
higher rates of stillbirth compared to women who are having their second birth.
14. Multivariable analysis of perinatal related deaths from 2008 to 2015 showed that maternal 
ethnicity, age, deprivation decile, and multiple pregnancy were, variably, independent predictors 
of late termination of pregnancy, stillbirth and/or neonatal death. (It should be noted however 
that the numerator denominator bias arising from use of ethnicity derived from the PMMRC 
dataset in the numerator and MAT dataset in the denominator in this analysis may have led to 
inaccurate estimates of risk. This issue is outlined and discussed with regard to Māori mothers and 
babies in the Māori chapter. It is expected that this issue can be resolved by the inclusion of birth 
registration ethnicity data (BDM) in the MAT dataset in future years (as recommended again this 
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Ma- ori 0.90 0.83 0.97 0.53 0.44 0.64 0.93 0.83 1.03 1.18 1.02 1.36
Pacific 1.09 1.00 1.20 0.65 0.52 0.82 1.17 1.03 1.33 1.32 1.11 1.57
Indian 1.50 1.32 1.71 1.36 1.04 1.78 1.46 1.21 1.75 1.74 1.36 2.22
Other Asian 0.94 0.84 1.05 1.30 1.07 1.57 0.76 0.64 0.90 0.91 0.72 1.15
Other  0.69 0.62 0.77 0.76 0.62 0.93 0.69 0.59 0.81 0.62 0.49 0.78
New Zealand 
European
1.00 1.00 1.00 1.00
Age#
   <20 1.62 1.45 1.81 1.62 1.25 2.12 1.49 1.28 1.75 1.81 1.49 2.20
   20–24 1.11 1.01 1.21 1.18 0.97 1.43 1.11 0.98 1.25 1.05 0.89 1.23
   25–29 1.00 1.00 1.00 1.00
   30–34 0.97 0.89 1.05 1.03 0.87 1.23 1.00 0.89 1.12 0.85 0.73 1.00
   35–39 1.19 1.09 1.30 1.29 1.07 1.55 1.16 1.02 1.31 1.17 0.99 1.38
   ≥40 1.51 1.32 1.72 1.80 1.38 2.34 1.47 1.22 1.78 1.34 1.03 1.74
Deprivation decile# 
(per unit)
1.05 1.03 1.06 0.99 0.97 1.02 1.05 1.03 1.07 1.08 1.06 1.11
Year of birth# 0.99 0.98 1.01 1.00 0.97 1.03 0.99 0.97 1.00 1.00 0.98 1.03
Sex+
   Male 1.00 1.00 1.00 1.00
   Female 0.95 0.90 1.00 1.03 0.91 1.16 0.97 0.90 1.05 0.85 0.76 0.94
Multiple pregnancy* 4.28 3.91 4.69 2.07 1.60 2.67 4.01 3.52 4.56 6.73 5.80 7.81
* Data for numerator from the PMMRC dataset.
#  Data for numerator from the MAT dataset. 
+ Data for numerator from the MAT dataset, then the PMMRC dataset if MAT data are missing.
OR = odds ratio.
CI = confidence interval.
15. There is a significantly higher rate of perinatal related mortality than the national rate among 
residents of Counties Manukau DHB. There is a significantly higher stillbirth rate than the national 
rate among residents of Counties Manukau DHB. There is a significantly higher neonatal death 
rate than the national rate among residents of Counties Manukau and Waikato DHBs.
16. There continues to be a statistically significant reduction in perinatal related death at 37–38 
weeks (p=0.025) and at 41 weeks and above (p=0.047) and a significant reduction in stillbirths 
at 37–40 weeks (p=0.0018) from 2007 to 2015 using chi-squared test for trend. The rate of 
stillbirth at 41 weeks and beyond for 2015 is higher than in any year from 2007 to 2014.
a. Review of the 17 stillbirths in 2015 from 41 weeks without congenital abnormality, against 
the Auckland Consensus Guideline on Induction of Labour (Wise et al 2014) and against best 
practice for antenatal assessment in women with risk factors, found the care provided did not 
follow the guideline and/or best practice in 6 of the 17 stillbirths. This related to best practice 
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Gestation at birth (weeks)
2007–2009 2010–2012 2013–2015
to perform serial growth scans following antepartum haemorrhage; best practice for obstetric 
review and/or to perform serial growth scans for BMI >35 in three pregnancies; and to offer 
induction of labour for diabetes with suspected small for gestational age (SGA) pregnancies, 
and for hypertension.
17. In 2015, one-quarter of perinatal related deaths were determined at local review to have 
contributory factors, and just over half of these (14 percent) were determined to be potentially 
avoidable deaths.
Investigation of perinatal related mortality
18. In 2015, 52 percent of babies who died in the perinatal period were optimally investigated 
(Table 3.57). Of the remainder, 8 percent were not investigated and 40 percent were 
partially investigated. There is a statistically significant increase from 2007 to 2015 in optimal 
investigation among perinatal related deaths, an increase in partial investigation, and a decrease 
in no investigation. 
19. Perinatal death investigation continues to be significantly less frequent among babies of Māori 
and Pacific mothers than other ethnicities (20 percent had no investigation).
20. In 2015, data on the usefulness of post-mortem were available for 205 (83 percent) of deaths 
where post-mortem was performed, showing that in 118 deaths (48 percent) the post-mortem 
confirmed the clinical diagnosis, in 40 (16 percent) the post-mortem changed the diagnosis and 
resulted in altered counselling to parents for future pregnancies, in 27 (11 percent) additional 
information was gained but this did not change the clinical diagnosis, and in 20 (8 percent) of 
deaths, the post-mortem was non-contributory. 
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3-year rolling direct MMR 3-year rolling indirect MMR 3-year rolling MMR 1-year MMR
MMR = maternal mortality ratio
Rolling three-year maternal mortality ratio represented at final year of triennium.
Maternal mortality
21. In 2015, 11 deaths within the definition of maternal mortality were reported to the PMMRC. One 
coincidental death was reported in 2015. 
22. The maternal mortality ratio in New Zealand was 15.6/100,000 maternities (95% confidence 
interval (CI) 10.8–22.5/100,000) for the three years 2013–2015. There has been no statistically 
significant change in maternal mortality ratio in New Zealand since data collection by the 
PMMRC began in 2006 (chi-squared test for trend p=0.25).
23. In 2015, there were three direct deaths (one from amniotic fluid embolism and two from venous 
thromboembolism) and eight indirect deaths (five from suicide and three from pre-existing medical 
conditions).
24. Suicide continues to be the leading single cause of maternal death in New Zealand. 
25. The maternal mortality ratio in New Zealand continues to be significantly higher than that in the 
UK (8.54/100,000 maternities for the 2012–2014 triennium). Specifically, maternal death from 
amniotic fluid embolism is four times higher and maternal death from suicide seven times higher 
than in the UK.
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Cause-specific maternal mortality ratios in New Zealand 2006–2015 and the UK 2006–2014 (with 










































NZ 2006–2015 UK 2006–2014
AFE = amniotic fluid embolism.       
PPH = postpartum haemorrhage.       
VTE = venous thromboembolism.        
‘Other direct’ includes anaesthesia, cardiomyopathy, other.      
‘Pre-existing medical’ includes cardiac, indirect neurological, indirect malignancies.  
In New Zealand data, ‘Other indirect’ includes only non-obstetric sepsis.
26. From 2006 to 2015 the Maternal Mortality Review Working Group (MMRWG) found that post-
mortem resulted in a change in clinical diagnosis in 10 percent (n=11) of maternal deaths. One 
quarter of mothers who died did not have a post-mortem examination.
27. Women aged 40 and older, Māori and Pacific mothers, and mothers who have had three 
previous births at ≥20 weeks are at higher risk of maternal mortality.
28. More than half of the mothers who died in pregnancy or the peripartum period were overweight 
or obese, and 34 percent were known smokers.
29. Alcohol or substance use was noted in a quarter of mothers who died, and a history of family 
violence was noted in at least 9 percent.
30. Contributory factors were identified in 62 percent of maternal deaths in the years 2006–2015, 
and 39 percent were identified as potentially avoidable.
Māori perinatal and maternal mortality
31. There are considerable differences demonstrated in comparative perinatal related mortality 
rates between Māori and New Zealand European mothers when using different denominators 
(BDM versus MAT). It is hypothesised that the birth registration dataset provides the best source 
of ethnicity data (given this is provided by parents when they register their child’s birth) and 
eliminates numerator–denominator bias as these data are provided by BDM to the PMMRC for 
deaths. 
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Perinatal related mortality rolling three-year rates (per 1000 births) by ethnicity and year (Māori and New 

















Total perinatal death - Māori - MAT denominator Total perinatal death - NZ European - MAT denominator
Total perinatal death - Māori - BDM denominator Total perinatal death - NZ European - BDM denominator
32. After adjusting for measured maternal age, deprivation decile, baby sex, year of birth, and 
multiple pregnancy, odds of perinatal related mortality (2008–2015) were lower for Māori 
mothers compared to New Zealand European mothers (adjusted odds ratio (OR) 0.91 (95% CI 
0.84–0.99)). However, there is an excess of neonatal deaths of babies born under 28 weeks 
gestation to Māori mothers (adjusted OR 1.46 (95% CI 1.18–1.81)).
33. There is a significant reduction in neonatal mortality rate for New Zealand European babies born 
at 23–24 weeks compared to those born at 20–22 weeks, but no similar reduction in risk among 
Māori babies. 
34. Māori and New Zealand European mothers have similar risks of perinatal related mortality 
irrespective of age. However, there are more perinatal deaths among Māori mothers under 20 
years as there are more than twice as many young Māori mothers as New Zealand European.
35. There is a more prominent increase in death from spontaneous preterm birth with increasing 
deprivation quintile among Māori mothers than among New Zealand European mothers.
36. There is a statistically significantly higher maternal mortality ratio among Māori compared to 
New Zealand European mothers combining data from 2006–2015 (26.3 and 13.5 respectively); 
relative risk (RR) 1.94 (95% CI 1.24–3.06).
37. Māori women are over-represented among maternal suicides.
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Neonatal encephalopathy
38. In 2015, there were 70 babies diagnosed with moderate and severe neonatal encephalopathy 
(NE) reported to the national dataset. There have been 423 babies reported from 2010–2015. 
The rate of NE for this period is 1.24/1000 term births. Although there appears to be a 
downward trend in rates, there is no statistically significant trend from 2010 to 2015.
39. NE is associated with maternal ethnicity, socioeconomic deprivation, gestation, birthweight, and 
nulliparity.
40. Pacific mothers are at increased risk of having a baby with NE compared to Other Asian, Other, 
and New Zealand European mothers. Mothers of Māori and Indian ethnicity are at increased risk 
of having a baby with NE compared to mothers of Other Asian and Other ethnicities.
41. Increasing socioeconomic deprivation is associated with increased risk of NE.
42. Waikato, Taranaki, and Capital & Coast district health boards (DHBs) continue to have 
statistically higher unadjusted rates of NE compared to the national rate.
43. Acute peripartum events were reported in 101 cases (24 percent) of all 423 cases in 2010–
2015, of which abruption (31 cases) and shoulder dystocia (26 cases) were the most common.
44. There is no apparent association between level of facility of birth and NE.
45. In 2015, 80 percent of babies born in New Zealand with moderate or severe NE were managed 
with induced cooling. A review of 22 babies with severe NE who were not cooled revealed 20 
were appropriately not cooled. Review of 32 babies with moderate NE who were not cooled 
revealed nine babies where transfer to a tertiary unit and cooling was possible and may have 
been indicated.
46. In 2015, the proportion of those cooled who were cooled within six hours of birth as 
recommended for maximal benefit was 79 percent.
47. Eighty-one of the 423 babies with NE during 2010–2015 (19.4 percent) died in the perinatal 
period (<28 days). A further nine babies are known to have died after discharge from three 
months to five years of age.
48. Of survivors during 2010–2015, 28 percent had a moderately or severely abnormal MRI (21 
percent of moderate and 66 percent of severe cases) and 46 percent had a normal or only mildly 
abnormal scan (49 percent of moderate and 30 percent of severe cases). Twenty-five percent of 
survivors during 2010–2015 did not have a magnetic resonance imaging (MRI) scan (30 percent 
of moderate and 2 percent of severe cases).
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Recommendations
The Mortality Review Committees’ Māori Caucus reiterate, “As a matter of urgency, the Ministry of 
Health update the National Maternity Collection (MAT), including the ethnicity data as identified by the 
parents in the birth registration process.” (PMMRC recommendation ninth report 2015).
Justification: 
The analyses in the Māori perinatal and maternal mortality chapter provide clear evidence of the issues 
around fit for purpose ethnicity data collection. Use of data from the same source for numerator and 
denominator (birth registration (BDM)) is demonstrated in Figure 5.1 to Figure 5.5 in comparison to 
using a numerator ethnicity variable from birth registration (BDM) in the numerator and MAT in the 
denominator. 
The sharing of BDM ethnicity data with the MAT dataset would allow maternity analyses the power to 
explore and address ethnic inequities, using an ethnicity definition akin to the Census definition, within 
a health dataset (MAT) which includes a wealth of maternity data.
Evidence: 
BDM includes ethnicity data provided by parents within six weeks of the birth of their baby in their own 
time and space. This collection is theoretically akin to Census data. These data are currently provided to 
the PMMRC for perinatal deaths, but are not made available for the denominator (MAT) set for analysis. 
BDM currently provide data on a regular basis to match against the MAT dataset to ensure that the MAT 
dataset includes all births. 
The PMMRC recommend the Ministry of Health: 
a. urgently require DHBs to provide complete and accurate registration data to the MAT dataset (as 
required of LMCs providing services to pregnant women in order to receive funding for those 
services). Specifically this should include women who present for birthing at DHB facilities without 
previous antenatal LMC registration and women who are provided primary maternity care by 
DHB maternity services 
b. require that the MAT dataset include complete registration and antenatal data on live and stillborn 
babies from 20 weeks gestation (including terminations of pregnancy).
Justification: 
Parity, BMI and smoking data, which are collected at the registration visit, were more often missing 
from the MAT dataset among mothers whose babies died and among mothers receiving their primary 
maternity care from DHB services. Mothers receiving primary maternity care from DHB services are 
women who were unregistered for antenatal care prior to their birth admission and women who were 
unable to access LMC care in the community. 
Adjusted analyses including these variables could not be progressed because BMI, smoking, and 
parity data were not missing at random. This means that it was not possible to provide robust adjusted 
estimates of perinatal related mortality risk by DHB or to adjust for parity, BMI, or smoking in estimates 
for ethnicity, age, and socioeconomic status.
Therefore, it is not possible to reassure women in New Zealand that DHBs where the perinatal mortality, 
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termination of pregnancy, stillbirth and neonatal death rates are significantly higher (or lower) than 
the national average are providing care which is at the standard of the national average. (Similarly it 
cannot be assumed that other DHBs might not have higher rates than expected if analyses were able to 
adjust for known risk factors). It has been assumed that differences in mortality rates by DHB are due 
to differences in the populations served eg by ethnicity, BMI, socioeconomic status, age, smoking, and 
parity, but this cannot be confirmed without the provision of accurate data from these facilities to enable 
appropriate analyses. 
Adjusted estimates could be calculated among women under LMC care alone (self-employed midwifery, 
private obstetrician and general practitioner care). However excluding women receiving other models 
of care, because women receiving no or DHB care were systematically different from those with LMC 
care by their risk profile and ethnicity, had an important effect on adjusted estimates for significant 
variables such as ethnicity and DHB.
Multivariable analyses in this report adjust only for ethnicity, socioeconomic status, age, baby sex, 
multiple pregnancy, and year of birth.
Evidence: 
During the years 2008-2015, 97-98 percent of BMI, smoking and parity data were missing among the 
8 percent of women who were either unregistered with an LMC prior to birth or who registered with 
a DHB providing primary maternity services and not providing data to the MAT dataset. During this 
time period, more than 10 percent of data were missing from residents of five DHBs, one of which was 
missing 48 percent of these data. These 8 percent of women are significantly different from women 
receiving care from LMCs by ethnicity, socioeconomic status and age and so their absence from the 
multivariable analysis has a significant effect on the adjusted risk estimates.
In 2015, 16 percent of women residing in Counties Manukau, 13 percent residing in Nelson 
Marlborough, and 6 percent residing in Hawkes Bay DHB areas had not had these data included in the 
MAT dataset, even though only 4-5 percent of data were missing for New Zealand overall. Five percent 
or less of smoking, BMI and parity data were missing from any other DHB region.
The PMMRC investigate why there has been no reduction in neonatal mortality in New Zealand. 
Justification: 
Neonatal mortality has remained static in New Zealand since 2007. The multivariable analyses in 
this report provide evidence of inequities for Māori in neonatal mortality, specifically among neonatal 
deaths after birth from 20 to 28 weeks. 
Evidence: 
There have been significant reductions reported in neonatal mortality in the UK, Australia and 
Scandinavia (Manktelow et al 2016; Australian Institute of Health and Welfare 2016; Heino and 
Gissler 2016).
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The PMMRC supports the development of a national interdisciplinary clinical practice guideline on the 
indications and timing for induction of labour, to guide clinicians to offer induction when appropriate 
(that is, where evidence shows that benefit to mother and/or baby outweighs risk) and to avoid 
induction when not appropriate.
Justification: 
In 2015 there was an increase in perinatal related mortality risk from 41 weeks compared to the lower 
rates of recent years. The risk in 2015 (3.19 per 1000 ongoing pregnancies) was the same as the risk 
in 2008 (3.15) and higher than the rates in any year from 2009 to 2014. 
Review of the 17 stillbirths from 41 weeks without congenital abnormality in 2015, against the 
Auckland Consensus Guideline on Induction of Labour (Wise et al 2014), and against best practice for 
antenatal assessment in women with risk factors, found the care provided did not follow the guideline 
and/or best practice in 6 of the 17 stillbirths. This related to best practice to perform serial growth 
scans following antepartum haemorrhage; best practice for obstetric review and/or to perform serial 
growth scans for BMI >35; and to offer induction of labour for increased risk.
Evidence: 
A clinical practice guideline on the induction of labour is ideally based on high quality research and 
formulates guidance on the indications, timing, and methods of induction; provides guidance on 
the balance of risk and benefit to the mother and/or baby where there is increased risk of perinatal 
mortality; and provides guidance on enhanced maternal and fetal surveillance where this is an 
alternative to induction of labour or where a mother declines the offer of induction of labour.  
In 2014 the DHBs in the Auckland region collaborated to publish a consensus guideline on induction of 
labour which could be operationalised as local guidelines by individual DHBs within the region taking 
into account local characteristics and resources (Wise et al 2014). This guideline document was used 
by the PMMRC to audit stillbirths from 41 weeks in 2015. It is timely to update this interdisciplinary 
guideline incorporating up to date evidence.
That district health boards with rates of perinatal related mortality and neonatal encephalopathy 
significantly higher than the national rate review, or continue to review, the higher rate of mortality or 
morbidity in their area and identify areas for improvement. 
Justification: 
There is a significantly higher rate of perinatal related mortality than the national rate among residents 
of Counties Manukau DHB (Figure 3.13)
There is a significantly higher stillbirth rate than the national rate among residents of Counties Manukau 
DHB (Figure 3.28)
There is a significantly higher neonatal death rate than the national rate among residents of Counties 
Manukau and Waikato DHBs (Figure 3.29)
Waikato, Taranaki and Capital and Coast DHBs have significantly higher rates of neonatal 
encephalopathy than the national rate (Figure 6.4).
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Evidence: 
Audits of perinatal deaths are required to understand causes and focus prevention efforts (The Lancet 
2016). 
Previous reports have shown that review of neonatal encephalopathy using a confidential enquiry 
methodology revealed suboptimal care in more than 50 percent of cases (Draper et al 2002; 
Kernaghan 2006).
Maternal mortality recommendations
The PMMRC recommend the HQSC establish a permanent Suicide Mortality Review Committee. 
Justification: 
The suicide-specific maternal mortality ratio in New Zealand from 2006 to 2015 was seven times that 
in the UK for 2006 to 2014 (RR 6.9 (95%CI 4.2-11.1)). The background rate of suicide among young 
women in New Zealand is high.
There is a lack of visibility of suicide out to one year postpartum in New Zealand. In the UK, the 
postpartum period from six weeks out to one year has been shown to be a more vulnerable time for 
women than pregnancy and the immediate postpartum period (Knight et al 2016). Suicide review will 
provide insight into the broader factors influencing suicide rates in New Zealand.
Māori maternal suicide
Recommendations from the Mortality Review Committees’ Māori Caucus.
Improved awareness and responsiveness to the increased risk for Māori women
Primary care (GPs, FPA), LMCs, TOP services, alcohol and drug services, and secondary and tertiary 
providers of maternity, obstetric, mental health, and maternal mental health services should improve 
their systems, guidelines and professional development to ensure that they are responsive to the 
identified increased risk for Māori women.
Justification:  
Māori women are over-represented among maternal suicides with Māori women accounting for 56 
percent of maternal suicides between 2006 and 2015. Most of the Māori women who died from 
suicide experienced multiple risk factors.  
Evidence: 
Culturally competent, responsive health services supported by an informed culturally competent 
workforce will improve access to high quality care, and health outcomes for pregnant Māori women.
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Risk assessment
Comprehensive assessment of risk factors for Māori women should be undertaken at diagnosis of 
pregnancy and/or on first presentation for antenatal care. This should be undertaken for all Māori 
women, regardless of age, including those who are seeking termination of pregnancy. 
Justification:  
Just over a quarter of the suicides occurred following a TOP. Nearly half of the suicides occurred in 
women 24 years of age and younger. Most women who died from suicide experienced multiple risk 
factors. Early recognition of these risk factors, particularly where there are multiple factors, will assist 
health services and professionals to provide better services for these women. See ‘Practice Point: Māori 
women and maternal suicide' on page 161.
Management
a. Where Māori women exhibit symptoms suggesting serious mental illness or distress, an urgent 
mental health assessment, including consultant psychiatrist review and consultation with perinatal 
mental health services, on the same day these symptoms are first noted should be undertaken  
b. Māori women who have a history of serious mental illness and are currently well should be 
referred to specialist mental health services for a mental health birth plan, and monitored 
closely by their maternity care provider +/- mental health services. Where such a woman has a 
miscarriage, the GP should be notified immediately and an explicit process for early follow up 
that includes a review of mental health status agreed with the GP.  
c. The referring doctor of women who undergo a TOP is expected to provide a free post-TOP follow 
up consultation 10-14 days after the procedure (Report of a Standards Committee to the Abortion 
Supervisory Committee 2009). The referring doctor should actively follow up Māori women 
referred for TOP to ensure this consultation is completed and review mental health status during 
this consultation. 
Justification:  
Half of the women had self-harmed or attempted suicide prior to or during the final pregnancy. Nearly 
half of the women in this review identified as having mental health issues were not referred to mental 
health services, or it is unclear if a referral was made or appropriately acted on. Post-TOP consultations 
were not mentioned in any of the reviews for deaths that occurred post-TOP. See ‘Practice Point: Māori 
women and maternal suicide' on page 161.
Communication and coordination
Communication and coordination between primary care (GPs, FPA), LMCs, TOP services, alcohol and 
drug services, and secondary providers of maternity, obstetric, mental health, and maternal mental 
health services should be improved and enhanced using a variety of means including but not limited to 
case management, integrated notes systems, and electronic transfer of information.
Justification: 
Over half of women had been seen by a general practitioner (GP) or at a Family Planning clinic (but 
mostly by a GP) in their final pregnancy.  Forty percent of women were involved with mental health or 
alcohol and drug services during their final pregnancy. Some women had multiple services involved in 
their care – including midwifery, specialist obstetric and mental health services. Service related issues 
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including poor communication between services, poor coordination, and inadequate follow up were 
identified as were potentially delayed and/or missed diagnoses of physical and/or mental health 
issues.  
Child and Youth Mortality Review
Child and Youth Mortality Review Committee (CYMRC) consider including information about whether 
female suicide cases were pregnant in the 12 months prior to their deaths in addition to the pregnancy 
status information currently collected.
Justification: 
In the UK, the postpartum period from six weeks out to one year has been shown to be a more 
vulnerable time for women than pregnancy and the immediate postpartum period (Knight et al 2016). 
PMMRC review maternal suicide deaths from six weeks to one year postpartum when they are aware 
of them and it is determined appropriate to do so. However, the PMMRC have no certainty that case 
ascertainment is complete for this extended period as there is no current requirement for notification of 
cases beyond the first six postpartum weeks. The CYMRC reviews all deaths for women up to the age of 
25 years and could potentially include pregnancy in the previous twelve months in their data collection 
and review. 
22
Overview of the 2017 Report of the PMMRC
Significant changes to the report 2017
This year, the report introduces two new chapters. The first, in collaboration with the Mortality Review 
Committees’ Māori Caucus, reports Māori perinatal and maternal mortality. This chapter includes 
a discussion of the definitions of ethnicity in the denominator datasets and their appropriateness 
for use for reporting perinatal mortality statistics. It includes analyses comparing Māori and New 
Zealand European perinatal and maternal mortality, and a review of Māori maternal suicide. Specific 
recommendations have been proposed based on this review. The second new chapter describes the 
current and future work of the newly formed Maternal Morbidity Working Group (MMWG) of the 
PMMRC.
The New Zealand National Maternity Collection (MAT) dataset has been used instead of the Births, 
Deaths and Marriages (BDM) birth registration dataset as the denominator for all analyses because it 
is the most complete record of births in a year and it contains more maternity clinical data. Therefore, 
this year the PMMRC reports associations between parity, smoking and body mass index (BMI) at 
registration with maternity care and perinatal mortality. Tables and figures also illustrate the associations 
between parity and maternal mortality and neonatal encephalopathy. 
Most analyses in this report that involve current associations with mortality use data from 2011 to 
2015. This is because there has been a significant reduction in some rates since the PMMRC started 
reporting in 2007. Time trend data are provided in two-year groupings or as rolling three-year rates. 
Demography of births in New Zealand
There have been some changes in the make-up of the New Zealand birthing population since the 
PMMRC started reporting mortality rates in 2007. Fewer mothers were under 20 years of age (4.7 
percent in 2015 compared to 7.9 percent in 2007) and fewer mothers are smoking in pregnancy. 
There were fewer births at 40 and more weeks of gestation and more births at 36 to 39 weeks 
gestation. 
Perinatal related mortality
Perinatal related mortality rates
In New Zealand, perinatal mortality is reported from 20 weeks gestation, and all terminations of 
pregnancy from 20 completed weeks gestation are included. The perinatal related mortality rate in 
2015 was 9.7/1000 births (approximately one death (late termination or stillbirth or neonatal death) 
for every 100 births from 20 weeks). This is the lowest rate reported since the PMMRC began collecting 
data in 2007. However, the rate in 2015 is significantly lower than the rate for the years 2007–2014 
combined. From 2007 to 2015 there was a significant reduction in stillbirths.
New Zealand uses the Perinatal Society of Australia and New Zealand (PSANZ) classification of cause 
of perinatal death. There was a significant reduction in hypoxic peripartum deaths from 2007 to 2015 
and a trend to reduced deaths from fetal growth restriction.
International comparisons of perinatal mortality
International comparison of perinatal mortality rates can be difficult because many countries do not 
collect information on births and deaths down to 20 weeks of gestation. For this reason, the PMMRC 
report mortality rates using the World Health Organization’s (WHO’s) international definition in 
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addition to the New Zealand definition. The international definition includes births and deaths from 
1000g (or from 28 weeks if birthweight is not known). Because very early perinatal deaths are 
excluded from this definition, and the cause of death in very early perinatal deaths is different from the 
cause of death at later gestations, this makes a difference to the findings described above using the 
New Zealand definition. 
If we consider the international definition, there was a significant reduction in the overall perinatal 
related mortality rate (p=0.0011) and in the stillbirth rate (p=0.00023) from 2007 to 2015. There 
were significant reductions in hypoxic peripartum death (p=0.0003), death from antepartum 
haemorrhage (p=0.031) and fetal growth restriction (p=0.015).
Using the UK definition, New Zealand perinatal mortality and stillbirth rates (defined from 24 weeks 
and excluding terminations of pregnancy and deaths where gestation was unknown) were significantly 
lower than UK rates in 2014, and the neonatal death rate was the same. New Zealand perinatal 
mortality rates (using the international definition from 1000g or 28 weeks and excluding terminations 
of pregnancy) were consistent with Scandinavian rates in 2014, excepting neonatal mortality, which 
was higher in New Zealand. The perinatal related mortality rate (using the New Zealand definition) in 
New Zealand in 2014 was significantly higher (11.2/1000 births) than the Australian rate (9.6/1000 
births).
The neonatal death rate has not changed significantly in New Zealand from 2007 to 2015. This will 
be investigated in detail in 2017–2018. Meanwhile there have been significant reductions in neonatal 
mortality in the UK (from 2004 to 2014), Australia and Scandinavia. In the UK, there have been 
reductions in neonatal mortality among babies born from 22 to 27 weeks, but no increase in survival of 
these babies has been seen in New Zealand.
Ethnicity and perinatal related mortality
Adjusted analyses described in this year’s report suggest that Māori mothers have a higher rate of 
neonatal death, but that overall there is no significant difference in perinatal related mortality between 
babies born to Māori mothers and babies born to New Zealand European mothers. 
Babies born to Indian mothers have significantly higher late termination of pregnancy, stillbirth and 
neonatal death rates compared to New Zealand European mothers. Babies born to Pacific mothers 
have significantly lower late termination of pregnancy rates, and significantly higher stillbirth and 
neonatal death rates compared to New Zealand European mothers.
The outlying causes of stillbirth and neonatal death among babies of Māori mothers are spontaneous 
preterm birth, antepartum haemorrhage, maternal conditions (mostly due to diabetes), hypertension, 
and deaths with no obstetric antecedent. (For a description of conditions included in each PSANZ 
perinatal death classification (PSANZ-PDC) category, see Classifications of the Perinatal Society of 
Australia and New Zealand (PSANZ 2009).
The outlying causes of stillbirth and neonatal death among babies of Pacific mothers are spontaneous 
preterm birth, maternal conditions, specific perinatal conditions, antepartum haemorrhage, 
hypertension, perinatal infection, congenital abnormality, and deaths with no obstetric antecedent.
Outlying causes of death among babies of Indian mothers are spontaneous preterm birth, fetal growth 
restriction, specific perinatal conditions, and antepartum haemorrhage. There may be an excess of 
other causes among babies of Indian mothers, but as numbers are small and confidence intervals are 
large, it is hard to confirm.
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Other clinical predictors of mortality
Mothers in their first pregnancy have higher stillbirth and neonatal death rates compared to women 
who are having their second birth, and mothers in their fourth or later pregnancies have higher rates of 
stillbirth.
After maternal age, ethnicity, multiple pregnancy, baby sex, and year of birth were accounted for, 
increasing socioeconomic deprivation was associated with an increase in the odds of stillbirth and of 
neonatal death. Mother’s age (<20 years and ≥40 years) was associated with increased odds of late 
termination of pregnancy, stillbirth and neonatal death. 
Gestation and perinatal mortality
There is a significant reduction from 2007 to 2015 in perinatal related death at 37–38 weeks and at 
41 weeks and above. There is a significant reduction in stillbirths at 37–40 weeks from 2007 to 2015.  
A number of initiatives to improve pregnancy care and/or to reduce perinatal death may be 
responsible for these reductions in mortality in late pregnancy since the PMMRC started reporting 
and making recommendations in 2007. Some changes in demography and the distribution of risk 
factors may also have had a small effect. Possible explanations for the observed reduction in perinatal 
mortality include: 
• reduced births among teenage women
• reduced rates of smoking among pregnant women
• reduced births at 40 weeks and beyond (presumably associated with increased rates of 
iatrogenic birth by induction or elective caesarean for at-risk pregnancies)
• structured review and reporting of perinatal deaths at all New Zealand DHBs
• increased education around the risks of SGA
• introduction of the GROW tool for recognition of reduced fetal growth and the Maternal Fetal 
Network guideline for management of SGA from 34 weeks gestation
• the Maternity Quality and Safety Programme
• introduction of learning from the maternal sleep position studies suggesting that left-sided sleep is 
associated with reduced odds of late stillbirth. 
The rate of stillbirth at 41 weeks and beyond for 2015 was, however, higher than in any year from 
2007 to 2014. Review of the 17 stillbirths from 41+0 weeks without congenital abnormality, against 
the Auckland Consensus Guideline on Induction of Labour (Wise et al 2014) and against best practice 
for antenatal assessment in women with risk factors, found the care provided did not follow the 
guideline and/or best practice in six of the 17 stillbirths. This related to best practice to perform serial 
growth scans following antepartum haemorrhage; best practice for obstetric review and/or to perform 
serial growth scans for BMI >35 in three pregnancies; and to offer induction of labour for diabetes with 
suspected SGA, and for hypertension.
Potentially avoidable perinatal mortality
Part of the local review of perinatal related mortality is assessment of contributory factors to perinatal 
related mortality and an assessment of whether deaths were potentially avoidable. In 2015, one-quarter 
of perinatal related deaths were determined at local review to have contributory factors, and just over 
half of these (14 percent overall) were determined to be potentially avoidable deaths.
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Investigation of perinatal related mortality
There has been a significant increase in optimal investigation of perinatal deaths since 2007, and in 
2015, 52 percent of babies who died were optimally investigated. There has also been a significant 
increase in the babies who have partial investigations (40 percent in 2015) and a significant fall in 
deaths that have no investigation (8 percent in 2015).
To help caregivers and parents discuss the merits of post-mortem investigation, the PMMRC collects data 
on the usefulness of the investigation in adding to knowledge about cause of death. In 2015, data on 
the usefulness of post-mortem were available for 205 (83 percent) of deaths where post-mortem was 
performed. In 118 deaths (48 percent) the post-mortem confirmed the clinical diagnosis. In 40 (16 
percent) the post-mortem changed the diagnosis and resulted in altered counselling to parents for future 
pregnancies. In 27 (11 percent) additional information was gained, but this did not change the clinical 
diagnosis, and in 20 (8 percent) of the deaths, the post-mortem was non-contributory. 
Perinatal death investigation rates continue to be significantly lower among babies of Māori and Pacific 
mothers compared to babies of mothers of other ethnicities. Compared to the overall 8 percent rate of 
no investigation of perinatal death, there is no investigation of 19.8 percent of babies of Māori mothers 
and 12 percent of babies of Pacific mothers.
Maternal mortality
Maternal mortality ratio
Maternal deaths are deaths of pregnant women or women within six weeks after pregnancy. Maternal 
mortality is expressed as a ratio compared to births from 20 weeks gestation even though maternal 
deaths may occur in or after pregnancy prior to 20 weeks (eg, after early termination of pregnancy 
or miscarriage). In 2015, 11 maternal deaths were reported to the PMMRC. One coincidental death 
(death of a pregnant woman or within six weeks of the end of a pregnancy which was unrelated to 
pregnancy; eg, death in a road traffic accident) was reported in 2015. 
The maternal mortality ratio in New Zealand was 15.6/100,000 maternities for the three years 2013–
2015. There has been no statistically significant change in maternal mortality ratio in New Zealand 
since data collection by the PMMRC began in 2006.
In 2015, there were three direct deaths (one from amniotic fluid embolism and two from venous 
thromboembolism) and eight indirect deaths (five from suicide and three from pre-existing medical 
conditions).
Suicide continues to be the leading single cause of maternal death in New Zealand. 
International comparisons
The maternal mortality ratio in New Zealand is significantly higher than that in the UK, which was 
8.54/100,000 maternities for the three years 2012–2014. Specifically, maternal death from amniotic 
fluid embolism is four times higher and maternal death from suicide seven times higher in New Zealand 
than in the UK.
Demography
Women aged 40 years and older, Māori and Pacific mothers, and mothers who have had three 
previous births from 20 weeks are at higher risk of maternal mortality.
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More than half of the mothers who died in pregnancy or the peripartum period were overweight or 
obese, and 34 percent were known smokers.
Alcohol or substance use was noted in a quarter of mothers who died, and a history of family violence 
was noted in at least 9 percent.
Maternal post-mortem
Post-mortem resulted in a change in clinical diagnosis in 10 percent (n=11) of maternal deaths from 
2006 to 2015. New or additional information was made available in a further 25 percent of women 
who had a post-mortem. However, one quarter of mothers who died did not have a post-mortem.
Potentially avoidable maternal death
Contributory factors were identified in 62 percent of maternal deaths in the years 2006–2015, and 39 
percent were identified as potentially avoidable.
Māori perinatal and maternal mortality
Perinatal mortality
The change in denominator for this report from the BDM birth registration dataset to the MAT dataset 
creates a particular problem for the analysis of mortality by ethnicity because the MAT dataset includes 
a derived variable (an algorithm to include the ethnicity from more than one dataset) for ethnicity, which 
differs from the self-defined variable in the BDM birth registration dataset. This variable increases the 
proportion of Māori in the MAT dataset and decreases the proportion of New Zealand Europeans. 
The potential effect of this on mortality rates if the PMMRC ethnicity is used for perinatal deaths is to 
reduce Māori perinatal mortality rates and to increase New Zealand European perinatal mortality rates. 
In the Māori mortality chapter, rates are given using both the birth registration (BDM) and maternity 
(MAT) denominators to illustrate the effect of these differences. Using the BDM denominator, Māori 
perinatal mortality rates are higher than New Zealand European perinatal mortality rates. Using the 
MAT denominator, Māori perinatal mortality rates are the same as New Zealand European perinatal 
mortality rates. To view these differences see Figure 5.1—Figure 5.5 in the main report. 
It is believed that the BDM birth registration dataset would provide the best source of ethnicity data 
because this is the ethnicity given by parents when they register their child’s birth. It is also the ethnicity 
collected by the PMMRC for perinatal deaths and cases of neonatal encephalopathy. 
After adjusting for measured potential confounders, overall perinatal related mortality does not differ 
between Māori and New Zealand European mothers. However, there is an excess of neonatal deaths 
of babies born under 28 weeks gestation to Māori mothers.
Māori and New Zealand European mothers have similar rates of perinatal related mortality by age. 
However, there are more perinatal deaths among Māori mothers under age 20 as there are more than 
twice as many Māori mothers under 20 years as New Zealand European.
Maternal mortality
There is a significantly higher (almost double) maternal mortality ratio among Māori mothers (26.3 per 
100,000 births from 20 weeks) compared to New Zealand European mothers (13.5 per 100,000 
births from 20 weeks) combining data from 2006–2015.
Māori women are over-represented among maternal suicides.
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Neonatal encephalopathy
Neonatal encephalopathy rates
Six years (2010–2015) and 423 neonatal encephalopathy (NE) cases have been described in this 
report. The rate of NE for this period was 1.24 cases per 1000 term births. Seventy cases were 
reported in 2015. Although there appears to be a downward trend in rates, there is no statistically 
significant trend from 2010–2015. 
Eighty-one of the 423 babies with NE from 2010–2015 (19.4 percent) died in the perinatal period 
(<28 days). A further nine babies are known to have died after discharge from three months to five 
years of age.
From 2016 the Neonatal Encephalopathy Working Group (NEWG) widened the inclusion criteria for 
the NE cohort and will include cases from 35 weeks gestation at birth in line with international literature 
and practice of cooling of babies of this age. These numbers will be included from next year, although 
rates of NE at term will continue to be reported. 
Demography of neonatal encephalopathy
NE is associated with maternal ethnicity, socioeconomic deprivation, gestation, birthweight, nulliparity, 
and baby sex.
Pacific mothers are at increased risk of having a baby with NE compared to Other Asian, Other, and 
New Zealand European mothers. Mothers of Māori and Indian ethnicity are at increased risk of having 
a baby with NE compared to mothers of Other Asian and Other ethnicities. 
Waikato, Taranaki, and Capital & Coast DHBs continue to have statistically higher unadjusted rates of 
NE compared to the national rate. Adjusted rates were not calculated.
Induced cooling
In 2015, 80 percent of babies born in New Zealand with moderate or severe NE were treated with 
induced cooling. 
In the dataset from 2011 to 2014 (4 years), 54 neonates were reported as not receiving full body 
cooling for NE. On further review 20 of the 22 severe NE infants were appropriately not cooled. In 
the moderate group it was determined that 23 of the 32 infants were appropriately not cooled. Of the 
remaining nine infants, transfer to a tertiary unit was possible and cooling may have been indicated. 
This review will lead to a new item in the dataset asking for the reason infants were ‘not cooled’.
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Summary of Key PMMRC 2016 Report Recommendations and Progress
Recommendation (PMMRC 10th report) Progress to date (updated June 2017)
Perinatal epidemiology
That the Perinatal Society of Australia and New Zealand perinatal 
death classification (PSANZ-PDC) system be modified to allow the 
classification of babies dying with placental pathology outside of 
unexplained antepartum death.
The PMMRC is working with PSANZ on the revision of the PSANZ-
PDC system. 
The revised version will be in use from January 2018. 
Perinatal mortality
That district health boards with rates of perinatal related mortality 
significantly higher than the national rate review, or continue to 
review, the higher rate of mortality in their area and identify areas 
for improvement.
Perinatal related mortality rates
Counties Manukau 
The recommendations from an independent review of perinatal 
mortality in Counties Manukau in 2012 are being implemented in 
an ongoing process of quality improvement. In 2017 further work 
will commence on the following initiatives:
• preterm birth 
• information for women and families in eight languages




Waikato DHB has undertaken a review of all neonatal deaths due 
to neurological causes from 2010 to 2014. 
Initiatives were identified to address modifiable risk factors in the 
following areas:
• improving early pregnancy care 
• management of pregnancy in obese women
• management of diabetes in pregnancy
• smoking cessation 
• maternal immunisation
• diagnosis and management of preterm labour
• management of high-risk pregnancies. 
In 2017 further work will commence on the following initiatives:
• intrapartum care and documentation
• education sessions to share learnings from reviews.
Bay of Plenty 
Bay of Plenty DHB has undertaken audits reviewing every perinatal 
death from 2010 to 2016. Initiatives were identified to address 
modifiable risk factors in the following areas:
• improving access to antenatal care 
• smoking cessation 
• prediction, diagnosis and management of preterm labour
• management of multiple pregnancies
• management of pregnancies at increased risk of fetal growth 
restriction
• management of decreased fetal movements
• optimising the management of pregnancy in obese women.
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Recommendation (PMMRC 10th report) Progress to date (updated June 2017)
Maternal mortality 
That a Perinatal and Infant Mental Health Network be established to 
provide an interdisciplinary and national forum to discuss perinatal 
mental health issues.
The PMMRC and the MMRWG are working with the Ministry of 
Health to clarify the remit and purpose of this network, to ensure 
supportive links with pre-existing regional perinatal and infant mental 
health networks, and to identify a work plan consistent with the needs 
of DHBs.
As recommended in the fifth report of the PMMRC (PMMRC 2011): 
All clinicians involved in the care of pregnant women should 
undertake regular multidisciplinary training in management of 
obstetric emergencies.
Sixteen DHBs provide multidisciplinary training in management 
of obstetric emergencies; this is provided in-house for all but one 
secondary hospital. 
Three DHBs have indicated attendance is mandatory for all obstetric, 
midwifery (core and lead maternity carer) and anaesthetic clinicians. 
One additional DHB indicated attendance was mandatory for all 
DHB obstetric, midwifery and anaesthetic staff. A further eight DHBs 
indicated it was mandatory, but only for some disciplines.
The most common areas identified as barriers to attendance were 
staffing and cost to attend. The most common areas identified as 
enablers to attendance were payment by the DHB and providing 
cover for staff to attend.
Neonatal encephalopathy 
That district health boards with rates of neonatal encephalopathy 
significantly higher than the national rate review, or continue to 
review, the higher rate of morbidity in their area and identify areas 
for improvement.
Taranaki 
Taranaki DHB reviews all unexpected admissions to the neonatal 
unit; this includes cases of NE. 
Current quality improvement initiatives include:
• improvements to the obstetric emergency call system 
• multidisciplinary training in obstetric emergencies for all 
clinicians at both Taranaki Base and Hawera hospitals
• fetal surveillance training 
• newborn life support training (New Zealand Resuscitation 
Council) 
• an improvement in numbers and rostering of obstetric doctors.
Taranaki DHB will continue to monitor and review all NE cases and 
implement quality improvements where indicated.
Capital & Coast 
Capital & Coast DHB has reviewed all term infants diagnosed with 
NE from 2010 to 2014. 
The benefit of multidisciplinary reviews was recognised and the 
review team recommends ongoing resourcing and support of 
multidisciplinary reviews of adverse events. 
On completion of the review document the findings were fed back 
to the steering group and further assessment and implementation of 
the findings and recommendations will be undertaken. 
The review is being presented at the national PMMRC annual 
conference in June 2017.
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1.1 Introduction
Maternity care in New Zealand
In New Zealand, maternity care is funded by the Ministry of Health. Maternity care is provided by 
20 district health boards (DHBs) nationally and by lead maternity carers (LMCs), who receive funding 
from the Ministry of Health. LMCs may be self-employed midwives, general practitioners (GPs), private 
obstetricians, or hospital-based midwives and obstetricians. Their services are free for eligible women, 
except in the case of private obstetricians, who have the right to charge co-payments for their services.
LMCs are required to sign access agreements with any maternity facility where they intend to provide 
care. Women have the right to choose whom they engage as their LMC. However, professional colleges 
and the Ministry of Health provide guidelines about appropriate care for mothers with risk factors.
The Guidelines for Consultation with Obstetric and Related Medical Services (Referral Guidelines) 
provide information about referring pregnant women, transferring clinical responsibility and transferring 
care in emergencies (Ministry of Health 2012a).
1.2 Methodology
Each of chapters 3–6 of the 11th report includes mortality or morbidity specific methodology. Included 
here are details of the denominator datasets used throughout this report and statistical methods, 
which apply to all chapters. A list of abbreviations and definitions can be found in Appendix B: List of 
Abbreviations and Appendix C: Definitions. 
Denominator data
New Zealand birth registrations
The birth registration dataset of New Zealand births is collated by Births, Deaths and Marriages 
(BDM) from birth notifications supplied by public and private hospitals, and by LMCs in the case of 
home births. Births are only added to the birth registration dataset when the birth is registered by the 
parents, which can occur up to some years following birth. The registration dataset is based on date of 
registration and so includes births from previous years and fewer than all births from the current year. 
While this dataset is representative of the total number of births in a year, it does not truly represent the 
denominator.
A disadvantage of the birth registration dataset for reporting maternity analyses in New Zealand is that 
it includes limited maternity data. The dataset does not retain an individual’s unique NHI identification 
number (for either the mother or the baby), and so the data it contains cannot easily be linked to 
hospital discharge data or LMC data for further analyses.
In 2015 (11th report), the birth registration dataset is used as the denominator to illustrate issues with 
the measurement of ethnicity in the Māori chapter.
New Zealand National Maternity Collection 
The New Zealand National Maternity Collection (MAT) is a relatively new initiative combining data 
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collected by LMCs, which are required to enable claims for payment, with hospital discharge data. 
In this report (2015 data, 11th report), we have changed the denominator dataset for most analyses 
from the BDM dataset of birth registrations in the calendar year to the MAT dataset, which includes all 
births in the calendar year. We believe this is the most accurate record of all births in New Zealand 
in a year, and this dataset has the advantage of including maternity data. Details of the development 
of an appropriate denominator dataset using the MAT dataset, details of the merge with the MAT 




Percentages have been displayed with one decimal place or without decimal places when the 
denominator is small. In some cases, due to rounding, the percentages do not add to exactly 100 
percent.
Figures
In figures where graphs have two y-axes, the data relating to the left-side y-axis are presented as 
bars, and the data relating to the right-side y-axis are presented as points, joined by a line where they 
represent continuous or ordinal data.
Tables
In any table where there are denominator data, the table includes a column for the absolute number 
of births and the proportion of all births in the time period, distributed by the levels of the variable of 
interest. There are columns for the absolute number of deaths that were terminations of pregnancy, 
stillbirths, neonatal deaths and total perinatal deaths, the proportions within each of these by the 
variable of interest, and the rate of death as a proportion of all births in that category of the variable of 
interest.
For example, Table 3.4 looks at perinatal related deaths by maternal age for 2015. There were 
10,145 births registered to mothers 20–24 years of age in 2015, which was 17.0 percent of all births. 
There were 43 stillbirths among mothers 20–24 years of age, which was 14.1 percent of all stillbirths 
in 2015. The stillbirth rate was 43/10,145 births or 4.24 stillbirths per 1000 births in 2015 to women 
20–24 years of age. 
Confidence intervals
Ninety-five percent confidence intervals (CIs) for perinatal mortality rates have been computed using the 
methods for vital statistics described by the Centers for Disease Control and Prevention (Heron 2011). 
The CI represents the degree of uncertainty around the point estimate of the rate for the particular 
period.
This uncertainty depends on the absolute number of deaths and the number of births from which the 
deaths arose. If the number of births is large, then the CI (ie, the level of uncertainty) is generally small; 
if the number of births is small, the CI is large. The CI represents the limits within which the ‘true’ rate 
is most likely to lie. This calculation is necessary when numbers are small because the point estimate 
of the rate calculated from the data given may by chance have taken a wide range of values. The CI 
describes this range.
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It is possible to compare rates by looking at the CI. If the CI for each rate does not overlap the estimate 
of the other rate, it is likely that the rates are different. This is equivalent to the rates being statistically 
significantly different at the p<0.05 level. If the CI does overlap the estimate, the rates may or may not 
be different.
Statistical testing
Where the text notes that there is a statistically significant difference or association, this indicates that a 
statistical test has been applied and that the p-value is less than (<) 0.05. Conversely, if a difference is 
said to be not statistically significant, then the p-value is equal to or greater than (≥) 0.05. If the words 
‘statistically significant’ are not used to describe a difference or association, it can be assumed that a 
statistical test has not been applied.
Where tests for trend have been used, a score test for linear trend of the log odds has been performed 
in STATA13 using the ‘tabodds’ function or in EpiInfo using the chi-squared test for trend or the chi-
squared test for trends in proportions using R. A p-value of <0.05 has been used to indicate statistical 
significance.
Multivariable analysis using logistic regression has been performed using ‘logistic’ in STATA13. 
Missing data
Cases that have missing data have still been included in the data tables and are generally discussed in 
the text. Percentages in the tables generally include missing data, although the text sometimes describes 
findings among women with complete data only. However, where missing data exceed 30 percent of 
all possible data points, the data have generally not been presented.
At the lower extremes of gestation and birthweight, denominator numbers are small and almost all 
babies will not survive. If the denominator set does not include all births for whatever reason, then it will 
appear that more babies died than were born. For this reason, perinatal related mortality rates at the 
lower extremes have not been reported.
Multiple-year data
In this report, the figures illustrating perinatal related mortality rates sometimes include combined data 
for the most recent five years that the PMMRC has collected data (2011–2015). This increases the 
numbers and so improves the confidence around the estimates given, while restricting to the most recent 
five years of data to minimise the impact of changes over time on rates.
In some tables two years of data have been combined so that all years of data collection since the 
inception of the PMMRC can be included within the limitations of space in one horizontal table. 
Individual year data can be accessed by searching previous PMMRC reports (http://www.hqsc.govt.
nz/our-programmes/mrc/pmmrc/).
In general, the data for the 2015 year alone are presented in table form in the text and the combined 
five or nine-year data in table form in the appendices to each section.
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2 Births in New Zealand 2015









Amended from Statistics New Zealand (2015). 
http://www.stats.govt.nz/browse_for_stats/population/births/BirthsAndDeaths_HOTPYeDec15.aspx 
http://www.stats.govt.nz/~/media/Statistics/Browse%20for%20stats/BirthsAndDeaths/HOTPYeDec15/bd-Dec15-all-tables.xls
There were 61,038 live births registered in New Zealand in 2015.
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There has been a significant change in the distribution of gestation at birth in New Zealand since 2007 
(Figure 2.2).
Specifically there has been a significant reduction in total births at 40 and 41+ weeks and a significant 
increase in births at 36, 37, 38 and 39 weeks gestation. This suggests that there has been an increase 
in iatrogenic births at and near term.
Table 2.1: Trends in birthweight among births in New Zealand 2007–2015
Birthweight 
(g)
2007–2008 2009–2010 2011–2012 2013–2014 2015 Chi-squared  
test for 
 trend (p)n % n % n % n % n %
<500 422 0.3 440 0.3 481 0.4 471 0.4 187 0.3 -
500–999 664 0.5 678 0.5 611 0.5 611 0.5 273 0.5 0.21
1000–1499 799 0.6 812 0.6 723 0.6 652 0.5 376 0.6 0.19
1500–1999 1,561 1.2 1,509 1.2 1,502 1.2 1,397 1.2 649 1.1 0.11
2000–2499 4,566 3.5 4,630 3.5 4,624 3.7 4,372 3.6 2,161 3.6 0.040
2500–2999 16,554 12.7 16,777 12.8 16,204 12.8 16,033 13.3 7,966 13.3 <0.0001
3000–3499 40,392 30.9 41,034 31.4 39,907 31.5 38,373 31.9 18,998 31.8 <0.0001
3500–3999 39,418 30.1 39,517 30.2 38,090 30.1 36,051 30 18,051 30.2 0.32
4000–4499 15,430 11.8 15,307 11.7 14,572 11.5 13,613 11.3 6,732 11.3 <0.0001
≥4500 3,461 2.6 3,184 2.4 3,031 2.4 2,794 2.3 1,252 2.1 <0.0001
Unknown 7,559 5.8 6,778 5.2 6,794 5.4 5,864 4.9 3,163 5.3 -
There has been a significant change in the distribution of birthweight since 2007. Specifically, there has 
been a reduction in babies born weighing 4000g or more, and an increase in babies born weighing 
2000g to 3500g. This is consistent with the changes in gestation at birth.
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There has been a consistent reduction in births among mothers under 20 years of age from 2008 so 
that these now constitute fewer than 5 percent of births (Figure 2.3). The majority of births in New 
Zealand are to women aged 25–29 (26.8 percent) and 30–34 (30.6 percent). There was a small 
increase in mothers birthing at 40 years of age and older from 2007 to 2010, but the proportion has 
been steady at 4.2–4.5 percent since 2010. In 2015, 4.2 percent of mothers were 40 or older. 
The greatest changes in maternal ethnicity from 2007 to 2015 are an increase in the proportion 
of births among Other Asian mothers and a reduction in the proportion to New Zealand European 
mothers, who now make up 10.4 and 37.2 percent of mothers respectively (Figure 2.4).
There has also been a small decrease in the proportions of mothers identifying as Māori and Pacific 
peoples. In 2015, 24.9 percent of mothers identified to BDM as Māori and 10.3 percent as Pacific.
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Figure 2.7: Distribution of deprivation quintiles (NZDep2013) by maternal prioritised ethnicity among 
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Figure 2.8: Distribution of maternal age by maternal prioritised ethnicity among births in 2015 (total 
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Figure 2.9: Distribution of maternal prioritised ethnicity by DHB of maternal residence among births in 

















DHB of maternal residence
Māori Pacific peoples Indian Other Asian Other (including unknown) NZ European
Figure 2.10: Distribution of deprivation quintiles (NZDep2013) by DHB of maternal residence among 
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3 Perinatal Mortality 2015
3.1 Methods
Perinatal mortality numerator data
The perinatal deaths presented in this report occurred between 1 January and 31 December 2015. For 
fetal deaths, the date of birth is used in place of the date of death. For neonatal deaths, the actual date 
of death is used.
An expanded description of data collection methods for this report is available in the first PMMRC 
report (PMMRC 2007). After the PMMRC was established in 2005 and following consultation with 
stakeholders, it was agreed that a review of all perinatal deaths would require the assistance of LMCs 
and the DHBs to collect detailed clinical information on each perinatal death.
The PMMRC approached all the DHBs, requesting their help to establish a network of local PMMRC 
coordinators. Individual coordinators within each DHB identify perinatal deaths and oversee the 
collection of the required data. These data are submitted to the Mortality Review Data Group at 
the University of Otago. The coordinators are also responsible for initiating local clinical reviews 
of each case, including assigning Perinatal Society of Australia and New Zealand perinatal death 
classifications (PSANZ-PDCs) for cause of death, determining contributory factors and potentially 
avoidable deaths, and ensuring appropriate, timely follow-up with parents.
The dataset of perinatal deaths is a compilation of data submitted by LMCs, local coordinators, the 
Ministry of Health and BDM. A website commissioned by the PMMRC and run by the University of 
Otago enables web-based data entry. LMCs and/or local coordinators are required to complete rapid 
reporting forms within 48 hours of a perinatal death.
One form contains information on the mother (eg, her past medical and obstetric history and details 
of the birth), and the other form contains information on the baby. The questions are reviewed and 
adjusted annually to ensure the data collection remains relevant and robust.
After local review, a multidisciplinary team led by the local coordinator completes the PMMRC 
classification form. The classification system that has been adopted is the PSANZ system of classification 
of cause of perinatal death (PSANZ 2009). This system includes both perinatal and neonatal 
classifications. The local coordinator also submits the post-mortem and histology reports with the 
classification form.
Figure 3.1 outlines the PMMRC process. A user guide describing the definitions and data elements 
used by the PMMRC is available online at: https://www.hqsc.govt.nz/assets/PMMRC/Publications/
guidelines-mother-baby-forms-perinatal-death-v10.pdf. 
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PMMRC numerator data validation
Data are regularly validated, using a standard set of queries, to eliminate duplicate records, complete 
missing mother or baby information, clarify DHB of residence (where this is inconsistent with the given 
residential address) and rectify other inconsistencies.
The national coordinator reviews all perinatal death classifications and discusses complicated cases 
with a PMMRC member with expertise in PSANZ classifications.
There were three late notifications added to the perinatal mortality dataset in 2016: two stillbirths and 
one termination of pregnancy, all in 2014. These deaths have been included in all analyses for this 
report.
Audit of perinatal numerator data 2013–2015
Each year, an audit is undertaken to compare the data submitted to the PMMRC with clinical records to 
assess the accuracy and completeness of the data, including review of the PSANZ-PDC.
The audit for the PMMRC’s 11th report focused on 52 babies who met the criteria for neonatal 
encephalopathy, comparing the accuracy of data submitted to the PMMRC to that in the clinical records 
from LMCs and DHBs. 
The audit reviewed 52 babies who meet the criteria for neonatal encephalopathy from 2013–2015 
and who were the subjects of a national review, including 10 babies who died. The following 
information relates to the audit of these 52 cases of neonatal encephalopathy. 
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Nine of the 10 neonatal deaths occurred within the first four weeks of life. The perinatal death 
classification (PSANZ-PDC) and the neonatal death classification (PSANZ-NDC) were all considered to 
be correct at audit. 
The majority of data items were entered correctly, with over 95 percent of data items correct. 
Information was missing or incorrectly noted around past obstetric history, gestation at registration with 
an LMC, LMC at birth and antenatal procedures (Doppler ultrasound). 
The neonatal encephalopathy and perinatal mortality databases were updated to reflect these findings. 
The PMMRC data collection forms were amended in 2016 to ensure that LMC at booking, LMC at birth, 
and LMC with clinical responsibility are collected accurately. 
Contributory factors and potentially avoidable perinatal related mortality
An assessment of contributory factors and potentially avoidable perinatal related death is completed 
by a multidisciplinary team led by the PMMRC local coordinators following local review and submitted 
along with the PSANZ-PDC. The PMMRC contributory factors and potentially avoidable perinatal death 
form includes questions that identify contributory factors related to organisational and/or management, 
personnel, and barriers to accessing and/or engaging with care. A death is considered potentially 
avoidable if the absence of the contributory factors may have prevented the death. From 2011, 
local coordinators were asked to indicate the main contributory factor(s) in identifying the death as 
potentially avoidable. See the ‘Contributory Factors for Mortality and Morbidity’ on page 78.
3.2 Perinatal Mortality Rates
The PMMRC perinatal related mortality rates are calculated from numerator data provided by LMCs, 
clinicians and DHB local coordinators, reviewed by local perinatal mortality review committees and 
collated centrally by a national coordinator, and denominator data from the MAT dataset of all births in 
New Zealand in a year. The use of MAT data in the denominator is a change to PMMRC reporting in 
2015 and is discussed in more detail in section “1.2 Methodology”’.
The calculation of perinatal related mortality by the PMMRC differs from the methodology used by 
the Ministry of Health in its reports, so the rates presented in this report may differ slightly from those 
reported in Ministry of Health documents. 
The PMMRC considers that this report presents as complete a set of perinatal related deaths as can 
currently be achieved for the 2015 year in New Zealand.
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Table 3.1: Summary of New Zealand perinatal mortality rates 2015
Using NZ definition Using UK definition*
n Rate n Rate
Total births  59,808  59,551 
Fetal deaths (terminations of pregnancy and stillbirths)#  412  6.89  -  - 
Terminations of pregnancy  107  1.79  -  - 
Stillbirths  305  5.10  212  3.56 
Early neonatal deaths <7 days  131  2.21  76  1.28 
Late neonatal deaths 7–27 days  35  0.59  34  0.57 
Neonatal deaths <28 days+  166  2.79  110  1.85 
Perinatal mortalities^  543  9.08  288  4.84 
Perinatal related mortalities•  578  9.66  322  5.41 
Perinatal mortalities excluding lethal and terminated fetal abnormalities~  402  6.72  249  4.18 
Perinatal related mortalities excluding lethal and terminated fetal abnormalities~  420  7.02  266  4.47 
* Rates calculated using UK definition for perinatal mortality: births from 24 weeks excluding terminations of pregnancy (CMACE 2011a).
# Fetal death rate per 1000 babies born (includes terminations and stillbirths).
+ Neonatal death rate per 1000 live born babies.
^ Fetal deaths and early neonatal deaths per 1000 babies born.
• Fetal deaths and early and late neonatal deaths per 1000 babies born.
~ Lethal and terminated fetal abnormalities are all perinatal related deaths with PSANZ-PDC of congenital abnormality and neonatal deaths.
with PSANZ-NDC of congenital abnormality.
The perinatal related mortality rate in New Zealand in 2015, which includes late terminations of 
pregnancy, stillbirths, and early and late neonatal deaths, from 20 weeks gestation to 27 days of life, 
was 9.7 per 1000 total births.
The perinatal related mortality rate in 2015 is the lowest reported since the PMMRC began collecting 
data in 2007, but the test for trend is not statistically significant over this time. The rate in 2015 is, 
however, significantly lower than the rate for the years 2007–2014 combined (p=0.025), and the 
overall perinatal related mortality rate at 10.0 and 9.7/1000 in two of the past three years was lower 
than in any single year during 2007–2012.
The significant decrease in the stillbirth rate from 2007 to 2015, reported previously, persists (chi-
squared test for trend p=0.0099). 
There is a statistically significant trend to a reduction in fetal deaths (stillbirths and late terminations of 
pregnancy combined) reported for the first time, from 2007 to 2015 (p=0.035) and, although the test 
for trend is not statistically significant, the late termination of pregnancy rate in 2015 was lower than 
any previously reported year (1.8/1000 births) and significantly lower than the years 2007–2014 
































Table 3.2: Summary of New Zealand perinatal mortality rates 2007–2015
* Fetal death rate per 1000 babies born (includes terminations and stillbirths).
# Neonatal death rate per 1000 live born babies.
+ Fetal deaths and early neonatal deaths per 1000 babies born.
^ Fetal deaths and early and late neonatal deaths per 1000 babies born.
• Lethal and terminated fetal abnormalities are all perinatal related deaths with PSANZ-PDC of congenital abnormality and neonatal deaths with PSANZ-NDC of 
congenital abnormality.
~ Included 2 late notification.
2007—2008 2009—2010 2011—2012 2013—2014 2015 Chi-squared test 
for trend (p)n Rate n Rate n Rate n Rate n Rate
Total births 130,826 130,666 126,539 120,231 59,808
Fetal deaths (terminations of pregnancy and stillbirths)* 1,037 7.9 1,045 8.0 995 7.9 924~ 7.7 412 6.9 0.035
Terminations of pregnancy 289 2.2 289 2.2 343 2.7 290 2.4 107 1.8 0.92
Stillbirths 748 5.7 756 5.8 652 5.2 634 5.3 305 5.1 0.0099
Early neonatal deaths <7 days 267 302 281 272 131 0.28
Late neonatal deaths 7–27 days 77 91 61 63 35 0.40
Neonatal deaths <28 days# 344 2.7 393 3.0 342 2.7 335 2.8 166 2.8 0.57
Perinatal mortalities+ 1,304 10.0 1,347 10.3 1,276 10.1 1196~ 9.9 543 9.1 0.18
Perinatal related mortalities^ 1,381 10.6 1,438 11.0 1,337 10.6 1259~ 10.5 578 9.7 0.13
Perinatal mortalities excluding lethal and terminated fetal 
abnormalities• 950 7.3 981 7.5 891 7.0 866 7.2 402 6.7 0.20
Perinatal related mortalities excluding lethal and 
terminated fetal abnormalities• 998 7.6 1,043 8.0 929 7.3 904 7.5 420 7.0 0.12
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Figure 3.2: Perinatal related mortality rolling three-year rates (per 1000 births) using New Zealand 
definitions 2007–2015
There has been a significant reduction in hypoxic peripartum deaths among total perinatal related 
deaths (births from 20 weeks) from 2007 to 2015 (chi-squared test for trend p=0.00031) and a trend 
to reduced deaths from fetal growth restriction (chi-squared test for trend p=0.053) (Table 3.26).
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There has been a significant decrease in the perinatal related mortality, fetal death, and stillbirth 
rates from 2007 to 2015 (chi-squared test for trend p=0.0011, p=0.0006, p=0.0002) using the 
international definition recommended by the World Health Organization (WHO) of perinatal related 
deaths from 1000g or from 28 weeks if birthweight is unknown. The perinatal related mortality rate 
(international definition) was 4.75/1000 births in 2007 and 4.2/1000 births in 2015. 
There has been no significant change in neonatal death or termination of pregnancy rates using 
the international definition from 2007 to 2015, although at 0.7/1000 the neonatal death rate 
(international definition) is the lowest reported from 2007 to 2015.
Statistically significant reductions in hypoxic peripartum death (p=0.0003), and death from antepartum 
haemorrhage (p=0.031) and fetal growth restriction (p=0.015) are in part responsible for the 
significant reduction in perinatal related mortality using the international definition (from 1000g or 28 
weeks if birthweight is unknown) (Table 3.27).
International comparisons
Direct international comparisons of perinatal mortality rates are difficult due to differences in definitions 
and in ascertainment of cases.
In the 2014 report from Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries 
across the UK (MBRRACE-UK) (Manktelow et al 2016) it is noted that while all late fetal losses and 
stillbirths from 22+0 weeks and neonatal deaths of babies live born from 20+0 weeks should be 
reported, the definition of reported mortality excludes births less than 24+0 weeks gestation and 
terminations of pregnancy and deaths where gestation is unknown. 
The perinatal mortality rate (stillbirths and neonatal deaths under seven days) in the UK in 2014 using 
the above definition was 5.34/1000 births (NZ 4.7 (95% CI 4.1–5.2)), and the perinatal related 
mortality rate was 5.88/1000 (NZ 5.1 (95% CI 4.6–5.7)). The stillbirth rate in the UK was 4.12/1000 
births in 2014 (NZ 3.3 (95% CI 2.8–3.7)), and the neonatal death rate was 1.76/1000 live births 
(NZ 1.8 (95% CI 1.5–2.2)). Perinatal mortality and stillbirth rates in New Zealand were significantly 
lower than in the UK, and the neonatal death rate was the same for 2014. 
Rates from the four Scandinavian countries, from the Pohjoismaiset Perinataalitilastot 2014 (Heino and 
Gissler 2016), using routinely collected data, the international definition, and excluding terminations of 
pregnancy, were reported as stillbirth 1.8–2.8/1000 births (NZ 2014 2.49), neonatal death 0.7–1.1 
(NZ 1.38), and perinatal mortality 2.3–3.96 (NZ 3.69). It is difficult to compare across countries 
as demography and background rates of contributing factors vary – for example, only 2 percent of 
mothers in Scandinavia are under 20 years of age (NZ 5.2 percent), and the preterm birth rate in 
Scandinavian countries varies from 5.1–5.8 percent (NZ 7.3 percent). In summary, New Zealand 
perinatal mortality rates were consistent with Scandinavian rates, excepting neonatal mortality, which 
was higher in New Zealand.
Australia’s Mothers and Babies 2014 reported a perinatal mortality rate of 14/1000 among babies 
of indigenous mothers and 9/1000 among babies of non-indigenous mothers (Australian Institute 
of Health and Welfare 2016). The overall perinatal related mortality rate reported for Australia was 
9.6/1000 births in 2014 compared to 11.2/1000 in 2014 in New Zealand. 
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Causes of perinatal related death
Table 3.3: Perinatal related deaths by primary perinatal death classification (PSANZ-PDC) 2015




Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=107 n=305 n=166 n=578
n % n % n % n %
Congenital abnormality  88  82.2  25  8.2  45  27.1  158  27.3 
Perinatal infection  3  2.8  12  3.9  7  4.2  22  3.8 
Hypertension  -  -  16  5.2  5  3.0  21  3.6 
Antepartum haemorrhage  3  2.8  46  15.1  30  18.1  79  13.7 
Maternal conditions  5  4.7  22  7.2  2  1.2  29  5.0 
Specific perinatal conditions  -  -  42  13.8  18  10.8  60  10.4 
Hypoxic peripartum death  -  -  9  3.0  8  4.8  17  2.9 
Fetal growth restriction  5  4.7  27  8.9  1  0.6  33  5.7 
Spontaneous preterm  3  2.8  19  6.2  43  25.9  65  11.2 
Unexplained antepartum death  -  -  87  28.5  -  -  87  15.1 
No obstetric antecedent  -  -  -  -  7  4.2  7  1.2 
Congenital abnormalities are the most common cause of perinatal related death (27.3 percent) using 
the PSANZ classification system, and 56 percent of these are deaths by termination of pregnancy. 
In 2015 compared to 2014, there were significantly fewer perinatal related deaths from spontaneous 
preterm birth (11.2 percent), demoting spontaneous preterm birth to the fourth most common cause of 
perinatal related death in 2015, after unexplained antepartum death (15.1 percent) and antepartum 
haemorrhage (13.7 percent).













































Perinatal death classification (PSANZ-PDC)
Termination of pregnancy Stillbirths Neonatal deaths
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Epidemiology and perinatal mortality
Sex
There is no significant association between the sex of the baby and perinatal related mortality rate in 
New Zealand (Table 3.29).
Maternal age
Figure 3.5 illustrates the crude associations between maternal age and perinatal related mortality from 
2011–2015. 
Maternal age is significantly associated with perinatal related death. Termination of pregnancy, stillbirth 
and neonatal death are all more frequent at the extremes of maternal age, although there are significant 
differences in the relationships among these (Figure 3.5). For example, although the ‘U-shaped’ 
association is evident for neonatal deaths, neonatal death is significantly more common among mothers 
under 20 years of age than all other ages, including mothers 40 years of age and older. Maternal age 
from 25 to 35 years is associated with the lowest rates of perinatal related mortality.
There have been significant changes in the distribution of maternal age in New Zealand from 2007 to 
2015. A chi-squared test for trend shows a significant reduction in the proportion of mothers under 20 
years of age and mothers 35–39 years of age, and an increase in mothers aged 20–34 years and 40 
years and older (Figure 2.3). 
After adjusting for the effects of socioeconomic status, ethnicity, multiple pregnancy, DHB of residence, 
sex of baby, and year of birth, mothers aged 40 years and older had significantly higher odds ratios 
for late termination of pregnancy, stillbirth, and neonatal death compared to mothers aged 25–29 
years (Table 3.12). Mothers aged 35–39 years had significantly higher odds ratios for late termination 
of pregnancy ad stillbirth compared to mothers aged 25–29 years. Age under 20 years was associated 
with significantly higher odds ratios for termination of pregnancy, stillbirth and neonatal death 
compared to mothers aged 25–29 years (Table 3.12).






Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
<20  2,835  4.7  5  4.7  1.76  22  7.2  7.76  18  10.8  6.41  45  7.8  15.87 
20–24  10,145  17.0  14  13.1  1.38  43  14.1  4.24  29  17.5  2.87  86  14.9  8.48 
25–29  16,013  26.8  27  25.2  1.69  88  28.9  5.50  35  21.1  2.20  150  26.0  9.37 
30–34  18,294  30.6  38  35.5  2.08  77  25.2  4.21  43  25.9  2.37  158  27.3  8.64 
35–39  9,981  16.7  20  18.7  2.00  56  18.4  5.61  31  18.7  3.13  107  18.5  10.72 
≥40  2,533  4.2  3  2.8  1.18  19  6.2  7.50  10  6.0  3.98  32  5.5  12.63 
Unknown  7  0.0  -  -  -  -  -  -  -  -  -  -  -  - 
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<20 20–24 25–29 30–34 35–39 ≥40 years
Figure 3.6 illustrates the association between maternal age and cause-specific stillbirth and neonatal 
mortality (late termination of pregnancy excluded). Especially noticeable are the associations between 
mothers under 20 years of age and death from spontaneous preterm birth, fetal growth restriction, 
and antepartum haemorrhage, and the association of stillbirth and neonatal death from congenital 
abnormality with both extremes of maternal age. Perinatal death from specific perinatal conditions 
(deaths associated with twinning) is also significantly associated with advanced maternal age. 
The higher rate of combined stillbirth and neonatal death from congenital abnormalities among teenage 
mothers is due to euploid (non-chromosomal) abnormalities, and among mothers 40 and older it is due 
to chromosomal abnormalities.
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Figure 3.6: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 
1000 births) (excluding termination of pregnancy) by maternal age (with 95% CIs) 2011–2015












PSANZ-PDC specific combined stillbirth/neonatal mortality rate/1000 births
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Ethnicity





Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
Māori  14,873  24.9  20  18.7  1.34  71  23.3  4.77  52  31.3  3.52  143  24.7  9.61 
Pacific peoples  6,165  10.3  4  3.7  0.65  39  12.8  6.33  28  16.9  4.57  71  12.3  11.52 
Indian  3,137  5.2  2  1.9  0.64  28  9.2  8.93  13  7.8  4.18  43  7.4  13.71 
Other Asian  6,194  10.4  11  10.3  1.78  27  8.9  4.36  15  9.0  2.44  53  9.2  8.56 
Other (including 
unknown)  7,205  12.0  12  11.2  1.67  26  8.5  3.61  6  3.6  0.84  44  7.6  6.11 
NZ European  22,234  37.2  58  54.2  2.61  114  37.4  5.13  52  31.3  2.36  224  38.8  10.07 
The distribution of perinatal related mortality by ethnicity differs in this year’s report compared to 
previous years of PMMRC reporting as a result of the change in denominator of all births from the 
BDM dataset to the MAT dataset. The definition of ethnicity differs between these datasets and this is 
responsible for the differences. This is discussed further in chapter 5.
There is significantly higher perinatal related mortality (2011–2015) among the children of mothers 
of Pacific and Indian ethnicities compared to mothers of Māori, Other Asian, Other (includes Other 
European, Middle Eastern, Latin American, African), and New Zealand European ethnicity.
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Māori Pacific peoples Indian Other Asian Other (including unknown) NZ European
The distribution of stillbirth by ethnicity mirrors that of perinatal related mortality. However, the 
distribution of neonatal mortality shows a different pattern, with a significantly higher neonatal 
mortality rate among the children of Māori, Pacific and Indian mothers than among mothers of Other 
Asian, Other (includes Other European, Middle Eastern, Latin American, African), and New Zealand 
European ethnicity. 
Termination of pregnancy deaths are significantly less common among Māori and Pacific mothers than 
mothers of all other ethnicities, and significantly more common among Indian and Other Asian mothers 
than among New Zealand European and Other ethnicity mothers.
Multivariable analyses to determine the independent effect of ethnicity after adjusting for age, 
deprivation decile, baby sex, multiple pregnancy, and year of birth showed that Māori mothers were at 
lower risk of termination of pregnancy (0.53 (95% CI 0.44-0.64)) and at higher risk of neonatal death 
(1.18 (95% CI 1.02-1.36)) compared to New Zealand European mothers (Table 3.12). 
After adjusting, Pacific mothers had decreased odds for late termination of pregnancy compared to 
New Zealand European mothers but increased odds for both stillbirth (1.17 (95% CIs 1.03-1.33)) and 
neonatal death (1.32 (95% CI 1.11-1.57)).   
Indian mothers had significantly increased odds for late termination of pregnancy (1.36 (95% CI 1.04-
1.78)), stillbirth (1.46 (95% CI 1.21-1.75)) and neonatal death (1.74 (95% CI 1.36-2.22)) compared 
to New Zealand European mothers.
Other Asian (non-Indian) women had increased odds of late termination of pregnancy (1.30 (1.07-
1.57)) but lower odds of stillbirth (0.76 (0.62-0.93)) compared to New Zealand European mothers.
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Women of Other ethnicities, including Other European, Middle Eastern, Latin American, African, had 
lower odds of all of late termination of pregnancy (0.76 (95% CI 0.62-0.93)), stillbirth (0.69 (95% CI 
0.59-0.81)), and neonatal mortality (0.62 (95% CI 0.49-0.78))compared to New Zealand European 
women.
These adjusted estimates were limited by the inability to include parity, BMI, and smoking in the 
multivariable models due to missing data.
Figure 3.8: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 
1000 births) (excluding termination of pregnancy) by maternal prioritised ethnicity (with 95% CIs) 
2011–2015
* 'All other' includes New Zealand European, Other Asian, Other (including unknown).
Figure 3.8 illustrates the associations between maternal prioritised ethnicity and cause-specific 
combined stillbirth and neonatal mortality rates. 
The outlying causes of stillbirth and neonatal death among babies of Māori mothers are spontaneous 
preterm birth, antepartum haemorrhage, maternal conditions (mostly due to diabetes), hypertension, 
and deaths with no obstetric antecedent. For a description of conditions included in each PSANZ-PDC 
category, see Table 3.70. An in-depth discussion of Māori perinatal related mortality can be found in 
chapter 5.
The outlying causes of stillbirth and neonatal death among babies of Pacific mothers are spontaneous 
preterm birth, maternal conditions, specific perinatal conditions, antepartum haemorrhage, 
hypertension, perinatal infection, congenital abnormality, and deaths with no obstetric antecedent.
Outlying causes of death among babies of Indian mothers are spontaneous preterm birth, fetal growth 
restriction, specific perinatal conditions, and antepartum haemorrhage. There may be an excess of 
other causes among babies of Indian mothers, but as numbers are small and confidence intervals are 
large, it is hard to confirm.












PSANZ-PDC specific combined stillbirth/neonatal mortality rate/1000 births
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Socioeconomic deprivation







Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
1 (least deprived) 8,366 14.0  20  18.7  2.39  36  11.8  4.30  19  11.4  2.29  75  13.0  8.96 
2 9,483 15.9  22  20.6  2.32  44  14.4  4.64  17  10.2  1.81  83  14.4  8.75 
3 10,746 18.0  20  18.7  1.86  44  14.4  4.09  25  15.1  2.34  89  15.4  8.28 
4 13,447 22.5  22  20.6  1.64  69  22.6  5.13  46  27.7  3.44  137  23.7  10.19 
5 (most deprived) 17,284 28.9  23  21.5  1.33  110  36.1  6.36  57  34.3  3.32  190  32.9  10.99 
Unknown 482 0.8  -  -  -  2  0.7  -  2  1.2  -  4  0.7  - 
































Quintile 1 (least deprived) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (most deprived)
Figure 3.9 illustrates an association between increased socioeconomic deprivation and perinatal 
related mortality. This association is less obvious in this report than previously. It is likely this is due to 
the change in area of domicile, which underpins the measure of deprivation, this year from the small 
geographic area represented by mesh block in the BDM dataset to the larger census area unit measure 
available in the MAT dataset. 
There is an increase in perinatal related death from termination of pregnancy with decreasing 
socioeconomic deprivation and an increase in stillbirth and neonatal death with increasing deprivation. 
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Figure 3.10: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 
1000 births) (excluding termination of pregnancy) by deprivation quintile (with 95% CIs) 2011–2015
Figure 3.10 illustrates the associations between socioeconomic deprivation quintile and cause-specific 
stillbirth and neonatal mortality rates. There is a significant increase in spontaneous preterm birth, 
maternal conditions, antepartum haemorrhage, hypertension, perinatal infection, and congenital 
abnormalities as causes of stillbirth and neonatal death with increasing socioeconomic deprivation. The 
suggested increase in death without obstetric antecedent is not statistically significant (p=0.11). 
The increase in death from termination of pregnancy among babies of mothers with decreasing 
deprivation may be due to increased access to antenatal diagnostic and/or termination of pregnancy 
services, or to increased risk of abnormalities and diseases leading to termination of pregnancy.
Similarly, the mechanisms for increased stillbirth and neonatal death with increasing socioeconomic 
deprivation are not well described, and similarly may involve a combination of access and disease risk 
factors. The importance of access is supported by the association between socioeconomic status and 
barriers to access and/or engagement with care contributory factors to perinatal related death (Figure 
3.27). 
Multivariable analysis, adjusting for maternal ethnicity, age, multiple pregnancy, year of birth, and sex 
of baby, found increasing socioeconomic deprivation (measured by deprivation decile) was significantly 
associated with increased risk of stillbirth and neonatal mortality but there was no increase in risk for 
late termination of pregnancy. 












PSANZ-PDC-specific combined stillbirth/neonatal mortality rate/1000 births
Quintile 1 (least deprived) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (most deprived)
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Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=102 n=296 n=164 n=562
n % n % Rate n % Rate n % Rate n % Rate
<18.50  1,591  2.7  1  1.0  0.63  3  1.0  1.89  4  2.4  2.52  8  1.4  5.03 
18.50–25.49  28,814  48.2  47  46.1  1.63  110  37.2  3.82  64  39.0  2.23  221  39.3  7.67 
25.50–30.49  14,236  23.8  27  26.5  1.90  81  27.4  5.69  34  20.7  2.41  142  25.3  9.97 
30.50–35.49  7,012  11.7  9  8.8  1.28  26  8.8  3.71  27  16.5  3.87  62  11.0  8.84 
35.50–40.49  3,355  5.6  4  3.9  1.19  25  8.4  7.45  13  7.9  3.91  42  7.5  12.52 
≥40.50  1,984  3.3  -  -  -  12  4.1  6.05  5  3.0  2.54  17  3.0  8.57 
Unknown  2,816  4.7  14  13.7  -  39  13.2  -  17  10.4  -  70  12.5  - 
* MAT data numerator and denominator.
Body mass index
Figure 3.11: Perinatal related death rates (per 1000 births) by maternal body mass index (BMI)* (with 
95% CIs) 2011–2015
* MAT data numerator and denominator.
The use of MAT data has facilitated the analysis of perinatal related mortality rates by BMI. MAT data 
have been used for all numerator data in the tables and figures. See section “1.2 Methodology”’ for 
explanation. Due to the format of the provided data, the WHO categories have been modified slightly.
Figure 3.11 shows the significant association between maternal BMI and perinatal related mortality. 





















<18.50 18.50–25.49 25.50–30.49 30.50–35.49 35.50–40.49 ≥40.50 BMI (kg/m2)
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Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
0  22,746  38.0  47  43.9  2.07  141  46.2  6.20  61  36.7  2.70  249  43.1  10.95 
1  19,149  32.0  32  29.9  1.67  72  23.6  3.76  57  34.3  2.99  161  27.9  8.41 
2  8,594  14.4  20  18.7  2.33  44  14.4  5.12  30  18.1  3.52  94  16.3  10.94 
3  3,301  5.5  5  4.7  1.51  21  6.9  6.36  10  6.0  3.05  36  6.2  10.91 
4  1,464  2.4  3  2.8  2.05  12  3.9  8.20  6  3.6  4.14  21  3.6  14.34 
≥5  1,284  2.1  -  -   -    15  4.9  11.68  2  1.2  1.58  17  2.9  13.24 
Unknown  3,270  5.5  -  -   -    -  -   -    -  -   -    -  -   -   
Figure 3.12: Perinatal related death rates (per 1000 births) by maternal parity (with 95% CIs) 2011–
2015
There is a significant increase in stillbirth and neonatal death with increasing BMI and a reduction in 
late termination of pregnancy with increasing BMI. 
Parity
The change to using the MAT data means that rates of perinatal related mortality can be presented by 
parity for the first time. For these analyses, numerator data are obtained from the PMMRC dataset and 
denominator data from the MAT dataset. These are univariable analyses – that is, they do not adjust 



























Parity 0 1 2 3 4 ≥5
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There is an increase in perinatal related mortality rate among nulliparous women (women having their 
first baby) compared to women having their second baby. There is increasing risk for women having 
their third and subsequent babies compared to their second, and this risk increases up to at least 
the sixth baby (parity 5). The risk for subsequent births is more difficult to estimate as the numbers of 
women in these parity groups are small, so the rate for the sixth or later births has been aggregated. 
The perinatal related mortality rate for women having their first baby approximates the risk for women 
having their fourth and fifth baby. The risk for women having their sixth or later baby is double the risk 
of women having their second baby.
There is an increase in risk of stillbirth and neonatal death among nulliparous women compared to 
women having their second baby. There is increasing risk for women having their third and subsequent 
babies compared to their second, and this risk increases up to the sixth baby (parity 5). Stillbirth risk for 
women having their first baby is similar to that of women having their third babies, and neonatal risk is 
similar to that of women having their third or fourth baby. 
There is no significant trend in rate of late termination of pregnancy with increasing parity; however, 
the rate of late termination of pregnancy is higher among women having their first baby than among 























DHB of maternal residence
Unadjusted perinatal related mortality rate NZ perinatal related mortality rate 2011–2015
Figure 3.13: Unadjusted perinatal related mortality rates (per 1000 births) by DHB of residence 
(mother) compared to average perinatal related mortality (with 95% CIs) 2011–2015
The red line in Figure 3.13 represents the New Zealand rate of perinatal related mortality for 2011–
2015 (10.0/1000 births). DHB rates are compared to the national rate, represented by the point 
estimate for 2011–2015 and a 95 percent CI. This analysis has been limited to 2011–2015 because 
there have been significant changes in the perinatal related mortality rate since 2007, and changes in 
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maternity care over the same time, and it was no longer appropriate to group all years. The use of data 
from 2011–2015 is consistent with a number of analyses in the perinatal report this year.
There is a significantly higher rate of perinatal related mortality than the national rate among residents 
of Counties Manukau DHB. 
Figures describing the rates of stillbirth and neonatal death compared to the national rates can be found 
in the appended Figure 3.28 and Figure 3.29. 
There is a significantly higher stillbirth rate than the national rate among residents of Counties Manukau 
DHB (Figure 3.28).
There is a significantly higher neonatal death rate than the national rate among residents of Counties 
Manukau and Waikato DHBs (Figure 3.29).
Maternal smoking, alcohol and substance use
Figure 3.14: Perinatal related mortality rates (per 1000 births) by smoking* at registration with 
maternity care* (with 95% CIs) 2011–2015






























Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=102 n=296 n=164 n=562
n % n % Rate n % Rate n % Rate n % Rate
Smoker  8,088 13.5  10  9.8  1.24  45  15.2  5.56  40  24.4  4.98  95  16.9  11.75 
Non-smoker  49,063 82.0  79  77.5  1.61  215  72.6  4.38  107  65.2  2.19  401  71.4  8.17 
Unknown  2,657 4.4  13  12.7  -  36  12.2  -  17  10.4  -  66  11.7  - 
* MAT data numerator and denominator.
The use of the MAT dataset denominator has facilitated the analysis of perinatal related mortality rates 
by smoking. MAT smoking data have been used for both numerator and denominator in the tables and 
figures reporting perinatal related mortality rates. The proportion of smokers in the PMMRC dataset is 
presented in Table 3.10 with data on smoking cessation, along with other data without a denominator. 
(See “Appendix D: Compiling the MAT Denominator and Numerator Data” for a more detailed 
description of the datasets.)
Among women who birthed in New Zealand in 2015 whose data are included in the MAT dataset, 
13.5 percent (or 14.2 percent of mothers with smoking data available) were smokers at registration 
with their LMC. Smoking data at registration were missing for 4.4 percent of mothers overall, and for 
11.7 percent of mothers of babies who died in the perinatal period. 
The smoking rate among mothers of babies who died was 16.9 percent at registration with an LMC 
according to data from the MAT dataset (or 19.2% of mothers with known smoking data) compared to 
a smoking rate of 21.1 percent at the time of death in the PMMRC dataset. 
Figure 3.14 shows that significantly more women who had a neonatal death or a stillbirth were 
smokers. It is possible that the true relative risk for smokers will differ from that presented here as it is 
likely that the rate of smoking among mothers with missing smoking data in the MAT dataset differs from 
that among mothers with data.
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Table 3.10: Maternal smoking, alcohol and substance use at the time of perinatal related death 2015




n=107 n=305 n=166 n=578
n % n % n % n %
Currently smoking
Yes  14  13.1  61  20.0  47  28.3  122  21.1 
No  93  86.9  243  79.7  119  71.7  455  78.7 
Smoking history (among current non-smokers)
Never smoked  75  70.1  200  65.6  84  50.6  359  62.1 
Stopped before this pregnancy  11  10.3  26  8.5  21  12.7  58  10.0 
Stopped <16 weeks gestation  5  4.7  10  3.3  10  6.0  25  4.3 
Stopped ≥16 weeks gestation  2  1.9  6  2.0  2  1.2  10  1.7 
Unknown  -  -  1  0.3  1  0.6  2  0.3 
Unknown  -  -  1  0.3  -  -  1  0.2 
Alcohol and substance use
Yes  9  8.4  25  8.2  19  11.4  53  9.2 
No  91  85.0  257  84.3  130  78.3  478  82.7 
Unknown  7  6.5  23  7.5  17  10.2  47  8.1 
Specific drugs
Alcohol  5  4.7  19  6.2  15  9.0  39  6.7 
Amphetamine/P  -  -  2  0.7  2  1.2  4  0.7 
Herbal highs  -  -  1  0.3  -  -  1  0.2 
Marijuana  5  4.7  8  2.6  7  4.2  20  3.5 
Methadone  -  -  -  -  1  0.6  1  0.2 
There has been a decrease in the proportion of current smokers among mothers of babies who died in 
the perinatal period from around 30 percent in 2007–2009 to 21 percent in 2015. This is associated 
with other changes in demography among the birthing population (eg, an increase in the proportion of 
Other Asian mothers who have low rates of smoking, and a reduction in births among women under 
20 years of age who have a high rate of smoking) and probably reflects a reduction in smoking in the 
general population. The New Zealand Health Survey data show a statistically significant reduction in 
current smoking among women in New Zealand from 18.9 percent in 2006/2007 to 15.0 percent in 
2014/2015 (Ministry of Health 2015a). 
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Table 3.11: Maternal smoking cessation support offered and perinatal related death 2015
Smoking cessation support 
offered (among current 
smokers and non-smokers 
other than those who have 
‘never smoked’)
Fetal deaths
Neonatal deaths Perinatal related deaths Termination of 
pregnancy Stillbirths
n=32 n=104 n=82 n=218
n % n % n % n %
No  9  28.1  28  26.9  22  26.8  59  27.1 
Yes – by LMC only  6  18.8  10  9.6  18  22.0  34  15.6 
Yes – referred to external agents  3  9.4  8  7.7  7  8.5  18  8.3 
Yes – referral declined  6  18.8  39  37.5  24  29.3  69  31.7 
Unknown  8  25.0  19  18.3  11  13.4  38  17.4 
In 2015, smoking cessation support was offered to approximately half of smoking or recently smoking, 
mothers of babies who died. 
Table 3.12: Adjusted odds ratios for perinatal related mortality, termination of pregnancy, stillbirth, 


















   Maori 0.90 0.83 0.97 0.53 0.44 0.64 0.93 0.83 1.03 1.18 1.02 1.36
   Pacific 1.09 1.00 1.20 0.65 0.52 0.82 1.17 1.03 1.33 1.32 1.11 1.57
   Indian 1.50 1.32 1.71 1.36 1.04 1.78 1.46 1.21 1.75 1.74 1.36 2.22
   Other Asian 0.94 0.84 1.05 1.30 1.07 1.57 0.76 0.64 0.90 0.91 0.72 1.15
   Other  0.69 0.62 0.77 0.76 0.62 0.93 0.69 0.59 0.81 0.62 0.49 0.78
   New Zealand European 1.00 1.00 1.00 1.00
Age#
   <20 1.62 1.45 1.81 1.62 1.25 2.12 1.49 1.28 1.75 1.81 1.49 2.20
   20–24 1.11 1.01 1.21 1.18 0.97 1.43 1.11 0.98 1.25 1.05 0.89 1.23
   25–29 1.00 1.00 1.00 1.00
   30–34 0.97 0.89 1.05 1.03 0.87 1.23 1.00 0.89 1.12 0.85 0.73 1.00
   35–39 1.19 1.09 1.30 1.29 1.07 1.55 1.16 1.02 1.31 1.17 0.99 1.38
   ≥40 1.51 1.32 1.72 1.80 1.38 2.34 1.47 1.22 1.78 1.34 1.03 1.74
Deprivation decile# (per unit) 1.05 1.03 1.06 0.99 0.97 1.02 1.05 1.03 1.07 1.08 1.06 1.11
Year of birth# 0.99 0.98 1.01 1.00 0.97 1.03 0.99 0.97 1.00 1.00 0.98 1.03
Sex+
   Male 1.00 1.00 1.00 1.00
   Female 0.95 0.90 1.00 1.03 0.91 1.16 0.97 0.90 1.05 0.85 0.76 0.94
Multiple pregnancy* 4.28 3.91 4.69 2.07 1.60 2.67 4.01 3.52 4.56 6.73 5.80 7.81
* Data for numerator from the PMMRC dataset.
# Data for numerator from the MAT dataset.
+ Data for numerator from the MAT dataset, then the PMMRC dataset if MAT data are missing. 
OR = odds ratio.
CI = confidence interval.
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Table 3.12 provides odds ratios (ORs) for perinatal related mortality, late termination of pregnancy, 
stillbirth, and neonatal death adjusted for co-variables included in the model. Significant associations 
are highlighted in red.
Gestation and birthweight and perinatal related mortality
Table 3.13: Perinatal related mortality rates (per 1000 births) by gestation and birthweight 2015
Total births
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
Gestation at birth (weeks)
20–22  168 0.3  66  61.7  *  73  23.9  *  36  21.7  *  175  30.3  * 
23–24  117 0.2  27  25.2  *  32  10.5  *  33  19.9  *  92  15.9  * 
25–27  206 0.3  8  7.5  38.83  31  10.2  150.49  13  7.8  77.84  52  9.0  252.43 
28–31  456 0.8  3  2.8  6.58  29  9.5  63.60  9  5.4  21.23  41  7.1  89.91 
32–36  3,635 6.1  3  2.8  0.83  48  15.7  13.20  27  16.3  7.53  78  13.5  21.46 
37–40  45,646 76.3  -  -  -  72  23.6  1.58  39  23.5  0.86  111  19.2  2.43 
≥41  9,105 15.2  -  -  -  20  6.6  2.20  9  5.4  0.99  29  5.0  3.19 
Unknown  475 0.8  -  -  -  -  -  -  -  -  -  -  -  - 
Birthweight (g)
<500  187  0.31  63  58.9  *  99  32.5  *  26  15.7  *  188  32.5  * 
500–999  273  0.46  36  33.6  131.87  48  15.7  175.82  54  32.5  285.71  138  23.9  505.49 
1000–1499  376  0.63  6  5.6  15.96  16  5.2  42.55  12  7.2  33.90  34  5.9  90.43 
1500–1999  649  1.09  1  0.9  1.54  27  8.9  41.60  8  4.8  12.88  36  6.2  55.47 
2000–2499  2,161  3.61  -  -  -  19  6.2  8.79  14  8.4  6.54  33  5.7  15.27 
2500–2999  7,966  13.32  -  -  -  31  10.2  3.89  21  12.7  2.65  52  9.0  6.53 
3000–3499  18,998  31.76  -  -  -  34  11.1  1.79  19  11.4  1.00  53  9.2  2.79 
3500–3999  18,051  30.18  -  -  -  23  7.5  1.27  6  3.6  0.33  29  5.0  1.61 
4000–4499  6,732  11.26  -  -  -  4  1.3  0.59  4  2.4  0.59  8  1.4  1.19 
≥4500  1,252  2.09  -  -  -  3  1.0  2.40  1  0.6  0.80  4  0.7  3.19 
Unknown  3,163  5.29  1  0.9  -  1  0.3  -  1  0.6  -  3  0.5  - 
* Denominator data unreliable where asterisk is present, and therefore rates have not been calculated.
There has been a reduction in stillbirth rate at term (Table 3.47), and a parallel reduction in perinatal 
related mortality rate of babies 3000–3499g (chi-squared test for trend p=0.024) and 4000–4499g 
(p=0.00035) from 2007 to 2015 (Table 3.48). 
A combination of fewer births beyond term and the known lower risk of stillbirth at term but prior to 
40 weeks, explain a small part of the reduction in stillbirths at term. A further reduction in term stillbirth 
risk may be due to appropriate iatrogenic birth (induction of labour or elective Caesarean) for risks 
identified at term. However the extent of this reduction cannot be estimated from the data available.
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Figure 3.15: Perinatal related mortality risk (per 1000 ongoing pregnancies) by gestational age at 





































Gestation at birth (weeks)
2007–2009 2010–2012 2013–2015
Figure 3.15 shows perinatal related mortality risk by gestation for three 3-year cohorts. It illustrates the 
higher mortality risk for babies from 20 to 24 weeks gestation and the marked increase in risk again 
near to term. 
The apparent increase in risk at 20–22 weeks seen in the earlier two time cohorts (2007–2012) is no 
longer statistically significant due to a decrease in deaths at 20–22 weeks in 2015.
There is a statistically significant decrease in perinatal related mortality risk from 2007 to 2015 at 
28–31 weeks (p=0.044), 37–38 weeks (p=0.025) and ≥41 weeks (p=0.047) (Table 3.46).
Of note in 2015 is an increase in perinatal related mortality risk from 41+0 weeks compared to the 
lower rates of recent years. The risk in 2015 (3.19 per 1000 ongoing pregnancies) was the same 
as the risk in 2008 (3.15) and higher than the rates in any year from 2009 to 2014. There were 29 
deaths from 41 weeks in 2015 (20 stillbirths and 9 neonatal deaths). The number of neonatal deaths 
is consistent with previous years. Twenty stillbirths is the largest number since 2007, and there were 
no more than nine stillbirths per year for the past four years (2011–2014). In 2015, stillbirths from 41 
weeks included deaths from congenital abnormality (PSANZ-PDC1), perinatal infection (PSANZ-PDC2), 
hypertension (PSANZ-PDC3), antepartum haemorrhage (PSANZ-PDC4), maternal conditions (PSANZ-
PDC5), specific perinatal conditions (PSANZ-PDC6), hypoxic peripartum death (PSANZ-PDC7), fetal 
growth restriction (PSANZ-PDC8), and unexplained (PSANZ-PDC10). 
Review of the 17 stillbirths from 41+0 weeks without congenital abnormality, against the Auckland 
Consensus Guideline on Induction of Labour (Wise et al 2014) and against best practice for antenatal 
assessment in women with risk factors, found the care provided did not follow the guideline and/or best 
practice in 6 of the 17 stillbirths. This related to best practice to perform serial growth scans following 
antepartum haemorrhage; best practice for obstetric review and/or to perform serial growth scans for 
BMI >35; and to offer induction of labour for increased risk.
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For the remaining 11 stillbirths, no antenatal risk factors were identified.
Management of Pregnancy after 41 Weeks
• Women with uncomplicated pregnancies should be offered induction of labour between 
41+0 and 42+0 weeks to avoid the risks of prolonged pregnancy, including an increased 
risk of perinatal mortality (NICE 2008).
• Women with risk factors for perinatal related mortality or complications of pregnancy should 
be offered obstetric assessment and induction of labour at earlier gestations.
• Women from 41+0 weeks pregnancy should be counselled about the limitations of research 
on increased fetal surveillance to reduce perinatal mortality after 41+0 weeks. Suggested 
surveillance includes ultrasound scan for fetal growth and liquor volume (by estimation of 
deepest pocket), cardiotocography (CTG), and prompt assessment in response to reported 
reduction in fetal movements.
RECOMMENDATION:
The PMMRC supports the development of a national interdisciplinary clinical practice guideline on the 
indications and timing for induction of labour, to guide clinicians to offer induction when appropriate 
(that is, where evidence shows that benefit to mother and/or baby outweighs risk) and to avoid induction 
when not appropriate.
Perinatal death classification (PSANZ-PDC and PSANZ-NDC) of fetal and neonatal deaths by 
gestational age at birth for 2011–2015 is available in Table 3.49 and Table 3.50.
Stillbirth
The significant reduction from 2007 to 2015 in perinatal related mortality is due to a significant 
reduction in stillbirths, specifically at 37–40 weeks (chi-squared test for trend p=0.0018) (Table 3.47). 
There has been a statistically significant reduction in hypoxic peripartum death from 2007 to 2015 
(p=0.0087) (Table 3.51). There is no significant reduction in stillbirths from 41 weeks, as shown in 
previous years (chi-squared test for trend p=0.18), due to the large number of stillbirths at 41 weeks in 
2015 (Table 3.47). 
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Table 3.14: Timing of stillbirths relative to labour by gestation 2015
Timing of stillbirth
All Stillbirths Stillbirths ≥23 weeks Stillbirths ≥37 weeks
Stillbirths ≥37 weeks 
without congenital 
abnormality
n=305 n=232 n=92 n=87
n % n % n % n %
Antepartum  219  71.8  184  79.3  63  68.5  61  70.1 
Intrapartum – total  68  22.3  34  14.7  20  21.7  17  19.5 
Intrapartum – first stage  24  7.9  17  7.3  12  13.0  11  12.6 
Intrapartum – second stage  8  2.6  4  1.7  3  3.3  3  3.4 
Intrapartum – unknown stage  36  11.8  13  5.6  5  5.4  3  3.4 
Unknown  18  5.9  14  6.0  9  9.8  9  10.3 
In 2015, there were 34 known intrapartum deaths from 23 weeks, and 20 at term (>37 weeks 
gestation). After a marked and statistically significant fall in term intrapartum deaths from 2007 to 
2013, there has been a rise in numbers in the last two years. The reduction from 2007 remains 
significant (chi-squared test for trend p=0.0014). Intrapartum deaths at 23–27 (p=0.34) and 28–36 
weeks (p=0.095) have not reduced significantly (Figure 3.17). 
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Figure 3.17: Intrapartum stillbirth rolling three-year risks (per 1000 ongoing pregnancies) by gestation 































23–27 28–36 ≥37 weeks
This is consistent with and probably due to a significant reduction in hypoxic peripartum deaths. 
In 2015, as in 2014, there were 17 hypoxic peripartum deaths. Sixteen were from 37 weeks, nine of 
which contributed to the 17 intrapartum stillbirths (without congenital abnormality) at term in 2015 (the 
remaining eight term intrapartum stillbirths were due to perinatal infection, hypertension, antepartum 
haemorrhage, and fetal growth restriction). In 2007 there were 25 intrapartum stillbirths at term, 18 of 
which were hypoxic peripartum deaths. 
Termination of pregnancy
The late termination of pregnancy rate in 2015 was lower than any previously reported year 
(1.8/1000 births) and significantly lower than the years 2007–2014 combined (p=0.004). However, 
the test for trend is not statistically significant over the years 2007–2015. 
There were 107 late terminations of pregnancy reported in 2015.
Terminations of pregnancy from 20 weeks gestation at birth contributed 18.5 percent of perinatal 
related deaths in 2014; 82.2 percent of these were associated with congenital abnormalities.
There were 14 terminations of pregnancy after 24 weeks in 2015. The primary antecedent 
classifications for these deaths were congenital abnormality in 11, and maternal conditions and fetal 
growth restriction in the remainder.
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Neonatal death
The neonatal death rate has not changed significantly in New Zealand from 2007 to 2015. Meanwhile 
there have been significant reductions in neonatal mortality in the UK (from 2004 to 2014), Australia, 
and Scandinavia (Manktelow et al 2016; Australian Institute of Health and Welfare 2016; Heino and 
Gissler 2016).
RECOMMENDATION:
The PMMRC investigate why there has been no reduction in neonatal mortality in New Zealand.
There were 166 neonatal deaths in 2015 contributing 28.7 percent of all perinatal related mortalities. 
Over one-quarter (27.1 percent) of neonatal deaths were babies with congenital abnormalities. Of the 
remainder, 30 percent died before 23 weeks and 56 percent before 25 weeks. Twenty neonates (12 
percent) died at term.
An attempt was made to resuscitate one of 36 neonatal deaths at 20–22 weeks, while 10/20 (50 
percent) at 23 weeks and 11/13 (85 percent) at 24 weeks were resuscitated. One-half of term 
neonates who died were not resuscitated. These babies died of congenital abnormality, perinatal 
infection, hypoxic peripartum death or died without obstetric antecedent (postnatal infection, accidental 
asphyxiation or sudden unexpected death in infancy (SUDI)).
Of the seven deaths from SUDI among the neonatal deaths in 2015, six deaths were associated with 
unsafe sleep, and these mothers were smokers. Two babies were small for gestational age (SGA) by 
customised birthweight centiles.
The association between PSANZ-PDC and PSANZ-NDC cause of death classifications for 2015 is 
shown in Table 3.53.
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Table 3.15: Clinical details of neonatal deaths 2015
Total Congenital abnormalities
Neonatal deaths excluding congenital abnormalities
20–22 23–24 25–27 28–36 ≥37 weeks
n=166 n=45 n=36 n=32 n=11 n=22 n=20
n % n % n       % n  % n %     n %     n %
Age at death (days)
0  73  44.0  16  35.6  31  86.1  16  50.0  1  9.1  6  27.3  3  15.0 
1–6  58  34.9  12  26.7  5  13.9  11  34.4  8  72.7  14  63.6  8  40.0 
7–13  20  12.0  11  24.4  -  -  3  9.4  1  9.1  2  9.1  3  15.0 
14–20  7  4.2  3  6.7  -  -  2  6.3  -  -  -  -  2  10.0 
21–27  8  4.8  3  6.7  -  -  -  -  1  9.1  -  -  4  20.0 
Place of death
Home  13  7.8  5  11.1  1  2.8  -  -  -  -  -  -  7  35.0 
Hospital
Delivery suite  48  28.9  11  24.4  21  58.3  12  37.5  -  -  2  9.1  2  10.0 
Antenatal ward  3  1.8  -  -  3  8.3  -  -  -  -  -  -  -  - 
Postnatal ward  3  1.8  2  4.4  -  -  -  -  -  -  -  -  1  5.0 
Neonatal unit  73  44.0  17  37.8  -  -  17  53.1  11  100.0  19  86.4  9  45.0 
Operating theatre  5  3.0  3  6.7  1  2.8  -  -  -  -  1  4.5  -  - 
Emergency department  3  1.8  1  2.2  1  2.8  -  -  -  -  -  -  1  5.0 
Other  17  10.2  6  13.3  9  25.0  2  6.3  -  -  -  -  -  - 
Other  1  0.6  -  -  -  -  1  3.1  -  -  -  -  -  - 
Apgar 5 minutes 
0–3  78  47.0  13  28.9  *  *  18  56.3  2  18.2  12  54.5  8  40.0 
4–5  13  7.8  7  15.6  *  *  3  9.4  2  18.2  -  -  -  - 
6–7  24  14.5  8  17.8  *  *  8  25.0  1  9.1  6  27.3  1  5.0 
≥8  38  22.9  17  37.8  *  *  1  3.1  5  45.5  4  18.2  11  55.0 
Unknown  13  7.8  -  -  *  *  2  6.3  1  9.1  -  -  -  - 
Resuscitation at birth 
Yes  87  52.4  24  53.3  *  *  21  65.6  11  100.0  19  86.4  11  55.0 
No  79  47.6  21  46.7  *  *  11  34.4  -  -  3  13.6  9  45.0 
Outcome of resuscitation
Baby resuscitated and 
transferred to another 
clinical care area
 73  44.0  19  42.2  *  *  17  53.1  10  90.9  17  77.3  10  50.0 
Baby unable to be 
resuscitated
 12  7.2  4  8.9  *  *  4  12.5  -  -  2  9.1  1  5.0 
Unknown  2  1.2  1  2.2  *  *  -  -  1  9.1  -  -  -  - 
* Not reported.
68
Figure 3.18: Neonatal death rates (per 1000 live births) by gestation and prioritised baby ethnicity 
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Māori Pacific peoples Indian All other*
* ‘All other’ includes New Zealand European, Other Asian, Other (including unknown).
After excluding babies dying with congenital abnormalities, babies of Māori, Pacific and Indian 
mothers are significantly more likely to die as neonates after birth at 20–22 and 23–24 weeks 
compared to those of New Zealand European and other ethnicity mothers. Babies of Māori mothers are 
significantly more likely to die after birth at 25–27 weeks and from 37 weeks than babies of mothers of 
New Zealand European and other ethnicities (Figure 3.18). Babies of Pacific mothers are significantly 
more likely to die after birth from 37 weeks than babies of mothers of New Zealand European and 
other ethnicities (Figure 3.18). 
The principal cause of neonatal death at 20–24 weeks is spontaneous preterm birth (Figure 3.19).
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Figure 3.19: Distribution of neonatal death classification (PSANZ-NDC) among neonatal deaths 




























Gestation at birth (weeks)
Extreme prematurity Cardio-respiratory disorders Infection Neurological Gastrointestinal Other
Figure 3.19 illustrates the changing distribution of cause of death with increasing gestation at birth 
among live born babies. Disease associated with extreme prematurity predominates at 20–24 weeks, 
while neurological causes become apparent from 23 weeks and become the most common cause of 
death from 28 weeks.
Multiple birth




Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808# n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
Singleton  57,837  96.7  105  98.1 1.82  276  90.5 4.77  146  88.0 2.54  527  91.2 9.11
Multiple  1,667  2.8  2  1.9 1.20  29  9.5 17.40  20  12.0 12.22  51  8.8 30.59
Multiples (1/2 died)  2  1.9  14  4.6  10  6.0  26  4.5 
Multiples (2/2 died)  -  -  15  4.9  9  5.4  24  4.2 
Multiples (1/3 died)  -  -  -  -  -  -  -  - 
Multiples (2/3 died)  -  -  -  -  -  -  -  - 
Multiples (3/3 died)  -  -  -  -  -  -  -  - 
Twin  1,625  2.7  2  1.9  1.23  29  9.5  17.85  19  11.4  11.92  50  8.7  30.77 
Dichorionic 
diamniotic
 2  1.9  13  4.3  10  6.0  25  4.3 
Monochorionic 
diamniotic
 -  -  12  3.9  9  5.4  21  3.6 
Monoamniotic  -  -  4  1.3  -  -  4  0.7 
* Multiples include twins, triplets and higher-order births. 
# Includes 304 unknowns.
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Termination of pregnancy Stillbirths Neonatal deaths Perinatal related deaths
There has been a significant increase in perinatal related deaths among multiple births from 2007 to 
2015, although there has been no apparent increase since 2011 (chi-squared test for trend p=0.046) 
(Table 3.54). The perinatal related death rate among multiple births in 2015 was 30.61/1000 total 
births, which is the same as the estimate in 2007 (30.88). The relative risk of perinatal related mortality 
among multiple compared to singleton pregnancies from 2011–2015 was 4.5.
From 2007 to 2015, 368 twins died in pregnancies involving the death of both twins, while 222 
babies died while their twin sibling survived. Some babies from twin pregnancies died after 28 days or 
were born before 20 weeks and so are not defined as perinatal related deaths and are excluded from 
the data.









n % n % n %
Clomiphene  23  0.8  16  4.3  39  1.2 
Follicle stimulating hormone (FSH)  3  0.1  3  0.8  6  0.2 
In vitro fertilisation (IVF) (including ICSI)  73  2.6  39  10.5  112  3.5 
Any of clomiphene/FSH/IVF  97  3.5  56  15.1  153  4.8 
ICSI = Intracytoplasmic sperm injection.
Fertility treatment is over-represented among multiple pregnancy deaths. Among deaths of babies in 
multiple pregnancies from 2011–2015, 15 percent were born to mothers who were given clomiphene 
or follicle stimulating hormone (FSH) or had in vitro fertilisation (IVF). Three percent of mothers of 
singleton babies who died received these fertility treatments.
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Vaginal bleeding in pregnancy
Table 3.18: Perinatal related deaths and vaginal bleeding during pregnancy 2015
Vaginal bleeding
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=107 n=305 n=166 n=578
n % n % n % n %
Yes  18  16.8  98  32.1  72  43.4  188  32.5 
No  81  75.7  194  63.6  90  54.2  365  63.1 
Unknown  8  7.5  13  4.3  4  2.4  25  4.3 
Gestation*
<20 weeks only  12  11.2  28  9.2  9  5.4  49  8.5 
≥20 weeks only  2  1.9  45  14.8  36  21.7  83  14.4 
<20 weeks and ≥20 weeks  4  3.7  25  8.2  27  16.3  56  9.7 
* Multiple bleeds can occur in pregnancy and can occur both before and after 20 weeks.
Vaginal bleeding in pregnancy is commonly found in association with perinatal related death. Overall, 
33 percent of mothers of babies who died in 2015 had some vaginal bleeding during pregnancy. 
Fourteen percent of mothers had new bleeding starting from 20 weeks, 10 percent had bleeding both 
before and after 20 weeks, and 8 percent had bleeding only prior to 20 weeks. Of those mothers who 
had bleeding before 20 weeks whose babies subsequently died in the perinatal period, about half (53 
percent) continued to have bleeding beyond 20 weeks.
Antepartum haemorrhage was the primary antecedent cause of death in 2015 for 13.7 percent of 
perinatal related deaths, 15.1 percent of stillbirths and 18.1 percent of neonatal deaths (Table 3.3).
Small for gestational age infants
Table 3.19: Perinatal related deaths and small for gestational age (customised SGA) among singleton 
deaths without congenital abnormalities 2015
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n % n % n % n %
Singleton deaths 20–22 weeks, 
excluding congenital abnormalities n=8 n=60 n=30 n=98
SGA  2  25.0  13  21.7  1  3.3  16  16.3 
Singleton deaths 23–36 weeks, 
excluding congenital abnormalities n=11 n=111 n=53 n=175
SGA  5  45.5  45  40.5  14  26.4  64  36.6 
Singleton deaths ≥37 weeks, 
excluding congenital abnormalities n=0 n=82 n=20 n=102
SGA  -  -  22  26.8  6  30.0  28  27.5 
SGA = small for gestation age (birthweight less than 10th customised centile).
Table 3.19 shows the absolute numbers and proportions of customised SGA babies among singleton 
perinatal related deaths without congenital abnormality in 2015.
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The overall rate of customised SGA among singleton deaths without congenital abnormalities in 2015 
was 28.8 percent, which is at least twice the rate expected in the population of births in New Zealand.
Customised SGA is defined as the lowest 10 percent of ‘optimal’ birthweights (Anderson et al 2012), 
so we would expect a rate in the general population of more than 10 percent, but there are currently no 
New Zealand normative data as maternal height and weight, required for the calculation of customised 
centiles, were not available in the MAT dataset this year.
At the Auckland tertiary maternity unit in New Zealand the rate of SGA in the birthing population was 
15.0 percent in 2015 (Auckland District Health Board 2016).
Customised SGA was more common among singleton deaths without congenital abnormalities at 
23–36 weeks than at 20–22 weeks (p=0.0004), more common at 23–36 weeks than at term (p=0.05) 
and more common at term than at 20–22 weeks (p=0.06). These associations are illustrated in Figure 
3.21.
Twenty-eight singleton babies without congenital abnormalities (of 102) died with SGA at term in 2015 
(27.5 percent). The primary antecedent cause of death classification for these term SGA babies was 
most commonly fetal growth restriction (11), followed by unexplained antepartum death (6).
Figure 3.21: Small for gestational age (customised SGA) by gestation among perinatal related deaths 
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Maternity care and place of birth
Table 3.20: Perinatal related deaths and maternal registration status 2015
Was the mother 
registered with a lead 
maternity carer (LMC)?
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=107 n=305 n=166 n=578
n % n % n % n %
Yes  103  96.3  285  93.4  162  97.6  550  95.2 
Self-employed midwife  86  80.4  236  77.4  124  74.7  446  77.2 
DHB care  10  9.3  39  12.8  29  17.5  78  13.5 
General practitioner  -  -  -  -  -  -  -  - 
Obstetrician (private)  7  6.5  10  3.3  9  5.4  26  4.5 
Other  -  -  -  -  -  -  -  - 
No  4  3.7  20  6.6  4  2.4  28  4.8 
Ninety-five percent of the mothers of babies who died in the perinatal period were registered with an 
LMC prior to diagnosis of perinatal related death. Mothers of stillborn babies tended more often to 
not be registered with an LMC (6.6 percent) than mothers of babies who died in the neonatal period 
(2.4 percent) (p=0.05). The proportion of mothers registered with an LMC in New Zealand in 2015 is 
unknown as the data for mothers registered with a DHB for primary maternity care are incomplete as 
not all facilities provide data to the MAT dataset. 
Seventy-seven percent of the mothers of babies who died in the perinatal period were registered with a 
self-employed midwife LMC, 13.5 percent with a hospital primary maternity service, and 4.5 percent 
with a private obstetrician. The MAT dataset shows that in 2015, 86.3 percent of mothers booked with 
a self-employed midwifery LMC, 5.5 percent with a private obstetrician, and very few (0.3 percent) 
with a GP. The remaining women are registered with DHB maternity services or are unregistered. These 
data are currently incomplete in the MAT dataset. 
Of mothers registered for LMC care prior to perinatal related death in 2015, 46.9 percent were 
registered before 10 weeks gestation, 75.3 percent before 14 weeks, and 9.5 percent after 19 weeks 
(Table 3.56).
Table 3.21: Intended place of birth versus actual place of birth among stillbirths and neonatal deaths 
2015
Intended place of 
birth
Actual place of birth






level 3 Other Unknown
n % n % n % n % n % n % n %
Home  10  3  30.0  -  -  -  -  3  30.0  4  40.0  -  -  -  - 
Birthing unit  43  -  -  7  16.3  -  -  7  16.3  28  65.1  1  2.3  -  - 
Hospital level 1  15  -  -  -  -  3  20.0  4  26.7  8  53.3  -  -  -  - 
Hospital level 2  173  1  0.6  -  -  -  -  143  82.7  28  16.2  -  -  1  0.6 
Hospital level 3  204  4  2.0  1  0.5  -  -  2  1.0  197  96.6  -  -  -  - 
Other  4  -  -  -  -  -  -  -  -  4  100.0  -  -  -  - 
Not registered  22  1  4.5  -  -  -  -  5  22.7  12  54.5  2  9.1  2  9.1 
Total  471  9  1.9  8  1.7  3  0.6  164  34.8  281  59.7  3  0.6  3  0.6 
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Table 3.21 shows the intended place of birth and actual place of birth for stillbirths and neonatal 
deaths in 2015. Thirteen of 68 mothers (19 percent) intending to birth in a primary setting (home, 
birthing unit or level 1 hospital) birthed in their intended location. These babies were born at 20, 22 
(2), 37, 39 (3), 40 (5), and 41 weeks gestation; four were stillbirths and nine were neonatal deaths. 
The primary antecedent causes of death for these babies in 2015 were congenital abnormality (4), 
antepartum haemorrhage (2), hypoxic peripartum death (2), fetal growth restriction (1), unexplained 
(2), and no obstetric antecedent (2). Of the mothers who did not give birth in their intended location, 
40 (59 percent) birthed in a tertiary hospital and 14 (21 percent) in a secondary hospital, presumably 
because of identified risk. 
The proportion of perinatal deaths birthed in primary settings is small compared to national rates of 
birthing in these settings (home 3.4 percent, birthing units and level 1 hospital combined 9.1 percent in 
2014) (Ministry of Health 2015b). 
Screening in pregnancy
Diabetes
In 2015, 80 percent of mothers who were at or beyond 28 weeks gestation and had no known pre-
existing diabetes and who gave birth to stillborn babies and neonates who died within a month of birth 
were screened for diabetes. From 2007 to 2015 there has been a significant reduction in unscreened 
mothers. In 2016, the PMMRC began to collect data on the uptake of HbA1c screening in line with the 
national guideline on diabetes in pregnancy (Ministry of Health 2014).
Family violence
Table 3.22: Perinatal related deaths and screening for family violence 2007–2015
2007—2008 2009—2010 2011—2012 2013—2014 2015
n=1,381 n=1,438 n=1,337 n=1,257 n=578
n % n % n % n % n %
Experienced family violence in this pregnancy
Yes  42  3.0  53  3.7  34  2.5  30  2.4  25  4.3 
No  575  41.6  588  40.9  608  45.5  612  48.6  346  59.9 
Not asked  441  31.9  293  20.4  315  23.6  307  24.4  104  18.0 
Unknown  323  23.4  504  35.0  380  28.4  310  24.6  103  17.8 
Referral to relevant support
Yes  28  66.7  32  60.4  27  79.4  19  63.3  20  80.0 
No  1  2.4  7  13.2  1  2.9  2  6.7  4  16.0 
Unknown  13  31.0  14  26.4  6  17.6  9  30.0  1  4.0 
For the first time since the PMMRC started reporting family violence screening among mothers of babies 
who died in the perinatal period, there has been a significant increase in the proportion of mothers 
screened (p<0.0001 for 2015 compared to 2014). 
There are numerous studies describing the association between family violence and adverse maternity 
outcomes. There is evidence that screening tools have good accuracy in the identification of women 
experiencing intimate partner violence; however, there is insufficient evidence on the effect of 
interventions to prevent family violence on perinatal mortality. 
The Ministry of Health guideline on routine inquiry for family violence in pregnancy was updated in 
June 2016 (Fanslow et al 2016).
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First and second trimester screening for congenital anomalies
Among women birthing in New Zealand in 2015, 72 percent completed either first or second trimester 
screening for Down syndrome and other conditions. This screening provides a risk result for trisomy 
21, 18, and 13 and some other rare genetic disorders. Rates of participation varied from 51.5 to 
84.2 percent by DHB of residence, 33.7 to 92.3 percent by maternal ethnicity, and from 88.9 to 54.2 
percent from least to most socioeconomically deprived (National Screening Unit 2017). 
In 2016, the PMMRC started collection of data on first and second trimester screening among 
pregnancies leading to perinatal related death.
Investigation of perinatal related deaths
Table 3.23: Perinatal related deaths and perinatal death investigations by ethnicity 2011–2015
Post-mortem 
examination offered









n=805 n=411 n=198 n=262 n=272 n=1,226 n=3,174
n % n % n % n % n % n % n %
Post-mortem offered and 
parental consent given
 186  23.1  126  30.7  92  46.5  116  44.3  132  48.5  575  46.9  1,227  38.7 
Post-mortem offered and 
parents declined
 553  68.7  250  60.8  96  48.5  119  45.4  110  40.4  560  45.7  1,688  53.2 
Post-mortem not offered  54  6.7  31  7.5  7  3.5  26  9.9  25  9.2  79  6.4  222  7.0 
Unknown  12  1.5  4  1.0  3  1.5  1  0.4  5  1.8  12  1.0  37  1.2 
Optimum investigation*  259  32.2  167  40.6  101  51.0  160  61.1  165  60.7  690  56.3  1,542  48.6 
Post-mortem  186  23.1  126  30.7  92  46.5  116  44.3  132  48.5  575  46.9  1,227  38.7 




34  4.2 19  4.6 5  2.5 13  5.0 10  3.7 56  4.6  137  4.3 
Partial investigations only#  380  47.2  192  46.7  84  42.4  90  34.4  81  29.8  451  36.8  1,278  40.3 
No investigation+  159  19.8  48  11.7  12  6.1  8  3.1  22  8.1  74  6.0  323  10.2 
Unknown  7  0.9  4  1.0  1  0.5  4  1.5  4  1.5  11  0.9  31  1.0 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical examination/investigation confirming diagnosis. 
Note: More than one option can be selected.
# No post-mortem; investigations may have included placental pathology, MRI, ultrasound scan or x-ray.
+ No post-mortem, placental pathology, MRI, ultrasound scan or x-ray.
In 2015, 52 percent of babies who died in the perinatal period were optimally investigated (Table 
3.57). Of the remainder, 8 percent were not investigated and 40 percent were partially investigated. 
There is a statistically significant trend to increasing optimal investigation among perinatal related 
deaths. This apparent improvement in optimal investigation rate is probably explained by a change in 
definition of optimal investigation allowing clinical examination/investigations to confirm the diagnosis 
of 21 to 43 cases per year from 2012. The trends to an increase in partial investigation (p=0.0016) 
and a decrease in no investigation (p<0.0001) have continued in 2015 and probably reflect a true 
improvement. 
In 2015, 43 percent of perinatal related deaths, 54 percent of stillbirths, and 42 percent of neonatal 
deaths underwent post-mortem. This compares to fewer than 50 percent of stillbirths and only a quarter 
of neonatal deaths in the UK (Manktelow et al 2016) in an environment where around 90 percent of 
parents are offered post-mortem. In 2015, the rate of placental pathology in New Zealand was 82 
76
percent among stillbirths, similar to the UK rate of 88 percent. 
Māori and Pacific perinatal related deaths are less likely to be optimally investigated than deaths in all 
other ethnic groups. While more Māori and Pacific perinatal related deaths are partially investigated 
than other ethnicities, overall they are less likely to have any investigation (optimal or partial) than 
deaths among other ethnicities (Table 3.23). From 2007 to 2015, there has been a significant 
improvement in the rate of optimal and partial investigation, and a decrease in no investigation for 
babies of Māori mothers. No significant change has occurred among babies of Pacific mothers. 
There is no difference in the proportion of parents and whānau offered post-mortem by ethnicity, 
but Māori and Pacific parents and whānau are less likely to give consent for post-mortem. There are 
currently no data collected on the offer of partial post-mortem. Options for partial investigation are 
listed in the text box below.
Perinatal Death Investigations
If families and whānau decline post-mortem examination they should be counselled on the other 
options, which, while not as helpful in finding a cause for perinatal death as post-mortem, may still 
contribute valuable information. 
Other investigations include:
• placental pathology 
• external examination by a perinatal pathologist, geneticist or paediatrician
• clinical photographs
• full body X-ray or babygram
• magnetic resonance imaging (MRI)
• needle biopsy of a particular organ or tissue
• ultrasound of specific organs.
None of these investigations will provide information that is as accurate as that obtained by a post-
mortem examination, but they provide more information than no examination at all. 
The findings of significant placental pathology can explain the cause of death and provide critical 
information for management and counselling of any future pregnancies.
Further information to help families and whānau who are trying to decide whether or not to 
consent to a post-mortem can be found at: http://www.hqsc.govt.nz/our-programmes/mrc/
pmmrc/publications-and-resources/publication/32/.
In 2015, data on the usefulness of post-mortem were available for 205 (83 percent) of the cases where 
post-mortem was performed. These data showed that in 118 deaths (48 percent) the post-mortem 
confirmed the clinical diagnosis, in 40 (16 percent) the post-mortem changed the diagnosis and resulted 
in altered counselling to parents for future pregnancies, in 27 (11 percent) additional information 
was gained but this did not change the clinical diagnosis, and in 20 (8 percent) the post-mortem was 
inconclusive. 
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Table 3.57 and Table 3.58 report the completeness of perinatal investigation and offer and decline of 
post-mortem for 2015. 
Maternal outcome
There were two maternal deaths associated with perinatal related deaths in 2015, both classified as 
indirect maternal deaths. Nine mothers whose babies died experienced serious morbidity in pregnancy, 
including pre-eclampsia, obstetric haemorrhage, uterine trauma, obstetric sepsis, morbidity associated 
with pre-existing medical conditions, and injuries in a motor vehicle accident (Table 3.60).
Contributory factors and potentially avoidable perinatal related death





related deathsTermination of 
pregnancy Stillbirths
n=107 n=305 n=166 n=578
n % n % n % n %
Contributory factors
Present  6  5.6  88  28.9  52  31.3  146  25.3 
Absent  100  93.5  216  70.8  112  67.5  428  74.0 
Missing data  1  0.9  1  0.3  2  1.2  4  0.7 
Potentially avoidable
Yes  1  0.9  50  16.4  30  18.1  81  14.0 
Contributory factors present but not potentially avoidable  5  4.7  36  11.8  22  13.3  63  10.9 
Contributory factors present but avoidability unknown  -  -  2  0.7  -  -  2  0.3 
In 2015, one-quarter of perinatal related deaths were determined at local review to have contributory 
factors, and just over half of these (14 percent) were determined to be potentially avoidable deaths.
Table 3.63 lists all the contributory factors identified by year of perinatal related death for 2009–2015. 
The following text box provides a list of the contributory factors framework used in the PMMRC reviews. 
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Contributory Factors for Mortality and Morbidity
Organisational and/or management factors
• Poor organisational arrangements of staff
• Inadequate education and training
• Lack of policies, protocols or guidelines
• Inadequate numbers of staff
• Poor access to senior clinical staff
• Failure or delay in emergency response
• Delay in procedure (eg, caesarean section)
• Inadequate systems/process for sharing of clinical information between services
• Delayed access to test results or inaccurate results
• Equipment (eg, faulty equipment, inadequate maintenance, inadequate quality or lack of 
equipment)
• Building and design functionality (eg, space, privacy, ease of access, lighting, noise, power 
failure, operating theatre in distant location)
Personnel factors
• Knowledge and skills of staff were lacking
• Delayed emergency response by staff
• Failure to maintain competence
• Failure of communication between staff
• Failure to seek help/supervision
• Failure to offer or follow recommended best practice
• Lack of recognition of complexity or seriousness of condition by care giver
Barriers to access and/or engagement with care
• No antenatal care
• Infrequent care or late booking
• Declined treatment or advice
• Obesity impacted on delivery of optimal care (eg, ultrasound scan)
• Substance use
• Family violence
• Lack of recognition of complexity or seriousness of condition
• Maternal mental illness
• Cultural barriers
• Language barriers
• Not eligible to access free care
• Environment (eg, isolated, long transfer, weather prevented transport)
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The most common main contributory factors to potentially avoidable perinatal related deaths are 
consistently barriers to access and/or engagement with care factors, responsible for 8 to 12 percent 
of perinatal related deaths each year from 2011 to 2015. Personnel factors are the main contributory 
factor to avoidable perinatal related death in 5 to 6 percent of perinatal related deaths, and 
organisational and/or management factors in 3 to 4 percent.
Figure 3.22: Contributory factors and potentially avoidable perinatal related death by perinatal death 
classification (PSANZ-PDC) 2015
Figure 3.22 illustrates the proportion of perinatal related deaths which were assessed as having 
contributory factors and to be potentially avoidable in 2015. The bottom bar (red) represents potentially 
avoidable deaths, the second bar (grey) deaths with contributory factors not assessed as potentially 
avoidable, and the top bar (blue) deaths without contributory factors.
The greatest proportion of potentially avoidable deaths in 2015 were identified among deaths from 
hypertension (5) (24 percent), maternal conditions (14) (48 percent), hypoxic peripartum deaths (8) 
(47 percent), fetal growth restriction (7) (21 percent), and deaths without obstetric antecedent (5) (71 
percent). 
As the number of deaths varies considerably by cause, the proportion of potentially avoidable deaths 
does not necessarily also represent the largest absolute number of potentially avoidable deaths. 
In 2015, the largest numbers of potentially avoidable deaths were among deaths due to maternal 
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Figure 3.23: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a 
percentage of all deaths in each PSANZ-PDC category) by perinatal death classification (PSANZ-PDC) 














































Perinatal death classification (PSANZ-PDC)
Organisation/management Personnel Barriers Specific contributory factor not identified
Figure 3.23 illustrates the main contributory factors in potentially avoidable perinatal related deaths by 
cause of death (PSANZ-PDC). If more than one main contributory factor was identified then the death is 
attributed to both contributory factors. 
For example, among 85 hypoxic peripartum deaths during 2011–2015, organisational and/or 
management factors were the main factor in 17 potentially avoidable deaths (20 percent), personnel in 
32 (38 percent), and barriers to access and/or engagement with care for 15 (18 percent) (Table 3.65).
The proportion of potentially avoidable perinatal related deaths was higher among babies of Māori 
and Pacific mothers than all other ethnicities, at 22 and 24 percent respectively (Figure 3.24). This 
is due to an excess of barriers to access and/or engagement with care among potentially avoidable 
deaths, which were responsible for 17 and 19 percent of perinatal related deaths in these ethnic 
groups (Figure 3.25).
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Figure 3.24: Contributory factors and potentially avoidable perinatal related deaths by maternal 
prioritised ethnicity (95% CIs surround the estimate of the proportion of cases within each ethnicity 
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Figure 3.25: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a 
























Maternal prioritised ethnicity 
Organisation/management Personnel Barriers
82




























Contributory factors and potentially avoidable Contributory factors BUT NOT or unknown if potentially avoidable No contributory factors Unknown
The proportion of potentially avoidable perinatal related deaths increases with increasing 
socioeconomic deprivation, due to increasing contribution from barriers to access and/or engagement 
with care (Table 3.68 and Table 3.69).
Figure 3.27: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a 


























































3.3 Perinatal Mortality Appended Tables and Figures 
Table 3.25: New Zealand perinatal mortality rates (per 1000 births) using the international definition 2007–2015




n Rate n Rate n Rate n Rate n Rate
Total births 129,725 129,530 125,423 119,134 59,344
Fetal deaths (terminations of pregnancy and stillbirths)* 419 3.2 430 3.3 357 2.8 317 2.7 164 2.8 0.0006
Terminations of pregnancy 20 0.2 26 0.2 37 0.3 25 0.2 7 0.1 0.63
Stillbirths 399 3.1 404 3.1 320 2.6 292 2.5 157 2.6 0.00023
Early neonatal deaths <7 days 124 127 119 104 57 0.75
Late neonatal deaths 7–27 days 63 61 42 47 28 0.40
Neonatal deaths <28 days# 187 1.4 188 1.5 161 1.2 151 1.2 85 0.7 0.46
Perinatal mortalities+ 543 4.2 557 4.3 476 3.8 421 3.5 221 3.7 0.0016
Perinatal related mortalities^ 606 4.7 618 4.8 518 4.1 468 3.9 249 4.2 0.0011
Perinatal mortalities excluding lethal and terminated fetal abnormalities• 444 3.4 442 3.4 349 2.8 327 2.7 177 3.0 0.00036
Perinatal related mortalities excluding lethal and terminated fetal abnormalities• 478 3.7 475 3.7 368 2.9 349 2.9 188 3.2 0.00011
* Fetal death rate per 1000 babies born (includes terminations and stillbirths).
# Neonatal death rate per 1000 live born babies.
+ Fetal deaths and early neonatal deaths per 1000 babies born.
^ Fetal deaths and early and late neonatal deaths per 1000 babies born.
• Lethal and terminated fetal abnormalities are all perinatal related deaths with PSANZ-PDC of congenital abnormality and neonatal deaths with PSANZ-NDC of congenital abnormality.
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n=130,826 n=130,666 n=126,539 n=120,231 n=59,808
n Rate n Rate n Rate n Rate n Rate
Congenital abnormality  382  2.92  393  3.01  404  3.19  348  2.89  158  2.64 0.63
Perinatal infection  57  0.44  53  0.41  40  0.32  44  0.37  22  0.37 0.29
Hypertension  41  0.31  56  0.43  39  0.31  26  0.22  21  0.35 0.21
Antepartum haemorrhage  129  0.99  157  1.20  138  1.09  144  1.20  79  1.32 0.12
Maternal conditions  50  0.38  70  0.54  62  0.49  73  0.61  29  0.48 0.075
Specific perinatal conditions  128  0.98  145  1.11  143  1.13  132  1.10  60  1.00 0.58
Hypoxic peripartum death  67  0.51  48  0.37  40  0.32  28  0.23  17  0.28 0.00031
Fetal growth restriction  108  0.83  101  0.77  93  0.73  84  0.70  33  0.55 0.053
Spontaneous preterm  192  1.47  223  1.71  187  1.48  186  1.55  65  1.09 0.22
Unexplained antepartum death  202  1.54  175  1.34  178  1.41  181  1.51  87  1.45 0.74
No obstetric antecedent  25  0.19  17  0.13  13  0.10  13  0.11  7  0.12 0.13
Table 3.27: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 
1000 births) using international definition (≥1000g or ≥28 weeks if birthweight unknown) 2007–2015
Perinatal death  
classification  
(PSANZ-PDC) 




 n=129,725  n=129,530  n=125,423  n=119,134  n=59,344 
n Rate n Rate n Rate n Rate n Rate
Congenital abnormality  127  0.98  141  1.09  149  1.19  114  0.96  61  1.03 0.90
Perinatal infection  32  0.25  28  0.22  21  0.17  21  0.18  12  0.20 0.22
Hypertension  14  0.11  25  0.19  12  0.10  11  0.09  10  0.17 0.63
Antepartum haemorrhage  48  0.37  47  0.36  30  0.24  29  0.24  17  0.29 0.031
Maternal conditions  23  0.18  38  0.29  24  0.19  36  0.30  15  0.25 0.24
Specific perinatal conditions  52  0.40  62  0.48  53  0.42  49  0.41  32  0.54 0.71
Hypoxic peripartum death  67  0.52  48  0.37  40  0.32  28  0.24  17  0.29 0.00030
Fetal growth restriction  61  0.47  62  0.48  50  0.40  41  0.34  14  0.24 0.015
Spontaneous preterm  16  0.12  29  0.22  19  0.15  14  0.12  14  0.24 0.54
Unexplained antepartum death  141  1.09  120  0.93  107  0.85  112  0.94  50  0.84 0.063
No obstetric antecedent  25  0.19  17  0.13  13  0.10  13  0.11  7  0.12 0.13
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Table 3.29: Perinatal related mortality rates (per 1000 births) by sex 2015
Sex
Fetal deaths
Neonatal deaths Perinatal related deathsTotal births Termination of pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
Male  30,497  51.0  52  48.6  1.71  148  48.5  4.85  90  54.2  2.97  290  50.2  9.51 
Female  28,937  48.4  55  51.4  1.90  157  51.5  5.43  76  45.8  2.65  288  49.8  9.95 
Unknown  374  0.6  -  -  -  -  -  -  -  -  -  -  -  - 









n=129,789 n=129,621 n=125,544 n=119,307 n=59,396
n Rate n Rate n Rate n Rate n Rate
Congenital abnormality  81  0.62  89  0.69  88  0.70  76  0.64  45  0.76 0.49
Extreme prematurity  109  0.84  142  1.09  122  0.97  132  1.11  51  0.86 0.25
Cardio-respiratory disorders  22  0.17  29  0.22  25  0.20  22  0.18  16  0.27 0.26
Infection  35  0.27  31  0.24  31  0.25  27  0.23  7  0.12 0.20
Neurological  64  0.49  68  0.52  48  0.38  49  0.41  31  0.52 0.37
Gastrointestinal  2  0.02  13  0.10  5  0.04  4  0.03  2  0.03 0.72
Other  31  0.24  21  0.16  23  0.18  25  0.21  14  0.24 0.94
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Table 3.30: Perinatal related mortality rates (per 1000 births) by maternal age and year excluding congenital abnormalities 2007–2015
Maternal 
age (years)
2007—2008 2009—2010 2011—2012 2013—2014 2015 Chi-squared 
test for 
trend (p)n N Rate n N Rate n N Rate n N Rate n N Rate
<20  112  10,452  10.7  104  9,535  10.9  92  8,077  11.4  93  6,423  14.5  35  2,826  12.4 0.062
20–24  207  23,178  8.9  231  24,272  9.5  181  23,582  7.7  174  21,439  8.1  69  10,128  6.8 0.020
25–29  238  31,649  7.5  241  32,224  7.5  215  32,056  6.7  222  31,541  7.0  112  15,976  7.0 0.28
30–34  230  36,541  6.3  235  35,861  6.6  223  35,362  6.3  232  35,026  6.6  110  18,246  6.0 0.88
35–39  170  23,677  7.2  189  23,099  8.2  164  21,609  7.6  131  20,187  6.5  75  9,951  7.5 0.49
≥40  41  4,961  8.3  43  5,293  8.1  54  5,457  9.9  51  5,265  9.7  19  2,520  7.5 0.62
Unknown  -  2  -  -  2  -  -  1  -  1  5  -  -  7  -  - 








n N Rate n N Rate n N Rate n N Rate n N Rate
Māori  292  33,739  8.7  326  33,520  9.7  250  32,091  7.8  254  29,354  8.7  110  14,804  7.4 0.12
Pacific peoples  147  15,743  9.3  160  15,086  10.6  133  14,207  9.4  137  12,714  10.8  54  6,132  8.8 0.72
Indian  36  3,743  9.6  50  4,010  12.5  51  4,527  11.3  58  5,226  11.1  37  3,124  11.8 0.61
Other Asian  45  8,242  5.5  54  9,335  5.8  62  11,212  5.5  50  12,272  4.1  41  6,173  6.6 0.90
Other (including 
unknown)
 72  14,371  5.0  74  14,955  4.9  86  14,413  6.0  64  14,326  4.5  27  7,166  3.8 0.20
NZ European  406  54,239  7.5  379  52,985  7.2  347  49,286  7.0  341  45,639  7.5  151  22,097  6.8 0.59
Table 3.32: Perinatal related mortality rates (per 1000 births) by deprivation quintile and year excluding congenital abnormalities 2007–2015
Deprivation 
quintile




n N Rate n N Rate n N Rate n N Rate n N Rate
1 (least deprived)  107  17,773  6.0  106  18,030  5.9  124  17,684  7.0  102  16,827  6.1  54  8,325  6.5  0.65 
2  141  19,011  7.4  157  19,197  8.2  167  18,975  8.8  116  18,613  6.2  55  9,429  5.8  0.097 
3  168  23,323  7.2  178  24,139  7.4  150  23,333  6.4  181  21,361  8.5  68  10,685  6.4  0.94 
4  219  30,855  7.1  226  30,227  7.5  181  29,354  6.2  191  26,923  7.1  99  13,380  7.4  0.69 
5 (most deprived)  358  37,777  9.5  372  37,028  10.0  303  35,330  8.6  308  34,806  8.8  140  17,198  8.1  0.074 
Unknown  5  1,338  -  4  1,270  -  4  1,060  -  6  1,001  -  4  479  -  - 
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Neonatal deaths Total perinatal related deathsTermination of 
pregnancy Stillbirths
n=306,578 n=740 n=1,591 n=843 n=3,174
n % n % Rate n % Rate n % Rate n % Rate
<20  17,393  5.7  53  7.2  3.05  130  8.2  7.47  106  12.6  6.16  289  9.1  16.62 
20–24  55,279  18.0  109  14.7  1.97  292  18.4  5.28  158  18.7  2.88  559  17.6  10.11 
25–29  79,766  26.0  165  22.3  2.07  380  23.9  4.76  205  24.3  2.59  750  23.6  9.40 
30–34  88,867  29.0  208  28.1  2.34  405  25.5  4.56  190  22.5  2.15  803  25.3  9.04 
35–39  51,944  16.9  154  20.8  2.96  281  17.7  5.41  136  16.1  2.64  571  18.0  10.99 
≥40  13,316  4.3  51  6.9  3.83  102  6.4  7.66  48  5.7  3.65  201  6.3  15.09 
Unknown  13  0.0  -  -  -  1  0.1  -  -  -  -  1  0.0  - 
Table 3.34: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates 





<20 20–24 25–34 35–39 ≥40
n=17,341 n=55,175 n=168,275 n=51,796 n=13,267
n % Rate n % Rate n % Rate n % Rate n % Rate
Congenital abnormality*  34  14.4  1.96  53  11.8  0.96  145  12.3  0.86  73  17.5  1.41  41  27.3  3.09 
Perinatal infection  11  4.7  0.63  16  3.6  0.29  54  4.6  0.32  13  3.1  0.25  1  0.7  0.08 
Hypertension  -  -  -  15  3.3  0.27  41  3.5  0.24  12  2.9  0.23  4  2.7  0.30 
Antepartum haemorrhage  33  14.0  1.90  57  12.7  1.03  178  15.1  1.06  50  12.0  0.97  17  11.3  1.28 
Maternal conditions  10  4.2  0.58  26  5.8  0.47  55  4.7  0.33  26  6.2  0.50  8  5.3  0.60 
Specific perinatal condition  16  6.8  0.92  37  8.2  0.67  156  13.2  0.93  63  15.1  1.22  25  16.7  1.88 
Hypoxic peripartum death  5  2.1  0.29  15  3.3  0.27  49  4.2  0.29  14  3.4  0.27  2  1.3  0.15 
Fetal growth restriction  18  7.6  1.04  40  8.9  0.72  100  8.5  0.59  30  7.2  0.58  9  6.0  0.68 
Spontaneous preterm#  67  28.4  3.86  92  20.4  1.67  168  14.2  1.00  59  14.1  1.14  16  10.7  1.21 
Unexplained antepartum 
death
 35  14.8  2.02  88  19.6  1.59  223  18.9  1.33  74  17.7  1.43  26  17.3  1.96 
No obstetric antecedent  7  3.0  0.40  11  2.4  0.20  11  0.9  0.07  3  0.7  0.06  1  0.7  0.08 
* Excludes two maternal age missing.
# Excludes one maternal age missing.
Table 3.35: Perinatal related mortality rates (per 1000 births) by baby prioritised ethnicity 2015
Total births
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
Ethnicity (baby)
Māori 15,915 26.6  25 23.4 1.57  78 25.6 4.90  58 34.9 3.67  161 27.9 10.12
Pacific peoples 6,122 10.2  3 2.8 0.49  41 13.4 6.70  27 16.3 4.44  71 12.3 11.60
Indian 3,339 5.6  4 3.7 1.20  30 9.8 8.98  14 8.4 4.24  48 8.3 14.38
Other Asian 6,130 10.2  10 9.3 1.63  27 8.9 4.40  15 9.0 2.46  52 9.0 8.48
Other (including 
unknown)
6,345 10.6  7 6.5 1.10  21 6.9 3.31  6 3.6 0.95  34 5.9 5.36
NZ European 21,957 36.7  58 54.2 2.64  108 35.4 4.92  46 27.7 2.11  212 36.7 9.66
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Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=306,578 n=740 n=1,591 n=843 n=3,174
n % n % Rate n % Rate n % Rate n % Rate
Ethnicity (mother)
Māori 76,637 25.0  129 17.4 1.68  414 26.0 5.40  262 31.1 3.44  805 25.4 10.50
Pacific peoples 33,230 10.8  51 6.9 1.53  221 13.9 6.65  139 16.5 4.22  411 12.9 12.37
Indian 12,978 4.2  48 6.5 3.70  99 6.2 7.63  51 6.0 3.97  198 6.2 15.26
Other Asian 29,867 9.7  98 13.2 3.28  108 6.8 3.62  56 6.6 1.89  262 8.3 8.77
Other (including unknown) 36,112 11.8  85 11.5 2.35  133 8.4 3.68  54 6.4 1.50  272 8.6 7.53
NZ European 117,754 38.4  329 44.5 2.79  616 38.7 5.23  281 33.3 2.41  1,226 38.6 10.41
Ethnicity (baby)
Māori 81,551 26.6  173 23.4 2.12  489 30.7 6.00  293 34.8 3.62  955 30.1 11.71
Pacific peoples 33,186 10.8  51 6.9 1.54  222 14.0 6.69  140 16.6 4.25  413 13.0 12.45
Indian 13,885 4.5  52 7.0 3.75  103 6.5 7.42  51 6.0 3.71  206 6.5 14.84
Other Asian 29,702 9.7  94 12.7 3.16  111 7.0 3.74  56 6.6 1.90  261 8.2 8.79
Other (including unknown) 31,290 10.2  43 5.8 1.37  103 6.5 3.29  43 5.1 1.38  189 6.0 6.04































Table 3.37: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding termination of pregnancy) by 




Māori Pacific peoples Indian Other Asian Other (including unknown) NZ European
n=76,510 n=33,177 n=12,935 n=29,776 n=36,008 n=117,461
n % Rate n % Rate n % Rate n % Rate n % Rate n % Rate
Congenital abnormality  91  13.5  1.19  54  15.0  1.63  14  9.3  1.08  29  17.7  0.97  30  16.0  0.83  128  14.3  1.09 
Perinatal infection  22  3.3  0.29  18  5.0  0.54  6  4.0  0.46  6  3.7  0.20  9  4.8  0.25  34  3.8  0.29 
Hypertension  23  3.4  0.30  14  3.9  0.42  5  3.3  0.39  3  1.8  0.10  5  2.7  0.14  22  2.5  0.19 
Antepartum haemorrhage  94  13.9  1.23  49  13.6  1.48  26  17.3  2.01  26  15.9  0.87  21  11.2  0.58  119  13.3  1.01 
Maternal conditions  36  5.3  0.47  31  8.6  0.93  7  4.7  0.54  6  3.7  0.20  6  3.2  0.17  39  4.3  0.33 
Specific perinatal conditions  59  8.7  0.77  43  11.9  1.30  25  16.7  1.93  24  14.6  0.81  27  14.4  0.75  119  13.3  1.01 
Hypoxic peripartum death  22  3.3  0.29  6  1.7  0.18  5  3.3  0.39  3  1.8  0.10  8  4.3  0.22  41  4.6  0.35 
Fetal growth restriction  47  7.0  0.61  25  6.9  0.75  17  11.3  1.31  11  6.7  0.37  13  7.0  0.36  84  9.4  0.72 
Spontaneous preterm  148  21.9  1.93  60  16.7  1.81  23  15.3  1.78  20  12.2  0.67  27  14.4  0.75  125  13.9  1.06 
Unexplained antepartum death  121  17.9  1.58  51  14.2  1.54  22  14.7  1.70  35  21.3  1.18  41  21.9  1.14  176  19.6  1.50 
No obstetric antecedent  13  1.9  0.17  9  2.5  0.27  -  -  -  1  0.6  0.03  -  -  -  10  1.1  0.09 
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Table 3.38: Distribution of births by deprivation decile (NZDep2013) 2015




1 (least deprived)  3,981  6.7 
2  4,385  7.3 
3  4,571  7.6 
4  4,912  8.2 
5  5,255  8.8 
6  5,491  9.2 
7  6,794  11.4 
8  6,653  11.1 
9  8,267  13.8 
10 (most deprived)  9,017  15.1 
Unknown  482  0.8 





Neonatal deaths Perinatal related deathsTermination of 
pregnancy
Stillbirths
n=306,578 n=740 n=1,591 n=843 n=3,174
n % n % Rate n % Rate n % Rate n % Rate
1 (least deprived)  43,097  14.1  124  16.8  2.88  202  12.7  4.69  86  10.2  2.01  412  13.0  9.56 
2  47,287  15.4  130  17.6  2.75  209  13.1  4.42  86  10.2  1.83  425  13.4  8.99 
3  55,733  18.2  152  20.5  2.73  255  16.0  4.58  147  17.4  2.66  554  17.5  9.94 
4  70,052  22.8  156  21.1  2.23  348  21.9  4.97  174  20.6  2.50  678  21.4  9.68 
5  (most deprived)  87,854  28.7  175  23.6  1.99  570  35.8  6.49  344  40.8  3.95  1,089  34.3  12.40 
Unknown  2,555  0.8  3  0.4  -  7  0.4  -  6  0.7  -  16  0.5  - 
Table 3.40: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 




Quintile 1 (least 
deprived) Quintile 2 Quintile 3 Quintile 4
Quintile 5 (most 
deprived)
n=42,989 n=47,169 n=55,586 n=69,903 n=87,675
n % Rate n % Rate n % Rate n % Rate n % Rate
Congenital abnormality  29  10.1  0.67  36  12.2  0.76  59  14.7  1.06  87  16.7  1.24  133  14.6  1.52 
Perinatal infection  12  4.2  0.28  8  2.7  0.17  18  4.5  0.32  14  2.7  0.20  43  4.7  0.49 
Hypertension  9  3.1  0.21  7  2.4  0.15  12  3.0  0.22  11  2.1  0.16  33  3.6  0.38 
Antepartum haemorrhage  37  12.8  0.86  42  14.2  0.89  37  9.2  0.67  74  14.2  1.06  141  15.4  1.61 
Maternal conditions  9  3.1  0.21  11  3.7  0.23  15  3.7  0.27  26  5.0  0.37  64  7.0  0.73 
Specific perinatal condition  52  18.1  1.21  42  14.2  0.89  54  13.4  0.97  60  11.5  0.86  87  9.5  0.99 
Hypoxic peripartum death  10  3.5  0.23  12  4.1  0.25  23  5.7  0.41  14  2.7  0.20  25  2.7  0.29 
Fetal growth restriction  30  10.4  0.70  26  8.8  0.55  28  7.0  0.50  48  9.2  0.69  65  7.1  0.74 
Spontaneous preterm  34  11.8  0.79  42  14.2  0.89  66  16.4  1.19  83  15.9  1.19  174  19.0  1.98 
Unexplained antepartum 
death
 63  21.9  1.47  65  22.0  1.38  85  21.1  1.53  98  18.8  1.40  135  14.8  1.54 
No obstetric antecedent  3  1.0  0.07  4  1.4  0.08  5  1.2  0.09  7  1.3  0.10  14  1.5  0.16 
PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: 11th ANNUAL REPORT 91
Table 3.41: Perinatal related mortality rates (per 1000 births) by maternal body mass index (BMI) at 





Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=306,578 n=711 n=1,530 n=836 n=3,077
n % n % Rate n % Rate n % Rate n % Rate
<18.50  8,034  2.6  18  2.5  2.24  29  1.9  3.61  16  1.9  2.00  63  2.0  7.84 
18.50–25.49  148,638  48.5  332  46.7  2.23  576  37.6  3.88  302  36.1  2.04  1,210  39.3  8.14 
25.50–30.49  70,839  23.1  154  21.7  2.17  381  24.9  5.38  183  21.9  2.60  718  23.3  10.14 
30.50–35.49  34,346  11.2  52  7.3  1.51  161  10.5  4.69  107  12.8  3.13  320  10.4  9.32 
35.50–40.49  15,719  5.1  29  4.1  1.84  91  5.9  5.79  61  7.3  3.91  181  5.9  11.51 
≥40.50  9,152  3.0  7  1.0  0.76  65  4.2  7.10  30  3.6  3.30  102  3.3  11.15 
Unknown  19,850  6.5  119  16.7  -  227  14.8  -  137  16.4  -  483  15.7  - 
* MAT data numerator and denominator.




Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=306,578 n=740 n=1,591 n=843 n=3,174
n % n % Rate n % Rate n % Rate n % Rate
0  112,664  36.7  311  42.0  2.76  666  41.9  5.91  372  44.1  3.33  1,349  42.5  11.97 
1  96,025  31.3  245  33.1  2.55  412  25.9  4.29  235  27.9  2.46  892  28.1  9.29 
2  43,031  14.0  107  14.5  2.49  240  15.1  5.58  114  13.5  2.67  461  14.5  10.71 
3  17,268  5.6  44  5.9  2.55  134  8.4  7.76  56  6.6  3.28  234  7.4  13.55 
4  7,308  2.4  14  1.9  1.92  57  3.6  7.80  26  3.1  3.59  97  3.1  13.27 
≥5  7,124  2.3  17  2.3  2.39  75  4.7  10.53  36  4.3  5.12  128  4.0  17.97 
Unknown  23,158  7.6  2  0.3  -  7  0.4  -  4  0.5  -    13  0.4  - 
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Table 3.43: Perinatal related mortality rates (per 1000 births) by DHB of maternal residence 2015




Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=59,808 n=107 n=305 n=166 n=578
n % n % Rate n % Rate n % Rate n % Rate
Northland  2,159  3.6  5  4.7  2.32  14  4.6  6.48  5  3.0  2.34  24  4.2  11.12 
Waitemata  7,665  12.8  13  12.1  1.70  29  9.5  3.78  16  9.6  2.10  58  10.0  7.57 
Auckland  5,980  10.0  10  9.3  1.67  30  9.8  5.02  15  9.0  2.53  55  9.5  9.20 
Counties Manukau  8,311  13.9  13  12.1  1.56  40  13.1  4.81  32  19.3  3.88  85  14.7  10.23 
Waikato  5,366  9.0  3  2.8  0.56  30  9.8  5.59  18  10.8  3.38  51  8.8  9.50 
Bay of Plenty  2,831  4.7  4  3.7  1.41  17  5.6  6.00  5  3.0  1.78  26  4.5  9.18 
Lakes  1,535  2.6  2  1.9  1.30  9  3.0  5.86  2  1.2  1.31  13  2.2  8.47 
Tairawhiti  746  1.2  1  0.9  1.34  6  2.0  8.04  1  0.6  1.35  8  1.4  10.72 
Taranaki  1,540  2.6  2  1.9  1.30  7  2.3  4.55  6  3.6  3.92  15  2.6  9.74 
Hawke’s Bay  2,026  3.4  5  4.7  2.47  6  2.0  2.96  3  1.8  1.49  14  2.4  6.91 
Whanganui  822  1.4  -  -  -  8  2.6  9.73  4  2.4  4.91  12  2.1  14.60 
MidCentral  2,143  3.6  6  5.6  2.80  8  2.6  3.73  5  3.0  2.35  19  3.3  8.87 
Wairarapa  465  0.8  -  -  -  3  1.0  6.45  2  1.2  4.33  5  0.9  10.75 
Capital & Coast  3,593  6.0  8  7.5  2.23  19  6.2  5.29  10  6.0  2.80  37  6.4  10.30 
Hutt Valley  1,997  3.3  2  1.9  1.00  11  3.6  5.51  7  4.2  3.53  20  3.5  10.02 
Nelson Marlborough  1,441  2.4  2  1.9  1.39  6  2.0  4.16  3  1.8  2.09  11  1.9  7.63 
West Coast  370  0.6  2  1.9  5.41  3  1.0  8.11  1  0.6  2.74  6  1.0  16.22 
Canterbury  6,316  10.6  20  18.7  3.17  36  11.8  5.70  17  10.2  2.72  73  12.6  11.56 
South Canterbury  669  1.1  -  -  -  2  0.7  2.99  5  3.0  7.50  7  1.2  10.46 
Southern  3,467  5.8  9  8.4  2.60  19  6.2  5.48  7  4.2  2.04  35  6.1  10.10 
Other*  366  0.6  -  -  -  2  0.7  -  2  1.2  -  4  0.7  - 
* Other includes Overseas, Unknown and Other.
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Table 3.44: Perinatal related mortality rates (per 1000 births) by DHB of maternal residence 2011–
2015




Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=306,578 n=740 n=1,591 n=843 n=3,174
n % n % Rate n % Rate n % Rate n % Rate
Northland  11,121  3.6  25  3.4  2.25  72  4.5  6.47  36  4.3  3.27  133  4.2  11.96 
Waitemata  39,506  12.9  115  15.5  2.91  164  10.3  4.15  75  8.9  1.91  354  11.2  8.96 
Auckland  32,160  10.5  117  15.8  3.64  151  9.5  4.70  77  9.1  2.41  345  10.9  10.73 
Counties Manukau  42,711  13.9  107  14.5  2.51  273  17.2  6.39  165  19.6  3.90  545  17.2  12.76 
Waikato  27,027  8.8  49  6.6  1.81  156  9.8  5.77  93  11.0  3.47  298  9.4  11.03 
Bay of Plenty  14,373  4.7  28  3.8  1.95  77  4.8  5.36  51  6.0  3.57  156  4.9  10.85 
Lakes  7,581  2.5  24  3.2  3.17  40  2.5  5.28  22  2.6  2.93  86  2.7  11.34 
Tairawhiti  3,671  1.2  6  0.8  1.63  16  1.0  4.36  12  1.4  3.29  34  1.1  9.26 
Taranaki  7,805  2.5  9  1.2  1.15  42  2.6  5.38  26  3.1  3.35  77  2.4  9.87 
Hawke’s Bay  10,925  3.6  29  3.9  2.65  56  3.5  5.13  27  3.2  2.49  112  3.5  10.25 
Whanganui  4,203  1.4  7  0.9  1.67  27  1.7  6.42  11  1.3  2.64  45  1.4  10.71 
MidCentral  10,920  3.6  31  4.2  2.84  45  2.8  4.12  25  3.0  2.31  101  3.2  9.25 
Wairarapa  2,508  0.8  2  0.3  0.80  19  1.2  7.58  5  0.6  2.01  26  0.8  10.37 
Capital & Coast  18,713  6.1  36  4.9  1.92  75  4.7  4.01  42  5.0  2.26  153  4.8  8.18 
Hutt Valley  9,946  3.2  18  2.4  1.81  57  3.6  5.73  23  2.7  2.33  98  3.1  9.85 
Nelson Marlborough  7,696  2.5  13  1.8  1.69  35  2.2  4.55  18  2.1  2.35  66  2.1  8.58 
West Coast  1,923  0.6  4  0.5  2.08  11  0.7  5.72  7  0.8  3.67  22  0.7  11.44 
Canterbury  30,586  10.0  77  10.4  2.52  167  10.5  5.46  68  8.1  2.24  312  9.8  10.20 
South Canterbury  3,217  1.0  4  0.5  1.24  11  0.7  3.42  12  1.4  3.75  27  0.9  8.39 
Southern  17,649  5.8  37  5.0  2.10  92  5.8  5.21  43  5.1  2.45  172  5.4  9.75 
Other*  2,337  0.8  2  0.3  -  5  0.3  -  5  0.6  -  12  0.4  - 
* Other includes Overseas, Unknown and Other.
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Figure 3.28: Unadjusted stillbirth rates (per 1000 births) by DHB of residence (mother) compared to 
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Figure 3.29: Unadjusted neonatal mortality rates (per 1000 births) by DHB of residence (mother) 
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Table 3.45: Perinatal related mortality rates (per 1000 births) by smoking at registration with maternity care* 2011–2015
Maternal smoking at 
registration
Total births Fetal deaths Neonatal deaths Perinatal related deaths
Termination of pregnancy Stillbirths
n=306,578 n=711 n=1,530 n=836 n=3,077
n % n % Rate n % Rate n % Rate n % Rate
Smoker  42,858 14.0  59 8.3  1.38  261 17.1  6.09  167 20.0  3.93  487 15.8  11.36 
Non-smoker  245,435 80.1  536 75.4  2.18  1,049 68.6  4.27  536 64.1  2.20  2,121 68.9  8.64 
Unknown  18,285 6.0  116 16.3  -  220 14.4  -  133 15.9  -  469 15.2  - 
* MAT data numerator and denominator.
Table 3.46: Perinatal related mortality risk (per 1000 ongoing pregnancies) 2007–2015
2007—2008 2009—2010 2011—2012 2013—2014 2015 Chi-squared 












Gestation at birth (weeks)
20–22  411  435  3.37  440  464  3.58  461  482  3.85  459  470  3.93  168  175  2.95 0.34
23–24  248  179  1.39  258  186  1.44  247  189  1.52  260  183  1.54  117  92  1.55 0.24
25–27  473  126  0.98  465  143  1.11  402  122  0.98  373  104  0.88  206  52  0.88 0.22
28–31  1,088  122  0.95  1,098  118  0.92  1,013  108  0.87  929  95  0.80  456  41  0.70 0.041
32–36  7,799  169  1.33  7,976  191  1.50  7,829  160  1.30  7,430  176  1.50  3,635  78  1.34 0.89
37–38  25,858  124  1.04  26,755  140  1.17  26,598  129  1.12  27,046  94  0.85  13,567  42  0.77 0.025
39–40  69,054  154  1.65  69,218  137  1.48  67,425  110  1.24  64,326  111  1.34  32,079  69  1.68 0.32
≥41  24,166  71  2.94  23,422  58  2.48  21,156  37  1.75  18,653  26  1.39  9,105  29  3.19 0.047
Unknown  1,729  1  -  1,034  1  -  1,408  -  -  755  -  -  475  -  - 
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20–22  411  197  1.53  440  180  1.39  461  225  1.80  459  173  1.45  168  66  1.11 0.36
23–24  248  47  0.37  258  51  0.39  247  61  0.49  260  63  0.53  117  27  0.46 0.067
25–27  473  24  0.19  465  29  0.22  402  29  0.23  373  26  0.22  206  8  0.14 0.95
28–31  1,088  13  0.10  1,098  10  0.08  1,013  16  0.13  929  12  0.10  456  3  0.05 0.74
≥32  126,877  8  0.06  127,371  19  0.15  123,008  12  0.10  117,455  16  0.14  58,386  3  0.05 0.57
Unknown  1,729  -  -  1,034  -  -  1,408  -  -  755  -  -  475  -  - 
Stillbirths
20–22  411  174  1.35  440  182  1.40  461  175  1.40  459  199  1.67  168  73  1.23 0.24
23–24  248  65  0.51  258  74  0.57  247  65  0.52  260  57  0.48  117  32  0.54 0.77
25–27  473  73  0.57  465  71  0.55  402  60  0.48  373  50  0.42  206  31  0.52 0.18
28–31  1,088  81  0.63  1,098  80  0.62  1,013  64  0.52  929  63  0.53  456  29  0.49 0.070
32–36  7,799  118  0.93  7,976  126  0.99  7,829  109  0.89  7,430  121  1.03  3,635  48  0.82 0.84
37–40  94,912  197  1.65  95,973  189  1.58  94,023  161  1.40  91,372  132  1.20  45,646  72  1.32 0.0018
≥41  24,166  39  1.61  23,422  33  1.41  21,156  18  0.85  18,653  12  0.64  9,105  20  2.20 0.18
Unknown  1,729  1  -  1,034  1  -  1,408  -  -  755  -  -  475  -  - 
Neonatal deaths
20–22  40  64  0.50  78  102  0.79  61  82  0.66  87  98  0.83  29  36  0.61 0.049
23–24  136  67  0.52  133  61  0.47  121  63  0.51  140  63  0.53  58  33  0.56 0.52
25–27  376  29  0.23  365  43  0.33  313  33  0.27  297  28  0.24  167  13  0.22 0.68
28–31  994  28  0.22  1,008  28  0.22  933  28  0.23  854  20  0.17  424  9  0.15 0.35
32–36  7,673  43  0.34  7,836  51  0.40  7,709  40  0.33  7,300  46  0.39  3,584  27  0.46 0.43
37–40  94,715  81  0.68  95,779  83  0.70  93,861  77  0.67  91,233  66  0.60  45,574  39  0.71 0.84
≥41  24,127  32  1.33  23,389  25  1.07  21,138  19  0.90  18,641  14  0.75  9,085  9  0.99 0.14































Table 3.48: Perinatal related mortality rates (per 1000 births) by birthweight and year (2007–2015)
Birthweight 
(g)




N n Rate N n Rate N n Rate N n Rate N n Rate
<500  422  429  -  440  461  -  481  501  -  471  475  -  187  188  -  - 
500–999  664  340  512.05  678  354  522.12  611  314  513.91  611  312  510.64  273  138  505.49 0.90
1000–1499  799  88  110.14  812  103  126.85  723  90  124.48  652  71  108.90  376  34  90.43 0.39
1500–1999  1,561  83  53.17  1,509  85  56.33  1,502  71  47.27  1,397  70  50.11  649  36  55.47 0.62
2000–2499  4,566  84  18.40  4,630  80  17.28  4,624  89  19.25  4,372  87  19.90  2,161  33  15.27 0.93
2500–2999  16,554  110  6.64  16,777  111  6.62  16,204  102  6.29  16,033  81  5.05  7,966  52  6.53 0.17
3000–3499  40,392  121  3.00  41,034  119  2.90  39,907  89  2.23  38,373  74  1.93  18,998  53  2.79 0.024
3500–3999  39,418  68  1.73  39,517  69  1.75  38,090  52  1.37  36,051  57  1.58  18,051  29  1.61 0.48
4000–4499  15,430  38  2.46  15,307  33  2.16  14,572  15  1.03  13,613  18  1.32  6,732  8  1.19 0.00035
≥4500  3,461  13  3.76  3,184  9  2.83  3,031  3  0.99  2,794  5  1.79  1,252  4  3.19 0.13
Unknown  7,559  7  -  6,778  14  -  6,794  11  -  5,864  9  -  3,163  3  -  - 





20–22 23–27 28–31 32–36 37–40 ≥41 weeks
n % n % n % n % n % n %
Congenital abnormality  706  391  55.4  179  25.4  40  5.7  58  8.2  30  4.2  8  1.1 
Perinatal infection  64  19  29.7  17  26.6  8  12.5  6  9.4  10  15.6  4  6.3 
Hypertension  67  11  16.4  24  35.8  8  11.9  15  22.4  8  11.9  1  1.5 
Antepartum haemorrhage  229  126  55.0  38  16.6  16  7.0  30  13.1  18  7.9  1  0.4 
Maternal conditions  136  41  30.1  32  23.5  19  14.0  22  16.2  21  15.4  1  0.7 
Specific perinatal conditions  255  78  30.6  56  22.0  22  8.6  46  18.0  50  19.6  3  1.2 
Hypoxic peripartum death  39  -  -  -  -  -  -  3  7.7  24  61.5  12  30.8 
Fetal growth restriction  196  19  9.7  47  24.0  34  17.3  36  18.4  53  27.0  7  3.6 
Spontaneous preterm  193  142  73.6  40  20.7  7  3.6  4  2.1  -  -  -  - 
Unexplained antepartum death  446  84  18.8  76  17.0  33  7.4  81  18.2  159  35.7  13  2.9 
Total  2,331  911  39.1  509  21.8  187  8.0  301  12.9  373  16.0  50  2.1 
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Table 3.50: Perinatal death classification (PSANZ-PDC) and neonatal death classification (PSANZ-
NDC) of neonatal deaths by gestational age 2011–2015
Death classification 
(PSANZ) Total
20–22 23–27 28–31 32–36 37–40 ≥41 weeks
n % n % n % n % n % n %
Perinatal death classification (PSANZ-PDC)
Congenital abnormality  204  2  1.0  8  3.9  18  8.8  67  32.8  95  46.6  14  6.9 
Perinatal infection  42  10  23.8  9  21.4  3  7.1  4  9.5  10  23.8  6  14.3 
Hypertension  19  2  10.5  11  57.9  3  15.8  2  10.5  1  5.3  -  - 
Antepartum haemorrhage  132  62  47.0  59  44.7  4  3.0  5  3.8  2  1.5  -  - 
Maternal conditions  28  7  25.0  6  21.4  4  14.3  7  25.0  4  14.3  -  - 
Specific perinatal conditions  80  35  43.8  18  22.5  9  11.3  8  10.0  9  11.3  1  1.3 
Hypoxic peripartum death  46  -  -  -  -  1  2.2  3  6.5  31  67.4  11  23.9 
Fetal growth restriction  14  -  -  3  21.4  1  7.1  2  14.3  7  50.0  1  7.1 
Spontaneous preterm  245  98  40.0  119  48.6  14  5.7  14  5.7  -  -  -  - 
No obstetric antecedent  33  -  -  -  -  -  -  1  3.0  23  69.7  9  27.3 
Neonatal death classification (PSANZ-NDC)
Congenital abnormality  209  2  1.0  7  3.3  18  8.6  71  34.0  97  46.4  14  6.7 
Extreme prematurity  305  214  70.2  91  29.8  -  -  -  -  -  -  -  - 
Cardio-respiratory disorders  63  -  -  44  69.8  11  17.5  3  4.8  5  7.9  -  - 
Infection  65  -  -  30  46.2  5  7.7  7  10.8  15  23.1  8  12.3 
Neurological  128  -  -  45  35.2  10  7.8  22  17.2  40  31.3  11  8.6 
Gastrointestinal  11  -  -  8  72.7  3  27.3  -  -  -  -  -  - 
Other  62  -  -  8  12.9  10  16.1  10  16.1  25  40.3  9  14.5 
Total  843  216  25.6  233  27.6  57  6.8  113  13.4  182  21.6  42  5.0 
Table 3.51: Perinatal death classification (PSANZ-PDC) specific stillbirth rates (per 1000 births) 2007–
2015
Perinatal death  
classification 
(PSANZ-PDC)




n=130,826 n=130,666 n=126,539 n=120,231 n=59,808
n Rate n Rate n Rate n Rate n Rate
Congenital abnormality  63  0.48  67  0.51  62  0.49  55  0.46  25  0.42 0.67
Perinatal infection  36  0.28  33  0.25  19  0.15  22  0.18  12  0.20 0.057
Hypertension  25  0.19  42  0.32  20  0.16  17  0.14  16  0.27 0.31
Antepartum haemorrhage  94  0.72  99  0.76  79  0.62  78  0.65  46  0.77 0.44
Maternal conditions  33  0.25  49  0.38  32  0.25  43  0.36  22  0.37 0.30
Specific perinatal condition  91  0.70  105  0.80  93  0.73  82  0.68  42  0.70 0.67
Hypoxic peripartum death  33  0.25  18  0.14  20  0.16  10  0.08  9  0.15 0.0087
Fetal growth restriction  94  0.72  83  0.64  79  0.62  77  0.64  27  0.45 0.097































Table 3.52: Intrapartum stillbirth rates (per 1000 ongoing pregnancies) by gestation excluding congenital abnormalities 2007–2015
Gestation at 
birth (weeks)
2007—2008 2009—2010 2011—2012 2013—2014 2015 Chi-squared 
test for trend 
(p)n N Rate n N Rate n N Rate n N Rate n N Rate
23–27  21  128,494 0.16  31  128,970 0.24  26  124,444 0.21  18  118,814 0.15  8  59,070 0.14 0.34
28–36  11  127,835 0.09  7  128,324 0.05  7  123,873 0.06  5  118,258 0.04  2  58,780 0.03 0.095
≥37  46  119,020 0.39  38  119,335 0.32  21  115,117 0.18  13  109,971 0.12  17  54,718 0.31 0.0014
Table 3.53: Association between perinatal death classification (PSANZ-PDC) and neonatal death classification (PSANZ-NDC) among all 
neonatal deaths 2015
Perinatal death classification (PSANZ-PDC) Total








Infection Neurological Gastro-intestinal Other
Congenital abnormality  45  45  -  -  -  -  -  - 
Perinatal infection  7  -  3  -  3  1  -  - 
Hypertension  5  -  -  1  1  2  -  1 
Antepartum haemorrhage  30  -  20  2  -  7  -  1 
Maternal conditions  2  -  -  -  -  1  -  1 
Specific perinatal conditions  18  -  9  3  1  2  1  2 
Hypoxic peripartum death  8  -  -  -  -  8  -  - 
Fetal growth restriction  1  -  -  -  -  -  -  1 
Spontaneous preterm  43  -  19  10  1  10  1  2 
No obstetric antecedent  7  -  -  -  1  -  -  6 
100







Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=71 n=320 n=244 n=635
n Rate n Rate n Rate n Rate
2007  2,011  3  1.49  34  16.91  25  12.66  62  30.83 
2008  1,924  3  1.56  33  17.15  18  9.53  54  28.07 
2009  1,849  5  2.70  32  17.31  31  17.11  68  36.78 
2010  1,906  9  4.72  35  18.36  35  18.80  79  41.45 
2011  1,827  18  9.85  48  26.27  27  15.33  93  50.90 
2012  1,804  14  7.76  34  18.85  32  18.22  80  44.35 
2013  1,745  7  4.01  41  23.50  16  9.43  64  36.68 
2014  1,727  10  5.79  34  19.69  40  23.77  84  48.64 
2015  1,667  2  1.20  29  17.40  20  12.22  51  30.59 
Chi-squared test 
for trend (p) 0.10 0.33 0.23 0.047
Table 3.55: Chorionicity and number of babies lost among twin perinatal related deaths 2007–2015
2007—2008 2009—2010 2011—2012 2013—2014 2015 Total
n=109 n=133 n=159 n=139 n=50 n=590
n % n % n % n % n % n %
Twin type
Dichorionic diamniotic  49  45.0  56  42.1  68  42.8  64  46.0  25  50.0  262  44.4 
Monochorionic diamniotic  54  49.5  64  48.1  79  49.7  69  49.6  21  42.0  287  48.6 
Monoamniotic  2  1.8  9  6.8  4  2.5  3  2.2  4  8.0  22  3.7 
Other multiple  4  3.7  1  0.8  3  1.9  -  -  -  -  8  1.4 
Unknown  -  -  3  2.3  5  3.1  3  2.2  -  -  11  1.9 
Loss of twin pairs or one twin
Both twins died  60  55.0  80  60.2  108  67.9  96  69.1  24  48.0  368  62.4 
One twin died  49  45.0  53  39.8  51  32.1  43  30.9  26  52.0  222  37.6 
Table 3.56: Gestation at registration by lead maternity carer among perinatal related deaths 2015
Lead maternity carer
Gestation (weeks) at registration
Total
<10 10–13 14–19 ≥20 Unknown
n % n % n % n % n %
Self-employed midwife  446  227  50.9  123  27.6  53  11.9  35  7.8  8  1.8 
DHB care  78  17  21.8  26  33.3  19  24.4  16  20.5  -  - 
Obstetrician (private)  26  14  53.8  7  26.9  4  15.4  1  3.8  -  - 
Total  550  258  46.9  156  28.4  76  13.8  52  9.5  8  1.5 
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Table 3.57: Perinatal related deaths and completeness of perinatal death investigations 2015
Perinatal death investigation
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=107 n=305 n=166 n=578
n % n % n % n %
Optimum investigation*  67  62.6  165  54.1  69  41.6  301  52.1 
Post-mortem  44  41.1  154  50.5  50  30.1  248  42.9 
Karyotype  23  21.5  12  3.9  11  6.6  46  8.0 
Clinical examination/investigations 
confirm diagnosis
6  5.6 3  1.0 12  7.2  21  3.6 
Partial investigations only #  35  32.7  104  34.1  90  54.2  229  39.6 
No investigation +  4  3.7  35  11.5  7  4.2  46  8.0 
Unknown  1  0.9  1  0.3  -  -  2  0.3 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical examination/investigation confirming diagnosis. 
Note: More than one option can be selected.
# No post-mortem; investigations may have included placental pathology, MRI, ultrasound scan or x-ray.
+ No post-mortem, placental pathology, MRI, ultrasound scan or x-ray.
Table 3.58: Perinatal related deaths and rates of offer and decline of post-mortem examination 2015
Post-mortem examination offered
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=107 n=305 n=166 n=578
n % n % n % n %
Post-mortem offered and parental consent given  44  41.1  154  50.5  50  30.1  248  42.9 
Post-mortem offered and parents declined  55  51.4  139  45.6  98  59.0  292  50.5 
Post-mortem not offered  8  7.5  9  3.0  12  7.2  29  5.0 
Unknown  -  -  3  1.0  6  3.6  9  1.6 
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Table 3.59: Optimal investigation of perinatal related death by DHB of maternal residence 2015
DHB of maternal residence 
Perinatal related 
deaths Offered post-mortem Optimal investigation*
n=578
n n % n %
Northland  24  22  91.7  10  41.7 
Waitemata  58  54  93.1  33  56.9 
Auckland  55  50  90.9  35  63.6 
Counties Manukau  85  79  92.9  40  47.1 
Waikato  51  50  98.0  19  37.3 
Bay of Plenty  26  26  100.0  13  50.0 
Lakes  13  13  100.0  5  38.5 
Tairawhiti  8  6  75.0  1  12.5 
Taranaki  15  14  93.3  7  46.7 
Hawke’s Bay  14  12  85.7  7  50.0 
Whanganui  12  9  75.0  7  58.3 
MidCentral  19  19  100.0  10  52.6 
Wairarapa  5  5  100.0  3  60.0 
Capital & Coast  37  37  100.0  21  56.8 
Hutt Valley  20  18  90.0  14  70.0 
Nelson Marlborough  11  9  81.8  7  63.6 
West Coast  6  6  100.0  3  50.0 
Canterbury  73  69  94.5  46  63.0 
South Canterbury  7  5  71.4  2  28.6 
Southern  35  34  97.1  16  45.7 
Overseas  4  3  75.0  2  50.0 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical examination/investigation confirming diagnosis.
Table 3.60: Perinatal related deaths and maternal outcome 2015
Maternal outcome
Fetal deaths
Neonatal deaths Perinatal related deathsTermination of 
pregnancy Stillbirths
n=107 n=305 n=166 n=578
n % n % n % n %
Alive and generally well  107  100.0  295  96.7  165  99.4  567  98.1 
Alive but with serious morbidity  -  -  9  3.0  -  -  9  1.6 
Maternal death  -  -  1  0.3  1  0.6  2  0.3 
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Table 3.61: Perinatal related deaths by primary and associated perinatal death classification (PSANZ-
PDC) 2015











n=578 n=578 n=578 n=578
n % n % n % n %*
Congenital abnormality  158  27.3  7  1.2  2  0.3  163  28.2 
Perinatal infection  22  3.8  4  0.7  -  -  26  4.5 
Hypertension  21  3.6  7  1.2  2  0.3  30  5.2 
Antepartum haemorrhage  79  13.7  24  4.2  2  0.3  105  18.2 
Maternal conditions  29  5.0  2  0.3  -  -  31  5.4 
Specific perinatal condition  60  10.4  1  0.2  1  0.2  62  10.7 
Hypoxic peripartum death  17  2.9  10  1.7  2  0.3  28  4.8 
Fetal growth restriction  33  5.7  30  5.2  1  0.2  62  10.7 
Spontaneous preterm  65  11.2  65  11.2  5  0.9  134  23.2 
Unexplained antepartum death  87  15.1  1  0.2  -  -  87  15.1 
No obstetric antecedent  7  1.2  -  -  -  -  7  1.2 
* Percentages are not mutually exclusive.
Table 3.62: Neonatal deaths by primary and associated neonatal death classification (PSANZ-NDC) 
2015











n=166 n=166 n=166 n=166
n % n % n % n %*
Congenital abnormality  45  27.1  4  2.4  -  -  46  27.7 
Extreme prematurity  51  30.7  -  -  -  -  51  30.7 
Cardio-respiratory disorders  16  9.6  7  4.2  2  1.2  20  12.0 
Infection  7  4.2  3  1.8  -  -  10  6.0 
Neurological  31  18.7  5  3.0  1  0.6  37  22.3 
Gastrointestinal  2  1.2  -  -  -  -  2  1.2 
Other  14  8.4  3  1.8  -  -  17  10.2 
* Percentages are not mutually exclusive.
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Table 3.63: Detail of contributory factors among perinatal related deaths 2009–2015
Contributory factors 2009—2010 2011—2012 2013—2014 2015
n % n % n % n %
Any contributory factor  364  25.3  372  27.8  331  26.3  146  25.3 
Organisational and/or management factors  67  4.7  73  5.5  56  4.4  32  4.4 
Poor organisational arrangements of staff  12  10  5  - 
Inadequate education and training  15  9  6  2 
Lack of policies, protocols or guidelines  14  20  10  10 
Inadequate numbers of staff  3  6  3  1 
Poor access to senior clinical staff  6  4  2  - 
Failure or delay in emergency response  10  5  12  2 
Delay in procedure (eg, caesarean section)  13  15  13  2 
Inadequate systems for sharing of clinical 
information
 -  5  4  11 
Delayed access to test results or inaccurate results  7  11  4  5 
Equipment (eg, faulty equipment, inadequate 
maintenance, inadequate quality or lack of 
equipment)
 7  8  7  3 
Building and design functionality (eg, space, 
privacy, ease of access, lighting, noise, power 
failure, operating theatre in distant location)
 -  1  2  1 
Other  10  10  2  3 
Not stated  -  4  3  7 
Personnel factors  96  6.7  107  8.0  98  7.8  55  7.5 
Knowledge and skills of staff were lacking  30  34  25  19 
Delayed emergency response by staff  13  6  7  2 
Failure to maintain competence  5  3  -  - 
Failure of communication between staff  19  21  13  11 
Failure to seek help/supervision  13  17  5  6 
Failure to offer or follow recommended best 
practice
 57  61  50  27 
Lack of recognition of complexity or seriousness of 
condition by care giver
 2  18  35  27 
Other  1  2  4  2 
Barriers to access and/or engagement with care  266  18.5  265  19.8  241  19.1  106  14.5 
No antenatal care  50  62  50  22 
Infrequent care or late booking  64  91  88  33 
Declined treatment or advice  26  39  53  28 
Obesity impacted on delivery of optimal care (eg, 
ultrasound scan)
 7  5  9  4 
Substance use  42  36  21  13 
Family violence  15  15  19  13 
Lack of recognition of complexity or seriousness of 
condition by the woman and/or family
 42  60  59  31 
Maternal mental illness  13  10  8  4 
Cultural barriers  14  20  6  1 
Language barriers  9  13  4  4 
Not eligible to access free care  5  9  3  2 
Environment (eg, isolated, long transfer, weather 
prevented transport)
 24  25  17  7 
Other  26  20  22  9 
Not stated  2  -  -  - 
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Table 3.64: Contributory factors and potentially avoidable perinatal related death by perinatal death 
classification (PSANZ-PDC) 2015











factors BUT NOT 




n=578 n % n % n % n %
Congenital abnormality  158  5  3.2  9  5.7  144  91.1  -  - 
Perinatal infection  22  3  13.6  1  4.5  18  81.8  -  - 
Hypertension  21  5  23.8  5  23.8  11  52.4  -  - 
Antepartum haemorrhage  79  10  12.7  16  20.3  51  64.6  2  2.5 
Maternal conditions  29  14  48.3  6  20.7  8  27.6  1  3.4 
Specific perinatal conditions  60  6  10.0  2  3.3  52  86.7  -  - 
Hypoxic peripartum death  17  8  47.1  -  -  8  47.1  1  5.9 
Fetal growth restriction  33  7  21.2  4  12.1  22  66.7  -  - 
Spontaneous preterm  65  11  16.9  11  16.9  43  66.2  -  - 
Unexplained antepartum death  87  7  8.0  11  12.6  69  79.3  -  - 
No obstetric antecedent  7  5  71.4  -  -  2  28.6  -  - 
Table 3.65: Main contributory factor(s) in potentially avoidable perinatal related death by perinatal 
death classification (PSANZ-PDC) 2011–2015











n n % n % n % n %
Congenital abnormality  910  2  0.2  6  0.7  7  0.8  -  - 
Perinatal infection  106  3  2.9  12  11.4  17  16.2  -  - 
Hypertension  86  5  5.8  13  15.1  16  18.6  -  - 
Antepartum haemorrhage  361  7  1.9  15  4.2  33  9.2  -  - 
Maternal conditions  164  11  6.1  19  11.7  61  38.0  2  1.2 
Specific perinatal conditions  335  15  4.5  20  6.0  18  5.4  -  - 
Hypoxic peripartum death  85  17  20.0  32  37.6  15  17.6  -  - 
Fetal growth restriction  210  13  6.2  35  16.7  31  14.8  -  - 
Spontaneous preterm  438  11  2.5  18  4.1  58  13.1  -  - 
Unexplained antepartum death  446  6  1.6  14  3.1  44  10.1  -  - 
No obstetric antecedent  33  1  3.0  3  9.1  19  57.6  -  - 
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Table 3.66: Contributory factors and potentially avoidable perinatal related death by maternal 
prioritised ethnicity (95% CIs surround the estimate of the proportion of cases within each ethnicity 





Contributory factors and 
potentially avoidable
Contributory 






n=3,174 n % 95% CI n % n % n %
Māori  805  180  22.4 19.53–25.40  146  18.1  467  58.0  12  1.5 
Pacific peoples  411  98  23.8 19.80–28.27  59  14.4  251  61.1  3  0.7 
Indian  198  25  12.6 8.34–18.07  15  7.6  155  78.3  3  1.5 
Other Asian  262  21  8.0 5.03–11.99  9  3.4  228  87.0  4  1.5 
Other (including unknown)  272  27  9.9 6.64–14.11  28  10.3  212  77.9  5  1.8 
NZ European  1,226  167  13.6 11.75–15.67  74  6.0  966  78.8  19  1.5 
Table 3.67: Main contributory factor(s) in potentially avoidable perinatal related deaths by maternal 








n n % 95% CI n % 95% CI n % 95% CI
Māori  805  17  2.1 1.23–3.36  42  5.2 3.79–6.99  138  17.1 14.60–19.93
Pacific peoples  411  11  2.7 1.34–4.74  22  5.4 3.38–7.99  77  18.7 15.08–22.85
Indian  198  4  2.0 0.55–5.09  16  8.1 4.69–12.79  10  5.1 2.45–9.09
Other Asian  262  7  2.7 1.08–5.43  10  3.8 1.85–6.91  8  3.1 1.33–5.93
Other (including unknown)  272  8  2.9 1.28–5.71  17  6.3 3.68–9.82  8  2.9 1.28–5.71
NZ European  1,226  44  3.6 2.62–4.79  80  6.5 5.21–8.06  78  6.4 5.06–7.88
Table 3.68: Contributory factors and potentially avoidable perinatal related death by deprivation 







Contributory factors and 
potentially avoidable
Contributory 






n=3,174 n % 95% CI n % n % n %
1 (least deprived)  412  50  12.1 9.14–15.69  25  6.1  332  80.6  5  1.2 
2  425  51  12.0 9.07–15.47  25  5.9  343  80.7  6  1.4 
3  554  75  13.5 10.80–16.67  43  7.8  422  76.2  14  2.5 
4  678  98  14.5 11.89–17.33  53  7.8  519  76.5  8  1.2 
5 (most deprived)  1,089  239  21.9 19.52–24.52  183  16.8  656  60.2  11  1.0 
Unknown  16  5  31.3 11.02–58.66  2  12.5  7  43.8  2  12.5 
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Table 3.69: Main contributory factor(s) in potentially avoidable perinatal related deaths by deprivation 








n n % 95% CI n % 95% CI n % 95% CI
1 (least deprived)  412  16  3.9 2.24–6.23  25  6.1 3.96–8.83  17  4.1 2.42–6.52
2  425  13  3.1 1.64–5.17  21  4.9 3.08–7.45  28  6.6 4.42–9.38
3  554  15  2.7 1.52–4.43  39  7.0 5.05–9.50  39  7.0 5.05–9.50
4  678  17  2.5 1.47–3.98  31  4.6 3.13–6.43  61  9.0 6.95–11.41
5 (most deprived)  1,089  27  2.5 1.64–3.59  71  6.5 5.13–8.15  169  15.5 13.42–17.81
Unknown  16  3  18.8 -  -  - -  5  31.3 -
Table 3.70: Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–
2015
Perinatal death  
classification  
(PSANZ-PDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=1,381 n=1,438 n=1,337 n=1,259 n=578 n=5,415
n % n % n % n % n % n %
Congenital abnormality
1.1 Central nervous system  86  6.2  71  4.9  76  5.7  80  6.4  23  4.0  313  5.8 
1.2 Cardiovascular system  51  3.7  52  3.6  50  3.7  47  3.7  28  4.8  200  3.7 
1.3 Urinary system  25  1.8  26  1.8  28  2.1  23  1.8  10  1.7  102  1.9 
1.4 Gastrointestinal system  10  0.7  7  0.5  8  0.6  7  0.6  6  1.0  32  0.6 
1.5 Chromosomal  108  7.8  134  9.3  119  8.9  109  8.7  47  8.1  470  8.7 
1.6 Metabolic  4  0.3  7  0.5  6  0.4  3  0.2  6  1.0  20  0.4 
1.7 Multiple/Non-chromosomal 
syndromes
 51  3.7  46  3.2  58  4.3  33  2.6  21  3.6  188  3.5 
1.8 Other congenital abnormality
1.81 Musculoskeletal  8  0.6  16  1.1  25  1.9  24  1.9  8  1.4  73  1.3 
1.82 Respiratory  2  0.1  2  0.1  2  0.1  -  -  -  -  6  0.1 
1.83 Diaphragmatic hernia  9  0.7  15  1.0  10  0.7  6  0.5  4  0.7  40  0.7 
1.84 Haematological  -  -  2  0.1  4  0.3  2  0.2  -  -  8  0.1 
1.85 Tumours  8  0.6  2  0.1  4  0.3  4  0.3  1  0.2  18  0.3 
1.88 Other specified congenital 
abnormality
 13  0.9  6  0.4  7  0.5  5  0.4  -  -  31  0.6 
1.9 Unspecified congenital 
abnormality
 7  0.5  7  0.5  7  0.5  5  0.4  4  0.7  26  0.5 
Perinatal infection
2.1 Bacterial
2.11 Group B Streptococcus  13  0.9  16  1.1  3  0.2  9  0.7  6  1.0  41  0.8 
2.12 E. coli  5  0.4  7  0.5  2  0.1  5  0.4  -  -  19  0.4 
2.13 Listeria monocytogenes  3  0.2  4  0.3  1  0.1  6  0.5  2  0.3  14  0.3 
2.14 Spirochaetal (eg, syphilis)  -  -  -  -  1  0.1  -  -  -  -  1  0.0 
2.18 Other bacterial  7  0.5  1  0.1  6  0.4  8  0.6  2  0.3  22  0.4 
2.19 Unspecified bacterial  5  0.4  4  0.3  4  0.3  3  0.2  4  0.7  16  0.3 
2.2 Viral
2.21 Cytomegalovirus  9  0.7  11  0.8  6  0.4  4  0.3  3  0.5  30  0.6 
2.22 Parvovirus  4  0.3  -  -  8  0.6  -  -  1  0.2  12  0.2 
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Perinatal death  
classification  
(PSANZ-PDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=1,381 n=1,438 n=1,337 n=1,259 n=578 n=5,415
n % n % n % n % n % n %
2.23 Herpes simplex virus  3  0.2  1  0.1  1  0.1  3  0.2  -  -  8  0.1 
2.28 Other viral  -  -  1  0.1  -  -  -  -  -  -  1  0.0 
2.29 Unspecified viral  3  0.2  -  -  -  -  -  -  -  -  3  0.1 
2.3 Protozoal (eg, Toxoplasma)  1  0.1  3  0.2  4  0.3  3  0.2  1  0.2  11  0.2 
2.5 Fungal  -  -  -  -  -  -  1  0.1  -  -  1  0.0 
2.8 Other specified organism  -  -  -  -  1  0.1  -  -  -  -  1  0.0 
2.9 Other unspecified organism  4  0.3  5  0.3  3  0.2  2  0.2  3  0.5  14  0.3 
Hypertension
3.1 Chronic hypertension: essential  3  0.2  2  0.1  4  0.3  5  0.4  2  0.3  14  0.3 
3.2 Chronic hypertension: 
secondary, (eg, renal disease)
 3  0.2  1  0.1  1  0.1  1  0.1  1  0.2  6  0.1 
3.3 Chronic hypertension: 
unspecified
 2  0.1  2  0.1  -  -  2  0.2  -  -  6  0.1 
3.4 Gestational hypertension  3  0.2  4  0.3  5  0.4  2  0.2  1  0.2  14  0.3 
3.5 Pre-eclampsia  22  1.6  33  2.3  20  1.5  13  1.0  13  2.2  88  1.6 
3.51 Pre-eclampsia: With laboratory 
evidence of thrombophilia
 -  -  3  0.2  1  0.1  -  -  1  0.2  4  0.1 
3.6 Pre-eclampsia superimposed 
on chronic hypertension
 6  0.4  6  0.4  8  0.6  3  0.2  2  0.3  23  0.4 
3.61 Pre-eclampsia superimposed 
on chronic hypertension: 
With laboratory evidence of 
thrombophilia
 1  0.1  2  0.1  -  -  -  -  -  -  3  0.1 
3.9 Unspecified hypertension  1  0.1  3  0.2  -  -  -  -  1  0.2  4  0.1 
Antepartum haemorrhage (APH)
4.1 Placental abruption  77  5.6  81  5.6  67  5.0  61  4.8  20  3.5  286  5.3 
4.11 Placental abruption: With 
laboratory evidence of 
thrombophilia
 8  0.6  5  0.3  6  0.4  1  0.1  2  0.3  20  0.4 
4.2 Placenta praevia  3  0.2  8  0.6  2  0.1  2  0.2  -  -  15  0.3 
4.3 Vasa praevia  1  0.1  2  0.1  1  0.1  -  -  2  0.3  4  0.1 
4.8 Other APH  17  1.2  18  1.3  15  1.1  38  3.0  36  6.2  88  1.6 
4.9 APH of undetermined origin  23  1.7  43  3.0  47  3.5  42  3.3  19  3.3  155  2.9 
Maternal conditions
5.1 Termination of pregnancy 
for maternal psychosocial 
indications
 9  0.7  5  0.3  9  0.7  5  0.4  3  0.5  28  0.5 
5.2 Diabetes/Gestational diabetes  19  1.4  32  2.2  23  1.7  27  2.1  12  2.1  101  1.9 
5.3 Maternal injury  -  -  -  -  -  -  1  0.1  -  -  1  0.0 
5.31 Maternal injury: Accidental  2  0.1  3  0.2  3  0.2  5  0.4  3  0.5  13  0.2 
5.32 Maternal injury: Non-
accidental
 3  0.2  2  0.1  -  -  3  0.2  1  0.2  8  0.1 
5.4 Maternal sepsis  1  0.1  5  0.3  3  0.2  5  0.4  2  0.3  14  0.3 
5.5 Antiphospholipid syndrome  5  0.4  10  0.7  3  0.2  7  0.6  2  0.3  25  0.5 
5.51 Other maternal thrombophilia 
(if considered cause of death)
 1  0.1  -  -  2  0.1  -  -  1  0.2  3  0.1 
Table 3.70:  Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–
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Perinatal death  
classification  
(PSANZ-PDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=1,381 n=1,438 n=1,337 n=1,259 n=578 n=5,415
n % n % n % n % n % n %
5.6 Obstetric cholestasis  -  -  -  -  -  -  1  0.1  -  -  1  0.0 
5.8 Other specified maternal 
conditions
 10  0.7  13  0.9  19  1.4  19  1.5  5  0.9  61  1.1 
Specific perinatal conditions
6.1 Twin–twin transfusion  32  2.3  54  3.8  41  3.1  36  2.9  7  1.2  163  3.0 
6.2 Fetomaternal haemorrhage  10  0.7  21  1.5  20  1.5  7  0.6  13  2.2  58  1.1 
6.3 Antepartum cord complications 
(eg, cord haemorrhage; 
true knot with evidence of 
occlusion)
 27  2.0  -  -  -  -  -  -  -  -  27  0.5 
6.31 Cord haemorrhage  2  0.1  2  0.1  2  0.1  3  0.2  1  0.2  9  0.2 
6.32 True knot with evidence of 
occlusion
 1  0.1  5  0.3  7  0.5  4  0.3  1  0.2  17  0.3 
6.38 Other  1  0.1  23  1.6  18  1.3  11  0.9  9  1.6  53  1.0 
6.4 Uterine abnormalities, eg, 
bicornuate uterus, cervical 
incompetence
 25  1.8  22  1.5  24  1.8  26  2.1  14  2.4  97  1.8 
6.5 Birth trauma (typically infants 
of >24 weeks gestation or 
>600g birthweight)
 -  -  1  0.1  -  -  -  -  -  -  1  0.0 
6.6 Alloimmune disease
6.61 Alloimmune disease: Rhesus  -  -  -  -  1  0.1  1  0.1  -  -  2  0.0 
6.64 Alloimmune disease: 
Alloimmune thrombocytopenia
 1  0.1  3  0.2  -  -  2  0.2  -  -  6  0.1 
6.68 Alloimmune disease: Other  -  -  -  -  -  -  -  -  1  0.2  -  - 
6.7 Idiopathic hydrops  7  0.5  5  0.3  8  0.6  6  0.5  5  0.9  26  0.5 
6.8 Other specific perinatal 
conditions (includes 
iatrogenic conditions such as 
rupture of membranes after 
amniocentesis, termination 
of pregnancy for suspected 
but unconfirmed congenital 
abnormality)
6.81 Rupture of membranes after 
amniocentesis
 6  0.4  1  0.1  3  0.2  1  0.1  1  0.2  11  0.2 
6.82 Termination of pregnancy for 
suspected but unconfirmed 
congenital abnormality
 -  -  -  -  -  -  3  0.2  -  -  3  0.1 
6.83 Fetal subdural haematoma  2  0.1  2  0.1  -  -  1  0.1  1  0.2  5  0.1 
6.88 Other  14  1.0  6  0.4  19  1.4  30  2.4  7  1.2  69  1.3 
6.89 Unspecified  -  -  -  -  -  -  1  0.1  -  -  1  0.0 
Hypoxic peripartum death
7.1 With intrapartum 
complications
7.11 With intrapartum 
complications: Uterine rupture
 2  0.1  3  0.2  2  0.1  -  -  3  0.5  7  0.1 
7.12 With intrapartum 
complications: Cord prolapse
 3  0.2  6  0.4  6  0.4  1  0.1  2  0.3  16  0.3 
Table 3.70:  Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–
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Perinatal death  
classification  
(PSANZ-PDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=1,381 n=1,438 n=1,337 n=1,259 n=578 n=5,415
n % n % n % n % n % n %
7.13 With intrapartum 
complications: Shoulder 
dystocia
 2  0.1  2  0.1  -  -  -  -  -  -  4  0.1 
7.18 With intrapartum 
complications: Other
 10  0.7  5  0.3  5  0.4  4  0.3  1  0.2  24  0.4 
7.2 Evidence of non-reassuring 
fetal status in a normally 
grown infant (eg, abnormal 
fetal heart rate, fetal scalp 
ph/lactate, fetal pulse 
oximetry without intrapartum 
complications)
 27  2.0  20  1.4  20  1.5  17  1.4  6  1.0  84  1.6 
7.3 No intrapartum complications 
and no evidence of non-
reassuring fetal status
 3  0.2  2  0.1  3  0.2  4  0.3  3  0.5  12  0.2 
7.9 Unspecified hypoxic 
peripartum death
 20  1.4  10  0.7  4  0.3  2  0.2  2  0.3  36  0.7 
Fetal growth restriction (FGR)
8.1 With evidence of reduced 
vascular perfusion on Doppler 
studies and/or placental 
histopathology (eg, significant 
infarction, acute atherosis, 
maternal and/or fetal vascular 
thrombosis or maternal floor 
infarction)
 71  5.1  61  4.2  63  4.7  51  4.1  17  2.9  246  4.5 
8.2 With chronic villitis  1  0.1  1  0.1  1  0.1  3  0.2  3  0.5  6  0.1 
8.3 No placental pathology  11  0.8  11  0.8  5  0.4  6  0.5  1  0.2  33  0.6 
8.4 No examination of placenta  7  0.5  5  0.3  7  0.5  4  0.3  3  0.5  23  0.4 
8.8 Other specified placental 
pathology
 16  1.2  22  1.5  17  1.3  20  1.6  7  1.2  75  1.4 
8.9 Unspecified or not known 
whether placenta examined
 2  0.1  1  0.1  -  -  -  -  2  0.3  3  0.1 
Spontaneous preterm
9.1 Spontaneous preterm 
with intact membranes, or 
membrane rupture <24 hours 
before delivery
9.11 Spontaneous preterm 
with intact membranes, or 
membrane rupture <24 
hours before delivery: With 
chorioamnionitis
 36  2.6  55  3.8  40  3.0  56  4.4  18  3.1  187  3.5 
9.12 Spontaneous preterm 
with intact membranes, or 
membrane rupture <24 hours 
before delivery: Without 
chorioamnionitis
 32  2.3  27  1.9  19  1.4  18  1.4  6  1.0  96  1.8 
9.13 Spontaneous preterm 
with intact membranes, or 
membrane rupture <24 
hours before delivery: No 
examination of placenta
 1  0.1  3  0.2  3  0.2  9  0.7  -  -  16  0.3 
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Perinatal death  
classification  
(PSANZ-PDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=1,381 n=1,438 n=1,337 n=1,259 n=578 n=5,415
n % n % n % n % n % n %
9.17 No clinical signs of 
chorioamnionitis, no 
examination of placenta
 16  1.2  31  2.2  24  1.8  14  1.1  8  1.4  85  1.6 
9.19 Spontaneous preterm 
with intact membranes, or 
membrane rupture <24 hours 
before delivery: Unspecified or 
not known whether placenta 
examined
 16  1.2  16  1.1  7  0.5  3  0.2  -  -  42  0.8 
9.2 Spontaneous preterm with 
membrane rupture ≥24 hours 
before delivery
9.21 Spontaneous preterm with 
membrane rupture ≥24 
hours before delivery: With 
chorioamnionitis
 43  3.1  60  4.2  45  3.4  56  4.4  24  4.2  204  3.8 
9.22 Spontaneous preterm with 
membrane rupture ≥24 hours 
before delivery: Without 
chorioamnionitis
 8  0.6  5  0.3  9  0.7  3  0.2  1  0.2  25  0.5 
9.23 Spontaneous preterm with 
membrane rupture ≥24 hours 
before delivery: With clinical 
evidence of chorioamnionitis, 
no examination of placenta
 5  0.4  7  0.5  10  0.7  6  0.5  2  0.3  28  0.5 
9.27 No clinical signs of 
chorioamnionitis, no 
examination of placenta
 6  0.4  6  0.4  12  0.9  13  1.0  2  0.3  37  0.7 
9.29 Spontaneous preterm with 
membrane rupture ≥24 hours 
before delivery: Unspecified or 
not known whether placenta 
examined
 5  0.4  3  0.2  5  0.4  -  -  2  0.3  13  0.2 
9.3 Spontaneous preterm with 
membrane rupture of unknown 
duration before delivery
9.31 Spontaneous preterm with 
membrane rupture of unknown 
duration before delivery: With 
chorioamnionitis
 7  0.5  2  0.1  5  0.4  3  0.2  2  0.3  17  0.3 
9.32 Spontaneous preterm with 
membrane rupture of unknown 
duration before delivery: 
Without chorioamnionitis
 4  0.3  1  0.1  1  0.1  3  0.2  -  -  9  0.2 
9.33 Spontaneous preterm with 
membrane rupture of unknown 
duration before delivery: 
With clinical evidence 
of chorioamnionitis, no 
examination of placenta
 3  0.2  -  -  1  0.1  -  -  -  -  4  0.1 
9.37 No clinical signs of 
chorioamnionitis, no 
examination of placenta
 -  -  3  0.2  2  0.1  1  0.1  -  -  6  0.1 
Table 3.70:  Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–
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Perinatal death  
classification  
(PSANZ-PDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=1,381 n=1,438 n=1,337 n=1,259 n=578 n=5,415
n % n % n % n % n % n %
9.39 Spontaneous preterm with 
membrane rupture of unknown 
duration before delivery: 
Unspecified or not known 
whether placenta examined
 10  0.7  4  0.3  4  0.3  1  0.1  -  -  19  0.4 
Unexplained antepartum death
10.1 With evidence of reduced 
vascular perfusion on Doppler 
studies and/or placental 
histopathology (eg, significant 
infarction, acute atherosis, 
maternal and/or fetal vascular 
thrombosis or maternal floor 
infarction)
 28  2.0  23  1.6  28  2.1  16  1.3  5  0.9  95  1.8 
10.2 With chronic villitis  3  0.2  1  0.1  5  0.4  2  0.2  3  0.5  11  0.2 
10.3 No placental pathology  56  4.1  50  3.5  39  2.9  46  3.7  11  1.9  191  3.5 
10.4 No examination of placenta  43  3.1  35  2.4  33  2.5  30  2.4  17  2.9  141  2.6 
10.8 Other specified placental 
pathology
 59  4.3  58  4.0  72  5.4  87  6.9  50  8.7  276  5.1 
10.9 Unspecified or not known 
whether placenta examined
 13  0.9  8  0.6  1  0.1  -  -  1  0.2  22  0.4 
No obstetric antecedent
11.1 Sudden infant death syndrome 
(SIDS)
11.11 SIDS Category IA: Classic 
features of SIDS present, 
completely documented
 -  -  -  -  -  -  1  0.1  -  -  1  0.0 
11.13 SIDS Category II: Infant deaths 
that meet Category I except for 
one or more features
 1  0.1  2  0.1  -  -  -  -  -  -  3  0.1 
11.2 Postnatally acquired infection  3  0.2  3  0.2  5  0.4  2  0.2  1  0.2  13  0.2 
11.3 Accidental asphyxiation  3  0.2  -  -  1  0.1  1  0.1  1  0.2  5  0.1 
11.4 Other accident, poisoning or 
violence (postnatal)
 1  0.1  -  -  2  0.1  -  -  -  -  3  0.1 
11.8 Other specified  1  0.1  1  0.1  1  0.1  2  0.2  -  -  5  0.1 
11.9 Unknown/Undetermined  2  0.1  -  -  2  0.1  1  0.1  -  -  5  0.1 
11.91 Unclassified sudden infant 
death
 14  1.0  10  0.7  2  0.1  6  0.5  4  0.7  32  0.6 
11.92 Other Unknown/Undetermined  -  -  1  0.1  -  -  -  -  1  0.2  1  - 
Table 3.70:  Perinatal related death and primary perinatal death classification (PSANZ-PDC) 2007–
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Table 3.71: Neonatal death and primary neonatal death classification (PSANZ-NDC) 2007–2015
Neonatal death  
classification  
(PSANZ-NDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=344 n=393 n=342 n=335 n=166 n=1,580
n % n % n % n % n % n %
Congenital abnormality
1.1 Central nervous system  4  1.2  12  3.1  9  2.6  10  3.0  3  1.8  38  2.4 
1.2 Cardiovascular system  21  6.1  13  3.3  9  2.6  12  3.6  6  3.6  61  3.9 
1.3 Urinary system  11  3.2  9  2.3  10  2.9  4  1.2  3  1.8  37  2.3 
1.4 Gastrointestinal system  3  0.9  -  -  3  0.9  3  0.9  3  1.8  12  0.8 
1.5 Chromosomal  13  3.8  20  5.1  25  7.3  16  4.8  12  7.2  86  5.4 
1.6 Metabolic  2  0.6  6  1.5  6  1.8  3  0.9  6  3.6  23  1.5 
1.7 Multiple/Non-chromosomal 
syndromes
 15  4.4  14  3.6  10  2.9  15  4.5  6  3.6  60  3.8 
1.8 Other congenital abnormality
1.81 Musculoskeletal  -  -  1  0.3  5  1.5  5  1.5  2  1.2  13  0.8 
1.82 Respiratory  1  0.3  1  0.3  2  0.6  -  -  -  -  4  0.3 
1.83 Diaphragmatic hernia  6  1.7  11  2.8  6  1.8  3  0.9  3  1.8  29  1.8 
1.84 Haematological  -  -  1  0.3  -  -  1  0.3  -  -  2  0.1 
1.85 Tumours  3  0.9  -  -  -  -  2  0.6  1  0.6  6  0.4 
1.88 Other specified congenital 
abnormality
 2  0.6  1  0.3  3  0.9  2  0.6  -  -  8  0.5 
Extreme prematurity
2.1 Not resuscitated  85  24.7  123  31.3  105  30.7  126  37.6  46  27.7  485  30.7 
2.2 Unsuccessful resuscitation  24  7.0  19  4.8  17  5.0  5  1.5  5  3.0  70  4.4 
2.9 Unspecified or not known 
whether resuscitation 
attempted
 -  -  -  -  -  -  1  0.3  -  -  1  0.1 
Cardio-respiratory disorders
3.1 Hyaline membrane disease/
Respiratory distress syndrome 
(RDS)
 13  3.8  13  3.3  8  2.3  9  2.7  7  4.2  50  3.2 
3.2 Meconium aspiration 
syndrome
 -  -  -  -  -  -  2  0.6  -  -  2  0.1 
3.3 Primary persistent pulmonary 
hypertension
 -  -  1  0.3  2  0.6  1  0.3  1  0.6  5  0.3 
3.4 Pulmonary hypoplasia  7  2.0  5  1.3  6  1.8  6  1.8  3  1.8  27  1.7 
3.5 Chronic neonatal lung disease 
(typically, bronchopulmonary 
dysplasia)
 -  -  4  1.0  1  0.3  -  -  -  -  5  0.3 
3.6 Pulmonary haemorrhage  -  -  5  1.3  4  1.2  2  0.6  1  0.6  12  0.8 
3.7 Pneumothorax  -  -  -  -  -  -  1  0.3  -  -  1  0.1 




4.111 Congenital bacterial: Group B 
Streptococcus
 8  2.3  8  2.0  2  0.6  4  1.2  1  0.6  23  1.5 
4.112 Congenital bacterial: E. coli  1  0.3  3  0.8  6  1.8  2  0.6  2  1.2  14  0.9 
4.113 Congenital bacterial: Listeria 
monocytogenes
 1  0.3  -  -  -  -  2  0.6  1  0.6  4  0.3 
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Neonatal death  
classification  
(PSANZ-NDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=344 n=393 n=342 n=335 n=166 n=1,580
n % n % n % n % n % n %
4.118 Congenital bacterial: Other 
bacterial
 3  0.9  2  0.5  4  1.2  4  1.2  1  0.6  14  0.9 
4.119 Congenital bacterial: 
Unspecified bacterial
 3  0.9  4  1.0  2  0.6  3  0.9  -  -  12  0.8 
4.12 Acquired bacterial
4.121 Acquired bacterial: Group B 
Streptococcus
 -  -  -  -  4  1.2  -  -  -  -  4  0.3 
4.122 Acquired bacterial: E. coli  3  0.9  1  0.3  -  -  -  -  -  -  4  0.3 
4.125 Acquired bacterial: Other 
Gram negative bacilli (other 
than E. coli)
 2  0.6  1  0.3  1  0.3  1  0.3  1  0.6  6  0.4 
4.126 Acquired bacterial: 
Staphylococcus aureus
 3  0.9  1  0.3  1  0.3  3  0.9  1  0.6  9  0.6 
4.127 Acquired bacterial: Coagulase 
negative Staphylococcus
 3  0.9  -  -  -  -  1  0.3  -  -  4  0.3 
4.128 Acquired bacterial: Other 
specified bacterial
 -  -  5  1.3  2  0.6  1  0.3  -  -  8  0.5 
4.129 Acquired bacterial: 
Unspecified bacterial
 2  0.6  -  -  -  -  -  -  -  -  2  0.1 
4.2 Viral
4.21 Congenital viral
4.211 Congenital viral: 
Cytomegalovirus
 1  0.3  -  -  2  0.6  -  -  -  -  3  0.2 
4.213 Congenital viral: Herpes 
simplex virus
 2  0.6  -  -  1  0.3  3  0.9  -  -  6  0.4 
4.218 Congenital viral: Other 
specified viral
 -  -  -  -  2  0.6  -  -  -  -  2  0.1 
4.22 Acquired viral
4.223 Acquired viral: Herpes simplex 
virus
 -  -  1  0.3  1  0.3  1  0.3  -  -  3  0.2 
4.228 Acquired viral: Other specified 
viral
 1  0.3  1  0.3  1  0.3  -  -  -  -  3  0.2 
4.229 Acquired viral: Unspecified 
viral
 1  0.3  -  -  -  -  -  -  -  -  1  0.1 
4.5 Fungal  -  -  -  -  -  -  1  0.3  -  -  1  0.1 
4.9 Unspecified organism  1  0.3  4  1.0  2  0.6  1  0.3  -  -  8  0.5 
Neurological
5.1 Hypoxic ischaemic 
encephalopathy/Perinatal 
asphyxia (typically infants 
of >24 weeks gestation or 
>600g birthweight)
 54  15.7  56  14.2  33  9.6  29  8.7  19  11.4  191  12.1 
5.2 Intracranial haemorrhage
5.21 Intraventrical haemorrhage  7  2.0  8  2.0  14  4.1  18  5.4  12  7.2  59  3.7 
5.22 Subgaleal haemorrhage  1  0.3  1  0.3  -  -  -  -  -  -  2  0.1 
5.23 Subarachnoid haemorrhage  1  0.3  -  -  -  -  -  -  -  -  1  0.1 
5.24 Subdural haemorrhage  -  -  1  0.3  -  -  1  0.3  -  -  2  0.1 
5.28 Other intracranial 
haemorrhage
 -  -  1  0.3  -  -  1  0.3  -  -  2  0.1 
5.8 Other  1  0.3  1  0.3  1  0.3  -  -  -  -  3  0.2 
Table 3.71:  Neonatal death and primary neonatal death classification (PSANZ-NDC) 2007–2015
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Neonatal death  
classification  
(PSANZ-NDC)
2007—2008 2009—2010 2011—2012 2013—2014 2015 2007–2015
n=344 n=393 n=342 n=335 n=166 n=1,580
n % n % n % n % n % n %
Gastrointestinal
6.1 Necrotising enterocolitis  2  0.6  11  2.8  4  1.2  4  1.2  2  1.2  23  1.5 
6.8 Other  -  -  2  0.5  1  0.3  -  -  -  -  3  0.2 
Other
7.1 Sudden infant death syndrome 
(SIDS)
7.11 SIDS Category IA: Classic 
features of SIDS present and 
completely documented
 -  -  -  -  -  -  1  0.3  -  -  1  0.1 
7.13 SIDS Category II: Infant deaths 
that meet category I except for 
one or more features
 1  0.3  2  0.5  -  -  -  -  -  -  3  0.2 
7.2 Multisystem failure
7.21 Multisystem failure: Secondary 
to intrauterine growth 
restriction
 -  -  3  0.8  -  -  2  0.6  1  0.6  6  0.4 
7.28 Multisystem failure: Other 
specified
 -  -  1  0.3  3  0.9  4  1.2  2  1.2  10  0.6 
7.29 Multisystem failure: 
Unspecified/undetermined 
primary cause or trigger event
 -  -  -  -  1  0.3  -  -  -  -  1  0.1 
7.3 Trauma
7.31 Trauma: Accidental  3  0.9  -  -  3  0.9  2  0.6  2  1.2  10  0.6 
7.32 Trauma: Non accidental  -  -  -  -  1  0.3  -  -  -  -  1  0.1 
7.4 Treatment complications  3  0.9  -  -  -  -  -  -  -  -  3  0.2 
7.41 Treatment complications: 
Surgical
 -  -  -  -  -  -  -  -  1  0.6  1  0.1 
7.42 Treatment complications: 
Medical
 2  0.6  -  -  -  -  1  0.3  -  -  3  0.2 
7.8 Other specified  3  0.9  2  0.5  2  0.6  6  1.8  2  1.2  15  0.9 
7.9 Unknown/Undetermined  1  0.3  -  -  3  0.9  1  0.3  -  -  5  0.3 
7.91 Unclassified sudden infant 
death
 11  3.2  -  -  -  -  -  -  1  0.6  12  0.8 
7.911 Unclassified sudden infant 
death: Bed sharing
 7  2.0  11  2.8  8  2.3  7  2.1  5  3.0  38  2.4 
7.912 Unclassified sudden infant 
death: Not bed sharing
 -  -  2  0.5  2  0.6  1  0.3  -  -  5  0.3 
Table 3.71:  Neonatal death and primary neonatal death classification (PSANZ-NDC) 2007–2015
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4 New Zealand Maternal Mortality 2015
4.1 Introduction
The New Zealand Maternal Mortality Review Working Group (MMRWG) was established in 2006 
to develop a process for the national collection of data, to review maternal deaths and to identify 
potentially avoidable causes, with the expectation that this would lead to improvements in care.
The terms of reference of the PMMRC require the committee to review ‘direct’ maternal deaths. The 
MMRWG also reviews ‘indirect’ deaths, in particular (but not solely) those related to medical conditions 
exacerbated by pregnancy and those related to mental health.
Figure 4.1: New Zealand maternal mortality ratio (per 100,000 maternities) by mortality data source 
1973–2015 
MMR = maternal mortality ratio.
MDAC = Maternal Deaths Assessment Committee.
* Data from the MDAC, including maternal deaths to three months postpartum.
** Data from routine New Zealand datasets (ie, the BDM Mortality Collection and the National Minimum Dataset, including maternal deaths to six weeks 
postpartum.
+ Data from the PMMRC, including maternal deaths to six weeks postpartum.
Prior to 1992, maternal mortality in New Zealand was reported by the Maternal Deaths Assessment 
Committee (MDAC). This committee stopped meeting in 1995, and maternal mortality was then 
reported from data held in the National Minimum Dataset (NMDS) of hospital discharges and in the 
Mortality Collection from BDM. During this period of reporting from national datasets, the maternal 
mortality ratio was considerably lower than it had been during the years of the existence of the MDAC. 
When the PMMRC was established in 2006, and maternal mortality ratio reported again in the context 
of mandatory facilitated reporting, the maternal mortality ratio appeared to increase again. In the 
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maternities reported from 1995 to 2005. In reality, the maternal mortality ratio reported from routine 
data from 1991 to 2006 was artefactually low (Figure 4.1). 
As the PMMRC ascertainment process collects more cases than are found in routine datasets, the 
PMMRC estimate of the New Zealand maternal mortality ratio is necessarily higher, and a comparable 
ratio should be used when comparing New Zealand ratios with international ratios. 
As outlined in recent reports, incomplete ascertainment of cases in the absence of mandatory and 
facilitated reporting leads to under-reporting of maternal mortality internationally (Johnson et al 2014; 
Knight et al 2014; PMMRC 2014).
4.2 Methodology
Definitions
The definitions adopted by the MMRWG are based on the WHO definitions from the International 
Classification of Diseases (10th edition) as follows.
Maternal related death: death of a woman while pregnant or within 42 days of termination of 
pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or 
aggravated by the pregnancy or its management, but not from accidental or incidental causes (WHO 
n.d.).
The cause of each death is sub-classified using the Confidential Enquiry into Maternal and Child Health 
classification system (Lewis 2007).
Direct maternal deaths: those resulting from obstetric complications of the pregnant state (pregnancy, 
labour or puerperium), from interventions, omissions, incorrect treatment or from a chain of events 
resulting from the above.
Indirect maternal deaths: those resulting from previous existing disease or disease that developed 
during pregnancy and was not due to direct obstetric causes but that was aggravated by the 
physiologic effects of pregnancy. All maternal deaths by suicide are included in the New Zealand data 
as indirect deaths.
Coincidental maternal deaths: deaths from unrelated causes that happen to occur in pregnancy or the 
puerperium.
These definitions exclude late maternal deaths, occurring between 42 days and one year following 
the birth, even though it is known that some pregnancy related deaths occur in this later period. The 
MMRWG may consider and review these deaths where they can be identified.
In the latest report of the UK surveillance system (Knight et al 2016), suicide has been reported as 
a direct death in line with The WHO Application of ICD-10 to Deaths during Pregnancy, Childbirth 
and Puerperium: ICD MM (WHO 2012). The MMRWG acknowledges the importance of continuing 
to be able to benchmark against other jurisdictions; however, they have chosen not to change the 
classification of suicide in this report of deaths 2006–2015. Suicide is the single most common cause 
of maternal death in New Zealand and represents a separate work stream apart from other direct and 
indirect causes of maternal death. Retaining the current classification allows New Zealand to compare 
deaths from psychiatric causes to those in the UK for 2006–2014 (Figure 4.3). 
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Maternal mortality ratio is the number of maternal related deaths per 100,000 maternities. 
Maternities are defined here as all births at 20 weeks or beyond or weighing 400g or more if gestation 
was unknown. Pregnancies ending before 20 weeks are not included in this working definition because 
the absolute number of pregnancies ending before this time is unknown.
The term ‘ratio’ is used to describe ‘incidence’ of maternal mortality because cases included in the 
numerator may arise from pregnancies that end before 20 weeks. From 2006 to 2015, 29 percent 
of all maternal deaths (54 percent of antepartum (in pregnancy) maternal deaths and 13 percent of 
postpartum deaths) occurred under 20 weeks. As the total number of pregnancies ending before 20 
weeks is unknown, the denominator cannot include all women at risk and thus the estimate cannot truly 
be called a ‘rate’.
The variable definition of ‘maternities’ creates unnecessary confusion when making international 
comparisons. The WHO recommends 100,000 live births as the most available denominator in 
countries with limited vital statistics collection. In countries where fetal deaths are also collected, the 
WHO recommends the denominator be 100,000 live births plus fetal deaths of 20 weeks or greater 
gestation. The UK uses the number of pregnancies that result in a live birth at any gestation or a stillbirth 
at or after 24 completed weeks gestation (as only stillbirths at 24 or more weeks gestation are required 
to be notified by law) (Lewis 2007). Australia reports the number of women who gave birth to either a 
live or stillborn baby of 20 or more completed weeks gestation or weighing at least 400g at birth (as 
required to be reported to the National Perinatal Data Collection) (Sullivan et al 2008).
Contributory factors are organisational and/or management factors (eg, delays in procedures or 
accessing results; lack of policies, protocols or guidelines; lack of maintenance of equipment), personnel 
factors (eg, failure to maintain competence) and barriers to access and/or engagement with care (eg, 
unregistered pregnancies, language barriers, distance from adequate facilities) that the MMRWG 
considered contributed to the death. The subcategories within each group of factors considered are 
given in the ‘Contributory Factors for Mortality and Morbidity’ on page 78.
A potentially avoidable maternal death is where the absence of the contributory factor(s) may have 
prevented the death. From 2010, the MMRWG was asked to indicate the main contributory factor(s) in 
identifying the death as potentially avoidable.
More details on the process of development of the tool to assess contributory factors and potentially 
avoidable death have been published (Farquhar et al 2011).
Case ascertainment and data collection
Since 2006, the PMMRC has requested that all clinicians aware of a maternal death notify either their 
PMMRC DHB local coordinator or the PMMRC national coordinator. 
Deaths are brought to the MMRWG’s attention in the main by PMMRC DHB local coordinators (47 
percent) and other clinicians within DHBs (42 percent). Other sources include pathologists, Coronial 
Services and media reports. Often multiple notifications are received. 
Since July 2007, it has been a statutory requirement that all maternal deaths are notified to Coronial 
Services and a specific tick box on the death certificate reminds practitioners of the statutory 
requirement to report and to assist in ascertainment of all cases.
The MMRWG has developed a data collection tool for maternal deaths. Following notification of 
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a maternal death, the PMMRC national coordinator issues maternal death reporting forms to the 
appropriate local coordinator, who is then responsible for gathering the relevant clinical information 
from practitioners involved with the woman’s care.
All completed reporting forms, along with relevant clinical information and reports from DHBs, Coronial 
Services and any other relevant investigative processes, are reviewed by designated members of the 
MMRWG, who present a summary of each case to the working group. The MMRWG then discusses 
each case in detail, including assessing the presence of contributory factors and potential avoidability. 
Reports from local multidisciplinary review of maternal death are valuable in 1) informing the DHB of 
possible areas for improvement in care and 2) providing the MMRWG national review with insight 
into organisational and management factors that may not be apparent from clinical notes review 
alone.
The MMRWG has identified potentially avoidable maternal deaths since 2006. From 2009, the 
MMRWG started to use the same tool identifying contributory factors and potentially avoidable death 
as that used for perinatal deaths. The year 2015 was the 10th year of maternal death reporting under 
the auspices of the PMMRC. The number of maternal deaths each year is small. In this report, time 
trends in maternal mortality in New Zealand have been explored along with analyses that include all 
years of maternal mortality data (2006–2015).
PMMRC numerator data validation 
Data are regularly validated, using a standard set of queries, to complete missing information, clarify 
DHB of residence (where this is inconsistent with the given residential address) and rectify other 
inconsistencies.
At the end of each year, known deaths are cross-referenced with the Mortality Collection at the BDM 
Registry to ensure the collection is complete. This process ascertained a further nine indirect maternal 
deaths (due to suicide) in the 2006–2015 period. 
Denominator data
In this report, the MAT dataset has been used as the denominator set, in contrast to the BDM birth 
registration dataset used in previous years. This has had an impact on the magnitude of associations 
between ethnicity and socioeconomic deprivation and mortality and morbidity, as discussed elsewhere 
(section “1.2 Methodology”’ and chapter 5), and has facilitated the presentation of the association 
between parity and maternal mortality in this chapter. Maternal mortality ratios by BMI and smoking 
have not been presented because analyses undertaken for the perinatal chapter highlighted systematic 
differences between PMMRC data and MAT data for these variables suggesting a potential numerator–





Table 4.1: Maternal mortality ratio (per 100,000 maternities) and cause of maternal death 2006–2015
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2006–2015 2006–2015
n=105 Cause specific ratio
n n n n n n n n n n n % /100,000 maternities
Maternities  61,487  65,201  65,625  65,207  65,459  63,264  63,275  60,134  60,097  59,808  -  - 
Direct maternal death  6  5  4  5  1  2  2  5  2  3  35  33.3  5.56 
Amniotic fluid embolism  3  -  1  4  1  -  1  2  -  1  13  12.4  2.06 
Obstetric haemorrhage
<20 weeks gestation  -  1  -  -  -  -  -  1  -  -  2  1.9  0.32 
≥20 weeks gestation  1  -  1  -  -  -  -  -  1  -  3  2.9  0.48 
Venous thromboembolism  -  1  1*  -  -  1  -  -  1  2  6  5.7  0.95 
Peripartum cardiomyopathy  -  1  -  -  -  -  -  -  -  -  1  1.0  0.16 
Pre-eclampsia/Eclampsia  -  2  1  1  -  -  -  -  -  -  4  3.8  0.64 
Obstetric sepsis  2  -  -  -  -  1  1  2  -  -  6  5.7  0.95 
Indirect maternal death  7  5  5  9  8  6  8  7  1  8  64  61.0  10.17 
Pre-existing medical condition 
Cardiac  1  1  1  -  1  1  4  -  -  -  9  8.6  1.43 
Neurological  1  1  -  1  1  2  1  2  -  1  10  9.5  1.59 
Other pre-existing medical 
condition 
 1  2  1  -  1  1  -  1  1  2  10  9.5  1.59 
Non-obstetric sepsis  -  1  -  5  1  -  -  1  -  -  8  7.6  1.27 
Suicide  4  -  3  3  4  2  3  3  -  5  27  25.7  4.29 
Unclassifiable  2  1  -  -  -  1  -  1  1  -  6  5.7  0.95 
Total maternal deaths  15  11  9  14  9  9  10  13  4  11  105  100.0  16.68 
Single-year MMR  24.4  16.9  13.7  21.5  13.7  14.2  15.8  21.6  6.7  18.4  -  -  - 
Rolling three-year MMR  -  -  06-08  07-09  08-10  09-11  10-12  11-13  12-14  13-15  -  -  - 
 18.2  17.3  16.3  16.5  14.6  17.1  14.7  15.6  -  -  - 
Coincidental deaths  1  3  1  -  3  3  5  -  -  1  17  -  - 
* Pulmonary embolism and sepsis.
MMR = maternal mortality ratio
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There has been no statistically significant change in maternal mortality ratio in New Zealand since data 
collection by the PMMRC began in 2006 (chi-squared test for trend p=0.25).
In 2015, 11 deaths within the definition of maternal mortality were reported to the PMMRC. One 
coincidental death was reported in 2015. The maternal mortality ratio in New Zealand was therefore 
18.4/100,000 maternities (95% CI 9.2–32.9/100,000) for the year 2015. The three-year average 
maternal mortality ratio, calculated to obtain a more robust estimate of the New Zealand ratio given 
small and variable numbers of deaths per year, for 2013–2015, was 15.6/100,000 maternities (95% 
CI 10.8–22.5/100,000).
In 2015, there were three direct deaths (one from amniotic fluid embolism and two from venous 
thromboembolism) and eight indirect deaths (five from suicide and three from pre-existing medical 
conditions). 
Suicide (27), amniotic fluid embolism (AFE) (13), and pre-existing medical diseases (29) were the most 
frequent causes of maternal mortality in New Zealand during 2006–2015. Suicide continues to be the 
leading ‘single’ cause of maternal death in New Zealand. Suicide and AFE deaths from 2006 to 2013 
were discussed in detail in the 10th report of the PMMRC (PMMRC 2016).
































3-year rolling direct MMR 3-year rolling indirect MMR 3-year rolling MMR 1-year MMR
MMR = maternal mortality ratio. 
Rolling three-year maternal mortality ratio represented at final year of triennium.
Figure 4.2 demonstrates maternal mortality ratios for each year, and rolling three-year average total 
direct and indirect maternal mortality ratios. The rolling three-year average ratios are represented as an 
estimate plotted at the final year of the three-year period. For example, the three-year ratio for 2006–
2008 is plotted for 2008.
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International comparisons
It is difficult to compare maternal mortality ratios internationally due to differences in definitions and 
variations in systems for ascertainment of maternal death. 
Small differences in the denominator (number of maternities) result in very small changes when 
calculating the ratio, whereas small changes in the numerator (number of deaths) have a substantial 
impact on the ratio. 
It has been calculated that countries without dedicated maternal mortality confidential enquiry systems 
have poorer case ascertainment leading to under-reporting of 15 to 93 percent of cases (Cliffe 
et al 2008; Deneux-Tharaux et al 2005; Donati et al 2011; EURO-PERISTAT et al 2008; Johnson 
and Sullivan 2013; Knight et al 2014). This fact is well illustrated by MBRRACE-UK in the 2009–
2012 report for the UK and Ireland, which reported a maternal mortality ratio for 2009–2011 of 
5.57/100,000 from routine statistics and a ratio of twice that at 10.63/100,000 from the confidential 
enquiry process (Knight et al 2014).
The maternal mortality ratio for the UK based on confidential enquiry data for the triennium 2012–
2014 was 8.54/100,000 maternities (95% CI 7.40–9.81) (2.86/100,000 direct maternal mortality 
ratio; 5.68/100,000 indirect maternal mortality ratio) (Knight et al 2016). 
The New Zealand maternal mortality ratio for the triennium 2012–2014 was significantly higher than 
that reported by the UK at 14.7/100,000 maternities with 95% CI 9.7–21.4 (direct maternal mortality 
ratio 4.9/100,000 maternities (95% CI 2.2–9.3); indirect maternal mortality ratio 8.7/100,000 
maternities (95% CI 5.0–14.2)). 
In 2008–2012, there were 105 maternal deaths in Australia that occurred within 42 days of the end of 
pregnancy, representing a maternal mortality ratio of 7.1 deaths per 100,000 women who gave birth 
in Australia. The number of maternal deaths increased each year from 2008 to 2012. It is uncertain 
whether this is an actual increase or reflects improvements in case ascertainment (Humphrey et al 
2015). 
The Australian ratio is very similar to the New Zealand ratio at 7.14/100,000 maternities reported 
for 1995–2005, when New Zealand was using routine data sources for case ascertainment, but 
significantly lower than the New Zealand maternal mortality ratio reported by the PMMRC. As noted in 
the Australian report published in 2014, ‘the higher MMR [maternal mortality ratio] for New Zealand 
may reflect enhanced surveillance and centralised mortality review’, and numerous international papers 
on ascertainment of maternal mortalities would support this statement (Johnson et al 2014). The report 
also notes that the limited national level maternal mortality review process has a ‘significant impact on 
the quality and utility of the data collected’ and limits the ‘capacity for meaningful comparison of cases’. 
Reporting of maternal deaths to New Zealand Coronial Services 2006–2015
In 2015, all 11 maternal deaths were reported to Coronial Services and the Coroner accepted 
jurisdiction. A post-mortem was performed for nine deaths.
The MMRWG recommends that where a coroner declines jurisdiction in the case of a maternal death, 
a post-mortem should be offered as part of full investigation of cause of death. The MMRWG reviewed 
the contribution of the 79 post-mortems performed from 2006–2015 in determining cause of maternal 
death. Clinical diagnosis was confirmed in 52 (66 percent) and changed in 11 (14 percent). There 
were additional clinical findings in 9 (11 percent), and the post-mortem was non-contributory in 7 (9 
percent). The remaining 25 percent of maternal deaths (26) did not have a post-mortem. 
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The MMRWG recommends that post-mortem is always offered to families in cases of maternal death.
Causes of maternal death
Direct causes
As noted above, direct causes of maternal mortality contribute approximately one-third of maternal 
deaths compared to two-thirds from indirect causes. Direct causes include AFE, postpartum 
haemorrhage, venous thromboembolism, pre-eclampsia and sepsis. In New Zealand, AFE contributes 
almost 40 percent of direct deaths. As noted in definitions, suicide is reported with indirect deaths in 
this report.
Figure 4.3 shows cause-specific maternal mortality ratios for all maternal deaths, comparing ratios for 
New Zealand and the UK. The most notable differences are in deaths from AFE and suicide. 
Over the periods compared, the ratio of deaths from AFE was four times higher in New Zealand than 
in the UK (relative risk (RR) 4.0 (95% CI 2.1–7.6)). The highest cause-specific ratio for AFE in the UK in 
any triennium since 1985 was 0.80/100,000, less than half the ratio in New Zealand from 2006 to 
2015 (2.08/100,000 maternities). 
Further review of amniotic fluid embolism deaths 2006–2013 found that further attention to early 
recognition and prompt resuscitation might improve outcomes for AFE in New Zealand. The findings of 
the review were reported in the 10th report of the PMMRC (PMMRC 2016).
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Practice Point: Amniotic Fluid Embolism
Diagnosis
Consider AFE in the differential diagnosis when women present with acute behavioural changes such as sudden 
anxiety, agitation (eg, removing IV lines, oxygen masks, aggression) and dyspnoea in labour or immediately 
postpartum (within 30 minutes).
Any of the following that occur during labour, caesarean birth, dilation and evacuation or within 30 minutes 
postpartum without other explanation should alert the practitioner to the possibility of AFE (Thongrong et al 2013):
• acute hypotension
• cardiac arrest
• acute hypoxaemia or respiratory distress
• severe haemorrhage or coagulopathy.
Common signs and symptoms (adapted from Thongrong et al 2013)
System    Signs and symptoms
General – prodromal  Tingling, numbness, lightheaded, chest pain, vomiting, cough
Respiratory    Dyspnoea, bronchospasm, pulmonary oedema, acute respiratory    
    distress
Cardiovascular   Cyanosis, hypotension, transient hypertension, chest pain,    
    cardiopulmonary arrest
Neurological   Seizures, headache, loss of consciousness
Haematological   Coagulopathy, disseminated intravascular coagulation
Fetus    Fetal bradycardia
Management
A combination of early recognition with early and aggressive resuscitation is essential to achieve favourable 
outcomes for mothers and babies (RCOG 2011). 
If you have any concern regarding the possible diagnosis of AFE:
• if in a primary birthing setting and there is any indication/symptom of AFE, arrange urgent transfer to 
secondary/tertiary care as a life-threatening condition
• involve senior obstetric, anaesthetic, intensive, midwifery and neonatal staff early.
If maternal collapse occurs:
• Commence/continue cardiopulmonary resuscitation (CPR) if there is evidence of cardiac arrest or 
circulatory insufficiency such as profound hypotension, loss of consciousness or absence of a palpable 
pulse. 
• Instigate left uterine displacement in women with a palpable uterus. This is ideally done manually but can 
be done with left tilt if there is inadequate staffing to allow manual displacement. Ensure CPR is performed 
on a firm surface.
• Perimortem caesarean section needs to be considered at the commencement of CPR, and if there is no 
return of circulation, aim for delivery within five minutes. (See ‘Practice Point: Perimortem Caesarean 
Section’ in the ninth report of the PMMRC: http://www.hqsc.govt.nz/assets/PMMRC/Publications/
PMMRC_Ninth_Report_Practice_Points.pdf)
• Initiate the massive transfusion protocol, including the use of cryoprecipitate.
• Lifesaving interventions such as defibrillation and medication should not be withheld in the setting of 
pregnancy.
All clinicians involved in the care of pregnant women should undertake regular multidisciplinary training in 
management of obstetric emergencies.
Previous PMMRC Recommendation (Fifth Report (PMMRC 2011))
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Venous thromboembolism
Risk factors for increased risk of venous thromboembolism (VTE) in pregnancy have been identified 
(see the ‘“Risk factors for Pregnancy-Associated Venous Thromboembolism”’ text box below), but the 
evidence for management of risk is as yet limited. A comprehensive review of the available evidence 
is included in a 2012 Australasian opinion paper titled ‘Recommendations for the prevention of 
pregnancy-associated venous thromboembolism’ (McLintock et al 2012). As stated by the authors:
“The recommendations contained herein were reached by consensus and represent the opinion of the 
panel. The absence of randomised clinical trials in this area limits the strength of evidence that can be 
used, and it is acknowledged that they represent level C evidence. The panel advocates for appropriate 
clinical studies to be carried out in this patient population to address the inadequacy of present 
evidence.”
This paper includes a comprehensive review of the literature and tables and algorithms providing 
recommendations for prevention of VTE in pregnancy. The PMMRC supports the use of these and 
supports ongoing research to improve the knowledge in this area so that future guidelines can be based 
on high-level evidence. The recommendations outlined in this paper are supported in the Health Quality 
& Safety Commission’s National Policy Framework: VTE Prevention in Adult Hospitalised Patients in NZ 
(Health Quality & Safety Commission 2012, p 25).
Risk factors for Pregnancy-Associated Venous Thromboembolism
Clinical risk factors               Adjusted OR
Previous VTE        24.8
Age >35        1.4–1.7
Obesity (BMI >30kg ⁄ m2)      1.7–5.3
Active medical illness       2.1–8.7
Smoking       1.7–3.4
Family history VTE      2.9–4.1
Immobility       7.7–10.1
Varicose vein       2.4
Multiparity (>2)       1.6–2.9
Multiple pregnancy      1.6–4.2
Pre-eclampsia       3.0–5.8
Assisted reproduction technology    2.6–4.3
Hyperemesis       2.5
Additional postpartum risk factors
Planned caesarean section    1.3–2.7
Emergency caesarean section    2.7–4.0
Placental abruption     2.5–16.6
Postpartum infection     4.1–20.2
Postpartum haemorrhage     1.3–12.0
Adapted with permission from McLintock et al 2012.
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Figure 4.3: Cause-specific maternal mortality ratios (per 100,000 maternities) in New Zealand 2006–










































NZ 2006–2015 UK 2006–2014
AFE = amniotic fluid embolism.
PPH = postpartum haemorrhage.
VTE = venous thromboembolism. 
‘Other direct’ includes anaesthesia, cardiomyopathy, other.
‘Pre-existing medical’ includes cardiac, indirect neurological, indirect malignancies.
In New Zealand data, ‘Other indirect’ includes only non-obstetric sepsis.
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Survey of Multidisciplinary Training (MDT) in Management of Obstetric Emergencies 
In 2016/17, 21 PMMRC local coordinators from 20 DHBs completed a survey on MDT in their DHB. The 
survey was developed in consultation with the PMMRC, the MMRWG, the MMWG, Practical Obstetric Multi-
Professional Training (PROMPT) trainers and the National Maternity Monitoring Group (NMMG). 
• Sixteen DHBs (six tertiary and 10 secondary) provide MDT for maternity clinicians. Five tertiary and five 
secondary hospitals also hold MDT training in primary units. 
• MDT is a full day and is provided in-house for all but one DHB. 
• All MDTs include maternal collapse and post-partum haemorrhage, 89% eclampsia and shoulder 
dystocia, 78% cord prolapse, 67% APH, 61% unexpected breech, 44% neonatal resuscitation, and 50% 
sepsis.
• The instructors at 11 DHBs have attended ‘Train the Trainer’ days with PROMPT, and four attended 
formal training with other courses (eg, Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists (RANZCOG), Managing Obstetric Emergencies and Trauma (MOET)).
• The following are estimates of clinicians attending in the previous three years: 
• Midwives – hospital – 14 responses – 36 to 100% (average 80%). Six DHBs reported 100% 
attendance.
• Midwives – LMC – 14 responses – 8 to 100% (average 62%). Four DHBs reported 100% 
attendance.
• Obstetricians – 15 responses – 6 to 100% (average 65%). Five DHBs reported 100% attendance.
• Anaesthetists – 11 responses – 5 to 100% (average 27%). One DHB reported 100% attendance.
• (Responses for other disciplines are small so not reported.) 
• Three DHBs have indicated attendance is mandatory for all obstetric, midwifery (core and LMC) and 
anaesthetic clinicians. One other DHB indicated attendance was mandatory for all DHB obstetric, 
midwifery and anaesthetic staff. A further eight DHBs indicated it was mandatory but only for some 
disciplines.
• Attendance varied from annually to three-yearly.
• Fee structure varied from no payment to self-funding.
• Fifteen DHBs responded they provide backfill for staff; however, 16 of 18 responses named ‘backfill/
staffing’ as a barrier to attendance.
• Five responses named ‘cost’ as a barrier to attendance.
• Eight of 17 responses named ‘free/subsidised’ and six ‘backfill/staffing’ as enablers to attendance.
Previous PMMRC Recommendation (Fifth Report (PMMRC 2011))
All clinicians involved in the care of pregnant women should undertake regular multidisciplinary training 
in the management of obstetric emergencies.
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Indirect causes
Pre-existing medical disease and suicide were the most frequent causes of maternal mortality in New 
Zealand in 2006–2015, suicide being the leading ‘single’ cause of maternal death in New Zealand 
(4.3/100,000 maternities). A further five maternal deaths from suicide were reported in 2015, the 
largest number in a single year since the PMMRC began reporting in 2006.
In comparison, the cause-specific maternal mortality ratio for psychiatric causes for the UK for 2009–
2014 was 0.63/100,000 maternities, and 0.85/100,000 maternities is the highest ratio reported 
from the UK since 1994–1996 (Figure 4.3). The New Zealand ratio for psychiatric maternal deaths 
from 2006 to 2015 is almost seven times that reported for the UK for 2006–2014 (RR 6.9 (95% CI 
4.2–11.1)). Further review of maternal suicide deaths 2006–2013 was reported in the 10th report 
of the PMMRC, and specific analysis and commentary on Māori deaths from maternal suicide can be 
found in chapter 5 of this report.
Repeat themes arising in recent maternal suicide reviews include lack of recognition of the risk 
for pregnant women presenting with suicidal ideation and failure to refer promptly for assessment 
and treatment, lack of information sharing between services, and discontinuation or changes of 
antidepressant medication in pregnancy without full discussion of risks and or clinical oversight.
In 2016, the MMRWG recommended that a perinatal and infant mental health network, akin to that in 
the UK, be established to provide an interdisciplinary and national forum to discuss perinatal mental 
health issues such as service delivery, case identification, and pathways that cross a number of sectors, 
including primary care, mental health and maternity. This is in the early stages, with the PMMRC and 
MMRWG working with the Ministry of Health to clarify the remit and purpose of this network, to ensure 
supportive links with pre-existing local networks, and to identify a work plan consistent with the needs of 
DHBs.
RECOMMENDATION:
The PMMRC recommend the HQSC establish a permanent Suicide Mortality Review Committee. 
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Practice Point: Maternal Suicide
Pregnancy and the postpartum period are not protective against mental illness, and can be a trigger for onset 
and for deterioration of mental illness.
Early during a woman’s contact with services, ask about:
• past or present mental illness
• past or present treatment by a specialist mental health service, including in-patient care
• family history of severe mental illness, including perinatal mental illness in a first degree relative.
Women who have a history of severe mental illness should be referred to a secondary mental health service 
even if currently well, as their risk of relapse in the postpartum period may be high. They need an appropriate 
mental health birth plan and monitoring for the peripartum period. 
Any of the following suggests a serious mental illness and requires urgent assessment by mental health services, 
including early consultant psychiatrist review and consultation with perinatal mental health services:
• suicidal ideation (new or increasing thoughts)
• suicide attempts 
• psychotic symptoms
• recent significant change in mental state including fluctuating or emergence of new symptoms
• pervasive guilt or hopelessness
• ongoing beliefs of inadequacy as a mother
• a sense of estrangement or disconnection from the infant.
Women should have continuity of, and culturally appropriate, mental health care. During pregnancy and the 
postpartum period there may be more than one mental health team involved – in such cases there should be 
one identified individual who coordinates care.
All clinicians involved in a woman’s care need relevant mental health history and current knowledge of a 
woman’s pregnancy to support them to provide the best care. Routine sharing of relevant information across 
general practice, LMC and mental health service interfaces will enable better-informed care, and any concerns 
regarding risk need to be clearly communicated to all clinicians involved.
Pregnant and postpartum women who use substances often have complex social and mental health needs, and 
face additional barriers in accessing services.
Previous PMMRC Recommendations (revised in the 10th PMMRC report)
Maternal mental health screening should be included as part of standard antenatal care, and women 
with a previous history of serious affective disorder or other psychoses should be referred for psychiatric 
assessment and management even if they are currently well. 
Strategies are required to improve communication and coordination between the full range of primary 
maternity providers (eg LMC, GP) and secondary providers (eg mental health services, maternal mental 
health services, and maternity, including termination of pregnancy services).
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Demographic characteristics




































Mothers aged 40 years and older contributed 12 percent of maternal deaths but only 4 percent of 
maternities from 2006 to 2015. The maternal mortality ratio for mothers aged 40 years and older was 
three times higher, at 50.5/100,000 maternities, compared to 15.4/100,000 among mothers under 
40 years of age during this period.
There have been 13 mortalities among mothers 40 years of age and older between 2006 and 2015, 
including seven direct and six indirect deaths. Numbers are small so it is hard to determine any 
statistically significant associations between age and cause of death, although suicide tends to be more 
often a cause of maternal death among younger women, and pre-existing medical conditions among 
older women. 




































Figure 4.5: Maternal mortality ratios (per 100,000 maternities) by prioritised ethnicity (with 95% CIs) 
2006–2015
The maternal mortality ratio for Māori and Pacific mothers from 2006–2015 was almost twice that of 
New Zealand European mothers (RR 1.9 (95% CI 1.2–3.1) and RR 1.8 (95% CI 1.0–3.2) respectively). 
A discussion of Māori maternal mortality can be found in chapter 5.


































The risk of maternal mortality appears to increase with increasing deprivation quintile. In previous 
reports, we used smaller area mesh block data for deprivation, and last year reported that the risk for 
women living in the most deprived 20 percent of residential areas from 2006 to 2014 was 2.5 times 
that of those in the least deprived 20 percent. In 2015, with a change to MAT data, we are using the 
larger census area unit for measuring deprivation, and the apparent association seen in Figure 4.6 is 
not statistically significant (chi-squared test for trend p=0.11). 
The 2016 report on maternal deaths in the UK 2012–2014 reported that the relative risk of maternal 
mortality was 1.62 (95% CI 0.92–2.99) for women residing in the most deprived ‘Index of Multiple 
Deprivation’ quintile areas in England compared to women in the least deprived quintile areas (Knight 
et al 2016). The equivalent relative risk for 2006–2015 for New Zealand is 1.5 (95% CI 0.8–3.0).
































Figure 4.7 shows a clear association between maternal parity and maternal mortality ratio. There is a 
statistically significant increase in mortality for women in their fourth or later pregnancy compared to 
women who have had one, two or three births. Increased parity is likely to be confounded by the effects 
of other related variables such as socioeconomic status, age, obesity, smoking, and worsening chronic 
medical illnesses. 
The distribution of cause of direct and indirect deaths varied by parity. There were nine direct deaths 
among nulliparous women, most commonly from pre-eclampsia (3) or VTE (3). There were 15 indirect 
deaths among nulliparous women, 12 of which were from suicide.
There were 25 direct deaths among multiparous women, of which 12 were from amniotic fluid 
embolism. Among 48 indirect deaths, 14 were due to suicide and the remainder spread fairly evenly 
across non-obstetric sepsis (8), pre-existing cardiac disease (7), pre-existing neurological disease (10) 
and other pre-existing medical diseases (9). 
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Clinical characteristics





<18.5  3  2.9 
18.5–24.99  35  33.3 
25–29.99  18  17.1 
30–34.99  22  21.0 
≥35  23  21.9 
Unknown  4  3.8 
Current smoker
Yes  36  34.3 
No  66  62.9 
Unknown  3  2.9 
Alcohol and substance use
Yes  26  24.8 
No  71  67.6 
Unknown  8  7.6 
Family violence in this pregnancy
Yes  9  8.6 
No  55  52.4 
Not asked  23  21.9 
Unknown  18  17.1 
Maternal mortality ratios by BMI and smoking in pregnancy are not presented, as explained in the 
methods. However, more than half of the mothers who died in pregnancy or the peripartum period 
were overweight or obese, and 34 percent were known smokers (Table 4.2). 
Alcohol or substance use was noted in a quarter of mothers who died and a history of family violence 
in at least 9 percent. Information on family violence was unavailable for 39 percent, unknown in 17 
percent and no screening was undertaken in 22 percent. Evidence of family violence prior to or during 
pregnancy among deaths from any cause from 2012 to 2014 in the UK was reported in 6 percent of 
cases, with data missing for 40 percent of cases (Knight et al 2016). 
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Place of baby’s birth
Community (not in a health care facility)  4 3.8
Hospital  60 57.1
Baby not born at time of mother’s death  40 38.1
Unknown  1 1.0
Place of maternal death
Hospital  65  61.9 
Community  40  38.1 
Time of death related to pregnancy
Antepartum (antepartum/intrapartum)  41  39.0 




Gestation at antepartum maternal death (weeks)
<20  22  53.7 
20–27  9  22.0 
28–36  9  22.0 




Gestation at birth of postpartum maternal death (weeks)
<20  8  12.5 
20–27  8  12.5 
28–36  15  23.4 
37–42  33  51.6 
Postnatal day at postpartum maternal death (days)
0  17  26.6 
1–6  16  25.0 
7–13  8  12.5 
14–27  12  18.8 
28–41  10  15.6 
Unknown  1  1.6 
Approximately two-thirds of maternal deaths occurred in hospital and one-third in the community. The 
high frequency of community deaths makes maternal mortality review challenging because collecting 
full details of the woman’s clinical and social history and engagement with health care in preparation 
for the review is often resource intensive with a need to connect with a variety of sources.
Approximately a third (39 percent) of maternal deaths occurred during pregnancy, half prior to 20 
weeks and almost all of the remainder prior to term (37 weeks). Of the 41 deaths during pregnancy, 
three quarters were indirect and the most common cause was suicide (17 deaths). Five of the 41 
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deaths in pregnancy were direct (AFE, haemorrhage, sepsis and VTE), 31 indirect (suicide, pre-existing 
medical disease, and sepsis), and five were unclassifiable. 
Of the postpartum deaths, half occurred after the baby’s birth at term. A quarter occurred within the 
first day of birth and half within the first week. Postpartum deaths were more often due to direct causes 
(30/64) than antepartum deaths, 33 were indirect, and one was unclassifiable. The most common 
direct cause was AFE (12 deaths). Among the 33 indirect deaths, the most common cause was suicide 
(10 deaths). Pre-existing medical conditions were responsible for a further 18.









n % n % n %
Maternal death <20 weeks  30  28.6  22  53.7  8  12.5 
Maternal death ≥20 weeks
Did not deliver  18  17.1  18  43.9  -  - 
Stillborn  6  5.7  -  -  6  9.4 
Early neonatal death  5  4.8  -  -  5  7.8 
Late neonatal death  -  -  -  -  -  - 
Alive after one month of age  46  43.8  1  2.4  45  70.3 
Seventy-five mothers (71 percent) died at or after 20 weeks gestation. Of these mothers, 18 (24 
percent) died prior to the baby’s birth and the babies were not born; there were 11 perinatal deaths 
(15 percent) and 46 (61 percent) babies survived.
Perimortem caesarean section
Perimortem caesarean section needs to be considered at the commencement of CPR following maternal 
collapse to enable effective resuscitation. Perimortem caesarean section can save the life of both the 
mother and the infant.
Between 2006 and 2015 perimortem caesarean section was undertaken in 10 maternal deaths as part 
of the resuscitation of the mother to improve the chance of survival following a collapse. Seven babies 
were live born, three babies were stillborn and one live born baby died as an early neonatal death.
Contributory factors and potentially avoidable maternal deaths
Thirty-nine percent of maternal deaths were identified as potentially avoidable, and contributory factors 
were identified in 62 percent of maternal deaths in the years 2006–2015 Table 4.5. The presence of 
contributory factors and the assessment of potentially avoidable death did not vary by whether maternal 
deaths were classified as direct or indirect.
Contributory factors were identified in each of organisational and/or management, personnel, and 
barriers to access and/or engagement with care in 40 to 42 percent of cases overall, but barriers were 
less often identified among direct deaths (23 percent) than among indirect (56 percent).
Similar rates were identified in the MBRRACE-UK in-depth review of maternal deaths in the UK for the 
years 2009–2014, which reported improvements to care may have made a difference to outcome 
in 42 percent of cases overall, and improvements to care which would have made no difference to 
outcome for a further 12 percent of cases.
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n=105 n=35 n=64 n=6
n % n % n % n %
Was death potentially avoidable?
Yes  41  39.0  14  40.0  27  42.2  -  - 
No  60  57.1  21  60.0  37  57.8  2  33.3 
Unknown  4  3.8  -  -  -  -  4  66.7 
Contributory factors present  65  61.9  22  62.9  42  65.6  1  16.7 
Organisational/management factors  42  40.0  17  48.6  25  39.1  -  - 
Poor organisational arrangements of staff  6  3  3  - 
Inadequate education and training  12  6  6  - 
Lack of policies, protocols or guidelines  24  11  13  - 
Inadequate numbers of staff  1  1  -  - 
Poor access to senior clinical staff  4  2  2  - 
Failure or delay in emergency response  5  3  2  - 
Delay in procedure (eg, caesarean section)  2  1  1  - 
Inadequate systems/process for sharing of clinical information 
between services
 19  3  16  - 
Delayed access to test results or inaccurate results  3  2  1  - 
Equipment (eg, faulty equipment, inadequate maintenance, 
inadequate quality or lack of equipment)
 1  1  -  - 
Building and design functionality (eg, space, privacy, ease of access, 
lighting, noise, power failure, operating theatre in distant location)
 3  3  -  - 
Other  10  4  6  - 
Personnel factors  42  40.0  15  42.9  26  40.6  1  16.7 
Knowledge and skills of staff were lacking  18  7  10  1 
Delayed emergency response by staff  9  5  4  - 
Failure of communication between staff  11  4  7  - 
Failure to seek help/supervision  8  3  5  - 
Failure to offer or follow recommended best practice  12  2  9  1 
Lack of recognition of complexity or seriousness of condition by care 
giver
 27  8  19  - 
Other  1  1  -  - 
Barriers to access and/or engagement with care  44  41.9  8  22.9  36  56.3  -  - 
No antenatal care  6  1  5  - 
Infrequent care or late booking  9  4  5  - 
Declined treatment or advice  14  3  11  - 
Obesity impacted on delivery of optimal care (eg, ultrasound scan)  4  2  2  - 
Substance use  11  -  11  - 
Family violence  9  1  8  - 
Lack of recognition of complexity or seriousness of condition by the 
woman and/or family
 18  3  15  - 
Maternal mental illness  13  -  13  - 
Cultural barriers  1  -  1  - 
Language barriers  2  -  2  - 
Not eligible to access free care  1  -  1  - 
Environment (eg, isolated, long transfer, weather prevented transport)  4  1  3  - 































Table 4.6: Demographic characteristics among maternal deaths 2006–2015
Maternities
Maternal deaths
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2006–2015
n=629,557 n=15 n=11 n=9 n=14 n=9 n=9 n=10 n=13 n=4 n=11 n=105 Maternal mortality ratio
n % n n n n n n n n n n n % /100,000 maternities
Maternal age (years)
<20  41,848  6.7  -  -  1  1  1  1  2  -  -  -  6  5.7  14.34 
20–24  113,387  18.1  3  2  -  -  -  1  3  3  -  1  13  12.4  11.47 
25–29  158,144  25.2  3  1  3  4  3  3  1  5  2  2  27  25.7  17.07 
30–34  179,440  28.6  2  5  3  4  1  1  2  3  -  4  25  23.8  13.93 
35–39  109,312  17.4  4  2  2  3  2  2  2  -  1  3  21  20.0  19.21 
≥40  25,769  4.1  3  1  -  2  2  1  -  2  1  1  13  12.4  50.45 
Unknown  17  0.0  -  -  -  -  -  -  -  -  -  -  -  -  - 
Ethnicity (prioritised)
Māori  159,681  25.4  9  2  4  4  3  5  8  4  -  3  42  40.0  26.30 
Pacific peoples  71,351  11.4  1  2  -  6  3  3  -  1  1  -  17  16.2  23.83 
Indian  22,491  3.6  1  1  -  1  -  -  -  -  -  -  3  2.9  13.34 
Other Asian  50,823  8.1  -  -  2  1  -  -  -  2  -  1  6  5.7  11.81 
Other (including unknown)  72,305  11.5  1  1  -  -  -  -  -  -  -  1  3  2.9  4.15 
NZ European  251,266  40.0  3  5  3  2  3  1  2  6  3  6  34  32.4  13.53 
Deprivation quintile
1 (least deprived)  87,648  14.0  1  2  1  2  3  -  -  1  -  1  11  10.5  12.55 
2  94,606  15.1  1  1  1  1  -  1  2  2  2  -  11  10.5  11.63 
3  114,050  18.2  4  1  2  2  -  4  1  3  2  3  22  21.0  19.29 
4  145,356  23.1  3  3  2  4  3  -  3  4  -  4  26  24.8  17.89 
5 (most deprived)  180,525  28.7  6  4  3  5  3  4  4  3  -  3  35  33.3  19.39 
Unknown  5,732  0.9  -  -  -  -  -  -  -  -  -  -  -  -  - 
Parity*
0  226,124  35.9  2  4  5  1  3  1  4  3  2  2  27  25.7  11.94 
1–3  309,732  49.2  7  4  3  8  4  5  5  7  2  7  52  49.5  16.79 
4+  30,304  4.8  5  3  1  5  2  3  1  2  -  1  23  21.9  75.90 
Unknown  63,397  10.1  1  -  -  -  -  -  -  1  -  1  3  2.9  4.73 
* Defined prior to conception of the index pregnancy.
4.4 Maternal Mortality Appended Tables
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5 Māori Perinatal and Maternal Mortality 2015
5.1 Introduction
This specific chapter has been added to the 11th report of the PMMRC to explore the impact of 
perinatal and maternal mortality on Māori, to begin to explore the reasons behind any inequities found, 
to monitor improvements in outcomes, and to provide recommendations where there is a need for 
improvement.
5.2 Methods
Ethnicity is collected by health providers in New Zealand according to guidelines produced by 
the Ministry of Health. These data are collected centrally into various databases from which data 
is extracted to prepare this report. Ethnicity for babies who die is drawn firstly from the BDM birth 
registration dataset, then from the BDM death registration dataset, and then from the forms completed 
by the LMC after a death has occurred if neither of the former is available. Ethnicity for mothers of 
babies who die is drawn firstly from the BDM birth registration dataset and, if that is unavailable, then 
from the forms completed by the LMC after a death has occurred. Ethnicity for mothers who die is 
collected from the BDM death registration dataset and, if that is unavailable, from the forms completed 
by the LMC after a death has occurred. If ethnicity is extracted from different sources according to 
ethnicity, this might result in some bias of associations between death and ethnicity. 
In 2015, 57 percent of Māori babies who died had their ethnicity extracted from the BDM birth 
registration dataset, 9 percent from the BDM death registration dataset, and 34 percent from the LMC 
rapid reporting form to the PMMRC. In contrast, in 2015, ethnicity of 78 percent of New Zealand 
European babies was extracted from the BDM birth registration dataset, 3 percent from the BDM death 
registration dataset, and 19 percent from the LMC rapid reporting form. 
In 2015, 55 percent of ethnicity data for the mothers of Māori babies was extracted from the BDM birth 
registration dataset compared to 79 percent of New Zealand European, and the remainder of each 
from the LMC rapid reporting form.
From 2006 to 2015, ethnicity of mothers who died was obtained from the BDM death registration 
dataset for 93 percent of recorded Māori maternal deaths and 100 percent of New Zealand European 
maternal deaths. 
In PMMRC reports prior to this 11th report, the denominator used for analyses was births registered 
by BDM in the year in which the deaths occurred. This denominator was used because it was believed 
to be the best estimate of birth numbers in a year. BDM ethnicity is collected from the parents when 
they register their child’s birth, so it should be similar to Census ethnicity. Ethnicity of perinatal deaths 
(numerator) is also obtained from BDM. 
This year (11th report) the PMMRC has moved to using the MAT dataset as the denominator, because it 
is now the best estimate of births in a year in New Zealand and because it is a rich source of maternity 
data. However, ethnicity is not collected in the same way as in the BDM birth registration dataset, 
and is defined using an algorithm from various datasets which provide data to the MAT. There is the 
potential that using this denominator may introduce numerator–denominator bias in the association 
between ethnicity and perinatal mortality. Therefore, in this chapter we have presented perinatal 
mortality rates using both the new MAT denominator and the old BDM denominator and compared 
them.
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Numerator data in this chapter are sourced from the PMMRC dataset.
Prioritised ethnicity is reported, as recommended by the New Zealand Ministry of Health for health 
outcomes (Ministry of Health 2004). 
Māori mortality has been compared to New Zealand European mortality rather than non-Māori 
because Pacific and Indian mothers also have higher maternal and perinatal mortality and morbidity 
rates, and including these ethnicities in the comparator group may underestimate the inequities for 
Māori mothers.
Maternal rather than baby ethnicity is used principally for analyses, consistent with the remainder of the 
report, because maternity care is provided to mothers.
The analyses in this chapter in most instances use all the available data for perinatal (2007–2015) and 
maternal (2006–2015) mortality to explore time trends and to ensure estimates are robust.
5.3 Perinatal Mortality
There is no excess unadjusted relative risk of total perinatal related mortality from 2011 to 2015 for 
Māori compared to New Zealand European using the PMMRC numerator with the MAT denominator. 
The rate of late termination of pregnancy among Māori mothers was approximately half that among 
New Zealand European mothers from 2011–2015 (RR 0.60 (95% CI 0.49–0.74)). The relative risk 
of neonatal death after birth at less than 28 weeks gestation was higher for Māori (RR 1.70 (95% CI 
1.34–2.16)) (Table 5.1).
The unadjusted relative risk of total perinatal related mortality from 2011 to 2015 was higher for 
Māori compared to New Zealand European using the PMMRC numerator and the BDM denominator 
(1.28 (95% CI 1.17–1.40)). The rates of stillbirth and neonatal mortality were both elevated for Māori 
compared to New Zealand European, and the rate of late termination of pregnancy among Māori 
mothers was lower than that among New Zealand European mothers from 2011–2015 (RR 0.76 (95% 
CI 0.62–0.93)) (Table 5.1).
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Table 5.1: Perinatal related mortality rates by ethnicity (Māori and New Zealand European) 2011–
2015
Denominator is MAT births
Māori NZ European
 n (MAT)=76,637  n (MAT)=117,754 
n % Rate n % Rate RR 95% CI
Termination of pregnancy  129  16.02  1.68  329  26.84  2.79  0.60  0.49–0.74 
Stillbirths  414  51.43  5.40  616  50.24  5.23  1.03  0.91–1.17 
Neonatal death <28 weeks at birth  144  17.89  1.88  130  10.60  1.10  1.70  1.34–2.16 
Neonatal death ≥28 weeks at birth  118  14.66  1.54  151  12.32  1.28  1.20  0.94–1.53 
Total perinatal related mortality  805  100.0  10.50  1,226  100.0  10.41  1.01  0.92–1.10 
Denominator is BDM birth registrations
Māori NZ European
 n (MAT)=68,788  n (MAT)=133,794 
n % Rate n % Rate RR 95% CI
Termination of pregnancy  129  16.02  1.88  329  26.84  2.46  0.76  0.62–0.93 
Stillbirths  414  51.43  6.02  616  50.24  4.60  1.31  1.15–1.48 
Neonatal death <28 weeks at birth  144  17.89  2.09  130  10.60  0.97  2.15  1.70–2.73 
Neonatal death ≥28 weeks at birth  118  14.66  1.72  151  12.32  1.13  1.52  1.19–1.93 
Total perinatal related mortality  805  100.0  11.70  1,226  100.0  9.16  1.28  1.17–1.40 
Figure 5.1 to Figure 5.5 illustrate the association between ethnicity and perinatal mortality using 
alternately the MAT and BDM denominator datasets. Both are provided for continuity with previous 
reports and until it is possible to include the registration dataset parent-defined ethnicities in the MAT 
dataset so that analyses can use consistent numerator and denominator data which is collected as 
similarly as possible to Census ethnicity data.
RECOMMENDATION: 
The Mortality Review Committees’ Māori Caucus reiterate, “As a matter of urgency, the Ministry of Health 
update the National Maternity Collection (MAT), including the ethnicity data as identified by the parents 
in the birth registration process.” (PMMRC recommendation ninth report 2015)
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Figure 5.1: Perinatal related mortality rolling three-year rates (per 1000 births) by ethnicity and year 

















Total perinatal death - Māori - MAT denominator Total perinatal death - NZ European - MAT denominator
Total perinatal death - Māori - BDM denominator Total perinatal death - NZ European - BDM denominator
Figure 5.2: Termination of pregnancy rolling three-year rates (per 1000 births) by ethnicity and year 
















TOP - Māori - MAT denominator TOP - NZ European - MAT denominator
TOP - Māori - BDM denominator TOP - NZ European - BDM denominator
TOP = termination of pregnancy.
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Figure 5.3: Stillbirth rolling three-year rates (per 1000 births) by ethnicity and year (Māori and New 


















Stillbirth - Māori - MAT denominator Stillbirth - NZ European - MAT denominator
Stillbirth - Māori - BDM denominator Stillbirth - NZ European - BDM denominator
The use of the MAT ethnicity denominator data makes considerable difference to the comparison of 
Māori and New Zealand European rates. Using the MAT denominator reduces the apparent inequity 
between Māori and New Zealand European perinatal mortality rates.
There has been a significant reduction in stillbirth in New Zealand from 2007 to 2015. It appears 
that there has been a reduction among Māori and New Zealand European babies, although only 
the reduction among Māori babies is statistically significant (chi-squared test for trend 0.05 (BDM 
denominator) 0.04 (MAT denominator)).
There has been no statistically significant change in late termination of pregnancy rate among either 
New Zealand European or Māori mothers.
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Figure 5.4: Neonatal death <28 weeks rolling three-year rates (per 1000 live births) by ethnicity and 
















NND<28 - Māori - MAT denominator NND<28 - NZ European - MAT denominator
NND<28 - Māori - BDM denominator NND<28 - NZ European - BDM denominator
NND<28 = neonatal death at less than 28 weeks gestation.
The most apparent difference between Māori and New Zealand European perinatal mortality rates is 
among neonatal deaths of babies born at less than 28 weeks gestation, when the most common cause 
of death is spontaneous preterm birth (Figure 5.4).
However, there is also a significant difference between Māori and New Zealand European mortality 
rates among neonatal deaths of babies born from 28 weeks gestation (Figure 5.5). The three year 
rolling rates for 2012 to 2014 and 2013 to 2015 suggest that, after a period of apparent reduction, 
the size of the inequity is increasing.  
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Figure 5.5: Neonatal death ≥28 weeks rolling three-year rates (per 1000 live births) by ethnicity and 















NND≥28 - Māori - MAT denominator NND≥28 - NZ European - MAT denominator
NND≥28 - Māori - BDM denominator NND≥28 - NZ European - BDM denominator
NND≥28 = neonatal death at or beyond 28 weeks gestation.
Figure 5.6: Neonatal death rates (per 1000 live births) by gestation and ethnicity (Māori and New 


































Gestation at birth (weeks)
Māori neonatal deaths NZ European neonatal deaths
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After excluding babies dying with congenital abnormalities, babies of Māori mothers are significantly 
more likely to die as neonates at all gestational ages at birth represented except at 28 to 31 weeks 
compared to babies of New Zealand European mothers. There is a significant drop in the neonatal 
death rate from birth at 20–22 weeks to birth at 23–24 weeks among babies of New Zealand 
European mothers but no equivalent drop among babies of Māori mothers.
Comparisons of neonatal death rates among babies of Māori mothers compared to other ethnicities can 
be found in section 3.2 (Figure 3.18). 
The principal cause of neonatal death at 20–24 weeks is spontaneous preterm birth (Figure 3.19).
Table 5.2: Perinatal related mortality rates (per 1000 births) by maternal ethnicity (Māori and New 
Zealand European) and maternal age 2011–2015
Maternal age (years)
Māori NZ European
 n (MAT)=76,632  n (MAT)=117,752 
n (MAT) n % Rate n (MAT) n % Rate RR 95% CI
<20  10,136  148  18.39  14.60  4,022  78  6.36  19.39  0.75  0.57–0.99 
20–24  23,788  214  26.58  9.00  16,549  175  14.27  10.57  0.85  0.70–1.04 
25–29  19,460  176  21.86  9.04  29,748  280  22.84  9.41  0.96  0.80–1.16 
30–34  13,457  153  19.01  11.37  38,047  326  26.59  8.57  1.33  1.10–1.60 
35–39  7,440  77  9.57  10.35  23,715  271  22.10  11.43  0.91  0.71–1.16 
≥40  2,351  37  4.60  15.74  5,671  96  7.83  16.93  0.93  0.64–1.36 
Total  76,632  805  100.0  10.50  117,752  1,226  100.0  10.41  1.01  0.93–1.09 
Note: Unknown maternal age in MAT = 5 Māori and 2 NZ European.
Table 5.2 highlights the marked difference in age distribution between Māori and New Zealand 
European mothers and how this impacts on numbers of deaths. Māori perinatal mortality rates are 
similar to New Zealand European at all maternal age groups except <20 years, and 30–34 years. The 
perinatal related mortality rate for mothers under 20 years is lower among Māori mothers compared to 
New Zealand European mothers. However, as there are many more younger Māori mothers (10,136 
from 2011 to 2015 compared to 4,022 New Zealand European), there are more Māori perinatal 
deaths(148 compared to 78). The rate of perinatal related death is higher among Māori compared to 
New Zealand European mothers aged 30–34 years.
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Figure 5.7: Spontaneous preterm* perinatal related mortality rates (per 1000 births) by deprivation 


















Māori NZ European Total
* Spontaneous preterm includes any baby dying where spontaneous preterm birth is a PSANZ-PDC whether it is the primary, secondary or third antecedent cause.
Figure 5.7 shows perinatal related death rates from spontaneous preterm birth by deprivation. Māori 
rates of perinatal death due to spontaneous preterm labour in the two least deprived quintiles are 
similar to New Zealand European rates. For both Māori and New Zealand European groups the rates 
of spontaneous preterm birth increase with increasing deprivation. However, the gradient of increase is 
more marked among Māori than New Zealand European mothers.
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Figure 5.8: Burden of perinatal related death due to spontaneous preterm birth by deprivation and 



































Figure 5.8 illustrates the absolute burden of spontaneous preterm birth by ethnicity. Māori mothers 
make up 25 percent of mothers and New Zealand European mothers make up 37 percent, and yet the 
absolute number of deaths from spontaneous preterm birth is higher among Māori than New Zealand 
European mothers. It also further illustrates, as in Figure 5.7, the much smaller social gradient among 
New Zealand European mothers. 
Figure 5.9: Spontaneous preterm perinatal related mortality rates (per 1000 births) by maternal age 

















Māori NZ European Total
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Ethnicity does not explain the higher rate of perinatal related death from spontaneous preterm birth at 
the extremes of maternal age. Perinatal related death from spontaneous preterm birth is more common 
among Māori at all categories of maternal age except 40 years and older.
Table 5.3: Ethnic-specific primary death classification (PSANZ–PDC) and neonatal death classification 




 n (MAT)=76,637  n (MAT)=117,754 
n % Rate n % Rate RR 95% CI
Perinatal death classification (PSANZ-PDC)
Congenital abnormality  188  23.35  2.45  384  31.32  3.26  0.75  0.63–0.90 
Perinatal infection  25  3.11  0.33  39  3.18  0.33  0.98  0.60–1.63 
Hypertension  25  3.11  0.33  30  2.45  0.25  1.28  0.75–2.18 
Antepartum haemorrhage  98  12.17  1.28  133  10.85  1.13  1.13  0.87–1.47 
Maternal conditions  44  5.47  0.57  49  4.00  0.42  1.38  0.92–2.07 
Specific perinatal conditions  66  8.20  0.86  135  11.01  1.15  0.75  0.56–1.01 
Hypoxic peripartum death  22  2.73  0.29  41  3.34  0.35  0.82  0.49–1.38 
Fetal growth restriction  48  5.96  0.63  92  7.50  0.78  0.80  0.57–1.14 
Spontaneous preterm  155  19.25  2.02  137  11.17  1.16  1.74  1.38–2.19 
Unexplained antepartum 
death
 121  15.03  1.58  176  14.36  1.49  1.06  0.84–1.33 
No obstetric antecedent  13  1.61  0.17  10  0.82  0.08  2.00  0.88–4.56 
Neonatal death classification (PSANZ-NDC)
Congenital abnormality  60  22.90  0.80  78  27.76  0.67  1.19  0.85–1.67 
Extreme prematurity  86  32.82  1.15  87  30.96  0.75  1.53  1.13–2.06 
Cardio-respiratory disorders  34  12.98  0.45  18  6.41  0.16  2.92  1.65–5.17 
Infection  19  7.25  0.25  21  7.47  0.18  1.40  0.75–2.60 
Neurological  37  14.12  0.49  55  19.57  0.47  1.04  0.69–1.58 
Gastrointestinal  5  1.91  0.07  2  0.71  0.02  3.87  0.75–19.93 
Other  21  8.02  0.28  20  7.12  0.17  1.62  0.88–3.00 
There is a significantly higher rate of total perinatal related death of babies of Māori mothers compared 
to New Zealand European mothers from spontaneous preterm birth (RR 1.74 (95% CI 1.38–2.19)), and 
of neonatal death (relative risk of death from extreme prematurity 1.53 (95% CI 1.13–2.06) and from 
cardio-respiratory disorders (RR 2.92 (95% CI 1.65–5.17)) (Table 5.3).
Multivariable analysis
Table 5.4 shows the crude and adjusted odds of total perinatal related mortality from 2008–2015 for 
Māori mothers compared to New Zealand European mothers adjusting for maternal age, deprivation 
decile, year of birth, baby sex, and multiple birth.
As noted previously, the definition of ethnicity is limited by the datasets available and current 
knowledge of which measure is the best of maternal ethnicity. This analysis uses PMMRC data for 
numerator and MAT for denominator as in the univariate tables above.
There are considerable missing parity, smoking, and BMI data from early pregnancy, principally from 
women under the care of DHB maternity clinics at hospitals where these data are not, and/or were not 
previously, sent to the Ministry of Health. The principal contributors to these missing data were Auckland 
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DHB (28 percent) and Counties Manukau DHB (16 percent) until 2012, and, since 2013, Counties 
Manukau DHB (49%). Due to the distribution of these missing data in relation to the deaths and to 
important predictor variables, and therefore potential confounding, only variables present for almost all 
women in the numerator and denominator have been included in the final multivariable model.
Table 5.4: Rates, and crude and adjusted odds ratios, for perinatal related mortality among Māori and 
New Zealand European births 2008–2015 
Births Perinatal related deaths OR crude OR adjusted
n=325,778 n=3,340 n=325,662 n=296,992
n n Rate OR 95%CI OR 95%CI
Ethnicity*
Māori 127,299 1,323 10.39 1.02 0.95 1.10 0.91 0.84 0.99
New Zealand European 198,479 2,017 10.16 1.00
Age#
<20 26,398 380 9.28 1.56 1.38 1.77 1.55 1.36 1.77
20–24 66,921 668 9.98 1.08 0.97 1.20 1.07 0.96 1.19
25–29 79,672 739 9.28
30–34 86,170 772 8.96 0.97 0.87 1.07 0.95 0.86 1.06
35–39 53,828 590 10.96 1.18 1.06 1.32 1.16 1.04 1.30
≥40 12,780 191 14.95 1.62 1.38 1.90 1.54 1.30 1.81
Missing data 9 0
Deprivation decile (MAT) 
(median(IQR)) (per unit)
7 (4-9) 7 (4-9) 1.04 1.02 1.05 1.04 1.03 1.06
Year of birth (per year)# 0.99 0.98 1.01 0.99 0.98 1.01
Sex+
Male 166,275 1,746 10.50
Female 157,201 1,573 10.01 0.95 0.89 1.02 0.94 0.88 1.01
Indeterminate or unknown 2,302 21 9.12
Plurality*
Singleton 313,440 2,902 9.26
Multiple 9,853 394 39.99 4.46 4.00 4.96 4.37 3.91 4.88
Unknown 2,485 44
* Numerator from the PMMRC dataset.
# Numerator from the MAT dataset.
+ Numerator from the MAT dataset or the PMMRC if missing in the MAT.
IQR = interquartile range.
The analyses in Table 5.4 and Table 5.5 use the PMMRC numerator and MAT denominator for 
ethnicity. Using this combination of numerator and denominator there is no significant difference in the 
unadjusted odds of perinatal related mortality for Māori mothers compared to New Zealand European. 
After adjusting for the potential confounders listed in the table, Māori mothers were less likely to have a 
child die in the perinatal period than New Zealand European mothers. (OR 0.91 (95% CI 0.84-0.99)).
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Table 5.5: Rates, and crude and adjusted odds ratios, for neonatal mortality among live born babies to 
Māori and New Zealand European mothers at less than 28 weeks gestation 2008–2015 
Live births Neonatal deaths <28 weeks OR crude OR adjusted
n=323,366 n=458 n=323,336 n=294,786
n n Rate OR 95%CI OR 95%CI
Ethnicity*
Māori 126,427 250 1.98 1.87 1.56 2.25 1.46 1.18 1.81
New Zealand European 196,939 208 1.06 1.00
Age#
<20 26,149 72 2.75 1.93 1.44 2.60 1.71 1.26 2.33
20–24 66,441 94 1.41 0.99 0.75 1.30 0.89 0.67 1.17
25–29 79,149 113 1.43
30–34 85,585 82 0.96 0.67 0.50 0.89 0.71 0.53 0.95
35–39 53,392 75 1.40 0.98 0.73 1.32 1.05 0.78 1.42
≥40 12,641 22 1.74 1.22 0.77 1.93 1.28 0.81 2.04
Missing data 9 0
Deprivation decile (MAT) 
(median(IQR)) (per unit)
7 (4-9) 8 (5-9) 1.14 1.10 1.18 1.10 1.06 1.15
Year of birth (per year)# 1.02 0.98 1.06 1.02 0.98 1.06
Sex+
Male 165,035 249 1.51
Female 156,048 207 1.33 0.88 0.73 1.06 0.88 0.73 1.06
Indeterminate or unknown 2,283 2
Plurality*
Singleton 311,298 332 1.07 1.00 1.00
Multiple 9,611 118 12.28 11.64 9.43 14.38 11.94 9.61 14.84
Unknown 2,457 8
* Numerator from the PMMRC dataset.
# Numerator from the MAT dataset.
+ Numerator from the MAT dataset or the PMMRC if missing in the MAT.
IQR = interquartile range.
 
Table 5.5 shows the crude and adjusted odds of neonatal death after birth at less than 28 weeks 
gestation for Māori mothers compared to New Zealand European mothers (using the PMMRC 
numerator and MAT denominator for ethnicity). Babies of Māori mothers were significantly more likely 
to suffer neonatal death after birth at less than 28 weeks than babies of New Zealand European 
mothers even after adjusting for maternal age, deprivation decile, year of birth, multiple pregnancy, 
and baby sex (OR 1.46 (95% CI 1.18–1.81)).
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Table 5.6: Contributory factors to perinatal related deaths (excluding termination of pregnancy) by 
ethnicity (Māori and New Zealand European) 2011–2015
Māori NZ European
 n (MAT)=676  n (MAT)=897 
n % n % RR 95% CI
Any Contributory factor  304  44.97  222  24.75  1.82  1.58–2.09 
Potentially avoidable  175  25.89  158  17.61  1.47  1.21–1.78 
Organisational/management factors  35  5.18  61  6.80  0.76  0.51–1.14 
Poor organisational arrangements of staff  2  0.30  8  0.89 
Inadequate education and training  1  0.15  11  1.23 
Lack of policies, protocols or guidelines  4  0.59  19  2.12 
Inadequate numbers of staff  -  -  3  0.33 
Poor access to senior clinical staff  2  0.30  3  0.33 
Failure or delay in emergency response  6  0.89  8  0.89 
Delay in procedure (eg, caesarean section)  7  1.04  8  0.89 
Inadequate systems/process for sharing of clinical information between 
services
 5  0.74  9  1.00 
Delayed access to test results or inaccurate results  3  0.44  8  0.89 
Equipment (eg, faulty equipment, inadequate maintenance, inadequate 
quality or lack of equipment)
 5  0.74  5  0.56 
Building and design functionality (eg, space, privacy, ease of access, 
lighting, noise, power failure, operating theatres in a distant location)
 1  0.15  -  - 
Other  7  1.04  3  0.33 
Personnel factors  64  9.47  100  11.15  0.85  0.63–1.14 
Knowledge and skills of staff were lacking  18  2.66  36  4.01 
Delayed emergency response by staff  3  0.44  8  0.89 
Failure to maintain competence  -  -  2  0.22 
Failure of communication between staff  12  1.78  20  2.23 
Failure to seek help/supervision  8  1.18  10  1.11 
Failure to offer or follow recommended best practice  38  5.62  47  5.24 
Lack of recognition of complexity or seriousness of condition by care 
giver
 16  2.37  32  3.57 
Other  3  0.44  2  0.22 
Barriers to access and/or engagement with care  259  38.31  126  14.05  2.73  2.26–3.29 
No antenatal care  64  9.47  22  2.45 
Infrequent care or late booking  103  15.24  24  2.68 
Declined treatment or advice  42  6.21  34  3.79 
Obesity impacted on delivery of optimal care (eg, ultrasound scan)  4  0.59  2  0.22 
Substance use  43  6.36  16  1.78 
Family violence  25  3.70  8  0.89 
Lack of recognition of complexity or seriousness of condition  58  8.58  46  5.13 
Maternal mental illness  11  1.63  3  0.33 
Cultural barriers  5  0.74  2  0.22 
Environment (eg, isolated, long transfer, weather prevented transport)  18  2.66  20  2.23 
Other  28  4.14  12  1.34 
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Contributory factors were identified significantly more often among perinatal deaths of babies born to 
Māori mothers compared to New Zealand European mothers (RR 1.82 (95% CI 1.58–2.09)) and they 
were more often assessed to be potentially avoidable (RR 1.47 (95% CI 1.21–1.78)). There was no 
significant difference in the proportion of organisational and/or management factors and personnel 
factors identified by local reviewers, but significantly more barriers to access and/or engagement with 
care were identified.
5.4 Maternal Mortality
Table 5.7: Maternal mortality ratios (per 100,000 maternities) by ethnicity (Māori and New Zealand 
European) 2006–2015
Māori NZ European
 n=160,018  n=251,931 
n Ratio n Ratio RR 95% CI
Maternal deaths  42  26.25  34  13.50  1.94  1.24–3.06 
As ethnicity for a mother who dies cannot be obtained directly from the mother, numerator–denominator 
bias is likely to be less apparent in these data when using the MAT denominator (supported by 
unpublished analyses), therefore only estimates using MAT data are provided.
There is a statistically significantly higher maternal mortality ratio among Māori (26.3/100,000 
maternities) compared to New Zealand European (13.5/100,000 maternities) mothers combining 
data from 2006–2015 (Table 5.7). However, rolling three-year ratios (Figure 5.10) show evidence of a 
convergence of rates by ethnicity in the most recent three-year period.
Figure 5.10: Maternal mortality ratios (per 100,000 maternities) by ethnicity (Māori and New Zealand 


















Māori - BDM denominator NZ European - BDM denominator
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Table 5.8: Maternal mortality ratios (per 100,000 maternities) by ethnicity (Māori and New Zealand 
European) and maternal age 2006–2015 
Maternal age (years)
Māori NZ European
 n (MAT)=160,018  n (MAT)=251,931 
N n Ratio N n Ratio RR 95% CI
<25  72,352  11  15.20  45,088  5  11.09  1.37  0.48–3.95 
25–29  39,011  13  33.32  60,692  7  11.53  2.89  1.15–7.24 
30–34  28,108  5  17.79  82,545  11  13.33  1.33  0.46–3.84 
35–39  15,969  10  62.62  52,462  8  15.25  4.11  1.62–10.40 
≥40  4,572  3  65.62  11,141  3  26.93  2.44  0.49–12.07 
Unknown  6  -  -  3  -  -  -  - 
Total  160,018  42  26.25  251,931  34  13.50  1.94  1.24–3.06 
This table, along with Table 5.2, is a reminder of the different age distribution of Māori mothers 
compared to New Zealand European mothers. As numbers of deaths are small, especially when 
separated by age group, it is difficult to conclude much about the association between age and 
maternal mortality risk, although it is likely that there is an increased mortality risk in older women in 
both groups, as there is among New Zealand mothers overall (Figure 4.4). At all ages there was a 
higher relative risk for Māori compared to New Zealand European mothers, but this was not always 
statistically significant. 
Table 5.9: Maternal mortality ratio (per 100,000 maternities) by ethnicity (Māori and New Zealand 
European) and time of death 2006–2015 
Time of death
Māori NZ European
 n (MAT)=160,018  n (MAT)=251,931 
n Ratio n Ratio RR 95% CI
Antepartum (including intrapartum)  16  10.00  15  5.95  1.68  0.83–3.40 
Postpartum  26  16.25  19  7.54  2.15  1.19–3.89 
There was a statistically significantly higher maternal mortality ratio in the postpartum period for Māori 
mothers compared to European mothers. A similar magnitude effect is seen in the antepartum period, 
suggesting that there are inequities in the rates at both times.
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Table 5.10: Ethnic-specific maternal cause of death by ethnicity (Māori and New Zealand European) 
2006–2015
Māori NZ European
 n (MAT)=160,018  n (MAT)=251,931 
n % Ratio n % Ratio RR* 95% CI
Cause of death
Direct  12  28.6  7.50  10  29.4  3.97  1.89  0.82–4.37 
Amniotic fluid embolism  7  16.7  4.37  3  8.8  1.19 
Obstetric haemorrhage  -  -  -  2  5.9  0.79 
Venous thromboembolism  1  2.4  0.62  2  5.9  0.79 
Peripartum cardiomyopathy  1  2.4  0.62  -  -  - 
Pre-eclampsia/Eclampsia  -  -  -  2  5.9  0.79 
Obstetric sepsis  3  7.1  1.87  1  2.9  0.40 
Indirect  28  67  17.50  20  58.8  7.94  2.20  1.24–3.91 
Pre-existing medical condition:
Cardiac  6  14.3  3.75  2  5.9  0.79 
Neurological  3  7.1  1.87  5  14.7  1.98 
Other pre-existing medical 
condition
 3  7.1  1.87  4  11.8  1.59 
Non-obstetric sepsis  1  2.4  0.62  1  2.9  0.40 
Suicide  15  35.7  9.37  8  23.5  3.18  2.95  1.25–6.96 
Unclassifiable  2  5  1.25  4  11.8  1.59 
* Relative risks are calculated only where at least five cases are reported.
There were more direct and indirect maternal deaths among Māori compared to New Zealand 
European mothers, although the difference among direct deaths does not reach statistical significance. 
Māori mothers were almost three times more likely to die from suicide (RR 2.95 (95% CI 1.25–6.96)).
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Table 5.11: Contributory factors and potentially avoidable maternal mortality by ethnicity (Māori and 
New Zealand European) 2006–2015
Māori NZ European
 n (MAT)=42  n (MAT)=34 
n % n % RR 95% CI
Was death potentially avoidable?
Yes  15  35.7  14  41.2  0.87  0.49–1.54 
No  13  31.0  9  26.5  1.17  0.57–2.40 
Unknown  14  33.3  11  32.4  1.03  0.54–1.97 
Contributory factors present  28  66.7  22  64.7  1.03  0.74–1.43 
Organisational/management factors  19  45.2  14  41.2  1.10  0.65–1.85 
Poor organisational arrangements of staff  2  4.8  4  11.8 
Inadequate education and training  5  11.9  6  17.6 
Lack of policies, protocols or guidelines  9  21.4  10  29.4 
Inadequate numbers of staff  -  -  -  - 
Poor access to senior clinical staff  1  2.4  3  8.8 
Failure or delay in emergency response  2  4.8  2  5.9 
Delay in procedure (eg, caesarean section)  1  2.4  -  - 
Inadequate systems/process for sharing of clinical 
information between services
 10  23.8  7  20.6 
Delayed access to test results or inaccurate results  -  -  2  5.9 
Equipment (eg, faulty equipment, inadequate maintenance, 
inadequate quality or lack of equipment)
 1  2.4  -  - 
Building and design functionality (eg, space, privacy, ease of 
access, lighting, noise, power failure, operating theatres in a 
distant location)
 3  7.1  -  - 
Other  4  9.5  3  8.8 
Personnel factors  15  35.7  16  47.1  0.76  0.44–1.30 
Knowledge and skills of staff were lacking  5  11.9  7  20.6 
Delayed emergency response by staff  5  11.9  2  5.9 
Failure of communication between staff  4  9.5  6  17.6 
Failure to seek help/supervision  4  9.5  -  - 
Failure to offer or follow recommended best practice  3  7.1  5  14.7 
Lack of recognition of complexity or seriousness of condition 
by care giver
 10  23.8  11  32.4 
Barriers to access and/or engagement with care  24  57.1  13  38.2  1.49  0.91–2.47 
No antenatal care  4  9.5  2  5.9 
Infrequent care or late booking  5  11.9  1  2.9 
Declined treatment or advice  8  19.0  5  14.7 
Obesity impacted on delivery of optimal care (eg, ultrasound 
scan)
 1  2.4  -  - 
Substance use  9  21.4  2  5.9 
Family violence  7  16.7  2  5.9 
Lack of recognition of complexity or seriousness of condition  7  16.7  7  20.6 
Maternal mental illness  6  14.3  6  17.6 
Environment (eg, isolated, long transfer, weather prevented 
transport)
 2  4.8  2  5.9 
Other  5  11.9  2  5.9 
There was no difference between Māori and New Zealand European mothers in the proportion of 
contributory factors identified or in deaths assessed as potentially avoidable at national review. 
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5.5 Māori Maternal Death by Suicide
Authors Associate Professor Sue Crengle and Dr Paula King
He mea tika kia mahara rātou kua whetūrakatia i te paepae o Matariki, o Rehua hoki.
Kore rawa e mimiti te puna roimata, te puna aroha, ki kā tini aitua e haere nei he huna mai tā Hine-
Nui-te-Pō. 
E kā kakano o te kōpū, kāre e takihia ou taki tuatahi ki te ao ora, moe mai rā i roto i te rakimarie o tā 
tātou nei Kaihaka i ruka rawa.  
Āpiti hono tātai hono, te huka mate ki te huka mate, Āpiti hono tātai hono, te hunga ora ki te huka ora.
Tihei Mauri Ora! 
The information described in this section was obtained from national maternal mortality reviews, the 
2015–16 national re-review by the MMRWG (PMMRC 2016, pp 122–131) and, where the woman 
was under 25 years, supplemented by reviews undertaken by the Child and Youth Mortality Review 
Committee (CYMRC). The information used in the mortality review processes is obtained from the health 
professionals associated with the woman and her care, the coroner’s report and findings, and in the 
CYMRC reviews from other agencies that may have had involvement with the young person. The depth 
of information available from these sources is quite variable, so it is possible that factors described for 
some women may also have been relevant to other women but were not documented.
Māori women are over-represented among maternal suicides. Overall, between 2006 and 2015, 27 
women who were pregnant or within six weeks of pregnancy committed suicide. Fifteen (56 percent) of 
these women were Māori. 
Information about the women and their final pregnancy
Just under half of the women were under 25 years of age; 20 percent were aged 18–24 years and 
27 percent were under 17 years old. The remainder (53 percent) of the women were 25 years of age 
or older. Most of the Māori women who died following a termination of pregnancy and one who died 
after miscarriage were under 25 years of age. A higher proportion of Māori deaths were in the age 
group 24 years and younger compared to non-Māori maternal suicide deaths. (PMMRC 2016)
Eight (53 percent) deaths occurred during the pregnancy, four (27 percent) occurred following a 
termination of pregnancy, and three (20 percent) occurred after a miscarriage or a live birth. Most of 
the deaths during pregnancy (6 of 8 cases) occurred in the first 20 weeks, and in two deaths there 
was no information available that confirmed the woman was aware she was pregnant. Eight women 
died within six weeks of a live birth or termination of pregnancy. This differs from non-Māori, for whom 
there were fewer deaths during pregnancy less than 20 weeks gestation (n=2), more deaths between 
20 weeks gestation and birth (n=6), and fewer deaths following a termination of pregnancy/live birth/
miscarriage (n=2) (PMMRC 2016, pp 122–131).
Thirteen of the 15 deaths were due to hanging. 
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Time of death in relation to pregnancy 
Post termination of pregnancy 4 27
During pregnancy 8 53
Postpartum/Post miscarriage 3 20
Age at death
24 years and younger 7 47
≥25 years 8 53
Time of death 
<20/40 weeks gestation 6 40
≥20/40 weeks gestation 2 13
≤7 days after birth/termination of pregnancy 2 13
8 days to 6 weeks after birth/termination of pregnancy 5 33
Lead maternity carer involvement 
Not applicable* 8 53
Yes 3 20
 No 4 20
Previous pregnancies
Nil 3 20
Live births 6 40
Unknown# 6 40
Children in care of others 4 27
Child, Youth and Family involved during final pregnancy 2 13
Antenatal barriers to care+ 3 20
Postnatal issues
Not home/Missing some postnatal visits 2 13
Delayed/Missed diagnosis of mental/physical health problem 4 27
GP/Family Planning involved 
 Yes 9 60
 No 3 13
Reviews suggest had involvement^ 3 20
Mental health or alcohol and drug services involved during pregnancy and prior to death 6 40
Other life stressors at time of death
Relationship problems 12 80
Other life stressors 6 40
Substance use at time of death
Alcohol 3 20
Other drugs 2 13
Substance use during pregnancy 7 47
Mental health service involvement prior to pregnancy
No identified previous mental health issues 5 33
Yes 3 20
Identified mental health issue and no involvement• 7 47
Self-harm/Suicide attempts prior to or during the final pregnancy 8 53
Family history of mental health/suicide 4 27
Family violence 11 73
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Factors associated with the pregnancy and the period between pregnancy and death
For just over half of the women (8 cases; 53 percent) the involvement of an LMC in the pregnancy 
was not indicated because the woman may have been unaware she was pregnant, had a planned 
termination of pregnancy or had an early miscarriage. Four cases were not under an LMC’s care at the 
time of death, and three were. Some antenatal and postnatal visits were missed in all three cases where 
an LMC was involved. The reviews of these cases document difficulties such as transport and phone 
difficulties that impacted on this care. 
Other services were involved with the women during their pregnancy and prior to their death. Most 
of the women (9 cases; 60 percent) had seen a GP (or in a small number of cases, a Family Planning 
service) during their pregnancy. Mental health services or alcohol and drug services were involved 
with six women during or after pregnancy prior to their deaths. In some cases multiple services were 
involved (eg, midwives, secondary and tertiary specialist obstetric and mental health services, and 
GPs). Child, Youth and Family was notified/involved in two cases but the extent of their involvement is 
not clear from the review notes. In three cases the reviews documented poor communication between 
the various services involved. Potentially delayed or missed diagnosis of physical and/or mental health 
issues was identified in five reviews. Poor coordination and/or lack of follow-up were identified in three 
cases. 
For 12 (80 percent) of the women their relationship with their partner/ex-partner was a source of 
stress due to recent break ups, arguments and, in six cases, family violence. For a number of these 
women other stressors such as financial concerns, legal proceedings, housing difficulties, limited 
phone availability, transport difficulties, exposure to drug/alcohol use by others around her, and fetal 
abnormality were also noted. 
Alcohol, with or without other drugs, was identified at post-mortem in three women (20 percent). 
Alcohol use alone or in combination with other drugs, or use of other drugs alone during the final 
pregnancy was identified in seven women; in one case referral to alcohol and drug services was 
mentioned in the patient’s notes but it is unclear if this had been acted on. Two women were seeing 
alcohol and drug services prior to pregnancy and may have had ongoing involvement with these 
services during the pregnancy. 
Other factors that may have contributed to outcome
The majority of women (11 cases, 73 percent) had a documented history of witnessing or experiencing 
family violence as a child, and/or family violence as an adult, and/or sexual abuse or assault. 
A past history of mental health issues was common (10 cases). A referral that resulted in the woman 
being seen at mental health services was only documented in two deaths. 
Eight women (53 percent) had self-harmed or attempted suicide prior to or during the final pregnancy. 
A history of mental health illness and/or suicide among family members was documented in four 
women’s cases.
Four women (27 percent) had existing children who were in the care of other people. 
* Termination of pregnancy/unaware that was pregnant/miscarriage. 
# Termination of pregnancy only; combination live birth/miscarriage/termination of pregnancy.
+ Eg, transport/missing some antenatal visits.
^ Eg, early dating ultrasound scan, early booking with midwife. 
• Not referred/referred but not seen or unclear if had been seen/unclear if had been referred or seen.
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Summary
This section highlights patterns of findings that may be associated with increased risk of suicide for 
Māori women. Early identification of these patterns among pregnant Māori women may provide health 
professionals opportunities to intervene in order to prevent suicides in the future. The deaths of all 
women under the age of 25 are reviewed by the CYMRC. It would be possible to estimate whether 
suicide rates among pregnant and non-pregnant Māori women are different from these reviews. 
For women 25 years of age and older there is no comprehensive multiagency review of deaths due 
to suicide, which makes it very difficult to assess whether suicide rates between pregnant and non-
pregnant women in this age group differ. 
Just under half of the suicides occurred in young women. Most of these women were under 17 years of 
age and a fifth were aged 18–24 years. This differs from the pattern seen in non-Māori women. 
Over half of women had been seen by a GP or at a Family Planning clinic (but mostly by a GP) in the 
final pregnancy. Forty percent of women were involved with mental health or alcohol and drug services 
during their final pregnancy. In addition, 47 percent were documented as having an identified mental 
health issue and were either not referred, referred but not seen, or it was unclear if they had been 
referred or seen by mental health services. Some women had multiple services involved in their care 
– including midwifery, specialist obstetric and mental health services. Service related issues including 
poor communication between services, poor coordination, and inadequate follow-up were identified, as 
were potentially delayed and/or missed diagnoses of physical and/or mental health issues. 
A number of stressors affecting the women were also identified. Difficulties in the women’s relationships 
with their partners or ex-partners were noted in the majority (80 percent) of cases. Other significant 
stressors included financial or legal concerns, difficulties with housing, and availability of phones and 
transport. 
Experiencing family violence and sexual abuse/assault as a child and/or as an adult was also very 
common. 
A past history of mental health issues, regardless of whether the woman was seen by mental health 
services, is a common factor, as is a history of self-harm or previous suicide attempts. Alcohol and drug 
use during the final pregnancy was noted in review of just under half of the women’s cases. 
Most of the women who died from suicide experienced multiple risk factors. Early recognition of these 
risk factors, particularly where there are multiple factors, will assist health services and professionals to 
provide better services for these women. 
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Practice Point: Māori women and risk factors for maternal suicide
Pregnancy and the postpartum period are not protective against mental illness, and can be a 
trigger for onset and for deterioration of mental illness.
Comprehensive assessment of risk factors for Māori women should be undertaken at confirmation 
of pregnancy and/or on first presentation for antenatal care. This assessment should be done for 
all Māori women, regardless of age, including those seeking a termination of pregnancy.  
This assessment should include:
• Assessment of current social situation including relationship with partner/ex-partner, whānau 
supports, and social stressors such as financial issues, housing, whether their other children 
are in care of other people, and phone and transport availability.
• Previous and current experience of family violence, sexual abuse and assault.  
• Past history of mental health issues including self-harm and previous suicide attempts, use of 
alcohol and other drugs, and family history of mental health illnesses or suicide.  
• History of TOP or miscarriage in the previous twelve months.
Where Māori women have symptoms suggesting serious mental illness, urgent referral is indicated. 
Māori women who have a history of serious mental illness that are currently well should be referred 
to a secondary mental health service. See ‘Practice Point: Māori women and maternal suicide’.
If risk factor(s) are identified, the impact of these on the woman’s health and wellbeing should be 
discussed and appropriate referral(s) made. Assessment of the impact of these risk factors should 
continue throughout pregnancy and the postnatal period. 
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Practice Point: Māori women and maternal suicide
Where Māori women exhibit symptoms suggesting serious mental illness, an urgent mental health 
assessment, including consultant psychiatrist review and consultation with perinatal mental health 
services, on the same day these symptoms are first noted should be undertaken.  
Symptoms include: 
• Recent significant change in mental state including fluctuating or emergence of new symptoms
• Suicidal ideation (new or increasing)
• Suicide attempts
• Psychotic symptoms
• Pervasive guilt or hopelessness
• Ongoing beliefs of inadequacy as a mother
• A sense of estrangement or disconnection from the infant.
Māori women who have a history of serious mental illness that are currently well should be referred 
to a specialist mental health service as they may have increased risk of relapse during pregnancy, 
in the peripartum or postnatal period. They need an appropriate mental health birth plan and 
monitoring for the peripartum period. Close monitoring by their maternity care provider +/- mental 
health services during these periods is required. Mental health services should assure rapid access 
to their services if there is a deterioration in a woman’s mental health. Where such a woman has a 
miscarriage, the GP should be notified immediately and an explicit process for early follow up, that 
includes a review of mental health status, agreed with the GP.  
Doctors who refer Māori women for TOPs should actively follow up these women to ensure they have 
their free post-TOP check. This check should specifically include assessment of mental health status.  
Māori women should have access to culturally appropriate mental health and/or alcohol and drug 
care. 
During pregnancy and the postpartum period there may be more than one mental health team 
involved—in such cases there should be one identified individual who coordinates care.
All clinicians involved in a Māori women’s need relevant mental health/substance use history and 
current knowledge of a woman’s pregnancy to support them to provide the best care. Routine 
communication and sharing of relevant information across all services providing care to the women 
during pregnancy and the postpartum period will enable high quality, better informed care. Any 
concerns regarding risk need to be clearly communicated to all clinicians involved.
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5.6 Recommendations
In addition to the maternal mortality practice points and noted previous recommendations developed by 
the PMMRC, the following recommendations are made.
The Mortality Review Committees’ Māori Caucus recommends:
Improved awareness and responsiveness to the increased risk for Māori women
Primary care (GPs, FPA), LMCs, TOP services, alcohol and drug services, and secondary and tertiary 
providers of maternity, obstetric, mental health, and maternal mental health services should improve their 
systems, guidelines and professional development to ensure that they are responsive to the identified 
increased risk for Māori women.
Risk assessment
Comprehensive assessment of risk factors for Māori women should be undertaken at diagnosis of 
pregnancy and/or on first presentation for antenatal care.  This should be undertaken for all Māori 
women, regardless of age, including those who are seeking termination of pregnancy. 
See ‘Practice Point: Māori women and risk factors for maternal suicide’ on page 160.
Management
a. Where Māori women exhibit symptoms suggesting serious mental illness or distress, an urgent 
mental health assessment, including consultant psychiatrist review and consultation with perinatal 
mental health services, on the same day these symptoms are first noted should be undertaken
b. Māori women who have a history of serious mental illness and are currently well should be referred 
to specialist mental health services for a mental health birth plan, and monitored closely by their 
maternity care provider +/- mental health services. Where such a woman has a miscarriage, the 
GP should be notified immediately and an explicit process for early follow up that includes a review 
of mental health status agreed with the GP.
c. The referring doctor of women who undergo a TOP is expected to provide a free post-TOP follow 
up consultation 10–14 days after the procedure (Report of a Standards Committee to the Abortion 
Supervisory Committee 2009). The referring doctor should actively follow up Māori women 
referred for TOP to ensure this consultation is completed and review mental health status during this 
consultation. 
See ‘Practice Point: Māori women and maternal suicide’ on page 161.
Communication and coordination
Communication and coordination between primary care (GPs, FPA), LMCs, TOP services, alcohol and 
drug services, and secondary providers of maternity, obstetric, mental health, and maternal mental health 
services should be improved and enhanced using a variety of means including but not limited to case 
management, integrated notes systems, and electronic transfer of information.
Child and Youth Mortality Review
Child and Youth Mortality Review Committee (CYMRC) consider including information about whether 
female suicide cases were pregnant in the 12 months prior to their deaths in addition to the pregnancy 
status information currently collected.
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5.7 Māori Perinatal and Maternal Mortality Appended Tables and Figures
Table 5.13: Perinatal related mortality rates (per 1000 births) by ethnicity (Māori and New Zealand 






<28 weeks at 
birth
Neonatal death 




n n Rate n Rate n Rate n Rate n Rate
Māori
2007  16,819  20  1.19  106  6.30  26  1.56  27  1.62  179  10.64 
2008  17,035  11  0.65  100  5.87  31  1.83  28  1.65  170  9.98 
2009  16,900  29  1.72  111  6.57  40  2.39  29  1.73  209  12.37 
2010  16,779  19  1.13  105  6.26  41  2.46  29  1.74  194  11.56 
2011  16,242  31  1.91  95  5.85  24  1.49  26  1.61  176  10.84 
2012  16,031  34  2.12  77  4.80  33  2.07  19  1.19  163  10.17 
2013  14,899  24  1.61  82  5.50  29  1.96  21  1.42  156  10.47 
2014  14,592  20  1.37  89  6.10  34  2.35  24  1.66  167  11.44 
2015  14,873  20  1.34  71  4.77  24  1.62  28  1.89  143  9.61 
NZ European
2007  27,358  76  2.78  157  5.74  28  1.03  36  1.33  297  10.86 
2008  27,252  87  3.19  148  5.43  23  0.85  51  1.89  309  11.34 
2009  26,883  69  2.57  164  6.10  20  0.75  37  1.39  290  10.79 
2010  26,431  74  2.80  127  4.80  36  1.37  32  1.22  269  10.18 
2011  25,170  77  3.06  126  5.01  23  0.92  35  1.40  261  10.37 
2012  24,429  66  2.70  123  5.03  27  1.11  34  1.40  250  10.23 
2013  23,265  58  2.49  121  5.20  23  1.00  28  1.21  230  9.89 
2014  22,656  70  3.09  132  5.83  34  1.51  25  1.11  261  11.52 
2015  22,234  58  2.61  114  5.13  23  1.04  29  1.31  224  10.07 
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Table 5.14: Perinatal related mortality rates (per 1000 births) by ethnicity (Māori and New Zealand 






<28 weeks at 
birth
Neonatal death 




n n Rate n Rate n Rate n Rate n Rate
Māori
2007  15,384  20  1.30  106  6.89  26  1.70  27  1.77  179  11.64 
2008  15,530  11  0.71  100  6.44  31  2.01  28  1.82  170  10.95 
2009  14,646  29  1.98  111  7.58  40  2.76  29  2.00  209  14.27 
2010  14,877  19  1.28  105  7.06  41  2.78  29  1.97  194  13.04 
2011  14,244  31  2.18  95  6.67  24  1.70  26  1.84  176  12.36 
2012  14,143  34  2.40  77  5.44  33  2.35  19  1.35  163  11.53 
2013  13,488  24  1.78  82  6.08  29  2.17  21  1.57  156  11.57 
2014  12,942  20  1.55  89  6.88  34  2.65  24  1.87  167  12.90 
2015  13,971  20  1.43  71  5.08  24  1.73  28  2.02  143  10.24 
NZ European
2007  31,281  76  2.43  157  5.02  28  0.90  36  1.16  297  9.49 
2008  30,863  87  2.82  148  4.80  23  0.75  51  1.67  309  10.01 
2009  29,684  69  2.32  164  5.52  20  0.68  37  1.26  290  9.77 
2010  29,750  74  2.49  127  4.27  36  1.22  32  1.08  269  9.04 
2011  28,383  77  2.71  126  4.44  23  0.82  35  1.24  261  9.20 
2012  27,676  66  2.38  123  4.44  27  0.98  34  1.24  250  9.03 
2013  26,229  58  2.21  121  4.61  23  0.88  28  1.07  230  8.77 
2014  25,126  70  2.79  132  5.25  34  1.36  25  1.00  261  10.39 
2015  26,380  58  2.20  114  4.32  23  0.88  29  1.11  224  8.49 
Table 5.15: Neonatal death rates (per 1000 live births) by gestation and ethnicity (Māori and New 
Zealand European prioritised mother ethnicity) 2011–2015 (excluding congenital abnormalities)
Gestation at birth (weeks)
Māori NZ European
Live 
births  Neonatal deaths 
Live 
births  Neonatal deaths 
n (MAT) n % Rate n (MAT) n % Rate RR 95% CI
20–22  74  59  29.35  0.79  61  63  31.03  0.54  1.45  1.02–2.07 
23–24  127  59  29.35  0.79  87  42  20.69  0.36  2.17  1.46–3.23 
25–27  246  25  12.44  0.33  246  20  9.85  0.17  1.93  1.07–3.48 
28–36  5,566  19  9.45  0.25  8,087  36  17.73  0.31  0.82  0.47–1.42 
≥37  69,020  39  19.40  0.52  107,654  42  20.69  0.36  1.44  0.93–2.22 
Total  75,033  201  100.0  2.68  116,135  203  100.0  1.75  1.53  1.26–1.86 
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Table 5.16: Maternal mortality ratios (per 100,000 maternities) by ethnicity (Māori and New Zealand 





2006  15,848  9  56.79 
2007  16,819  2  11.89 
2008  17,035  4  23.48  30.18 2006–2008
2009  16,900  4  23.67  19.70 2007–2009
2010  16,779  3  17.88  21.69 2008–2010
2011  16,242  5  30.78  24.04 2009–2011
2012  16,031  8  49.90  32.62 2010–2012
2013  14,899  4  26.85  36.04 2011–2013
2014  14,592  -  -  26.36 2012–2014
2015  14,873  3  20.17  15.78 2013–2015
New Zealand European
2006  26,253  3  11.43 
2007  27,358  5  18.28 
2008  27,252  3  11.01  13.60 2006–2008
2009  26,883  2  7.44  12.27 2007–2009
2010  26,431  3  11.35  9.93 2008–2010
2011  25,170  1  3.97  7.64 2009–2011
2012  24,429  2  8.19  7.89 2010–2012
2013  23,265  6  25.79  12.35 2011–2013
2014  22,656  3  13.24  15.64 2012–2014
2015  22,234  6  26.99  22.01 2013–2015
* Denominator is MAT; numerator is PMMRC.
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6 Neonatal Encephalopathy 2015
6.1 Methodology
Case definition
Neonatal encephalopathy (NE): a clinically defined syndrome of disturbed neurological function within 
the first week of life in the term (≥37 weeks) infant, manifested by difficulty in initiating and maintaining 
respiration, depression of tone and reflexes, subnormal level of consciousness and often seizures 
(Nelson and Leviton 1991). This dataset includes Sarnat stages 2 or 3 equivalent to moderate and 
severe only.
The introduction of induced cooling has made the definition of NE more difficult as cooling is frequently 
initiated before many of the defining signs of NE have appeared, and has been used for increasingly 
milder cases. This is evident from data in the UK TOBY Cooling Register with a decrease in the 
proportion of infants with suspected clinical seizures before cooling started, an increase in Apgar 
scores and in first blood base excess from 2007 to 2011 (Azzopardi et al 2012). It is usual to include 
babies who warrant cooling in the dataset even though they may, due to the ameliorative effects of the 
cooling, never reach the level of morbidity consistent with moderate NE. 
Although hypoxia-ischemia is the predominant pathology, reported cases of term infants with NE are 
included in this dataset whatever the cause. Therefore, the full cohort includes a small number of cases 
where NE is associated with hypoglycaemia, congenital abnormality of the central nervous system, or 
infection.
Case ascertainment
Cases were initially identified with the assistance of the New Zealand Paediatric Surveillance Unit and 
the collection of data facilitated by paediatricians, LMCs and the national coordination service of the 
PMMRC, as described in detail in the fifth report of the PMMRC (PMMRC 2011). Since 2012, cases 
have been notified by key clinicians in neonatal units and the PMMRC local coordinators. 
From 2016 the Neonatal Encephalopathy Working Group (NEWG) widened the inclusion criteria for 
the NE cohort and will include cases from 35 weeks gestation at birth in line with international literature 
and practice of cooling from this gestation (American College of Obstetricians and Gynecologists 
2014). 
PMMRC numerator data validation 
Data are regularly validated, using a standard set of queries, to eliminate duplicate records, complete 
missing mother or baby information, clarify DHB of residence (where this is inconsistent with the given 
residential address) and rectify other inconsistencies.
At the end of each year, PMMRC DHB local coordinators and key clinicians in special care and 
neonatal units are contacted to ensure the collection is complete.
Denominator data
Denominator data, as used elsewhere in this 11th report for the first time, are the births included in 
the MAT dataset collated by the Ministry of Health. For calculation of rates, the denominator set was 
restricted to births at term (as is the numerator).
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6.2 Findings
In 2015 there were 70 cases of moderate and severe NE reported to the national dataset. There 
have been 423 cases reported from 2010–2015, making the NE rate for 2010–2015 1.15/1000 
births (95% CI 1.04–1.26) (423/368,647 births) or 1.24/1000 term births (95% CI 1.13–1.36) 
(423/339,781 term births). Although there appears to be a downward trend in the NE rate (Figure 
6.1), there is no significant trend (chi-squared test for trend p=0.39).
























In a 2013 paper, Lee et al estimated that in countries with a neonatal mortality rate <5/1000 births, 
such as New Zealand, the median incidence of NE associated with intrapartum events (including mild 
NE) was 1.60/1000 births (range 0.68–3.75/1000) for 1980 to 2013 with evidence of reduced 
incidence over time from some studies (Lee et al 2013). This would suggest that at 1.15/1000 births 
for moderate and severe NE, New Zealand is within international incidence rates. Case fatality rate 
among babies with severe NE was 76.8 percent (range 61.9–91.7 percent) compared to 59 percent in 
the New Zealand cohort. 
Of survivors reported in the Lee et al paper, 26.4 percent (range 22.1–30.8 percent) developed 
moderate to severe neurodevelopmental impairment, and 14 percent (range 8.8–19.2 percent) 
developed mild neurodevelopment impairment. These outcomes largely reflect the pre-cooling era. 
The UK TOBY Cooling Register reported results on 48 percent of trial participants at two years of age. 
Although this is limited follow-up, it was felt that these children were not systematically different from 
all children entered in the trial. Cerebral palsy was clinically diagnosed in 22 percent (Azzopardi et al 
2012).
In 2017, the NEWG has looked at preliminary data from the B4 School Check programme in New 
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Zealand relating to babies reported to the NEWG in the first two years of the cohort. Details of these 
findings will be included in the 2018 report.
Demography and neonatal encephalopathy
In this 11th report, the PMMRC has moved to reporting using the MAT dataset as the denominator for 
rates. While this denominator has a number of advantages in that it is the best record of births in New 
Zealand in a year and it includes a wealth of maternity data, the use of the MAT dataset raises the issue 
of the measurement of ethnicity in different routine datasets. A comparison of Figure 6.2 with Figure 
3.1 in the 10th PMMRC report (‘Neonatal encephalopathy rates (per 1000 term births) by maternal 
prioritised ethnicity 2010–2014’) illustrates this (PMMRC 2016). In the report last year, the NE rate for 
babies of Māori mothers was reported as 1.48/1000 term babies (95% CI 1.19–1.81), and this year 
it is reported as 1.32/1000 term births (95% CI 1.07–1.56). It is not certain which of these is correct. 
The issue of ethnicity differences in the BDM and MAT denominator datasets is discussed further in 
section “1.2 Methodology” and chapter 5. 
Mothers of Pacific ethnicity are at increased risk of having a baby with NE compared to Other Asian, 
Other, and New Zealand European mothers. Mothers of Māori and Indian ethnicity are at increased 
risk of having a baby with NE compared to mothers of Other Asian and Other ethnicities. 
Increasing socioeconomic deprivation is associated with increased risk of NE. There has been a 
fairly consistent finding across the years of lower risk among mothers living in deprivation quintile 4 
compared with quintiles 2, 3, and 5, although numbers are small and there is huge variation in the 
association by year. There is no obvious explanation for this finding.
There is no statistically significant association between maternal age and NE risk. 
Maternal Pacific ethnicity remained a predictor of NE after adjusting for gestation at birth, year of birth, 
deprivation quintile, multiple pregnancy and maternal age (PMMRC 2016).
Figure 6.2: Neonatal encephalopathy rates (per 1000 term births) by maternal prioritised ethnicity 
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DHB of maternal residence
Figure 6.4: Neonatal encephalopathy rates (per 1000 term births) by DHB of maternal residence* 




















DHB of maternal residence 
NE rate/1000 term births NE rate NZ
* Excludes any DHB with fewer than three cases.
Figure 6.4 includes combined data for NE by DHB of maternal residence for 2010–2015. 
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Waikato, Taranaki, and Capital & Coast DHBs, all previously identified as outliers, have statistically 
higher rates of NE than the national rate. All DHBs should be routinely identifying and undertaking 
multidisciplinary review of cases of moderate and severe NE. In 2017, the NEWG will be asking DHBs 
to report on whether, and how, they have reviewed the cases reported to the NEWG from their DHB as 
occurring in 2016.
Previous PMMRC Recommendation (Eighth Report (PMMRC 2014)) 
That all DHBs review local incident cases of neonatal encephalopathy (Sarnat stages 2 and 3). The 
findings of these reviews should be shared at multidisciplinary local forums and form the basis of quality 
improvements as appropriate.
Gestation, sex, birthweight and plurality
Table 6.1: Neonatal encephalopathy rates (per 1000 term births) by gestation, sex, birthweight, 
plurality, parity 2010–2015
NZ registered births 




n % n % /1000 95% CI
Gestation at birth (weeks)
37  23,044  6.8  47  11.1  2.04  1.50–2.71 
38  57,781  17.0  70  16.5  1.21  0.94–1.53 
39  95,379  28.1  98  23.2  1.03  0.83–1.25 
40  103,048  30.3  105  24.8  1.02  0.82–1.21 
41  52,561  15.5  94  22.2  1.79  1.45–2.19 
≥42  7,968  2.3  9  2.1  1.13  0.52–2.14 
Sex
Male  173,772  51.1  235  55.6  1.35  1.18–1.53 
Female  165,992  48.9  188  44.4  1.13  0.97–1.29 
Unknown  17  0.0  -  -  -  - 
Birthweight (g)
<2,500  6,190  1.8  16  3.8  2.58  1.48–4.20 
2,500–3,999  267,004  78.6  355  83.9  1.33  1.19–1.47 
4,000–4,499  42,472  12.5  37  8.7  0.87  0.61–1.20 
≥4,500  8,595  2.5  15  3.5  1.75  0.98–2.88 
Unknown  15,520  4.6  -  -  -  - 
Plurality
Singleton  334,243  98.4  414  97.9  1.24  1.12–1.36 
Multiple  4,235  1.2  9  2.1  2.13  0.97–4.03 
Unknown  1,303  0.4  -  -  -  - 
Parity*
0  123,932  36.5  241  57.0  1.94  1.70–2.19 
1  107,534  31.6  98  23.2  0.91  0.74–1.11 
2  48,222  14.2  43  10.2  0.89  0.65–1.20 
3  18,860  5.6  21  5.0  1.11  0.69–1.70 
≥4  15,768  4.6  20  4.7  1.27  0.77–1.96 
Unknown  25,465  7.5  -  -  -  - 
* Defined after birth of the index case.
PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: 11th ANNUAL REPORT 171
There is a significant association between gestation at birth and NE risk (Table 6.1, Figure 6.5). There 
is a significantly higher rate of NE among babies born at 37 and at 41 weeks than among babies born 
at 38–40 weeks. The risk at 42 weeks and above is difficult to estimate as numbers are small and the 
CIs are necessarily wide.
The higher rate of NE reported among male babies (1.35/1000 term males) compared to female 
babies (1.13/1000 term females) almost reaches statistical significance (p=0.069). 
Babies <2500g at term were twice as likely to suffer NE than babies 2500–4000g, and almost three 
times as likely as babies 4000–4500g. 
There is no significant increase in NE among multiple births at term compared to singleton births.






















Gestation at birth (weeks)
Figure 6.6 shows the association between parity and rate of NE. This is possible for the first time this 
year because of the use of the MAT denominator. PMMRC data are presented in the numerator and 
MAT data in the denominator. The rate of NE among first births is twice that among second and third 
births, and 1.7 times that of fourth births, but not significantly higher than fifth or later births (p=0.06) 
(Figure 6.6). 
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Table 6.2: Maternal smoking, body mass index (BMI) and gestation at first antenatal visit among 





Yes  80  18.9 
No  339  80.1 
Unknown  4  0.9 
Maternal BMI (kg/m2) 
<18.50  3  0.7 
18.50–25.49  152  35.9 
25.50–30.49  123  29.1 
≥30.50  121  28.6 
Missing data for height and or weight  24  5.7 
Gestation first antenatal visit (weeks)
≤13  262  61.9 
14–19  56  13.2 
≥20  58  13.7 
Unknown  47  11.1 
Maternal smoking, BMI and gestation at first antenatal visit
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As described in section “1.2 Methodology”’, the numerator data in the PMMRC dataset for smoking 
and BMI are not congruent with the MAT data. To calculate rates of NE by smoking and BMI, the NE 
numerator data need to be merged with the MAT dataset. This is planned for the next PMMRC report. 
Table 6.2 shows smoking, BMI and gestation at first antenatal visit for cases identified from 2010–
2015. 
Among all mothers birthing in New Zealand with data in the MAT dataset in 2015, 14.2 percent of 
mothers with smoking data in the MAT dataset were smokers at registration with LMC care, compared 
to 18.9 percent of mothers of babies diagnosed with NE, suggesting an association between smoking 
and NE. 
Among mothers of babies diagnosed with NE, 28.6 percent had a BMI of 30.5 or greater compared 
to 20.6 percent among all mothers birthing in New Zealand in 2015, suggesting an increase in risk 
of NE with increased maternal BMI. This is consistent with increased risk of other adverse perinatal 
outcomes with increasing maternal BMI (Aune et al 2014; Cedergren 2004). 
At least some of the association between BMI and NE, and smoking and NE, may be due to 
confounding factors such as socioeconomic status.
Customised birthweight, antenatal complications and maternal outcome
Table 6.3: Customised birthweight centiles, antenatal complications and maternal outcome among 
neonatal encephalopathy cases by Sarnat stage 2010–2015
NE cases Primiparous (=1) Multiparous (≥2)
Sarnat stage
Moderate Severe
n=423 n=241 n=182 n=293 n=130
n % n % n % n % n %
Customised birthweight centiles
Small for gestational age  77  18.2 44  18.3 33  18.1  55  18.8  22  16.9 
Appropriate for gestational age  312  73.8 184  76.3 128  70.3  210  71.7  102  78.5 
Large for gestational age  34  8.0 13  5.4 21  11.5  28  9.6  6  4.6 
Antenatal complications
APH (≥20 weeks vaginal 
bleeding)
45 10.6 23 9.5 22 12.1  30 10.2  15 11.5
Hypertension 53 12.5 38 15.8 15 8.2  41 14.0  12 9.2
Pre-eclampsia 6 1.4 5 2.1 1 0.5  6 2.0  - 0.0
Gestational hypertension 18 4.3 14 5.8 4 2.2  17 5.8  1 0.8
Unspecified hypertension 29 6.9 19 7.9 10 5.5  18 6.1  11 8.5
Maternal trauma (antenatal)* 8 1.9 5 2.1 3 1.6  4 1.4  4 3.1
Induction of labour 102 24.1 65 27.0 37 20.3  75 25.6  27 20.8
Augmentation of labour 158 37.4 109 45.2 49 26.9  124 42.3  34 26.2
Epidural anaesthesia 114 27.0 83 34.4 31 17.0  89 30.4  25 19.2
Maternal outcome
Deceased 4 0.9 1 0.4 3 1.6  2 0.7  2 1.5
Alive but with serious morbidity 10 2.4 3 1.2 7 3.8  5 1.7  5 3.8
Alive and well 409 96.7 237 98.3 172 94.5  286 97.6  123 94.6
* Vehicular, violent personal injury, other.
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Among babies with NE from 2010–2015, 18 percent were small by customised birthweight centile, 
and this is higher than expected (around 12 percent in the birthing population), suggesting SGA babies 
are at higher risk of NE. 
The national rate of induction of labour (all births) was 24.4 percent in 2014 (28.7 percent among 
women having their first baby and 20.4 percent among women having subsequent babies), which is 
the same as that among mothers of babies diagnosed with NE (24.1 percent, 27.0 percent and 20.3 
percent respectively) (Ministry of Health 2015b).
Among mothers of babies diagnosed with NE, 27.0 percent had an epidural in labour compared to 
a national rate in 2014 of 27.1 percent (42.4 percent of women having their first baby, and 15.3 
percent of women having subsequent babies).
Over the five years of NE data collection, there have been four cases associated with maternal death 
and 10 with severe maternal morbidity. Of these 14 babies, seven had severe NE (50 percent) 
compared with 31 percent severe NE among all 423 cases of NE. 
Peripartum complications and mode of birth
Acute peripartum events were reported in 101 cases (24 percent). Of these, abruption (31 cases) 
and shoulder dystocia (26 cases) were the most common. Other complications included amniotic fluid 
embolism, maternal collapse, complications at birth of the second twin, vasa praevia and drug error. 
Blood stained liquor was noted in 9 percent of cases and meconium in 33 percent. 
Among babies diagnosed with NE, 43 percent were born by caesarean section, 31 percent by in 
labour caesarean section, which was most often performed for suspected fetal distress. This compares 
with a national caesarean section rate of 25.9 percent among all births in 2014 (Ministry of Health 
2015b). 
Eight babies (1.9 percent) were breech vaginal births at term, compared to 0.5 percent vaginal breech 
births in New Zealand in 2014 (Ministry of Health 2015b).
In 2016–2017 the NEWG has reviewed the maternity and early neonatal care of 48 babies born with 
NE in 2013–2015 who had an acute peripartum event. The findings of these reviews will be reported 
in the 12th report of the PMMRC in 2018.
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Acute peripartum events  101  23.9 
Cord prolapse  17  4.0 
Abruption  31  7.3 
Uterine rupture  9  2.1 
Shoulder dystocia  26  6.1 
Breech complication  9  2.1 
Other complication  9  2.1 
Liquor
Blood stained  36  8.5 
Thick meconium  89  21.0 
Thin meconium  53  12.5 
Mode of birth
Normal vaginal birth  171  40.4 
Operative vaginal birth  62  14.7 
Forceps  25  5.9 
Ventouse  35  8.3 
Unknown  2  0.5 
Vaginal breech birth   8  1.9 
Caesarean section birth  182  43.0 
Elective  9  2.1 
Prelabour emergency  40  9.5 
Antepartum haemorrhage/Abruption  5  1.2 
Suspected fetal distress  28  6.6 
Failed induction  1  0.2 
Other  6  1.4 
In labour emergency  133  31.4 
Antepartum haemorrhage/Abruption  10  2.4 
Suspected fetal distress  94  22.2 
Failure to progress/Cephalopelvic disproportion  11  2.6 
Other  17  4.0 
Unknown  1  0.2 
Attempt at operative vaginal birth before caesarean  12  2.8 
Place of birth
From 2010 to 2015, there were eight babies with NE who were birthed at home as intended. This 
is 1.9 percent of all cases of moderate or severe NE (Table 6.12). Eleven babies diagnosed with NE 
(2.6 percent) birthed at home. In 2014, 3.4 percent of babies were born at home in New Zealand, 
9.1 percent in a primary unit, 41 percent in a level 2 hospital and 46.4 percent in a tertiary hospital 
(Ministry of Health 2015b).
Previous PMMRC reports have shown that there is no association between place of birth and induced 
cooling among babies born in New Zealand with moderate and severe NE. More detail on intended 
and actual place of birth can be found in Table 6.12.
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LMC and neonatal encephalopathy rates
Consideration was given in this report to including rates of NE by LMC at registration because these 
data are collected by the NEWG, are available in the MAT denominator dataset, and because this 
question has been raised nationally (Wernham et al 2016). 
However, these data have not been included in this report for two reasons. Firstly, the denominator 
data do not accurately represent the models of maternity care available during the time period 2010–
2015. For example, there is no category for the model of shared GP and DHB primary care previously 
available at Counties Manukau DHB. Women under primary care at DHBs who are not currently 
providing data to the Ministry of Health are recorded as ‘no LMC care’, which cannot be separated 
from women who were truly not registered with an LMC. Secondly, New Zealand has an integrated 
model of maternity care, with referral guidelines (Ministry of Health 2012a) outlining processes and 
guidance for consultation, referral, and transfer of responsibility for care in response to maternal need 
that does not facilitate division of care by individual caregiver, and so the numerator data are not fit for 
the purpose either. 
The NEWG has previously reported on case review of cases of NE where there was no acute 
peripartum event (Sadler et al 2016) and are currently undertaking review of cases where there was 
an acute peripartum event. During this latter review, specific effort has been made to identify the 
responsible clinician at various intervals in the process, and to identify instances where there was delay 
in recognising a need for consultation and/or referral or a delay in providing consultation and/or 
transfer, and these data will be presented with the results of this review. The original case review did 
not specifically look at the potential role of the caregiver, or a group of caregivers, in the aetiology of 
NE, but also did not find this to be an identified contributing factor.
Immediate newborn wellbeing
Table 6.5: Immediate newborn wellbeing among neonatal encephalopathy babies 2010–2015 
2010 2011 2012 2013 2014 2015 Total
n=82 n=67 n=79 n=70 n=55 n=70 n=423
n % n % n % n % n % n % n %
Apgar scores
Apgar score <3 at 1 minute 48 58.5 41 61.2 47 59.5 40 57.1 37 67.3 38 54.3 251 59.3 
Apgar score <5 at 1 minute 65 79.3 54 80.6 62 78.5 58 82.9 49 89.1 50 71.4 338 79.9 
Apgar score <7 at 1 minute 73 89.0 61 91.0 70 88.6 65 92.9 53 96.4 58 82.9 380 89.8 
Apgar score <7 at 5 minutes 61 74.4 54 80.6 62 78.5 57 81.4 43 78.2 49 70.0 326 77.1 
Apgar score <7 at 10 minutes 39 47.6 38 56.7 49 62.0 32 45.7 29 52.7 34 48.6 221 52.2 
Apgar score <9 at 10 minutes 52 63.4 52 77.6 62 78.5 52 74.3 45 81.8 47 67.1 310 73.3 
Cord blood gases: summary data
Normal (none of pH ≤7, BE 
≤−12, lactate ≥6)
12 14.6 14 20.9 11 13.9 13 18.6 7 12.7 8 11.4 65 15.4 
Abnormal (any of pH ≤7, BE 
≤−12, lactate ≥6)
47 57.3 41 61.2 55 69.6 48 68.6 40 72.7 47 67.1 278 65.7 
No gases reported 23 28.0 12 17.9 13 16.5 9 12.9 8 14.5 15 21.4 80 18.9 
No gases and Apgar score <7 at 
1 minute
14 17.1 8 11.9 8 10.1 6 8.6 8 14.5 6 8.6 50 11.8 
No gases and Apgar score ≥7 at 
1 minute
8 9.8 4 6.0 5 6.3 3 4.3  -  - 9 12.9 29 6.9 
No gases and unknown Apgar 
score
1 1.2  -  -  -  -  -  -  -  -  -  - 1 0.2 
BE = base excess.
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Fifty-nine percent of the babies diagnosed with moderate or severe NE from 2010 to 2015 had an 
Apgar score under 3 at one minute, 80 percent under 5 at one minute, 77 percent under 7 at five 
minutes, and 52 percent still had a score under 7 at 10 minutes. Sixty-six percent had abnormal 
arterial or venous cord blood gases (defined as pH of ≤7.0 and/or base excess of ≤−12mmol/l and/
or lactate of ≥6mmol/l), and a further 12 percent who had no gas result had an Apgar score of ≤6 at 
one minute. These data indicate the majority of babies diagnosed with moderate and severe NE have 
evidence of asphyxia at birth.
There was a statistically significant reduction in the proportion of babies without cord gases reported 
from 2010 (28%) to 2014 (15%) (chi-squared test for trend p=0.02), but the proportion without cord 
gases increased to 21 percent in 2015. In 2015, nine of the 15 babies who did not have a cord 
gas taken had an Apgar score of 8 or 9 at one minute, and therefore cord gas may not have been 
indicated. 
The practice of collection and review of umbilical cord bloods may vary by DHB. For reference, the 
Auckland DHB guideline on management of umbilical cord blood results is given below. 
Management of Umbilical Cord Blood Results 
Management of umbilical cord lactate results 
Cord lactates should be taken and processed within 10 minutes of cord clamping.
Management of umbilical cord gas results 
Umbilical cord gases can be analysed within one hour of birth if clamped immediately after delivery. 
Both umbilical cord arterial and venous gases should be analysed.
 
 (Auckland District Health Board 2017)
Umbilical cord lactate result Action
Less than 6.0  Document results
6.0 or above Send paired umbilical cord gases
Umbilical cord gas result Action
pH less than 7.0 or base excess less than or 
equal to −12 mmol/L Call paediatrician for review. 
pH 7.0–7.15 or base excess −11 to −7 mmol/L  
Or umbilical cord gas result not available and 
cord lactate greater than or equal to 6.0 mmol/L
Monitor baby for signs of neonatal 
encephalopathy (hypotonia, poor feeding, 
lethargy, weak or absent suck/gag or 
Moro reflex, seizures).  
Call paediatrician if any concerns. 
pH above 7.15 and base excess above −7 
mmol/L Document results. 
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Induced cooling
Table 6.6: Induced cooling therapy among neonatal encephalopathy babies 2010–2015
Cooling
2010 2011 2012 2013 2014 2015 Total
n=82 n=67 n=79 n=70 n=55 n=70 n=423
n % n % n % n % n % n % n %
Yes  56  68.3  51  76.1  62  78.5  58  82.9  45  81.8  56  80.0  328  77.5 
No  26  31.7  16  23.9  17  21.5  12  17.1  10  18.2  14  20.0  95  22.5 
Age at cooling  n=56  n=51  n=62  n=58  n=45  n=56  n=328 
≤6 hours  46  82.1  39  76.5  53  85.5  47  81.0  39  86.7  44  78.6  268  81.7 
>6 hours  10  17.9  8  15.7  9  14.5  11  19.0  6  13.3  11  19.6  55  16.8 
Unknown time  -  -  4  7.8  -  -  -  -  -  -  1  1.8  5  1.5 
Induced cooling has been shown to reduce mortality by 25 percent and neurodevelopmental disability 
in survivors of NE by 23 percent (Jacobs et al 2013).
In 2015, 80 percent of babies born in New Zealand with moderate or severe NE were treated 
with induced cooling. The proportion of those cooled who were cooled within six hours of birth as 
recommended for maximal benefit was 79 percent. There has been little change in this rate over the 
years of data collection.
In the dataset from 2011 to 2014 (four years) 54 neonates were reported as not receiving full body 
cooling for NE. Twenty-two of these have been diagnosed with severe NE (grade III) and 32 with 
moderate NE (grade II). Eighteen out of the 22 severe NE cases died, and one of the moderate group.
Upon reviewing these cases, it seemed 20 of the 22 severe case infants were appropriately not 
cooled, reasons including early neonatal death, withdrawal of care, disseminated infection, and one 
late presentation with seizures on day 2. In only two severe cases cooling could have possibly been 
initiated; one infant was transferred to level 3 at 12h, the other developed seizures at 4h of age with 
normal cord gases.
In the moderate group it was determined that 23 were appropriately not cooled, reasons ranging 
from late presentations, to NE not related to hypoxic ischemic encephalopathy (HIE), and one case 
was considered but did not proceed to cooling. Of the remaining nine infants, cooling may have 
been indicated, as low pH on cord gases and earlier consultation could have prompted a transfer to a 
tertiary unit. 
This review will lead to an addition to the dataset asking for ‘reason not cooled’.
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Neonatal resuscitation
Table 6.7: Neonatal resuscitation and early neonatal management by Sarnat stage among neonatal 





n  % n % n %
Resuscitation at birth
Yes  387  91.5  266  90.8  121  93.1 
No  36  8.5  27  9.2  9  6.9 
Type of resuscitation at birth
Oxygen only  5  1.2  4  1.4  1  0.8 
IPPV with mask  268  63.4  191  65.2  77  59.2 
IPPV with ETT  233  55.1  141  48.1  92  70.8 
Cardiac massage  166  39.2  88  30.0  78  60.0 
Adrenaline  74  17.5  25  8.5  49  37.7 
Respiratory and ventilation management
Mechanical ventilation  339  80.1  223  76.1  116  89.2 
Nitric oxide  94  22.2  61  20.8  33  25.4 
Infection
Positive blood culture  16  3.8  11  3.8  5  3.8 
Antibiotics  386  91.3  275  93.9  111  85.4 
Anticonvulsant therapy  300  70.9  201  68.6  99  76.2 
Phenobarbitone  276  65.2  179  61.1  97  74.6 
Phenytoin  82  19.4  39  13.3  43  33.1 
Benzodiazepines  102  24.1  62  21.2  40  30.8 
Other  32  7.6  23  7.8  9  6.9 
IPPV = intermittent positive pressure ventilation.
ETT = endotracheal tube.
Table 6.7 (along with Table 6.5) further illustrates the poor condition of many babies who develop 
NE at birth. Among the cohort of 423 NE babies from 2010–2015, 92 percent were resuscitated at 
birth, 39 percent required cardiac massage, 17.5 percent adrenalin, and 55 percent intubation and 
intermittent positive pressure ventilation. 
In the dataset from 2011 to 2014 (four years), 18 neonates were reported as not receiving 
resuscitation at birth. Sixteen of these were reported as moderate and two as severe NE/HIE. 
On reviewing these cases, it seemed that in 10 cases, although there was no apparent need for 
resuscitation at birth, NE/HIE was recognised on clinical grounds/cord pH, and two of these neonates 
received body cooling. Other reasons for no resuscitation at birth were later presentation with 
parechovirus encephalitis (day 7), Streptococcus A sepsis day 2, inborn error of metabolism day 5, and 
four vascular events which would not have benefitted from earlier recognition and/or body cooling. 
One baby was retrospectively diagnosed with moderate HIE (on MRI) after developing seizures at 32h, 
and it remains unclear whether earlier recognition was possible.
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Table 6.8: Use of cooling and outcomes of encephalopathy by Sarnat stage among neonatal 
encephalopathy babies 2010–2015
Sarnat stage
NE babies Moderate Severe
n=423 n=293 n=130
n % n % n %
Induced cooling
Yes  328  77.5  236  72.0  92  28.0 
No  95  22.5  57  60.0  38  40.0 
Deceased
Yes  82  19.4  5  6.1  77  93.9 
No  341  80.6  288  84.5  53  15.5 
Babies with severe NE were significantly less likely to receive induced cooling (71 percent compared to 
81 percent; p=0.03). This is presumably because many of the severe babies are considered too unwell 
for cooling and are represented among the excess mortality in this group (59 percent compared to 2 
percent). Of the 80 babies with NE who died within the perinatal period, 18 (22 percent) died within 
the first day, 60 (74 percent) within the first three days, and 72 (89 percent) died within the first week 
of birth. A further eight babies died after one week but within four weeks of birth, and two babies died 
in the post-neonatal period (five and six weeks). As of the year ended December 2015, a further nine 
babies died after discharge from three months to five years of age.































Table 6.9: Investigations and neonatal outcome by Sarnat stage of neonatal encephalopathy survivors 2010–2015 
Investigations
2010 2011 2012 2013 2014 2015 Total NE survivors
Sarnat stage
Moderate Severe
n=59 n=54 n=67 n=59 n=44 n=58 n=341 n=288 n=53
n % n % n % n % n % n % n % n % n %
Examination on discharge/transfer
Normal  32  54.2  25  46.3  30  44.8  24  40.7  17  38.6  29.0  50.0  157  46.0  149  51.7  8  15.1 
Mild or moderate abnormality  14  23.7  20  37.0  19  28.4  23  39.0  17  38.6  14.0  24.1  107  31.4  88  30.6  19  35.8 
Severe abnormality  3  5.1  1  1.9  5  7.5  5  8.5  3  6.8  4.0  6.9  21  6.2  3  1.0  18  34.0 
Not examined  1  1.7  4  7.4  7  10.4  5  8.5  2  4.5  3.0  5.2  22  6.5  19  6.6  3  5.7 
Examined but finding unknown  3  5.1  1  1.9  5  7.5  2  3.4  2  4.5  2.0  3.4  15  4.4  11  3.8  4  7.5 
Missing data  6  10.2  3  5.6  1  1.5  -  -  3  6.8  6.0  10.3  19  5.6  18  6.3  1  1.9 
EEG investigation done at ≤3 days of life*  40  67.8  25  46.3  34  50.7  50  84.7  40  90.9  51.0  87.9  240  70.4  198  68.8  42  79.2 
MRI (investigation done)  41  69.5  35  64.8  43  64.2  50  84.7  38  86.4  48.0  82.8  255  74.8  203  70.5  52  98.1 
No MRI or Unknown  18  30.5  19  35.2  24  35.8  9  15.3  6  13.6  10.0  17.2  86  25.2  85  29.5  1  1.9 
Results of MRI 
Moderately/Severely abnormal  16  27.1  11  20.4  17  25.4  22  37.3  13  29.5  15.0  25.9  94  27.6  59  20.5  35  66.0 
Normal or only mildly abnormal  24  40.7  23  42.6  24  35.8  27  45.8  25  56.8  33.0  56.9  156  45.7  140  48.6  16  30.2 
Unknown result  1  1.7  1  1.9  2  3.0  1  1.7  -  -  -  -  5  1.5  4  1.4  1  1.9 
* Typically cot-side monitoring such as BrainZ.
EEG = electroencephalogram.
MRI = magnetic resonance imaging (of the brain).
There has been an increase in the proportion of surviving babies who had an MRI investigation since collection of NE data began, from 70 
percent in 2010 to 86 percent in 2014 (83 percent in 2015). 
Of survivors during 2010–2015, 28 percent had a moderately or severely abnormal MRI (21 percent of moderate and 66 percent of severe 
cases) and 46 percent had a normal or only mildly abnormal scan (49 percent of moderate and 30 percent of severe cases). Twenty-five 
percent of survivors during 2010–2015 did not have an MRI (30 percent of moderate and 2 percent of severe cases).  
Investigations and neonatal outcome by Sarnat stage (survivors)
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2016 Survey of DHBs and Discharge Examination for Babies Diagnosed with Neonatal 
Encephalopathy
In 2016 Clinical Directors of Neonatal Intensive Care and Special Care Baby Units were asked to 
provide details of discharge examination for babies diagnosed with NE.
This included:
• which tool, if any, was used for the discharge examination for babies diagnosed with NE 
• if a formal tool was not used for the discharge examination for babies diagnosed with NE, 
whether they had considered using a formal tool (such as the Dubowitz examination)
• what they thought were the barriers to using a formal tool for the discharge examination
• details of where the result of examination was documented. 
All six Level 3 Units advised that they use a formal tool to assist with the discharge examination for 
babies diagnosed with NE, either the Dubowitz examination or a modification of this. The practice 
was less consistent in the Level 2 Units. The barriers identified to the use of a formal tool included 
training in the use of the tool and interpretation of the findings given small numbers of babies 
diagnosed with NE in their DHBs.
Previous Recommendation (Seventh Report (PMMRC 2013))
In cases of neonatal encephalopathy (Sarnat stages 2 and 3): 
All babies with encephalopathy should undergo investigation to predict prognosis, including formal 
neurological examination, cerebral magnetic resonance imaging (MRI) and, if available, formal 
electroencephalography (EEG)
All parents of an affected child should have a formal discussion with the neonatologist/paediatrician 
providing care in order to review the prognosis and ongoing care of their child.
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6.3 Neonatal Encephalopathy Appended Tables
Table 6.10: Neonatal encephalopathy rates (per 1000 term births) by prioritised maternal ethnicity, 
maternal age and deprivation quintile 2010–2015
NZ registered births 




n % n % /1000 95% CI
Maternal ethnicity
Māori  84,321  24.8  111 26.2  1.32 1.07–1.56
Pacific peoples  37,362  11.0  66 15.6  1.77 1.37–2.25
Indian  13,689  4.0  21 5.0  1.53 0.95–2.35
Other Asian  32,213  9.5  29 6.9  0.90 0.60–1.29
Other (including unknown)  40,148  11.8  30 7.1  0.75 0.50–1.07
NZ European  132,048  38.9  166 39.2  1.26 1.07–1.45
Maternal age (years)
<20  19,795  5.8  28  6.6  1.41 0.94–2.04
20–34  248,554  73.2  316  74.7  1.27 1.13–1.41
35–39  57,495  16.9  63  14.9  1.10 0.84–1.40
≥40  13,931  4.1  16  3.8  1.15 0.66–1.87
Unknown  6  0.0 
Deprivation quintile
1 (least deprived)  47,980  14.1  44  10.4  0.92 0.67–1.23
2  52,482  15.4  69  16.3  1.31 1.02–1.66
3  62,378  18.4  89  21.0  1.43 1.15–1.76
4  78,121  23.0  78  18.4  1.00 0.79–1.25
5 (most deprived)  96,665  28.4  142  33.6  1.47 1.23–1.71
Unknown  2,155  0.6  1  0.2  - -
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n=339,781 n=82 n=67 n=79 n=70 n=55 n=70 n=423
n n n n n n n n /1000 95% CI
Northland  12,562  2  2  2  1  1  1  9  0.72 0.33–1.36
Waitemata  43,822  10  6  4  5  9  4  38  0.87 0.61–1.19
Auckland  35,869  4  8  4  8  5  6  35  0.98 0.68–1.36
Counties Manukau  47,137  14  11  14  6  5  4  54  1.15 0.86–1.49
Waikato  29,890  14  9  9  5  6  12  55  1.84 1.39–2.40
Bay of Plenty  16,000  3  4  2  3  1  6  19  1.19 0.71–1.85
Lakes  8,438  2  4  2  1  1  2  12  1.42 0.73–2.48
Tairawhiti  4,067  1  2  2  1  1  -  7  1.72 0.69–3.55
Taranaki  8,623  2  -  6  5  4  4  21  2.44 1.51–3.72
Hawke’s Bay  12,006  2  1  3  2  3  3  14  1.17 0.64–1.96
Whanganui  4,686  1  -  2  1  -  1  5  1.07 0.35–2.49
MidCentral  12,099  2  1  2  3  2  4  14  1.16 0.63–1.94
Wairarapa  2,830  1  -  -  -  1  -  2  0.71 0.09–2.55
Capital & Coast  20,716  6  4  9  10  3  7  39  1.88 1.34–2.57
Hutt Valley  11,048  4  4  2  5  2  -  17  1.54 0.90–2.46
Nelson and Marlborough  8,682  -  1  2  5  1  2  11  1.27 0.63–2.27
West Coast  2,111  -  1  2  -  2  -  5  2.37 0.77–5.53
Canterbury  34,042  11  6  7  2  6  6  38  1.12 0.79–1.53
South Canterbury  3,621  1  2  2  1  -  3  9  2.49 1.14–4.72
Southern  19,574  2  1  3  6  2  5  19  0.97 0.58–1.52
Other  1,958  -  -  -  -  -  -  -  - -
* Other includes Overseas, Unknown and Other.
Table 6.12: Actual and intended place of birth among neonatal encephalopathy cases 2010–2015
Intended place of 
birth
NE cases Actual place of birth





n % n % n % n % n % n % n %
Home  15  3.5  8  53.3  -  -  -  -  5  33.3  2  13.3  -  - 
Birthing unit  55  13.0  1  1.8  22  40.0  -  -  7  12.7  25  45.5  -  - 
Hospital level 1  22  5.2  -  -  -  -  7  31.8  3  13.6  12  54.5  -  - 
Hospital level 2  165  39.0  1  0.6  -  -  2  1.2  156  94.5  5  3.0  1  0.6 
Hospital level 3  160  37.8  1  0.6  -  -  1  0.6  1  0.6  157  98.1  -  - 
Unknown  6  1.4  -  -  -  -  -  -  2  33.3  4  66.7  -  - 
Total  423  11  2.6  22  5.2  10  2.4  174  41.1  205  48.5  1  0.2 
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7 Maternal Morbidity
The Symbolism of the Harakeke in Our Logo and Publications
We have a woven harakeke (flax) in our logo and along the side of our publications. The beauty 
of the harakeke is reflected in its symbolism and versatility. As a plant, it represents whānau, with 
the child at the centre. In its woven form, it reflects the strengthening of the whole through the 
overlaying weave. We chose the harakeke as our logo to acknowledge that by weaving women’s 
experiences and review processes together, we will gain a greater understanding of how the 
maternity system can be strengthened and improved.
7.1 Introduction
A Maternal Morbidity Working Group (MMWG) was established in May 2016, as a working group 
of the PMMRC, responsible for reviewing maternal morbidity and developing recommendations and 
quality improvement initiatives to help reduce maternal morbidity in New Zealand. This chapter serves 
as the first annual report of the MMWG, and explains the importance of learning from maternal 
morbidity, progress so far, and plans for the future.
Severe acute maternal morbidity (also known as maternal ‘near miss’) can be defined as ‘a very ill 
pregnant or recently delivered woman who would have died had it not been luck or good care was on 
her side’ (Mantel et al 1998). 
The PMMRC and other researchers (O’Malley et al 2016) use maternal death statistics and birth 
outcome records to measure the quality of maternity care. As maternity care has improved, the number 
of maternal deaths has decreased, and severe acute maternal morbidity has become another measure 
of the quality of maternity care in New Zealand (Lawton et al 2014; MacDonald et al 2016; Ministry 
of Health 2016; Sadler et al 2013) and in other developed countries (Say et al 2004). By reviewing 
cases of severe acute maternal morbidity, we can explore how our health system responds to women 
with serious and acute conditions, and identify potential improvements in maternity care.
To date, the largest audit of severe maternal morbidity in New Zealand is the Severe Acute Maternal 
Morbidity (SAMM) audit, run by the University of Otago and funded by the Ministry of Health. In this 
audit, clinicians met to review cases of severe maternal morbidity, defined as admission of a pregnant 
or postpartum woman to an intensive care unit, and determine whether the severe morbidity was 
potentially avoidable. The audit was external and multidisciplinary. In 2011, after a pilot at one DHB, 
the audit was extended to four DHBs, and then in 2013 introduced to all 20 DHBs (MacDonald et al 
2016).
The results of the SAMM audit across the 20 DHBs are not yet published. The pilot within four DHBs 
(Lawton et al 2014) of 98 cases found 39 percent were identified as potentially avoidable and 37 
percent as not avoidable but improvements in care were needed. The most common factors among 
potentially avoidable cases were related to clinical care: 71 percent of cases delayed or inappropriate 
treatment and 52 percent delayed or failure to diagnose or recognise high-risk status. The most common 
conditions were major postpartum haemorrhage (45 percent) and sepsis (17 percent), and 75 and 47 
percent of these were potentially avoidable or needed improvement in care respectively.
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An internal multidisciplinary review undertaken at Auckland DHB of two years of intensive care 
admissions of pregnant women and women in the postpartum period found similar results to the SAMM 
audit (Sadler et al 2013). Forty-eight percent of cases were identified as potentially avoidable, and 
contributory factors were found in a further 23 percent. The most common factor identified among 
potentially avoidable cases was lack of recognition of the complexity or seriousness of a condition by a 
caregiver (45 percent of cases). The most common conditions in potentially avoidable cases were again 
blood loss (27 percent of potentially avoidable cases) and sepsis (23 percent), which were two of the 
three most common reasons for admission to intensive care.
The role of the Maternal Morbidity Working Group
In March 2015, the Minister of Health announced that the SAMM audit would transition from its 
nascence as a research project to become a national review under the auspices of the Health Quality 
& Safety Commission (the Commission). The new programme transitioned to the Commission on 30 
June 2016 as a working group of the PMMRC, incorporating the previous Australasian Maternity 
Obstetric Surveillance System (AMOSS) working group, and is funded until 30 June 2019. To provide 
governance for the programme, the MMWG was established comprising clinicians and consumers in 
the maternity sector. The terms of reference and membership can be found on the PMMRC web page 
(http://www.hqsc.govt.nz/our-programmes/mrc/pmmrc/maternal-morbidity-and-mortality-information/
mmwg/).
The MMWG vision is ‘better maternity outcomes for New Zealand women’ and its aim is ‘to improve 
the quality and experience of maternity care for women, babies and whānau, informed by robust, 
consistent, reportable and women-centred maternal morbidity review’. 
To achieve this aim, the MMWG plans to:
• systematically review cases of severe maternal morbidity to identify ‘potentially avoidable factors’ 
and opportunities to improve care
• develop system-level recommendations, in collaboration with the sector, from the findings of these 
reviews
• develop and implement quality improvement initiatives, in collaboration with the sector, based on 
the recommendations.
The MMWG will collaborate with the national organisations who work to improve the care of pregnant 
women to ensure that their work streams are aligned.
MMWG activities in 2016
Since its establishment in May 2016, the MMWG has:
• developed and evaluated a methodology to review cases of severe maternal morbidity
• sought nominations and appointed members to multidisciplinary regional review panels, including 
consumers
• developed the terms of reference for these panels (available at http://www.hqsc.govt.nz/our-
programmes/mrc/pmmrc/maternal-morbidity-and-mortality-information/mmwg/) 
• added a section to the PMMRC website dedicated to introducing the MMWG’s work, and 
providing resources and information for clinicians and consumers
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• developed a process for women who have experienced severe maternal morbidity to share their 
experience, which will inform the review panels
• conducted a stocktake to identify the strengths of local review of severe maternal morbidity cases 
in DHBs
• visited DHBs to discuss maternal morbidity and the work programme, which has strengthened the 
relationship between maternity and critical care services.
7.2 Reviews of Serious Acute Maternal Morbidity
Guiding principles of reviews
In developing a methodology for reviewing severe maternal morbidity, the MMWG identified four 
guiding principles. Maternal morbidity reviews will:
• focus on systems and processes (ie, not review individual clinicians or assign blame)
• identify aspects of systems or processes that could potentially have avoided or lessened the 
severity of the morbidity
• include the wider context (be woman-centred) and include information from all care providers and 
the experience of the woman and her whānau (if provided)
• ‘close the loop’ and identify opportunities for quality improvement in the maternity sector.
Defining and identifying cases
There are a number of different ways to identify cases, including resource-intensive audits of clinical 
records, analysis of administrative health data (Say et al 2004), queries of clinical databases, and 
negative reporting by individual clinicians as used by AMOSS in Australia and New Zealand in recent 
years.
The previous SAMM audit in New Zealand selected a proportion of maternity admissions to intensive 
care units (ICUs) and high dependency units (HDUs) for panel review (Lawton et al 2014). Previous 
research has shown that nearly all maternity ICU admissions are cases of severe morbidity (ie, high 
specificity) and make up more than three quarters of all severe acute maternal morbidity (ie, high 
sensitivity) (Geller et al 2004; You et al 2012).
ICUs and HDUs (including HDU-level units in maternity services) in New Zealand notify the MMWG 
whenever a pregnant or recently pregnant woman is admitted to their unit. The MMWG received 
121 notifications of admissions between September 2016 and December 2016, comparable to the 
number received in the SAMM audit in a similar period. Notifications include demographics, reason for 
admission, and treatment received. 
Instead of selecting a proportion of cases for panel review, cases will be selected based on specific 
criteria, which will be reconsidered each year based on trends in maternal morbidity and feedback 
from the maternity sector. The conditions from 2016 for review are severe maternal sepsis and 
unplanned peripartum hysterectomy.
Severe maternal sepsis is caused by the body’s reaction to infection (eg, pneumonia or urinary tract 
infection). We estimate that there could be up to 50 cases per year in New Zealand that meet our 
criteria for severe sepsis (Lawton et al 2014; Ministry of Health 2016). Sepsis is a focus for two 
reasons. First, the SAMM audit found that 24 percent of severe sepsis cases were potentially avoidable 
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(Lawton et al 2014). Second, less is known about the avoidable factors in severe maternal sepsis 
compared to other conditions like postpartum haemorrhage.
Peripartum hysterectomy is a surgical operation that removes a woman’s uterus. It is a procedure used 
when a woman has massive bleeding during birth, and is a last-resort, life-saving operation. Sometimes 
hysterectomies are ‘planned’, if it is identified that a woman has a pre-existing complication that puts 
her at high risk of uncontrollable bleeding. There are approximately 30 peripartum hysterectomies in 
New Zealand each year (note that it is not possible to differentiate between planned and unplanned 
with national inpatient data) (Ministry of Health 2016). The focus is on unplanned peripartum 
hysterectomy because of its severity. In some situations, peripartum hysterectomy may be prevented by 
earlier identification of pre-existing complications, or earlier detection of a woman’s deterioration. 
Information included in the review
Information from care providers
Once a case is selected for review, the LMC, GP and hospital are contacted for copies of the clinical 
notes. DHBs are also asked to provide a copy of their local review of the case (eg, root cause analysis). 
Additionally, any organisational information that may have affected the woman’s care is requested (eg, 
staffing levels).
Including the consumer in our reviews
The MMWG values the woman’s (consumer’s) voice in our reviews, as she provides the context of her 
pregnancy and the care that she received. 
A process has been developed to include the woman’s story in the reviews. Women whose cases are 
selected for review will be approached in a sensitive and appropriate way, and offered the opportunity 
to tell us about their experience. Women can withdraw from the process at any time. The women will 
not be identifiable outside of the panel review process. To ensure anonymity, their experiences will be 
combined into ‘composite stories’ in the next annual report. 
Written material has been developed for women whose cases are selected for review. This will be 
distributed to ICUs and HDUs and is available on the Commission’s website in English, te reo Māori 
and Samoan. This includes information for women on ‘Sharing your story about being very unwell 
while pregnant’. These are available at: http://www.hqsc.govt.nz/our-programmes/mrc/pmmrc/
publications-and-resources/publication/2833/.
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Figure 7.1: Summary diagram of MMWG review methodology
Panel reviews
The review process builds on the previous SAMM audit with four maternal morbidity review panels 
to cover the Northern, Midland, Central and South Island regions. Nominations were sought for 
panel members from professional colleges, DHBs, previous SAMM panel members, and through the 
Commission’s website. The panels are multi-disciplinary and include midwives, obstetricians, intensivists, 
GPs, and consumers. Each panel has at least one member with an understanding of Māori health. 
The panels review cases using a modified version of the PMMRC’s review tool. This tool is based on 
the London Protocol (Vincent and Amalberti 2016) and includes barriers to access and/or engagement 
with care factors, personnel factors, and organisational and/or management factors that may have 
affected care. (See the ‘Contributory Factors for Mortality and Morbidity’ on page 78.) The panels 
consider all of these factors to determine if the severity of the morbidity was potentially avoidable.
To ensure that the panel review process is consistent, all panel meetings will be co-chaired by the 
Maternity Specialist at the Commission. To ensure that the panel findings are consistent, a small number 
of cases will be reviewed by all of the panels, and the panels’ findings compared.
Woman admitted to ICU or HDU
ICU/HDU notifies the Health Quality & Safety Commission and provides basic clinical information
Cases are checked to ensure that they meet the MMWG’s review criteria 
(for 2016, the criteria are sepsis and unplanned peripartum hysterectomy)
Case notes are requested from hospitals, LMCs and GPs
Cases are distributed to regional panels so that no region reviews its own case
A small number of cases are distributed to at least two panels to audit the findings and ensure that they are consistent
For each case, regional panels identify potentially avoidable system factors in care
The MMWG reviews the findings from the regional panels
 Included in the annual report    Used to make system-level recommendations and  
       inform quality improvement
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Review findings will be used to develop recommendations and quality improvement initiatives, in 
collaboration with other national maternity groups and the maternity sector. Recommendations will be 
evidence-based and implementable.
7.3 Future Work
Improving local reviews and increasing sector capability
In October 2016, a survey was sent to stakeholders in the maternity sector asking about the current 
state of local reviews of maternal morbidity, their strengths, and support or changes that could improve 
them. The 68 responses to the survey will be used to assist DHBs and other health organisations to 
improve local review. 
The regional review panels will contribute to capability in the sector. Regional panel members will be 
champions of review and quality improvement in their local DHBs. There are also five professional 
development positions on the panels, which were offered to clinicians who were identified as future 
leaders, but who were relatively early in their careers and did not score highly enough to otherwise be 
selected for the panel. 
Measuring maternal morbidity in New Zealand
It is expected that over time there will be a decrease in the rates of severe maternal morbidity, but 
determining a reduction in the rates will be difficult as there is currently no consistent collection of severe 
maternal morbidity data across New Zealand. 
At present, severe maternal morbidity is measured through manual notifications of maternal admissions 
to ICUs and HDUs. The MMWG’s work in this area may increase engagement and therefore increase 
the number of manual notifications. The MMWG is exploring ways of using existing administrative 
datasets to reduce reliance on manual notifications into the future. 
Continuing to work with the maternity sector
We would like to thank everyone who has provided input into our programme so far. Your active 
engagement has helped us to develop the maternal morbidity review methodology and to guide our 
thinking for future collaborative work. We look forward to continuing to work together to improve the 
quality and experience of maternity care for women, babies and whānau.
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Appendix A: Summary of Key PMMRC Recommendations 
and Progress 2006–2013 Data
Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
Perinatal mortality
Methodology
As a matter of urgency, the Ministry of Health update the National 
Maternity Collection (MAT), including the ethnicity data as 
identified by the parents in the birth registration process.
The dataset has been made available to the PMMRC from 2014. 
However, we acknowledge that the dataset still does not include 
registration data from all DHBs that are providing primary maternity 
care. 
Update 2017 
The Ministry of Health is working towards a solution for including 
registration ethnicity data in the MAT dataset, and it is anticipated this 
will be completed in 2017. 
Ethnicity
Clinicians and LMCs should be encouraged to collect accurate 
ethnicity details at the time of booking.
The Primary Care Ethnicity Data Audit Toolkit has been produced 
and was implemented June 2015. See http://www.health.govt.nz/
publication/primary-care-ethnicity-data-audit-toolkit 
Update 2017
The Maternity Clinical Information System was intended to assist 
clinicians and LMCs to collect accurate standardised data, including 
ethnicity. The roll out of the Maternity Clinical Information System 
in DHBs has been problematic. A governance group is considering 
what shape this will take in the future.
Disparities
There is a need to recognise the independent impact of 
socioeconomic deprivation on perinatal death, specifically 
on preterm birth, which after congenital abnormality is the 
leading cause of perinatal death. Addressing the impact 
of poverty requires wider societal commitment as has been 
highlighted in the recent health select committee report on 
improving child health outcomes. The PMMRC supports the 
implementation of the recommendations. This report can be 
found at: http://www.parliament.nz/resource/en-nz/50DBSCH_
SCR6007_1/3fe7522067fdab6c601fb31fe0fd24eb6befae4a
There are a number of cross-agency initiatives that are underway to 
respond to, and reduce, the impact of socioeconomic deprivation on 
perinatal death and child health. These include: 
• The Healthy Families New Zealand Initiative. See http://
www.health.govt.nz/our-work/preventative-health-wellness/
healthy-families-nz 
• The Child Poverty Monitor. This was first published in 2013 
and provides data on a set of indicators that assess aspects 
of child poverty in New Zealand and their implications 
for child wellbeing. It is supported by the Office of the 
Children’s Commissioner, Child and Youth Epidemiology 
Service (University of Otago), and the JR McKenzie Trust. 
See http://www.nzchildren.co.nz/
• The Vulnerable Children Act 2014. On 1 July 2014 the 
Vulnerable Children Act was passed into law. The Act is a 
significant part of a range of comprehensive measures to 
protect and improve the wellbeing of vulnerable children 
and strengthen the child protection system. The chief 
executives of five government agencies are accountable for 
acting together to develop and implement a plan to protect 
our children from harm, working with families, whānau and 
communities.
• The Children’s Action Plan. The Children’s Action Plan 
operationalises the Vulnerable Children Act. Children’s 
teams have been set up across the country to work with 
vulnerable children, and across a range of local iwi and 
Māori, health, education, welfare and social organisations.
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
• Social Sector Trials. These have been established to test 
innovative ideas to improve social, health and educational 
outcomes in communities around New Zealand. One of the 
trials has a specific health focus. See http://www.health.
govt.nz/our-work/preventative-health-wellness/social-sector-
trials 
• Well Child/Tamariki Ora. The Ministry of Health is 
investigating how to more effectively integrate the Well 
Child/Tamariki Ora programme and GP practice services 
to be more attractive and responsive to women and families 
who are socially deprived or have socially complex needs.
Possible causes for the increase in perinatal related death of babies 
born to Pacific women, Māori women, women under the age of 
20 or over the age of 40 and women who live in areas of high 
socioeconomic deprivation should be researched. This information 
is necessary in order to develop appropriate strategies to reduce 
these possibly preventable deaths.
The Ministry of Health expects that perinatal mortality will be 
annually reviewed as part of the local maternity quality and safety 
programmes. Findings from the review process will assist DHBs and 
the wider maternity sector to identify and address local issues and 
risk factors.
Further research is warranted to understand the higher rate of 
perinatal related mortality in the Counties Manukau region.
An independent review of perinatal mortality in their region was 
commissioned by Counties Manukau DHB in late 2012. The 
recommendations from this review are being implemented in an 





The Ministry of Health, DHBs and professional colleges should 
collaboratively explore barriers to early booking with a view to 
increase the number of women who book with an LMC before 10 
weeks gestation. A national media campaign should be considered.
All DHBs are aware of the need to take actions that will increase the 
number of women who book before 10 weeks gestation. Barriers to 
early booking are being investigated and actions will be embedded 
in each respective DHB Maternal Quality and Safety Programme. 
Many DHBs are promoting media and social media campaigns 
such as the ‘Find Your Midwife’ website, which supports women 
to find and book with an LMC. See the following website for more 
information: www.findyourmidwife.co.nz 
The regional programme ‘5 Things to Do in the First 10 Weeks’ 
has been effective and widely supported. Key messages from this 
campaign are to: 
• engage early with an LMC 
• take folic acid and iodine
• make decisions about screening tests
• eat well and be active 
• avoid alcohol, recreational drugs and smoking.
The Ministry of Health advises that media campaigns and initiatives 
should be targeted at local level for best results.
Strategies to improve awareness of antenatal care services and 
increase access among women who are isolated for social, cultural 
or language reasons should be developed.
Some initiatives have been developed to improve access to 
antenatal care services for women who are isolated for social, 
cultural or language reasons. These include:
• The Language Line. See http://ethniccommunities.govt.nz/
story/using-language-line
• The TAHA Well Pacific Mother & Infant Service, which 
launched a smart phone application that provides 
information on pregnancy and parenting. See www.
tapuaki.org.nz
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
Perinatal mortality
That all maternity care providers identify women with modifiable 
risk factors for perinatal related death and work individually and 
collectively to address these.
Strategies to address modifiable risk factors include:
a. improving uptake of periconceptual folate
b. pre-pregnancy care for known medical disease such as 
diabetes
c. access to antenatal care
d. accurate height and weight measurement in pregnancy 
with advice on ideal weight gain
e. prevention and appropriate management of multiple 
pregnancy
f. smoking cessation
g. antenatal recognition and management of fetal growth 
restriction
h. prevention of preterm birth and management of threatened 
preterm labour
i. following evidence-based recommendations for indications 
for induction of labour
j. advice to women and appropriate management of 
decreased fetal movements.
All DHBs should report the availability and uptake of relevant 
services in their annual clinical report to ensure that these strategies 
are embedded and to identify areas for improvements.
DHBs are implementing strategies to address modifiable risk factors, 
and the Ministry of Health will also require DHBs to report on these 
strategies in their annual Maternity Quality and Safety Programme 
reports.
DHB strategies include early screening and encouraging women to: 
• engage early with an LMC 
• take folic acid and iodine 
• eat well and be active 
• avoid alcohol, recreational drugs and smoking.
Examples of DHB programmes include ‘5 Things to Do in the First 
10 Weeks’ and ‘As Soon As Pregnant (ASAP)’, which both promote 
the importance of:
• booking with a midwife as soon as you are pregnant 
• avoiding smoking, alcohol and recreational drugs 
• taking folic acid and iodine
• making a decision about screening tests
• eating well and staying active.





The ‘Healthy Babies, Healthy Futures’ programme provides 
ethnically specific workshops, text messaging and support for new 
mothers, pregnant women and their families. 
Some DHBs have established a GP liaison role within the hospital, 
which encourages pre-pregnancy and first trimester primary care. 
A pregnancy information pack has been developed to give to 
women at their first presentation to any health professional. This 
pack contains information about a wide variety of pregnancy issues, 
including folate, smoking, diet and immunisation. 
Offer education to all clinicians so they are proficient at screening 




c. alcohol and other substance use.
Family violence. All DHBs have measures in place for screening 
of family violence when women are admitted to hospital. They 
offer regular education sessions and training workshops to 
midwives and clinicians to help them identify, screen and refer 
women experiencing family violence. The shaken baby prevention 
programme has also been rolled out at a number of DHBs.
The Violence Inervention Programme supports health sector family 
violence programmes throughout New Zealand. See http://www.
health.govt.nz/our-work/preventative-health-wellness/family-violence
The PMMRC will be collaborating with the Family Violence Death 
Review Committee to further identify strategies to improve screening 
for family violence in the maternity setting.
Smoking. Smoking cessation programmes are a national health 
priority. The Ministry of Health, DHBs and a wide range of non-
governmental organisations have made significant progress on 
leading New Zealand towards being smokefree by 2025. 




Alcohol and other substance use. DHBs offer regular education 
sessions and training workshops to midwives and clinicians to help 
them identify, screen and refer women with alcohol and substance 
use.
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
That multi-disciplinary fetal surveillance training be mandatory for 
all clinicians involved in intrapartum care.
a. This training includes risk assessment for mothers and 
babies throughout pregnancy as well as intrapartum 
observations.
b. The aims include strengthening of supervision and support 
to promote professional judgement, interdisciplinary 
conversations and reflective practice.
Some DHBs reported that mandatory attendance at multi-disciplinary 
fetal surveillance training was required for all core staff. Other DHBs 
have responded that multi-disciplinary fetal surveillance training is 
occurring but is not compulsory.
LMCs and obstetric staff are encouraged to attend/undertake the 
online programme or workshop.
Other initiatives include education meetings where cardiotocograph 
(CTG) recordings from emergency caesareans or abnormal CTGs 
are reviewed as part of reflective practice, and all staff who provide 
intrapartum care are encouraged to undertake a ‘fresh eyes’ 
approach to CTG interpretation.
There is observational evidence that improved detection of fetal 
growth restriction, accompanied by timely delivery, reduces 
perinatal morbidity and mortality. The PMMRC recommends 
(amended from previous PMMRC reports) that assessment of fetal 
growth should incorporate a range of strategies including:
a. assessment and appropriate referral for risk factors for fetal 
growth restriction at first antenatal visit and throughout 
pregnancy 
b. accurate measurement of maternal height and weight at first 
antenatal assessment
c. ongoing assessment of fetal growth by measuring fundal-
symphysial height in a standardised way, recorded at each 
antenatal appointment, preferably by the same person
d. plotting of fundal height on a tool for detection of fetal 
growth restriction, such as a customised growth chart, from 
26 weeks gestation
e. if fetal growth restriction is confirmed by ultrasound, 
appropriate referral and assessment of fetal and maternal 
wellbeing and timely delivery are recommended. The 
New Zealand Maternal Fetal Medicine guideline (2013) 
describes criteria for the management of small for 
gestational age (SGA) pregnancies after 34 weeks.
The PMMRC supports the Ministry of Health initiative to explore the 
evidence and validate the use of customised growth charts in New 
Zealand, and to investigate the appropriate way to incorporate 
these into the national maternity record.
Update 2017
The Growth Assessment Protocol (GAP) (based on GROW) from the 
UK Perinatal Institute is being progressed. The Perinatal Institute is 
making the GAP application freely available to clinicians; however, 
they need to be trained and accredited to use it. 
The Ministry of Health is working on ensuring funding is also 
available for evaluation of the GAP. 
Public health initiatives
A high body mass index (BMI) at booking is an independent risk 
factor for stillbirth. Public health initiatives to prevent obesity prior to 
pregnancy should be supported.
From 2015, the Ministry of Health will report high maternal BMI 
as one of the New Zealand Maternity Clinical Indicators. This is 
expected to support DHBs and maternity services to plan for the 
care of obese pregnant women, as well as identify DHBs that should 
prioritise strategies that support healthy weight gain in pregnancy. 
Other initiatives that support this recommendation include:
• Eating for Healthy Pregnant Women/Ngā Kai Totika mā 
te Wahine Hapū. This is a public health resource and was 
updated in 2014. See https://www.healthed.govt.nz/
resource/eating-healthy-pregnant-womenng%C4%81-kai-
totika-m%C4%81-te-wahine-hap%C5%AB 
• A Ministry of Health web page provides information about 
healthy weight gain during pregnancy and provides links 
to helpful resources. See http://www.health.govt.nz/your-
health/healthy-living/pregnancy/healthy-weight-gain-during-
pregnancy
• The Healthy Families NZ initiative. This initiative encourages 
families to live healthy lives – by making good food choices, 
being physically active, sustaining a healthy weight, being 
smokefree and drinking alcohol only in moderation. It 
is funded by the Ministry of Health and commenced in 
September 2014. See http://www.health.govt.nz/our-
work/preventative-health-wellness/healthy-families-nz
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
• Investment in workforce development. In July 2013 the 
government announced it is investing $2.28 million in 
a new workforce development programme for health 
professionals who care for pregnant women and babies. 
The training programme will be implemented by Gravida 
and aims to give frontline health workers the latest evidence-
based research into how pregnancy and early life events 




In order to reduce perinatal related mortality associated with 
multiple pregnancies, the following is advised. 
a. All women undergoing assisted reproduction be offered 
single embryo transfer. 
b. The use of clomiphene for fertility treatment requires 
monitoring of hormonal response with ultrasound to 
determine the number of follicles. 
c. LMCs note that the referral guidelines recommend transfer 
of clinical responsibility for care of all women with multiple 
pregnancies to obstetrician-led care. 
The recommendations have been promoted through the Ministry of 
Health’s Maternity Quality and Safety Programme.
Clomiphene is being replaced with other medications such as 
letrozole, which has a much lower risk of multiple pregnancy.
The Guidelines for Consultation with Obstetric and Related Medical 
Services (Referral Guidelines) list multiple pregnancies as a reason 
for transfer of clinical responsibility with a clear pathway for 
determining a plan of care that may or may not involve the LMC.
Audit of congenital abnormalities
All primary care providers (if first contact of a pregnant woman 
with the health service) should offer first trimester screening and 
facilitate expeditious registration.
The National Screening Unit offers online education for practitioners 
who provide services within the antenatal and newborn screening 
programmes. These can be accessed at: https://www.nsu.govt.nz/
health-professionals/antenatal-screening-down-syndrome-and-other-
conditions 
See ‘Practice Point: Antenatal Screening for Down Syndrome and 
Other Conditions’ (PMMRC 10th annual report).
The importance of timely registration has been promoted through the 
National Maternity Monitoring Group (NMMG). The 2015 NMMG 
Annual Report can be accessed at: http://www.health.govt.nz/
publication/national-maternity-monitoring-group-annual-report-2015
Achieving optimal use of periconceptual folate by young women in 
New Zealand requires a policy for fortification of bread.
The Ministry of Health advice to women planning to become 
pregnant is to take folic acid supplements and continue to do so 
when pregnant. There is voluntary fortification of bread by some 
manufacturers.
The National Screening Unit review the cost benefit of the current 
algorithms in the first and second trimester screening programme 
so they are calibrated for maximal sensitivity for all chromosomal 
abnormalities.
The National Screening Unit has commenced a project to provide 
feedback to radiology practitioners on the quality of nuchal 
translucency and crown rump length measurements. This project 
includes best practice guidelines for nuchal translucency and crown 
rump length measurements. Further information, including guidelines 
and videos, can be found at www.nsu.govt.nz. Further analysis is 
occurring on investigating new technology (non-invasive prenatal 
testing) to be included in publicly funded screening.
The National Screening Unit review false negative screening tests. The National Screening Unit is reviewing the cases not detected 
through screening (false negatives). This analysis includes a review 
of information provided for screening, including the completeness of 
information on request forms provided to the laboratory, the impact 
of changes to the measurements and any trends in demographic 
information of women.
The National Maternal Fetal Medicine Network regularly audit time 
from referral to review to ensure that the majority of women are 
seen within seven days as recommended.
The New Zealand Maternal Fetal Medicine Network completed an 
audit at Auckland DHB in 2015, which confirmed that almost all 
women who had their referral triaged for review in less than seven 
days were seen in this timeframe.
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
Sudden unexpected death in infancy (SUDI)
National guidelines should be developed for safe sleeping 
arrangements in postnatal wards to improve ward safety and 
to model safe sleeping practices that parents can follow after 
discharge.
The Ministry of Health will be updating its publication Preventing 
Sudden Unexpected Death in Infancy in 2017. See http://www.
health.govt.nz/your-health/pregnancy-and-kids/first-year/helpful-
advice-during-first-year/safe-sleep 
The Ministry of Health has published guidance on observation of 
mother and baby in the immediate postpartum period in 2012. 
This guidance supports safe sleeping in postnatal wards: http://
www.health.govt.nz/publication/observation-mother-and-baby-
immediate-postnatal-period-consensus-statements-guiding-practice 
Guidance on safe sleeping and the Pēpi-pod Sleep Space 
Programme is also available on the Change for Our Children 
website. See http://www.changeforourchildren.co.nz/pepi_pod_
programme
Access to perinatal investigation and supporting parents
The Ministry of Health should require DHBs to ensure all providers of 
maternity services provide support to parents, families and whānau 
who have experienced perinatal and maternal loss, including 
providing access to information, counselling and clinical follow-up.
The Ministry of Health requires DHBs to provide appropriate 
services to support parents, families and whānau who have 
experienced perinatal and maternal loss, including providing 
access to information for counselling and clinical follow-up. See 
http://nsfl.health.govt.nz/service-specifications/current-service-
specifications/maternity-service-specifications 
The 2015 Survey of Bereaved Women found that 74 percent 
of women were satisfied or very satisfied with the care they 
received. Most women surveyed stated that they had received 
enough information, care and support. The full survey can be 
found at: https://www.health.govt.nz/system/files/documents/
publications/2015-survey-of-bereaved-women-sep15.pdf
The low uptake of post-mortems amongst families who experience 
perinatal loss should be investigated.
The 2015 Survey of Bereaved Women looked at the information 
provided to women and their decisions about post-mortem 
examination.
The full report can be found at: https://www.health.govt.nz/
system/files/documents/publications/2015-survey-of-bereaved-
women-sep15.pdf
The reasons for the difference in rates of optimally investigated 
perinatal deaths between DHBs needs investigation.
DHBs with post-mortem rates less than 50 percent were asked 
to provide a progress update on their implementation of this 
recommendation.
DHBs reported that geographical distances, the length of time 
families are separated from their babies, and family cultural beliefs 
can all be barriers to parents agreeing to a post-mortem.
Further information to help families and whānau who are trying to 





Improved communication between primary and secondary services 
is required. A variety of means should be used such as women-held 
maternity notes, integrated notes systems and electronic transfer of 
information.
Both the NMMG and the Maternity Quality and Safety Programme 
are working towards improved communication between primary 
and secondary services.
Update 2017
The Maternity Clinical Information System was intended to assist 
clinicians and LMCs to collect accurate standardised data. The roll 
out of the Maternity Clinical Information System in DHBs has been 
problematic. A governance group is considering what shape this 
will take in the future.
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
Maternal mental health
Maternal mental health services should be integrated into maternity 
services.
Under the Ministry of Health’s Rising to the Challenge: Mental 
Health and Addiction Service Development Plan 2012–2017, the 
Ministry will work with providers to support service improvement 
and will report on implementation progress over the next five years. 
The Rising to the Challenge document is available online:
http://www.health.govt.nz/publication/rising-challenge-mental-
health-and-addiction-service-development-plan-2012-2017
Access should be provided to a mother and baby unit in the North 
Island.
Following on from the Healthy Beginnings report, a three-bed 
mother-and-baby unit was opened in the Child and Family Unit in 
Starship Hospital in Auckland. This is a valuable resource in the 
treatment of acutely unwell mothers with their babies (Ministry of 
Health 2012b). 
Services have also been developed and extended across the 
continuum of care, including increased resourcing of community 
mental health perinatal services, and extension of respite and non-
governmental organisation services. This includes 24-hour perinatal 
phone advice for general mental health services managing acute 
presentations of mothers.
Termination of pregnancy services should undertake holistic 
screening for maternal mental health and family violence and 
provide appropriate support and referral.
The services providing termination of pregnancy to women advise 
that they comply with the Standards of Practice for the Provision 
of Counselling laid down by the Abortion Supervisory Committee. 
These are monitored as part of re-licensing. See http://www.
abortionservices.org.nz/docs/guides98.pdf 
It was noted that there were minimal opportunities in relation to 
training in the field of post-termination of pregnancy counselling 
practice.
Maternal mortality
Seasonal or pandemic influenza vaccination is recommended 
for all pregnant women regardless of gestation and for women 
planning to be pregnant during the influenza season.
a. Vaccination is also recommended for maternity care 
providers to reduce the risk to the women and babies 
under their care.
b. The PMMRC recommends that the Ministry of Health 
consult with women and maternity care providers to 
address barriers to the uptake of influenza vaccination in 
pregnancy and implement strategies to increase access to 
and awareness of the benefit of vaccination.
Immunisation against influenza is specifically promoted to pregnant 
women and available to all pregnant women free of charge.
The Ministry of Health immunisation team annually provides 
information and resources to clinicians and the public to support this 
recommendation. 
The Health Promotion Agency immunisation programme theme for 
2016 was Protecting Baby Begins at Pregnancy. Further information 
is available at: https://www.healthed.govt.nz/resource/protecting-
baby-starts-pregnancy 
A survey was recently conducted amongst pregnant women and 
women who had given birth in the last 12 months to understand 
their knowledge and attitudes towards influenza. The survey 
included attitudes to immunisation against influenza and whooping 
cough, and enablers and barriers to immunisation in pregnancy. 
See the following website for more information: http://www.health.
govt.nz/publication/immunisation-pregnant-women-audience-
research-pregnant-women 
A website has also been developed to help midwives, nurses and 
childbirth educators to quickly and easily find useful information 
and resources about immunisation in New Zealand. See http://
learnonline.health.nz/ 
All pregnant women with epilepsy on medication should be 
referred to a physician.
a. Women with a new diagnosis of epilepsy or a change in 
seizure frequency should be referred urgently.
b. The PMMRC recommends a review of epilepsy in the 
Guidelines for Consultation with Obstetric and Related 
Medical Services (Referral Guidelines).
Update 2017
The Guidelines for Consultation with Obstetric and Related Medical 
Services (Referral Guidelines) are under review. Part of the review 
will be reviewing up-to-date evidence related to maternal epilepsy. 
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
Team approach to care
Women with complex medical conditions require a multidisciplinary 
approach to care, including a multidisciplinary management plan 
for the pregnancy, birth and postpartum period. This plan must be 
communicated to all relevant caregivers. Each woman requiring 
such care should be assigned a key clinician to facilitate her 
care. Pregnant women who are admitted to hospital for medical 
conditions not related to pregnancy need to have specific pathways 
for perinatal care.
The Ministry of Health expects maternity services (LMCs and DHBs) 
to ensure all women in New Zealand have access to continuity of 
maternity care, and for DHBs to ensure 95 percent of pregnant 
women in their region receive continuity of primary maternity care. 
As outlined in the New Zealand Maternity Standards, DHBs are 
also expected to provide or accommodate continuity of specialist 
secondary or tertiary care where possible. 
DHBs are required to staff appropriately under the primary, 
secondary and tertiary maternity facilities and services 
specifications. 





Information about support for pregnant women and their babies 





Women who are unstable or clinically unwell should be cared for 
in the most appropriate place within each unit in order for close 
observation to occur. When observations are abnormal, clear 
documentation, early review by a senior clinician and development 
of a detailed management plan are required
DHBs support this recommendation and advise that unstable or 
clinically unwell women are cared for in the most appropriate place 
within their hospital. They also indicated that detailed management 
plans are developed if observations are abnormal.
The Guidelines for Consultation with Obstetric and Related Medical 
Services (Referral Guidelines) were developed for LMCs and DHBs. 
The aim is to improve the safety and quality of maternity care and 
to ensure women are referred by their LMC to the most appropriate 
level of care for their particular condition.
Update 2017
The Guidelines for Consultation with Obstetric and Related Medical 
Services (Referral Guidelines) are under review. 
Investigation of maternal deaths
In maternal deaths, where the coroner declines jurisdiction, a post-
mortem should be offered as part of full investigation of cause of 
death.
DHBs have advised that in cases of maternal death where the 
coroner declines jurisdiction, a post-mortem is offered as part of full 
investigation of cause of death.
Neonatal encephalopathy 
Widespread multidisciplinary education is required on the 
recognition of neonatal encephalopathy. This should include:
a. recognition of babies at increased risk by their history 
b. signs suggestive of encephalopathy
c. knowledge of clinical pathways to induced cooling if 
required.
The Accident Compensation Corporation (ACC) has facilitated 
a cross-Ministry initiative to look at reducing the incidence of 
treatment injury by developing strategies to address the issues 
raised by the NEWG. 
See ‘Practice Point: Recognising the Baby at Risk of Neonatal 
Encephalopathy’ in the ninth report of the PMMRC: http://www.
hqsc.govt.nz/assets/PMMRC/Publications/PMMRC_Ninth_Report_
Practice_Points.pdf
That all DHBs review local incident cases of neonatal 
encephalopathy (Sarnat stages 2 and 3). 
The findings of these reviews should be shared at multidisciplinary 
local forum and form the basis of quality improvements as 
appropriate.
Most DHBs have advised they review local incident cases of 
neonatal encephalopathy, which are conducted at a multi-
disciplinary level to identify areas of learning and improvement. 
The Ministry of Health has advised the Maternity Quality and 
Safety Programme coordinators of this recommendation.
Arterial and venous cord gases should be performed on all babies 
born with an Apgar score <7 at one minute, and if neonatal 
encephalopathy is clinically suspected in the immediate hours 
after birth, early consultation with a neonatal paediatrician is 
recommended in order to avoid a delay in commencing cooling.
The Ministry of Health expects this recommendation will become 
part of ongoing professional development and will be discussed 
within each DHB maternity quality and safety programme.
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Recommendation PMMRC 1st – 9th reports Progress to date (June 2017)
Strategies to reduce neonatal encephalopathy include continually 
improving the standard of neonatal resuscitation by all health 
professionals involved in providing peripartum care.
Neonatal resuscitation is an annual continuing education 
requirement for all midwives.
The New Zealand Resuscitation Council provides training for 
clinicians to deliver newborn life support courses in their region or 
organisations. See http://www.nzrc.org.nz/training/ 
ACC has facilitated a cross-Ministry initiative to look at reducing the 
incidence of treatment injury by developing a strategy to address 
the issues raised by the NEWG.
In cases of neonatal encephalopathy (Sarnat stages 2 and 3): 
• all babies with encephalopathy should undergo 
investigation to predict prognosis, including formal 
neurological examination, cerebral magnetic 
resonance imaging (MRI) and, if available, formal 
electroencephalography (EEG)
• all parents of an affected child should have a formal 
discussion with the neonatologist/paediatrician providing 
care in order to review the prognosis and ongoing care of 
their child.
Most DHBs have advised that parents of babies with moderate or 
severe neonatal encephalopathy (Sarnat stages 2 and 3) have a 
formal discussion with the neonatologist/paediatrician providing 
care to review the prognosis and ongoing care of their child.
Update 2017 
All six Level 3 Neonatal Units advised that they use a formal tool 
to assist with the discharge examination for babies diagnosed with 
NE, either the Dubowitz examination or a modification of this. 
The practice was less consistent in the Level 2 Units. The barriers 
identified to the use of a formal tool included training in the use of 
the tool and interpretation of the findings given small numbers of 
babies diagnosed with NE in their DHBs.
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Recommendation No further update
Perinatal mortality 
Birth information
Continued support and funding is required for DHBs and LMCs for 
collection of complete perinatal mortality statistics.
This recommendation has been integrated into core work by the 
Ministry of Health.
All babies, whether stillborn or live born, should be assigned a 
National Health Index (NHI) at the time of birth.
All DHBs are now issuing NHIs to stillborn babies at time of birth.
Early booking
All women should commence maternity care before 10 weeks. This 
enables:
• opportunity to offer screening for congenital abnormalities, 
sexually transmitted infections, family violence and maternal 
mental health, with referral as appropriate
• education around nutrition, smoking, alcohol and drug use 
and other at-risk behaviour
• recognition of underlying medical conditions, with referral 
to secondary care as appropriate
• identification of at-risk women (maternal age, obesity, 
maternal mental health problems, multiple pregnancy, 
socioeconomic deprivation, maternal medical conditions). 
This recommendation has been integrated into core work by the 
NMMG.
Teenage mothers (<20 years old)
LMCs should be aware that teenage mothers are at increased risk 
of stillbirth and neonatal death due to preterm birth, fetal growth 
restriction and perinatal infection. Maternity services need to 
address this risk, paying attention to: 
• maternity care before 10 weeks
• smoking cessation, prevention of preterm birth, screening 
for fetal growth restriction
• antenatal education
• undertaking research on the best model of care
• engagement with the Ministry of Education regarding 
education in the school setting.
This recommendation has been integrated into core work by the 
NMMG.
Disparities 
Clinicians and LMCs should be aware that Pacific women, Māori 
women, women under 20 or over 40 years of age, and those 
women who live in areas of high socioeconomic deprivation are at 
higher risk of a perinatal death.
The Ministry of Health expects that this awareness will be promoted 
within each DHB’s maternity quality and safety programme.
Contributory factors and potentially avoidable perinatal deaths
Key stakeholders providing health and social services to women at 
risk should work together and identify:
• reasons for barriers to accessing maternity care
• interventions to address barriers. 
Clinical services and clinicians have the following responsibilities: 
• continuing education
• local review linked to quality improvement
• up-to-date policies and guidelines that are implemented and 
audited
• culture of teamwork
• culture of practice reflection on patient outcomes linked to 
quality improvement 
• staff arrangements ensuring timely access to specialist 
services.
Ministry of Health to develop a plan to translate these 
recommendations into clinical practice.
This recommendation has been integrated into core work by the 
NMMG.
Previous PMMRC recommendations that have been implemented 
PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: 11th ANNUAL REPORT 201
Recommendation No further update
Antepartum haemorrhage
All women with bleeding during pregnancy, regardless of the 
apparent cause, should be monitored more closely for fetal growth 
and preterm birth.
This recommendation has been integrated into core work by the 
Ministry of Health.
Multiple pregnancies
All women with a multiple pregnancy should be offered an 
early specialist consultation, including ultrasound diagnosis of 
chorionicity prior to 14 weeks gestation. 
Women with high-risk monochorionic multiple pregnancies require 
fortnightly scans and specialist care.
This recommendation is promoted through the Ministry of Health’s 
Maternity Quality and Safety Programme. All DHBs recognise that 
monochorionic multiple pregnancies require early specialist care 
and are high risk. 
Advice is available through the New Zealand Maternal Fetal 
Medicine Network. See http://www.healthpoint.co.nz/public/new-
zealand-maternal-fetal-medicine-network/?solo=otherList&index=5
Sudden unexpected death in infancy (SUDI) 
The Ministry of Health should prioritise the preparation and 
dissemination of a comprehensive statement for parents and 
caregivers on risk factors and methods of prevention of SUDI to be 
provided to pregnant women.




Support is required for national reporting of maternal deaths. The Ministry of Health funds DHBs in their reporting of mortality 
data and collection of complete perinatal mortality statistics.
Maternal mental health
Clinicians and LMCs should be encouraged to conduct antenatal 
screening and document any mental health history to identify 
women who are at increased risk of mental illness.
Midwives attend a mandatory Practice Day once every three years 
as part of the Midwifery Council’s Recertification Programme. One 
of the key topics included within the current Practice Day is maternal 
mental health. The focus of this education has been on the midwifery 
role of screening, identifying and referring women with mental 
health concerns. 
This recommendation has been revised and included in the practice 
point on maternal suicide: 
• Maternal mental health screening should be included as 
part of standard antenatal care.
See ‘Practice Point: Maternal Suicide’ on page 129.
Women with a previous history of serious affective disorder or 
other psychoses should be referred for psychiatric assessment and 
management even if well. 
Clinicians are reminded that the most common cause of maternal 
death in New Zealand is suicide.
This recommendation has been revised and included in the practice 
point on maternal suicide. 
• Maternal mental health screening should be included as 
part of standard antenatal care.
• Women with a previous history of serious affective disorder 
or other psychoses should be referred for psychiatric 
assessment and management even if they are currently well.
See ‘Practice Point: Maternal Suicide’ on page 129. 
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Recommendation No further update
The committee notes the publication of the Healthy Beginnings report 
in January 2012 and supports the recommendations with particular 
regard to the establishment of mother and baby units in the North 
Island and the importance of screening for a history of mental health 
disorders.
A comprehensive perinatal and infant mental health service 
includes:
• screening and assessment
• timely interventions including case management, transition 
planning and referrals 
• access to respite care and specialist inpatient care for 
mothers and babies 
• consultation and liaison services within the health system 
and with other agencies; for example, primary care and 
termination of pregnancy services. 
Midwives attend a mandatory Practice Day once every three years 
as part of the Midwifery Council’s Recertification Programme. 
One of the key topics included within the current Practice Day is 
maternal mental health. The focus of this education has been on the 
midwifery role of screening, identifying and referring women with 
mental health concerns. 
This recommendation has been revised and included in the practice 
point on maternal suicide: 
• Maternal mental health screening should be included as 
part of standard antenatal care.
See ‘Practice Point: Maternal Suicide’ on page 129.
Seatbelts during pregnancy
There is a need for greater public awareness of the importance 
of wearing a seatbelt during pregnancy. All pregnant women 
should know that three-point seatbelts should be worn throughout 
pregnancy, with the lap strap placed as low as possible beneath 
the ‘bump’, lying across the thighs, and the diagonal shoulder strap 
placed above the ‘bump’, lying between the breasts.




Health care practitioners should follow the evidence-based 
management of hypertension in pregnancy recommended by the 
Society of Obstetric Medicine of Australia and New Zealand.
This can be accessed at: https://somanz.org/documents/
HTPregnancyGuidelineJuly2014.pdf 
The Ministry of Health is funding the development of a 
multidisciplinary clinical guideline for the treatment of hypertension 
in pregnancy. This was a recommendation from the NMMG.
Postpartum haemorrhage
Acute obstetric units should develop a massive transfusion protocol 
to respond to major obstetric haemorrhage.
A national guideline for the treatment of postpartum haemorrhage 
has been developed and distributed to professional colleges and 
DHBs. This can be accessed at: http://www.health.govt.nz/
publication/national-consensus-guideline-treatment-postpartum-
haemorrhage
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Appendix B: List of Abbreviations 
ACC  Accident Compensation Corporation
AFE  Amniotic fluid embolism
AMOSS Australasian Maternity Outcomes Surveillance System
APH  Antepartum haemorrhage
BDM  Births, Deaths and Marriages
BMI  Body mass index (kg/m2)
CI  Confidence interval
CPR  Cardiopulmonary resuscitation
CTG  Cardiotocograph
CYMRC Child and Youth Mortality Review Committee
DHB  District health board
EEG  Electroencephalograph
FSH  Follicle-stimulating hormone
GAP  Growth Assessment Protocol
GP  General practitioner
HDU  High dependency unit
HIE  Hypoxic ischemic encephalopathy
ICSI  Intracytoplasmic sperm injection
ICU  Intensive care unit
IPPV  Intermittent positive pressure ventilation
IVF  In vitro fertilisation
LMC  Lead maternity carer
MAT  New Zealand National Maternity Collection
MBRRACE-UK Mothers and Babies: Reducing risk through audits and confidential enquiries across the  
  UK
MDAC  Maternal Deaths Assessment Committee
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MDT  Multidisciplinary training
MMR  Maternal mortality ratio
MMRWG Maternal Mortality Review Working Group
MMWG Maternal Morbidity Working Group
MRI  Magnetic resonance imaging
NE  Neonatal encephalopathy
NEWG  Neonatal Encephalopathy Working Group
NHI  National Health Index
NMDS  National Minimum Dataset
NMMG  National Maternity Monitoring Group
NZDep  New Zealand Index of Deprivation 
OR  Odds ratio
PMMRC Perinatal and Maternal Mortality Review Committee
PPH  Postpartum haemorrhage
PSANZ  Perinatal Society of Australia and New Zealand
PSANZ-NDC PSANZ neonatal death classification
PSANZ-PDC PSANZ perinatal death classification
RR  Relative risk
SAMM  Severe Acute Maternal Morbidity
Sands  Stillbirth and Newborn Death Support
SGA  Small for gestational age
SUDI  Sudden unexpected death in infancy
TOP  Termination of pregnancy
UK  United Kingdom
VTE  Venous thromboembolism
WHO  World Health Organization
PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: 11th ANNUAL REPORT 205
Appendix C: Definitions
Perinatal and infant mortality
Definitions of perinatal and infant mortality
Fetal death
Fetal death is the death of a fetus at 20 weeks gestation or beyond (≥20 weeks) or weighing at least 
400g if gestation is unknown. Fetal death includes stillbirth and termination of pregnancy. Note that the 
term ‘stillbirth’ does not include terminations in this report. Where a termination of pregnancy died after 
birth, the pregnancy is included as a termination of pregnancy and therefore as a fetal death rather 
than as a neonatal death.
Termination of pregnancy
Termination of pregnancy is the interruption of an ongoing pregnancy. This report only includes 
termination of pregnancy from 20 weeks gestation. 
Fetal death rate
Fetal death rate is calculated as fetal deaths per 1000 babies born at 20 weeks gestation or beyond or 
weighing at least 400g if gestation is unknown.
Neonatal death
Neonatal death is the death of any baby showing signs of life at 20 weeks gestation or beyond (for 
the purposes of this PMMRC dataset) or weighing at least 400g if gestation is unknown. Early neonatal 
death is a death that occurs up until midnight of the sixth day of life. Late neonatal death is a death that 
occurs between the seventh day and midnight of the 27th day of life.
(Adapted from New Zealand Health Information Service 2007 and Ministry of Health 2010)
Gestation Birth 7 days 28 days 1 year
























Neonatal death rate is calculated as neonatal deaths per 1000 live born babies at 20 weeks gestation 
or beyond or weighing at least 400g if gestation is unknown.
Perinatal mortality rate
Perinatal mortality rate is calculated in New Zealand as fetal deaths and early neonatal deaths per 
1000 total babies born alive or born dead at 20 weeks gestation or beyond, or weighing at least 
400g if gestation is unknown.
In some places, this report refers to a UK definition of perinatal mortality, which was developed for the 
surveillance of perinatal deaths in the UK and is based on the UK legal definition of stillbirths, which 
excludes deaths before 24 weeks gestation and terminations of pregnancy (CMACE 2011).
Perinatal related mortality rate
Perinatal related mortality rate refers to fetal deaths and early and late neonatal deaths per 1000 total 
babies born at 20 weeks gestation or beyond or weighing at least 400g if gestation is unknown.
International (WHO) perinatal mortality rates
International (WHO) perinatal mortality rates are recommended by the WHO (2006) to facilitate 
international comparison. These are rates of fetal death, neonatal death, perinatal mortality and 
perinatal related mortality of babies weighing ≥1000g, or ≥28 weeks if birthweight is unknown, 
per 1000 total births of babies ≥1000g, or ≥28 weeks if birthweight is unknown. Babies without 
birthweight or gestation are to be included if they have been registered.
Lethal and terminated fetal abnormalities
Lethal and terminated fetal abnormalities are all perinatal related deaths classified by the PSANZ 
perinatal death classification system as PSANZ-PDC 1 (congenital abnormality) and neonatal 
deaths classified by the PSANZ neonatal death classification system as PSANZ-NDC 1 (congenital 
abnormality).
Intrapartum stillbirth rate
Intrapartum stillbirth rate calculates deaths of babies of at least 24 weeks gestation without congenital 
abnormality who entered labour alive but then died during labour as a rate per 1000 births 24 weeks 
and beyond without lethal congenital abnormality.
Other definitions
Contributory factors
Contributory factors are defined as modifiable components of the health system and issues of quality of 
care that cover a broad spectrum of organisational and/or management factors, personnel factors, and 
barriers to access and/or engagement with care factors.
Customised birthweight centiles
Customised birthweight centiles adjust newborn weight for maternal weight, height, ethnicity and parity, 
as well as for infant sex and gestation at birth. For fetal deaths, the gestation at the time of estimated 
death (not birth) is used to calculate the birthweight centile. If gestation at death is unknown or gestation 
at death is <20 weeks or is seven days or more prior to birth, then customised centile is not calculated.
PERINATAL AND MATERNAL MORTALITY REVIEW COMMITTEE: 11th ANNUAL REPORT 207
Ethnicity
Mother and baby ethnicities for perinatal related deaths were collected from two sources: from 
information supplied to the BDM Registrar (with priority given to information in the birth registration 
over information in the death registration) and from rapid reporting forms completed by LMCs (eg, in 
cases where the death had not been registered by the time of analysis), with information from BDM 
taking priority over data from rapid reporting forms. In both instances, ethnicity was recorded as that 
identified by the mother/parents. The ethnicity in the deaths dataset (held by BDM) is not validated. 
Death registration forms are usually completed by either the parents or a funeral director.
Mother and baby ethnicities in the birth registration denominator set are those provided by the parent(s) 
to BDM at birth registration and are thus consistent with numerator data.
Mother and baby ethnicities in the MAT denominator set are ‘derived from ethnic codes reported to 
NMDS birth and postnatal events, LMC Labour & Birth claims and NHI at time of delivery. The 3 highest 
priority ethnic codes that reach a threshold proportion are stored in the Aggregated Pregnancy table’ 
(National Health Board Business Unit 2011).
Ethnicity has been reported as prioritised ethnicity. This method is frequently used in health statistics in 
New Zealand. Multiple ethnicities can be identified for both mother and baby. The PMMRC follows the 
guidelines in Ethnicity Data Protocols for the Health and Disability Sector (Ministry of Health 2004) for 
prioritising ethnicity. These protocols prioritised ethnicity into the following hierarchy: Māori, Pacific 
peoples, Indian, Other Asian, Other (including Other European and Not Stated), and New Zealand 
European. Indian has been identified as a separate ethnicity from Other Asian because New Zealand 
data suggest that pregnancies of Indian women are at higher risk than those of Other Asian women.
Where multiple ethnic groups are recorded for an individual the process prioritises minority ethnic 
groups that might otherwise be swamped by New Zealand European. In doing so, it does not allow 
individuals to identify a group with which they most feel affinity. It is a simple system that results in 
relatively few groups for analysis and, when used across different datasets, ensures a standardised 
process is used.
In 2015, mothers’ ethnicity for the PMMRC dataset of perinatal related deaths has been extracted, 
in order of priority, from BDM registration of birth (67 percent) or PMMRC rapid response forms (33 
percent). Babies’ ethnicity for the PMMRC dataset of perinatal deaths has been extracted, in order of 
priority, from BDM registration of birth (67 percent), BDM registration of death (6 percent) or PMMRC 
rapid response forms (27 percent).
In 2015, the denominator MAT dataset included two ethnicities for 27.0 percent of all babies registered 
compared with two ethnicities for 26.0 percent of mothers registered. The dataset included three 
ethnicities for 5.2 percent of babies and three ethnicities for 4.5 percent of mothers. 
Mother and baby ethnicity-specific perinatal related mortality rates have again been reported. 
Lead maternity carer (LMC)
Lead maternity carer (LMC) is defined as the practitioner or caregiver who provides a woman and 
her baby with continuity of care throughout pregnancy, labour and birth, and the postnatal period as 
described in the Section 88 Primary Maternity Services Notice 2007, Subpart DA.
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Neonatal encephalopathy
Neonatal encephalopathy is a clinically defined syndrome of disturbed neurological function within the 
first week of life in the full-term infant, manifested by difficulty in initiating and maintaining respiration, 
depression of tone and reflexes, subnormal level of consciousness, and often seizures.
New Zealand Index of Deprivation 2006 and 2013 (NZDep2006/2013)
The New Zealand Index of Deprivation 2006 and 2013 (NZDep2006/2013) is an area-based 
measure of socioeconomic deprivation based on variables from the Census of Population and Dwellings 
in 2006 and 2013 in New Zealand (Atkinson et al 2014; Salmond et al 2007).
The score is assigned according to maternal place of residence and is presented as a decile or quintile. 
Increasing deciles of deprivation, from least deprived at decile 1 to most deprived at decile 10, are 
associated with higher mortality and rates of many diseases (Atkinson et al 2014; Salmond et al 2007). 
Census area unit-level data are used throughout this 11th report (in previous reports meshblock unit 
level data were used). Generally, data are presented as quintiles rather than deciles so that individual 
categories are large enough for analysis.
NZDep2013 deciles have been assigned to births and deaths from 2013 while NZDep2006 has been 
used for previous years. It was not possible to assign NZDep2013 to deaths prior to 2013 as in 2013 
some areas split and the new areas for individuals in historical datasets were not available.
Place of birth
Place of birth is defined for the data collection as:
• home: a home environment does not have to be the mother’s own home
• birthing unit: stand-alone birthing centre
• hospital level 1: a hospital with no neonatal or caesarean section facilities
• hospital level 2: a hospital that is unable to provide long-term ventilation for babies
• hospital level 3: a hospital with full neonatal intensive care including facilities for long-term 
ventilation
• other: for example, car, ambulance
• not registered: the woman has not registered at any facility.
Potentially avoidable death
Potentially avoidable death is when the absence of a contributory factor may have prevented the death.
Registration with a lead maternity carer (LMC)
Registration with a lead maternity carer (LMC) is the process by which a woman selects her LMC. 
This generally occurs at the time of the first antenatal visit with the LMC. Upon registration the LMC 
assumes clinical responsibility for maternity care. Clinical responsibility for care may transfer from the 
LMC to another service or provider for example, if a woman’s condition warrants transfer of clinical 
responsibility to a specialist.
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Appendix D: Compiling the MAT Denominator and 
Numerator Data
1. Denominator MAT data (all babies born ≥20 weeks): The MAT is a dataset based on mothers. For 
reporting, the PMMRC requires a dataset based on babies. To create a MAT denominator dataset 
with the correct number of babies, the ‘Delivery outcome’ field for each MAT mother was used as 
an indicator of the number of babies who should be in the denominator dataset. For example, if 
the delivery outcome variable was ‘Twin’, then two babies were expected. ‘Other multiple’ was 
assumed as three babies. This method was modified (and overridden) in cases where a MAT mother 
was linked by NHI to a PMMRC dataset mother, and the PMMRC data were then used to determine 
the number of expected babies. An ‘entry’ or ‘baby’ was added for each expected baby. If there 
was no MAT baby linked where a baby was expected, then a baby was created with no MAT baby 
data (but with mother data from the delivery or mother set). If there were more babies in the MAT 
baby set than expected, only the expected number of babies was kept in the dataset (except if these 
were perinatal death babies who were always kept in the set). If there were no ‘Delivery outcome’ 
data for a mother, then one baby was expected and this baby was created, again without MAT 
baby data but including mother data.
2. Numerator (perinatal related deaths): The PMMRC asked the Ministry of Health to assist to 
merge the PMMRC perinatal related deaths with their MAT mother and baby records so that the 
consistency of data in the PMMRC data collection and in the MAT dataset could be examined. 
The MAT consists of two sets, one of mothers and another of babies. Stillborn babies are often not 
included in the MAT dataset and so need to be matched to a mother record. 
a. Mothers of babies who died in the perinatal period (PMMRC dataset) were matched to mothers 
in the MAT set (delivery dataset) by matching the mother NHI and the date of birth allowing a 
28-day window either side of the recorded date of birth. 
b. Perinatal death babies (PMMRC dataset) were matched to MAT babies (birth set) by matching 
the baby NHI. 
c. Perinatal death babies (PMMRC dataset) were then matched to the mother MAT set (delivery 
dataset) using the matched PMMRC mother; that is, babies with no MAT birth (baby) dataset 
record were matched to their mother using the mother NHI. 
This process of matching resulted in a PMMRC to MAT match of 5783/5993 for 2007–2015 
(96.5%) of PMMRC perinatal death babies.
3. The following are some specific limitations to the use of the MAT dataset.
a. Deaths are included in the numerator set based on their year of death (as previously), but births 
are included in the MAT denominator according to their year of birth. Some babies are born 
in one year and die in the next, creating a numerator–denominator mismatch. For the purposes 
of these analyses, deaths will remain in the year of their death (to be comparable to previous 
years).
b. More than 90 percent of the smoking and BMI data are missing from the MAT dataset in 2007.
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c. As the PMMRC deaths have been merged where possible with records in the MAT dataset, 
data are now available from both the PMMRC dataset and the MAT denominator dataset 
for the mothers and babies of perinatal related deaths. It is therefore possible to examine the 
consistency of some of the collected data fields. Some variables have systematically different 
measurements in the PMMRC dataset compared to the MAT set; for example, BMI and smoking 
are systematically higher and more common in the PMMRC set than in the MAT set for the 
mothers of babies who died in the perinatal period. MAT data have therefore been used for the 
numerator as well as the denominator for BMI and smoking to avoid numerator–denominator 
bias (and as a consequence, the analysis is limited to mothers and babies where there was a 
successful match). For other variables (eg, parity) where the MAT and PMMRC data are variably 
inconsistent but not systematically different, the PMMRC data are used for the numerator deaths 
data because we believe these have been checked for accuracy more thoroughly than the MAT 
dataset and because it means all babies can be included in the analyses. 
d. Not all registration data are provided to the MAT (specifically, BMI, parity and smoking are 
missing for some mothers provided primary maternity care by DHBs). 
e. BMI in the MAT dataset is a numerical variable without decimal points. Individual women’s 
height and weight were not available for the analysis this year. As BMI has been rounded in the 
MAT dataset, a BMI of 20 in this dataset actually means that the calculated BMI fell between 
19.5 and 20.4. To allow for this, the WHO categories have been modified slightly (see Table 
3.7).
f. Smoking data are collected at time of death in the PMMRC dataset but at time of registration 
with an LMC and at two weeks postpartum in the MAT dataset.
g. Gestational age, birthweight, parity, and plurality data for perinatal related deaths have been 
defined from the PMMRC dataset. 
h. There are differences in the ethnicity defined for mothers and babies between the PMMRC 
dataset and the MAT dataset. In this report, ethnicity for perinatal related deaths has been 
defined by the data in the PMMRC dataset (primarily obtained from BDM registration). 
Denominator ethnicity is that defined in the MAT dataset. Ethnicity in the MAT is ‘derived from 
ethnic codes reported to NMDS birth and postnatal events, LMC Labour & Birth claims and NHI 
at time of delivery. The 3 highest priority ethnic codes that reach a threshold proportion are 
stored in the Aggregated Pregnancy table’ (National Health Board Business Unit 2011). Further 
analysis of the impact of differences in the collection and output of ethnicity data can be found in 
chapter 5.
i. In the MAT set, only census area unit based deprivation score is available as a measure of 
residence based deprivation. Previously, mesh block based deprivation score was used in 
PMMRC analyses. Census area units are larger than mesh blocks. Census area unit based 
deprivation score will be used for both numerator and denominator so that rates can still be 
presented.
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Appendix F: PMMRC DHB Local Coordinators (April 2017)
DHB DHB Local Coordinator Contact details
Northland Yvonne Morgan Clinical Charge Midwife  
Dr Kristy Wolff Obstetrician
Whangarei Hospital
Waitemata Dr Sue Belgrave Clinical Director of Obstetrics 




Auckland Professor Lesley McCowan Obstetrician 
Debbie Greenwood Midwife
Auckland City Hospital
Counties Manukau Dr Sarah Wadsworth Obstetrician 
Debbie Davies Midwife
Middlemore Hospital
Waikato Dr Sarah Waymouth Obstetrician  
Dr Isobel Camano Obstetrician 
Tracey Williams Midwife
Waikato Hospital
Bay of Plenty Margret Norris Midwife Leader Tauranga Hospital
Lakes Amanda Griffiths Midwife Rotorua Hospital
Tairawhiti Sheila Noakes Midwife Gisborne Hospital
Taranaki Belinda Chapman Midwife 
Laura Scholey Midwife
Taranaki Base Hospital
Hawke’s Bay Dr Lynda Croft Obstetrician 
Sara Paley Midwifery Educator
Hawke’s Bay Hospital
Whanganui Lucy Pettit Midwife 
Jo McDonnell Midwife
Whanganui Hospital
MidCentral Carole Collins Midwife Educator 
Dr Steven Grant Consultant Obstetrician
Palmerston North Hospital
Wairarapa Michelle Thomas Midwife Masterton Hospital
Capital & Coast Dr Rose Elder Consultant Obstetrician 
Hazel Irvine Midwife
Wellington Hospital
Hutt Valley Eleanor Martin Midwife 
Christine Hiess Midwife
Hutt Hospital
Nelson Marlborough Lois McTaggart Clinical Midwife Leader 
Graham Cross Clinical Midwife Manager
Nelson Hospital 
Wairau Hospital
West Coast Denise Stacey Midwife Grey Base Hospital
Canterbury Dianne Leishman Midwife 
Sonya Matthews Midwife
Christchurch Women’s Hospital
South Canterbury Teresa Back Midwife Timaru Hospital
Southern Jenny Humphries Director of Nursing and Midwifery 
Sheridan Massey Midwife  
Tracey Morris Midwife 
Dr Jana Morgan Obstetrician 
Meggan Zsemlye Obstetrician
Dunedin Hospital
Southland Hospital
